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  Foreword 
 
 
In a few months, the international community will commemorate 100 years of 
international drug control.  
A hundred years ago, substances that are internationally controlled today were 
unregulated and widely abused. The consumption of opiates in China alone was 
estimated to be more than 3,000 tons in morphine equivalent, far in excess of global 
consumption, both licit and illicit, today. In the United States, about 90 per cent of 
narcotic drugs were used for non-medical purposes. As drug abuse spread, an 
increasing number of people became familiar with the wretchedness, misery and 
evil connected with that affliction. 
The International Opium Commission, convened in Shanghai in 1909, brought an 
end to decades of indifference towards drug problems and is rightly regarded as 
having laid the foundation for the current international drug control system. From it, 
an international treaty system was created and expanded over the decades that 
followed. Today, the three main international drug control treaties form the 
foundation of that system: the Single Convention on Narcotic Drugs of 1961, the 
Convention on Psychotropic Substances of 1971 and the United Nations Convention 
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988.  
With over 95 per cent of Member States being parties to the international drug 
control conventions, multilateral drug control should be considered one of the 
greatest achievements of the twentieth century.  
For its part, the International Narcotics Control Board has managed, for the past 
40 years, a global control system that has continuously expanded. The number of 
internationally controlled substances has increased from a few dozen to more than 
200 today. In addition, national legitimate requirements for narcotic drugs and 
psychotropic substances have soared.  
Despite the ever-increasing scope of the international drug control system, 
diversions of narcotic drugs from the licit to the illicit market are virtually non-
existent. While diversions of psychotropic substances occur, the implementation of 
the 1971 Convention has resulted in a substantial reduction in the prescription of 
barbiturates and other hypnotics. The success of international cooperation in 
controlling the licit manufacture of and trade in narcotic drugs and most 
psychotropic substances has forced traffickers to resort to illicit drug manufacture.  
However, to pretend that challenges do not exist would be to deny reality. One such 
challenge is ensuring the availability of narcotic drugs used for medical purposes. 
For years, the Board has called on Governments to fulfil that treaty obligation and 
make the availability of drugs a priority public health issue. Nevertheless, large 
discrepancies in the consumption of those medicines remain. As a result of the 
underutilization of these drugs in many countries, the World Health Organization 
(WHO) estimates that perhaps as many as 86 million persons suffer from untreated 
moderate-to-severe pain each year. The problems behind this phenomenon are 
complex and defy simplistic solutions. Together with WHO, the Board has 
developed the Access to Controlled Medications Programme, which addresses the 
causes of the problems and assists Governments in their endeavours to prevent 
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unnecessary suffering. I encourage Governments to make use of the Programme to 
improve the availability of drugs for medical purposes, where appropriate. 
The treatment of addicts remains a difficult medical task. Such treatment should be 
carried out in line with sound medical practice and should not be used as an 
instrument to establish or maintain social control. Much attention has been paid 
recently to drug substitution programmes, which were initially developed as a last 
resort for those drug abusers who, for a variety of reasons, had not succeeded in 
overcoming their dependence through the use of other treatment modalities. While 
these programmes have their place in drug control policy, they should not 
necessarily be regarded as the ultimate goal but as an interim stage that would 
eventually lead to the development of a healthy, drug-free lifestyle. Moreover, drug 
substitution programmes should be supported by psychosocial care. The Board 
agrees to the use of substitution therapy in the treatment of drug dependence, always 
providing that this is delivered with appropriate medical supervision and can be 
reconciled with adequate measures to prevent abuse and diversion. Governments 
must also seriously address the other questions of demand reduction, particularly 
drug abuse prevention. We should recall the clear message of the twentieth special 
session of the General Assembly, held in 1998: drugs represent a danger for our 
societies, and drug control, control of both demand and supply, is the shared 
responsibility of all nations. 
The international community may wish to review the issue of cannabis. Over the 
years, cannabis has become more potent and is associated with an increasing 
number of emergency room admissions. Cannabis is often the first illicit drug that 
young people take. It is frequently called a gateway drug. In spite of all these facts, 
the use of cannabis is often trivialized and, in some countries, controls over the 
cultivation, possession and use of cannabis are less strict than for other drugs.  
Drug regulations are not a panacea. Regulations alone cannot eliminate illicit drug 
trafficking and abuse. I can therefore understand that the following question is often 
raised: Would it would be more economical to do away with all drug regulations and 
leave it to market forces to regulate the situation? I believe that this is the wrong 
question, similar to questioning whether it is economical to try to prevent car 
accidents or to treat infectious diseases. History has shown that national and 
international control of drugs can be effective and it is therefore the choice to be 
made. 
 
 
 
 
 
Hamid Ghodse 
President 
International Narcotics Control Board 
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 I. The international drug control conventions: history, achievements and 
challenges 
 
 
1. The focus of the present chapter is the origins of 
international drug control, in particular how it has 
evolved in the course of the twentieth century. The 
chapter also includes a discussion of the challenges 
currently facing the international community in 
applying the conventions, how Governments are 
responding to them and what further action they might 
wish to take. 
2. The historical development of international drug 
control is viewed through the lens of an increasingly 
globalized world, over a century that has seen the 
massive growth and transformation of commerce, 
finance, transport and communications. The falling 
away of barriers to trade and communications has 
contributed significantly to human development and 
brought immense benefits to society, but those benefits 
have been distributed unevenly. Poverty and economic 
inequality, the scarcity of vital resources, conflict, 
environmental degradation and climate change have 
created new tensions, and the most vulnerable sectors 
of society have been hit the hardest. Those factors in 
turn have created new challenges for the 
implementation of international drug control. 
3. Some of the challenges discussed in this chapter 
fall under the explicit authority of the conventions; 
other challenges were not envisaged at the time the 
conventions were being drawn up, yet they affect the 
capacity of Governments to implement the 
conventions. Those challenges include:  
 (a) Health-related challenges: how to ensure 
adequate availability of narcotic drugs and 
psychotropic substances to meet medical and scientific 
requirements for pain relief and for the treatment of 
drug-related health problems;  
 (b) Legal challenges: how to deal with differing 
interpretations and the implementation of the 
conventions;  
 (c) The challenge of drug abuse prevention: 
how to identify and disseminate reliable programmes 
and best practices that deter young people and other 
vulnerable segments of society from experimenting 
with drugs; 
 (d) The challenge of globalization: how to deal 
with the costs and benefits of globalization within the 
international drug control system. 
 
 
 A. History 
 
 
4. Drug control developed during a long process of 
global change and movement. The congresses of 
Westphalia (1648), Utrecht (1713) and Vienna (1814-
1815) created a series of international norms, such as 
the juridical equality of all States and the principle that 
each State was sovereign within its own territory. A 
consensus also emerged on the need for a balance of 
power. The growth of a body of international law and 
diplomacy led to the formation of the League of 
Nations and ultimately the United Nations. At the same 
time, international institutions were gradually 
established for financial and trade cooperation, boosted 
by the growth of trade in manufactured goods and by 
the increasing expansion and mobility of private 
capital.  
5. The introduction of controls over the opium trade 
in the early twentieth century occurred due to an 
exceptional confluence of interests of three important 
nations at that time. China, Great Britain and the 
United States of America all had different reasons for 
wishing to curb the opium trade: the Government of 
China, which had long resisted the importation of 
opium from India by the British, began a renewed 
campaign against domestic opium smoking and 
production. The Government of the United States 
wished to introduce laws against smoking opium on its 
territory and in homes to put an end to the smuggling 
of opium from the Philippines (which it had occupied 
in 1898). In Great Britain, the newly elected Liberal 
Government, strongly backed by the church-inspired 
anti-opium movement, began to reverse the pro-opium 
trade policies of previous Governments. The 
momentum brought 13 States together to discuss 
international drug control for the first time at the 
International Opium Commission, convened in 
Shanghai, China, in February 1909. The 
recommendations made in Shanghai were enshrined in 
the first legally binding, multilateral treaty of its kind 
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three years later: the International Opium Convention 
signed at The Hague on 23 January 1912.1 
6. Parties to the 1912 Convention agreed to control 
the production and distribution of opium and to impose 
limits on the manufacture and distribution of certain 
drugs; a mandatory system of record-keeping was 
imposed. The principle of drug use only for medical 
and scientific purposes was enshrined in international 
law for the first time. Germany, with backing from 
France and Portugal, insisted that all States should 
ratify the 1912 Convention before it could enter into 
force; however, the ensuing delay meant that the 
Convention entered into force only after the First 
World War, when ratification was incorporated into the 
1919 Treaty of Versailles. 
7. In 1920, international drug control came under 
the auspices of the League of Nations, and further 
international drug control treaties were enacted. The 
International Opium Convention signed at Geneva on 
19 February 19252 introduced many provisions that 
were later incorporated into the Single Convention on 
Narcotic Drugs of 1961,3 such as the furnishing of 
statistics on the production and stocks of opium and 
coca leaf, the system of import certificates and export 
authorizations for licit international trade in controlled 
drugs and controls over “Indian hemp”, as cannabis 
was known. The Convention for Limiting the 
Manufacture and Regulating the Distribution of 
Narcotic Drugs, signed at Geneva on 13 July 1931,4 
limited world manufacture of narcotic drugs to the 
amounts needed for medical and scientific purposes by 
introducing a mandatory system of estimates. The 
Convention of 1936 for the Suppression of the Illicit 
Traffic in Dangerous Drugs,5 signed at Geneva, was 
the first treaty explicitly targeting international drug 
trafficking, but it was signed by only 13 States and had 
limited impact because it entered into force in 1939, 
when the Second World War began. The Protocol for 
Limiting and Regulating the Cultivation of the Poppy 
Plant, the Production of, International and Wholesale 
Trade in, and Use of Opium,6 done at New York on 
__________________ 
 1 League of Nations, Treaty Series, vol. VIII, No. 222. 
 2 Ibid., vol. LXXXI, No. 1845. 
 3 United Nations, Treaty Series, vol. 520, No. 7515. 
 4 League of Nations, Treaty Series, vol. CXXXIX, 
No. 3219.  
 5 Ibid., vol. CXCVIII, No. 4648. 
 6 United Nations, Treaty Series, vol. 456, No. 6555. 
23 June 1953 under the auspices of the United Nations, 
introduced strict provisions on the consumption, 
production, export and stockpiling of raw opium, but 
did not enter into force until after the signing of the 
1961 Convention, which superseded it. 
8. The function of the 1961 Convention was to 
merge all existing multilateral treaties in the drugs 
field, to streamline the mechanisms of drug control and 
to extend the existing control system to the cultivation 
of plants grown as the raw material of narcotic drugs. 
Its aim, as with the previous treaties, was to ensure the 
provision of adequate supplies of narcotic drugs to be 
used for medical and scientific purposes, to prohibit all 
non-medical consumption of such drugs and to prevent 
the diversion of such drugs into the illicit market. The 
1972 Protocol amending the Single Convention on 
Narcotic Drugs of 19617 called for increased efforts to 
prevent the illicit production of, traffic in and use of 
narcotic drugs and to provide treatment and 
rehabilitation services for drug abusers. 
9. During the 1950s, concerns began to emerge 
about amphetamine and barbiturate abuse and the 
overprescription of sedatives and hallucinogens. Those 
issues were discussed by the World Health 
Organization (WHO) and by the Commission on 
Narcotic Drugs starting in the early 1960s. While there 
was agreement over the need to bring those substances 
under greater control, there was disagreement over 
whether to place them under the control of the 
1961 Convention or create a new treaty. There were 
fears of diluting the impact of the 1961 Convention and 
of deterring prospective parties from ratifying the 
Convention by adding a large number of substances to 
the list of controlled drugs. Moreover, many of the 
substances that needed to be brought under control 
were contained in pharmaceutical preparations that 
were being prescribed on a very large scale. The 
question of the dependence-producing effects of 
hallucinogens was also under debate. 
10. The Convention on Psychotropic Substances of 
19718 dealt with a more heterogeneous range of 
substances than the 1961 Convention and its 
scheduling arrangements also differed. In the 
1971 Convention, as in the 1961 Convention, 
substances were classified into four schedules 
__________________ 
 7 Ibid., vol. 976, No. 14151. 
 8 Ibid., vol. 1019, No. 14956. 
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according to their potential therapeutic use and their 
liability to abuse; however, the so-called “similarity 
concept” appearing in article 3 of the 1961 Convention 
– that every new substance that is “liable to similar 
abuse and productive of similar ill effects” as 
substances already controlled by the Convention is 
brought under the same degree of control as those 
substances – did not appear in the 1971 Convention. 
That has led to more complicated evaluation 
procedures and delays in scheduling, as the 
International Narcotics Control Board has noted in the 
past.9 Essentially, under the 1961 Convention narcotic 
drugs were considered hazardous until it was proved 
that they were not; psychotropic drugs remained 
uncontrolled unless WHO advised that there was 
“substantial evidence” that they were liable to abuse or 
constituted a public health and social problem that 
would warrant their placement under international 
control.10 The system of estimates was excluded from 
the 1971 Convention in the interests of the 
pharmaceutical manufacturing States, although that and 
many other gaps were corrected subsequently through 
recommendations made by the Board and sanctioned 
by the Economic and Social Council in its resolutions. 
A slower rate of accession meant that after it was 
opened for signature, the 1971 Convention took almost 
six years to enter into force, compared with less than 
four years for the 1961 Convention. 
11. The scheduling arrangements for both the 
1961 Convention and the 1971 Convention contain 
inconsistencies from a scientific perspective: cannabis 
and cannabis resin are narcotic drugs while some of 
their active ingredients are psychotropic substances 
and fall under a weaker control system. Coca leaf and 
cocaine are both narcotic drugs but amphetamines that 
have similar stimulating effects are psychotropic 
substances. No plant material is controlled under the 
1971 Convention; thus, the raw materials khat and 
ephedra remain uncontrolled, while their derivatives 
cathinone and ephedrine are controlled under the 
1971 Convention and the United Nations Convention 
__________________ 
 9 Effectiveness of the International Drug Control Treaties: 
Supplement to the Report of the International Narcotics 
Control Board for 1994 (United Nations publication, 
Sales No. E.95.XI.5), para. 65. 
 10 István Bayer, “Genesis and development of the 
international control of psychotropic substances”, paper 
prepared for the National Institute on Drug Abuse, 
United States of America, 1989, pp. 42-43. 
against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988,11 respectively.  
12. The 1988 Convention was perceived as necessary 
because of the growing transnational organized crime 
and drug trafficking and the difficulties of pursuing 
persons involved in drug-related crime and money-
laundering at the international level, issues that the 
1961 Convention and the 1971 Convention had not 
addressed in any detail. The aims of the 
1988 Convention were to harmonize the definition and 
scope of drug offences at the global level; to improve 
and strengthen international cooperation and 
coordination among the relevant authorities; and to 
provide them with the legal means to interdict 
international drug trafficking more effectively. 
Compared with the other two conventions, the 1988 
Convention is a more practical, “hands-on” legal 
instrument, with specific recommendations on the use 
of law enforcement techniques. It entered into force 
less than two years after it was opened for signature. 
 
 
 B. Achievements 
 
 
13. The international control system for narcotic 
drugs and psychotropic substances can be considered 
one of the twentieth century’s most important 
achievements in international cooperation: over 95 per 
cent of the Members of the United Nations 
(representing 99 per cent of the world’s population) are 
States parties to the three conventions. The number of 
substances controlled under the 1961 Convention and 
the 1971 Convention has risen steadily over the years: 
there are currently 119 narcotic drugs and 
116 psychotropic substances under international 
control. At the same time, demand for narcotic drugs 
and psychotropic substances has soared: for example, 
global consumption of morphine rose from less than 
5 tons in 1987 to 39.2 tons in 2007.12 Despite this, no 
cases involving the diversion of narcotic drugs from 
international trade were detected in 2007 and no cases 
involving the diversion of psychotropic substances in 
Schedules I or II from international trade have been 
__________________ 
 11 United Nations, Treaty Series, vol. 1582, No. 27627. 
 12 Narcotic Drugs: Estimated World Requirements for 
2009; Statistics for 2007 (United Nations publication, 
Sales No. E/F/S.09.XI.2). 
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detected since 1990,13 although overprescription, theft 
and diversion continue to occur at domestic level.  
14. The 1971 Convention was less successful in the 
beginning, for the reasons outlined above and because 
the majority of psychotropic substances are essential 
ingredients of widely consumed prescription drugs. 
However, improvements in control procedures, 
resulting from Economic and Social Council 
resolutions, have succeeded in preventing the diversion 
of substances in Schedule III or IV from international 
trade. The resolutions have also led to improved 
prescribing practices, particularly with regard to 
barbiturates and other hypnotics, while article 13 of the 
1971 Convention has provided parties with a legal 
basis for bilateral and multilateral cooperation and 
action against diversion. The 1988 Convention has 
facilitated the implementation of measures such as 
judicial cooperation, extradition, controlled deliveries 
and measures against money-laundering. It has also 
made it mandatory for States to control and monitor 
certain precursors, chemicals and solvents frequently 
used in illicit drug manufacture and has facilitated 
communication between Government authorities to 
identify suspicious transactions and prevent diversion.  
15. As reported by the United Nations Office on 
Drugs and Crime (UNODC) in 2008, progress has been 
made towards achieving the goals set in 1998 by the 
General Assembly at its twentieth special session. In 
the period 1998-2007, the number of countries affected 
by illicit drug crop cultivation was reduced; however, 
where such cultivation continues to occur, the 
problems have become more acute for the population 
as a whole. A prime example of this is Afghanistan, 
where opium is increasingly processed into morphine 
or heroin and where there has been an upsurge in 
cannabis cultivation. Afghanistan’s problems are not 
caused by illicit drug crop cultivation but in many 
respects they are aggravated by it, and they form part 
of a cycle of conflict and instability that is proving 
hard to break. Ongoing security problems, together 
with poor transport infrastructure, corruption and the 
lack of viable markets for alternative products have 
limited opportunities for sustained alternative 
economic development.  
__________________ 
 13 Report of the International Narcotics Control Board for 
2007 (United Nations publication, Sales No. E.08.XI.1), 
paras. 77 and 107. 
16. Progress has also been slow in parts of Oceania. 
Not all States in that region have acceded to the 
international drug control conventions. Africa is the 
region that made the least progress over the 10-year 
period 1998-2007. In that region, a series of complex 
developments, including political instability, weak 
monitoring capabilities, environmental degradation, 
economic underdevelopment and disadvantages 
resulting from subsidies given by developed countries 
to domestic agricultural and commodities markets, 
have caused a low level of implementation in all areas 
of drug control.  
 
 
 C. Challenges 
 
 
 1. Health challenges 
 
17. The international drug control conventions, 
backed by the Declaration on the Guiding Principles of 
Drug Demand Reduction,14 obliges parties to take 
steps to protect the health and welfare of their 
populations. Governments must ensure the provision of 
narcotic drugs and of psychotropic substances for 
medical and scientific purposes; they must take all 
practicable measures to prevent and reduce or 
eliminate drug abuse, to provide services for the 
treatment and rehabilitation of drug abusers and to 
establish effective measures to reduce the adverse 
health and social consequences of drug abuse. Meeting 
those obligations constitutes a major challenge for all 
Governments, but it is particularly difficult for less 
developed countries, whose Governments are often 
struggling to provide primary health care for their 
populations.  
18. When the 1961 Convention and the 
1971 Convention were drawn up, neither HIV nor the 
hepatitis C virus had been identified, and no reference 
is made in those conventions to the problem of blood-
borne infections associated drug abuse by injection. 
That link was identified by international health 
authorities only in the mid-1980s. Governments were 
subsequently encouraged to expand treatment capacity 
and to take measures to limit the transmission of 
blood-borne diseases, in order to deal with that 
__________________ 
 14 Adopted by the General Assembly at its twentieth 
special session in 1998 (Assembly resolution S-20/3, 
annex), the Declaration outlines the priority policies and 
strategies for reducing the demand for drugs worldwide. 
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problem.15 The 1988 Convention, primarily an 
international criminal law treaty, makes only generic 
references to health issues, requiring parties to adopt 
appropriate measures aimed at eliminating or reducing 
illicit demand for narcotic drugs and psychotropic 
substances, with a view to reducing human suffering 
(art. 14, para. 4). In the mid-1980s, some 
Governments, faced with increasing problems 
involving drug abuse by injection, viewed “harm 
reduction” as a pragmatic response, if not a solution, to 
those problems, and began to introduce measures to 
deal with that challenge.16 It was not until 1998, when 
the Declaration on the Guiding Principles of Drug 
Demand Reduction was adopted, that specific 
international policy guidelines were introduced to 
reduce the demand for drugs and reduce the adverse 
consequences of drug abuse to individuals and to 
society.  
19. Additional challenges have been created by the 
rising cost of health care in developed and developing 
countries. Developing countries have been particularly 
affected by HIV/AIDS, which in turn has been linked 
to a resurgence of tuberculosis, and malaria continues 
to afflict many parts of the globe. In developed 
countries, the ageing of populations, together with low 
birth rates, has reduced the share of the working 
population with respect to the population of retired 
persons, causing problems for health-care funding. 
Widespread recourse to so-called “lifestyle drugs”, 
relating to obesity, sexual performance and stress-
related conditions, has also caused health problems in 
many regions. Individuals in all walks of life are 
increasingly looking to drugs, whether prescribed or 
illicitly acquired, as a palliative for the problems of the 
modern world. 
__________________ 
 15 Report of the International Conference on Drug Abuse 
and Illicit Trafficking, Vienna, 17-26 June 1987 (United 
Nations publication, Sales No. E.87.I.18), chap. I, 
sect. A, “Comprehensive Multidisciplinary Outline of 
Future Activities in Drug Abuse Control”, target 33, 
para. 389. 
 16 There is no universally agreed definition of harm 
reduction; however, it is generally taken to mean a range 
of practical measures and policies that are aimed at 
reducing the negative consequences of drug abuse and 
that do not necessarily include abstinence. The Board 
believes that the goal of any programme to prevent drug 
abuse should be abstinence. 
20. The primary objective of the 1961 and 
1971 Conventions is to ensure the availability of 
controlled drugs for medical and scientific purposes 
and to prevent the non-medical use of those drugs. 
Access to narcotic drugs such as morphine and 
codeine, both on the WHO Model List of Essential 
Medicines, is considered by WHO to be a human right 
as defined by the International Covenant on Economic, 
Social and Cultural Rights (General Assembly 
resolution 2200 A (XXI), annex).17 Yet, according to 
WHO, access to controlled medicines is non-existent, 
or almost non-existent, in over 150 out of the 
193 member States of WHO, while almost 90 per cent 
of controlled medicines are consumed in Europe and 
North America. It is estimated, with a wide margin of 
uncertainty, that perhaps as many as 86 million persons 
suffer from untreated moderate-to-severe pain 
annually.18 
21. The Board has long been concerned that, despite 
the existence of plentiful supplies of opiate raw 
materials to meet global needs, many Governments do 
not ensure the wider availability of the essential 
medicines that derive from them.19 Even in countries 
that grow the raw materials from which those 
medicines are derived, it can happen that less than 
1 per cent of the population has access to appropriate 
pain relief.  
22. The reasons are varied and complex and may 
relate to longstanding cultural traditions. In many 
countries, medical schools provide little or no training 
in palliative medicine; tight restrictions and excessive 
paperwork deter doctors from prescribing opioids, and 
fears persist among patients and clinical staff alike 
with regard to the addictive potential of opioids – 
largely without foundation when administered under 
__________________ 
 17 “General Comment No. 14 (2000): the right to the 
highest attainable standard of health (article 12 of the 
International Covenant on Economic, Social and 
Cultural Rights)” (E/C.12/2000/4, 11 August 2000), 
para. 17. 
 18 World Health Organization, Access to Controlled 
Medications Programme: Biennial Report 2006-2007 
(Geneva, 2008), pp. 1-2. 
 19  Report of the International Narcotics Control Board for 
1999 (United Nations publication, Sales No. E.00.XI.1), 
paras. 30 and 40. 
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medical supervision in the treatment of moderate-to-
severe pain.20 
23. In order to deal more effectively with this 
challenge, in 2005 the World Health Assembly, in its 
resolution WHA 58.22, and the Economic and Social 
Council, in its resolution 2005/25, called on WHO to 
improve access to opioid analgesics. That led to the 
creation of the Access to Controlled Medications 
Programme, an initiative in which the Board is an 
active participant. The Board has been drawing 
attention to those problems for many years, and it will 
continue to promote that Programme. The Board calls 
on Governments to increase their support for the 
Programme.  
24. In addition to improving access to pain-relieving 
opioids, Governments are faced with the challenge of 
ensuring adequate supplies of controlled substances to 
meet the increasing demand for opioid substitution 
therapy, while at the same time preventing the 
diversion of those substances for illicit purposes. The 
Economic and Social Council, in its resolution 
2004/40, emphasized that psychosocially assisted 
pharmacological treatment was one of the treatment 
options available for improving the health, well-being 
and social functioning of persons dependent on opioids 
and for preventing the transmission of HIV and other 
blood-borne diseases. Such treatment is also associated 
with reducing the illicit use of opioids, criminal 
activity and deaths attributable to overdoses.21 
25. The Board acknowledges the challenge of 
preventing HIV transmission among persons who 
abuse drugs by injection and recognizes a spectrum of 
treatment modalities, including the use of substitution 
therapy in the treatment of drug abuse. However, 
substitute drugs should only be provided under a 
medically supervised treatment programme aimed at 
eventual abstinence and should be accompanied by 
adequate measures to prevent the abuse and diversion 
of drugs.  
 
__________________ 
 20 World Health Organization, “Briefing note: Access to 
Controlled Medications Programme”, March 2007. 
 21 World Health Organization, Joint United Nations 
Programme on HIV/AIDS and United Nations Office on 
Drugs and Crime, “Policy brief: reduction of HIV 
transmission through drug-dependence treatment”, 
Evidence for action on HIV/AIDS and injecting drug use 
series (WHO/HIV/2004.04). 
 2. Legal challenges 
 
26. The three international drug control conventions, 
like other international treaties, are not self-executing, 
and their provisions must be incorporated into 
domestic law by legislative acts. However, it is a 
principle of international law that the definition of 
offences lies solely within the powers of a State. Some 
of the provisions of the conventions state categorically 
that parties “shall provide…” or “shall furnish…”. 
Others are predicated with what is called a safeguard 
clause: “Having due regard to their constitutional, legal 
and administrative systems, …”; or “Subject to its 
constitutional principles and the basic concepts of its 
legal system…”. 
27. The process of translating legal obligations from 
the international to the national sphere may introduce 
discrepancies between national legal provisions and 
international norms and may also be coloured by 
political considerations. The Board acknowledges the 
respect accorded to national legal systems under the 
conventions but is concerned that differing 
interpretations of international obligations are 
weakening the overall efficacy of the control system.  
28. According to article 26 of the 1969 Vienna 
Convention on the Law of Treaties,22 “every treaty in 
force is binding upon the parties to it and must be 
performed by them in good faith.” A State that has 
contracted international obligations cannot excuse non-
observation of them by recourse to a deficiency or 
contradiction in domestic law.23 The fact that certain 
terms used in the conventions, such as “drug abuse”, 
“medical and scientific purposes” or measures adopted 
“with a view to reducing human suffering”, are not 
defined allows Governments to interpret them in 
diverse ways. In the Board’s view, some Governments 
interpret their international obligations in ways that 
call into question their commitment to pursuing the 
aims of the conventions.  
29. The Board considers that certain “harm 
reduction” measures are not in conformity with the 
__________________ 
 22 United Nations, Treaty Series, vol. 1155, No. 18232. 
 23 J. Obitre-Gama, “The application of international law 
into national law: policy and practice”, paper 
commissioned by the World Health Organization for the 
International Conference on Global Tobacco Control 
Law: towards a WHO Framework Convention on 
Tobacco Control, New Delhi, 7-9 January 2000. 
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conventions and serve primarily as a form of social 
control. Those measures include the establishment of 
so-called “coffee shops” where the sale, possession and 
consumption of small quantities of cannabis is 
tolerated, and so-called “drug consumption rooms”, 
where the illicit possession and consumption of 
controlled drugs are permitted. The Board accepts that 
any narcotic drug or psychotropic substance may be 
prescribed and administered under controlled medical 
and scientific conditions; however, the 1961 and 
1971 Conventions do not permit the illicit possession 
and use of controlled drugs that have not been 
medically prescribed. 
30. In a few countries a legal impasse has developed 
between international and national law with regard to 
the implementation of provisions concerning coca leaf. 
At the time the 1961 Convention was drawn up, the 
phasing out of coca bush cultivation was seen as 
beneficial for the people living in the Andean 
subregion, as well as a means to eliminate or reduce 
the illicit manufacture of and trafficking in cocaine at 
the international level. Today, there is a movement to 
elevate the status of the coca leaf to that of a symbol of 
national and ethnic identity used by indigenous peoples 
to reaffirm their cultural roots and historic rights. A 
few Governments have continued to permit the 
cultivation of coca bush and the use of coca leaves, and 
even to encourage those practices. 
31. The Board believes that drug control must be, and 
is, fully reconcilable with respect for human rights. 
However, the international drug control conventions do 
not accept the existence of a “right” to possess narcotic 
drugs or psychotropic substances unless they are to be 
used for medical or scientific purposes. The position of 
coca leaf in Schedule I of the 1961 Convention is clear: 
non-medical consumption of the coca leaf without 
prior extraction of its principal active alkaloids, 
including cocaine, is prohibited. In 1992, following a 
request from the Government of Bolivia to examine the 
issue, the WHO Expert Committee on Drug 
Dependence decided against recommending any 
change of control measures on the grounds of 
extractability: “coca leaf is appropriately scheduled ..., 
since cocaine is readily extractable from the leaf”.24 
__________________ 
 24  WHO Expert Committee on Drug Dependence: 
Twenty-eighth Report, WHO Technical Report Series, 
No. 836 (Geneva, World Health Organization, 1993). 
32. Despite the fact that Bolivia, on signing the 
1988 Convention, made a reservation with regard to 
article 3, paragraph 2, on the grounds that the 
provisions of that paragraph were “contrary to 
principles of its Constitution and basic concepts of its 
legal system”, Bolivia is still bound, according to 
article 25 of the 1988 Convention, by its prior 
obligations under the 1961 Convention. The Board 
reminds the Government of Bolivia of those 
obligations and invites it to remain committed to 
fulfilling its international treaty obligations. 
33. The inconsistent implementation of provisions on 
cannabis control is a legal challenge of a different 
nature, since no Government has legalized the 
cultivation of cannabis for non-medical use. The 
original objective of the 1961 Convention was to 
prohibit the use of cannabis in a few countries where 
its non-medical use was traditional. Today, its non-
medical use has virtually disappeared, and cannabis 
has become the most widely used illicit drug 
worldwide. In the past two decades, new, more potent 
forms of cannabis have been developed, mostly in 
industrialized countries. Sophisticated growing 
technologies produce cannabis with 
tetrahydrocannabinol (THC) levels that are 
considerably higher than that of the cannabis produced 
during the 1980s. That development may be associated 
with the increased demand for cannabis-related 
treatment services in several countries. Apart from the 
known risks of smoking tobacco, with which cannabis 
is frequently mixed, there are indications that cannabis 
consumption may be associated with an increased risk 
of psychotic disorders and schizophrenia. 
34. The Board believes that cannabis represents a 
challenge on several counts:  
 (a) The tolerance of “recreational” use of 
cannabis in many countries is at odds with the position 
of cannabis in Schedules I and IV of the 
1961 Convention;  
 (b) The relationship between the cannabis 
policies implemented in different countries and impact 
of those policies on patterns of illicit use is unclear; 
 (c) Public perceptions of the alleged “medical” 
uses of cannabis and its “recreational” use are 
overlapping and confusing; 
 (d) Developing countries that struggle to 
eliminate illicit cannabis cultivation are discouraged by 
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the tolerant policies of their wealthier neighbouring 
countries and, perhaps as a consequence, receive little 
alternative development assistance.  
 
 3. The challenges of prevention  
 
35. The issue of cannabis is closely related to the 
challenge of primary prevention for young people and 
other groups vulnerable to illicit drug use, given that 
cannabis tends to be the first and most widely used 
illicit drug. The welfare and protection of the young 
are priorities within the United Nations treaty system: 
the Convention on the Rights of the Child25 (art. 33) 
requires parties to the Convention to “take all 
appropriate measures, including legislative, 
administrative, social and educational measures, to 
protect children from the illicit use of narcotic drugs 
and psychotropic substances … and to prevent the use 
of children in the illicit production and trafficking of 
such substances” (art. 33). 
36. During the past century, considerable resources 
have been devoted to understanding the “preventive” 
and “risk” factors that influence first drug use. A study 
of youth in ethnic and indigenous groups revealed that 
social exclusion and isolation, perceived social and 
economic inequalities and an absence of community 
networks were among the significant risk factors.26 A 
global review of prevention programmes indicated that 
retention and engagement within education were 
critical protective elements of the structural 
environment shaping young people’s development. 
Truancy and exclusion from school may contribute to 
the development and consolidation of social networks 
and values that favour regular drug use and may 
exacerbate problems among the most marginalized and 
vulnerable youth.27 
37. The problem of drug abuse does not necessarily 
derive from age. The stresses of modern life and the 
constant pressure to achieve are frequently presented in 
terms that encourage reliance on pharmacological 
assistance. There is a sense, often reinforced by 
__________________ 
 25 United Nations, Treaty Series, vol. 1577, No. 27531. 
 26 Drug Abuse Prevention among Youth from Ethnic and 
Indigenous Minorities (United Nations publication, Sales 
No. E.04.XI.17), p. 10. 
 27 David Hawks, Katie Scott and Nyanda McBride, 
Prevention of Psychoactive Substance Use: a Selected 
Review of What Works in the Area of Prevention 
(Geneva, World Health Organization, 2002). 
targeted advertising, that artificial and chemical 
remedies can provide an answer to life’s problems. 
Youth are particularly vulnerable to marketing pressure 
and to the importance of “image”. The challenge for 
Governments, in the Board’s view, is to identify and 
disseminate policies appropriate to the national setting 
that are consistent with a more holistic or “ecological” 
approach to health and well-being and that encourage 
individuals to value and manage their own health.  
38. At the end of the 10-year reporting period 1998-
2007, the Executive Director of UNODC noted that, 
despite some improvements, progress in using 
prevention as part of the global response to the drug 
problem had been “modest at best”.28 For all 
Governments, understanding what prevention policies 
work and why is one of the greatest challenges. Most 
Member States (94 per cent) reported having carried 
out public information campaigns in 2007, but only 
half of those States reported that the results had been 
evaluated.29 The early onset of drug abuse has been 
identified as a predictor of the development and 
severity of subsequent health and social problems for 
the individual and for society as a whole. For that 
reason, the Board believes that intensified, sustained 
efforts by Governments to give priority to drug abuse 
prevention programmes targeting youth and other 
vulnerable groups would be cost-effective.  
39. The Board notes that there are evidence-based 
programmes for drug abuse prevention in a variety of 
geographical and socio-economic settings. Wider 
dissemination of the experiences gained in those 
programmes might help Governments to meet the 
challenge of reducing the demand for illicit drugs. 
There is evidence indicating that drug abuse prevention 
programmes can be most effective when:  
 (a) They are linked to the prevention of other 
problem behaviours such as alcohol and tobacco 
abuse;29 
 (b) They are based on reliable information on 
the nature and extent of the drug abuse situation and on 
__________________ 
 28 “Fifth report of the Executive Director on the world drug 
problem: drug demand reduction” 
(E/CN.7/2008/2/Add.1, 21 February 2008), paras. 10 and 
42. 
 29 Preventing Amphetamine-Type Stimulant Use among 
Young People: a Policy and Programming Guide (United 
Nations publication, Sales No. E.07.XI.7), p. 9. 
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the risk and protective factors that prevail in the 
community;30 
 (c) Programmes are tailored to age, gender and 
ethnicity, pay attention to the norms, values, 
aspirations and language of youth culture and involve 
the target group in planning, testing and evaluation;31 
 (d) The approach extends beyond the focus on 
drugs: life-skills education approaches are those with 
the most solid evidence of effectiveness,32 while 
parent- and family-based interventions can be useful in 
reinforcing family bonding and relationships;33 
 (e) More vulnerable youth and families can be 
identified by health, education and social services and 
should be offered appropriate psychosocial support; 
 (f) Media prevention campaigns are 
coordinated with corresponding activities at the grass-
roots level. It has been shown that media campaigns 
alone are unlikely to change attitudes or behaviour, 
despite effectively changing levels of information and 
awareness.34 
 
 4. The challenges of globalization 
 
40. Globalization has been facilitated by successive 
technological revolutions that have cut the costs of 
transportation, information and communications, 
bringing benefits to many. There are now more 
opportunities for developing countries to become 
integrated into the world economy, but the process is 
imperfect and incomplete and the benefits have been 
unevenly distributed. The educational and knowledge 
requirements imposed by global technologies and 
markets may marginalize or exclude those who lack the 
appropriate background, and that potentially limits the 
__________________ 
 30 Ibid., p. 10. 
 31 Ibid., p. 13. 
 32 “Fifth report of the Executive Director on the world drug 
problem: drug demand reduction” 
(E/CN.7/2008/2/Add.1, 21 February 2008), para. 14. 
 33 United States of America, Department of Health and 
Human Services, National Institutes of Health, 
Preventing Drug Use among Children and Adolescents: 
a Research-Based Guide for Parents, Educators, and 
Community Leaders, 2nd ed., NIH publication No. 04-
4212(A) (Bethesda, Maryland, National Institute on 
Drug Abuse, 2003), p. 2. 
 34 “Fifth report of the Executive Director on the world drug 
problem: drug demand reduction” 
(E/CN.7/2008/2/Add.1, 21 February 2008), para. 41. 
availability of the new technologies to a few countries, 
social groups and enterprises.35 
41. Increased trade and foreign direct investment 
have been accompanied by the growing influence of 
transnational corporations, with the result that 
Governments have less influence over the labour 
environment than in the past, particularly with regard 
to their more vulnerable populations. In many 
countries, there has been a weakening of social safety 
nets once provided by the state, the employer and the 
family, and a consequent reduction of social capital.  
42. Other problems such as poverty, climate change, 
environmental degradation, flooding, drought and the 
search for new sources of energy have resulted in 
shortages of staple foodstuffs and inflated prices of raw 
materials. Those consequences, together with the 
unknown consequences of the current global financial 
crisis, may contribute to social and political instability, 
conflicts over scarce resources and waves of economic 
migration. According to the Centre for Research on the 
Epidemiology of Disasters in Brussels, displacements 
resulting from environmental disasters such as floods 
and cyclones affected 197 million people in 2007, Asia 
being the continent most badly hit.36 Refugee flows 
linked to conflict have the greatest impact on 
developing countries: the poorest of those countries 
receive 80 per cent of all refugees. According to United 
Nations data, at the end of 2007 there were about 
11.4 million refugees: Iran (Islamic Republic of) and 
Pakistan together were hosting about 3 million 
refugees, almost all of them from Afghanistan, and the 
Syrian Arab Republic was hosting 1.5 million Iraqi 
refugees.37 
43. In the Board’s view, those developments pose 
serious challenges to the capacity of Governments to 
fulfil their international drug control obligations. It has 
been shown, for example, that the involvement of 
__________________ 
 35 United Nations, Economic Commission for Latin 
America and the Caribbean, Globalization and 
Development (LC/G.2157(SES.29/3)), report prepared 
for the twenty-ninth session of the Commission (2002). 
 36 Secretariat of the International Strategy for Disaster 
Reduction, “Disaster figures for 2007”, (UN/ISDR 
2008/01, 18 January 2008). 
 37 Office of the United Nations High Commissioner for 
Refugees, 2007 Global Trends: Refugees, Asylum-
seekers, Returnees, Internally Displaced and Stateless 
Persons (Geneva, June 2008). 
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small farmers in drug cultivation in the Andes is linked 
to poverty, insecurity and exclusion from mainstream 
society. There is no doubt that where unemployment is 
high and government presence is low or compromised, 
illicit drug crop cultivation and production can provide 
income. It is also true that the challenge of offering 
sustainable alternative livelihoods in rural and urban 
areas has been inadequately addressed: alternative 
development projects have reached an estimated 23 per 
cent of growers of illicit crops in the Andes and only 
5 per cent of such growers in Asia.38 Very few 
alternative development projects have been initiated in 
Africa, despite the extensive illicit cannabis cultivation 
in that region and the severity of the problems faced by 
its populations struggling to survive.  
44. As noted by the Board, alternative development 
must overcome a series of challenges, primarily related 
to cost and long-term sustainability. Significant 
resources are needed to improve infrastructure in 
remote rural areas with fragile ecosystems. Other 
problems include a lack of technical expertise, market 
price instability for alternative crops and the absence 
of public service provision for health, education, law 
and order and for agricultural credit facilities.39 
45. A growing number of organic coffee, fruit and 
other agricultural cooperatives are now under the 
umbrella of Fairtrade Labelling Organizations 
International (FLO), which unites labelling initiatives 
in North America, Europe and Oceania with networks 
of producer organizations from Africa, Latin America 
and the Caribbean and Asia. The aim is to improve the 
trading position of producer organizations in the 
southern hemisphere by providing sustainable 
livelihoods for farmers, workers and their 
communities. About 600 certified producer 
organizations in 59 countries now belong to FLO, with 
benefits reaching 7 million people, while consumers 
spent about 2 billion United States dollars on such 
products in 2006, an increase of 40 per cent over 
2005.40 The Board is aware that alternative 
__________________ 
 38  “Fifth report of the Executive Director on the world drug 
problem: Action Plan on International Cooperation on 
the Eradication of Illicit Drug Crops and on Alternative 
Development” (E/CN.7/2008/2/Add.2, 17 December 
2007), paras. 9 and 58.  
 39 Report of the International Narcotics Control Board for 
2005 (United Nations publication, Sales No. E.06.XI.2), 
para. 27.  
 40 See the website of the Fairtrade Foundation 
development projects in illicit drug crop cultivation 
areas are faced with difficult challenges. In the Board’s 
view, however, initiatives such as those mentioned 
above, which benefit directly from the opening up of 
markets through globalization, offer encouragement to 
efforts to extend the scope and sustainability of 
alternative development projects. 
46. The Board has noted that the deregulation and 
liberalization of commercial practices in the licit drug 
market has tended to weaken the regulatory power of 
Governments in terms of public control over trading 
and access to drugs, their prices and marketing 
practices.41 The existence of regional free trade areas 
such as the North American Free Trade Agreement, the 
Common Market of the South (MERCOSUR) and the 
European Union has had, in addition to many benefits, 
the unintended consequence of making it more difficult 
for Governments to monitor the movement of 
chemicals that are used in a wide variety of legitimate 
industrial uses but also in illicit drug manufacture. 
Advances in technology that enable tiny changes to be 
made to the molecular structure of substances, together 
with the fact that almost all pure substances are now 
easily recoverable, have blurred the distinction 
between licit and illicit manufacture and have led to 
rapid growth in the clandestine synthesis of “designer 
drugs”. Criminals now design and manufacture 
psychotropic drugs with the explicit aim of bypassing 
the restrictions imposed by international drug control 
regulations and then distribute those drugs in parallel 
markets outside the control system. Those 
developments pose particular challenges to the 
implementation of the international drug control 
conventions.  
47. The Board has long been concerned about the 
role of the Internet in the sale and distribution of 
controlled and uncontrolled substances and is aware of 
numerous cases involving illegal Internet pharmacies. 
While it recognizes that purchasing pharmaceuticals 
online can be beneficial, especially in areas where 
hospitals and pharmaceutical services are widely 
dispersed, it is alarmed that “rogue” pharmacies are 
encouraging drug abuse among vulnerable groups. In 
the United States, where the abuse of prescription 
__________________ 
(www.fairtrade.org.uk). 
 41 Report of the International Narcotics Control Board for 
2000 (United Nations publication, Sales No. E.01.XI.1), 
para. 33 (d). 
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drugs by young adults has risen sharply since 2002,42 it 
was reported that 34 illegal Internet pharmacies had 
dispensed more than 98 million dosage units of 
hydrocodone products during 2006. Given that in 
84 per cent of cases a valid prescription was not 
required for purchase, the risks for youth or other 
vulnerable groups is clearly high.43 
48. According to the European Monitoring Centre for 
Drugs and Drug Abuse, more and more online drug 
retailers have the potential to spread new drug-taking 
practices or products, and they use targeted marketing 
strategies that respond rapidly to users’ demands and to 
changing legal and market situations.44 
49. The Board, convinced that a coordinated global 
response is needed to address the illegal sale of drugs 
on Internet pharmacies and websites, has developed the 
Guidelines for Governments on Preventing Illegal 
Sales of Internationally Controlled Substances through 
the Internet.45 The Guidelines include 
recommendations promoting measures to facilitate 
national and multilateral cooperation, on legal steps 
such as the registration and licensing of Internet 
pharmacies and on campaigns to raise public 
awareness of the risks involved in online purchases. 
50. Linked to the growth of illegal Internet drug sales 
is another challenge for public health and drug control 
bodies: the advertising and sale of counterfeit drugs, 
defined by WHO as medicines that have been 
“deliberately and fraudulently mislabelled with respect 
to identity and/or source”. WHO, which has launched 
the International Medical Products Anti-Counterfeiting 
Taskforce (IMPACT), believes that 7-10 per cent of all 
pharmaceuticals may be counterfeit. In some African 
countries, the figure may be as high as 30-40 per cent. 
According to a study carried out in the United States, 
worldwide counterfeit drug sales will reach an 
__________________ 
 42 United States, Office of National Drug Control Policy, 
Current State of Drug Policy: Successes and Challenges 
(Washington D.C., March 2008), p. 7. 
 43  Report of the International Narcotics Control Board for 
2007 …, paras. 250-251. 
 44 European Monitoring Centre for Drugs and Drug Abuse, 
Annual Report 2007: the State of the Drugs Problem in 
Europe (Luxembourg, Office for Official Publications of 
the European Communities, 2007), p. 74. 
 45 “Guidelines for Governments on Preventing the Illegal 
Sale of Internationally Controlled Substances through 
the Internet”, to be subsequently issued as a United 
Nations publication. 
estimated US$ 75 billion in 2010, an increase of more 
than 90 per cent over the figure for 2005.46 
51. In addition to violating copyright provisions and 
constituting an economic crime, counterfeit medicines 
undermine national health-care systems, result in loss 
of confidence in drug control and law enforcement 
systems and pose serious health risks to users. 
Counterfeiting is inevitably greatest in regions where 
regulatory oversight is weakest and where vulnerable 
populations can be more easily exploited. While 
counterfeiting has become a lucrative international 
criminal activity, the response of law enforcement has 
continued to be ineffective, weak and focused on 
offences such as fake handbags and watches. 
Technology far outpaces the regulatory environment, 
and there is a lack of generally accepted norms at the 
international level.47 
52. Analysts of organized crime predicted some years 
ago that cybercrime, which can be defined as crime 
that is enabled by or directed against electronic 
communications devices, would increasingly be 
initiated from jurisdictions that have few if any laws 
against cybercrime and/or little capacity to enforce 
such laws. Nowadays, drug traffickers are reportedly 
among the most widespread users of encryption for 
Internet messaging and are able to hire high-level 
computer specialists to help evade law enforcement, 
coordinate shipments of illicit drugs and launder 
money. The Convention on Cybercrime,48 which 
entered into force on 1 July 2004, is to date the only 
multilateral treaty dealing with that problem. It was 
drafted by member States of the Council of Europe, 
together with Canada, Japan, South Africa and the 
United States, and is envisaged not as a European 
instrument but as a global instrument, to be supported 
on all continents. 
53. The challenges to the international drug control 
system are at least as daunting today as they were a 
century ago and perhaps more complex. The 
conventions continue to be highly relevant in the face 
of contemporary problems and challenges; in fact, they 
may be more necessary now than in the past. As global 
__________________ 
 46 World Health Organization, “Counterfeit medicines”, 
Fact Sheet, No. 275 (revised), November 2006. 
 47 United Nations Interregional Crime and Justice Research 
Institute, Counterfeiting: a Global Spread, a Global 
Threat (Turin, Italy, 2007). 
 48 Council of Europe, European Treaty Series, No. 185. 
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requirements for narcotic drugs and psychotropic 
substances increase, the conventions provide the 
framework to ensure that licit medical and scientific 
demand is matched by adequate global supply. Where 
globalization has weakened the power of Governments 
and strengthened corporate influence, there is all the 
more need for the rigour of independent multilateral 
oversight. The effectiveness of international drug 
control depends increasingly on a robust United 
Nations system to promote universal health and 
welfare with impartiality and responsibility.  
54. The international drug control system has stood 
the test of time with credit, but it is not perfect. It is 
undoubtedly capable of improvement; for that reason, 
there are procedures for its modification. The Board 
recognizes the difficulties faced by Governments in 
meeting their international treaty obligations and 
invites them to adopt constructive approaches to 
overcoming those obstacles instead of seeking 
individual solutions that may undermine the coherence 
and integrity of the international drug control system.  
 
 
 D. Recommendations 
 
 
55. To ensure more effective implementation of the 
international drug control conventions, the Board: 
 (a) Invites Governments to consider how best 
to ensure the efficient functioning of the 1961, 1971 
and 1988 Conventions;  
 (b) Encourages Governments to make greater 
investments in prevention, especially with regard to 
youth and vulnerable groups, and to utilize the 
experiences and best practices tested in a variety of 
settings;  
 (c) Invites Governments to study the 
discrepancies between international and domestic law 
with a view to fulfilling their obligations under the 
international drug control conventions and, in that 
context, to consider their “good faith” in pursuing the 
aims of the conventions;  
 (d) Encourages Governments of countries 
where the consumption of opioid analgesics is low to 
stimulate rational use of those drugs through measures 
promoted by the Access to Controlled Medications 
Programme and to ensure that such incentives are 
accompanied by measures to prevent the diversion of 
such drugs; and suggests (as it did in its report for 
1999)49 that Governments might consider working 
with the pharmaceutical industry with a view to 
making high-quality opioid analgesics more affordable 
in the poorest countries and that organizers of 
international aid programmes might consider donating 
essential drugs as part of their aid programmes; 
 (e) Recommends that Governments study the 
Fairtrade model (www.fairtrade.org.uk) with a view to 
improving the trading position and market access for 
products from alternative development projects in 
areas affected by illicit drug crop cultivation, taking 
into consideration the appropriateness and feasibility in 
each case;  
 (f) Urges Governments to make use of the 
Guidelines for Governments on Preventing the Illegal 
Sale of Internationally Controlled Substances through 
the Internet; 
 (g) Encourages Governments to support 
multilateral initiatives against cybercrime.  
 
 
__________________ 
 49  Report of the International Narcotics Control Board for 
1999 … . 
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 II. Operation of the international drug control system 
 
 A. Narcotic drugs 
 
 
 1. Status of adherence to the Single Convention on 
Narcotic Drugs of 1961 and that Convention as 
amended by the 1972 Protocol 
 
56. As at 1 November 2008, the number of States 
parties to the 1961 Convention or that Convention as 
amended by the 1972 Protocol50 stood at 186. Of those 
States, 183 were parties to the 1961 Convention as 
amended by the 1972 Protocol. Afghanistan, Chad and 
the Lao People’s Democratic Republic continue to be 
parties to the 1961 Convention in its unamended form 
only. The Board once again calls upon those three 
States to accede as soon as possible to the 
1972 Protocol amending the 1961 Convention. A total 
of eight States have not yet become parties to the 
1961 Convention: one State in Africa (Equatorial 
Guinea), one in Asia (Timor-Leste) and six in Oceania 
(Cook Islands, Kiribati, Nauru, Samoa, Tuvalu and 
Vanuatu). The Board reiterates its request to those 
States to become parties to the 1961 Convention 
without further delay. The high number of States in 
Oceania that have not yet become parties to the 
1961 Convention is a matter of a particular concern to 
the Board.  
 
 2. Cooperation with Governments 
 
  Submission of annual and quarterly statistical 
reports on narcotic drugs 
 
57. Parties to the 1961 Convention must submit 
statistical information on narcotic drugs pursuant to 
article 20 of the 1961 Convention. The statistical data 
and other information received from Governments are 
used by the Board in monitoring licit activities 
involving narcotic drugs throughout the world. This 
allows the Board to determine whether Governments 
have enforced treaty provisions requiring them to limit 
to medical and scientific purposes the licit manufacture 
of trade in and use of narcotic drugs while, at the same 
time, ensuring the availability of narcotic drugs for 
legitimate purposes. 
58. Parties to the 1961 Convention furnish to the 
Board annual statistical reports on production, 
__________________ 
 50  United Nations, Treaty Series, vol. 976, No. 14152. 
manufacture, consumption, stocks and seizures of 
narcotic drugs. They are also required to submit to the 
Board quarterly statistics on imports and exports of 
narcotic drugs. As at 1 November 2008, a total of 
168 States and territories had submitted annual 
statistics on narcotic drugs for 2007; that figure 
represents 80 per cent of the 211 States and territories 
required to furnish such statistics. A total of 188 States 
and territories provided quarterly statistics of imports 
and exports of narcotic drugs for 2007; that figure 
represents 89 per cent of the 211 States and territories 
requested to furnish those statistics. The rate of 
submission of annual statistics and of quarterly 
statistics is similar to that for previous years. Details of 
the statistical data received, including the status of 
compliance by individual parties with their reporting 
obligations, are included in the 2008 technical report of 
the Board on narcotic drugs.51  
59. Some States, including Belgium, China, 
Iran (Islamic Republic of), the Netherlands and the 
United States did not provide in 2008 the requested 
statistics in a timely manner. The late submission of 
reports makes it difficult for the Board to monitor licit 
activities related to narcotic drugs and delays the 
analysis by the Board of the worldwide availability of 
narcotic drugs for legitimate purposes, as well as its 
analysis of the global balance between the supply of 
opiate raw materials and the demand for those 
materials. 
60. Difficulties experienced in submitting the 
required statistical data have different reasons in 
different countries, including lack of qualified 
personnel, lack of financial resources and inadequate 
technological support. The Board examined that issue 
in detail in its report for 2007.52 The Board reiterates 
its concern that some Governments have been paying 
less attention to the control of licitly manufactured 
narcotic drugs, despite the growing abuse of those 
drugs. The Board calls again upon the Governments 
concerned to provide adequate resources to ensure the 
compliance of those authorities with all their control 
__________________ 
 51  Narcotic Drugs: Estimated World Requirements for 
2009; Statistics for 2007 … . 
 52  Report of the International Narcotics Control Board for 
2007…, paras. 236-241. 
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functions, including reporting obligations under the 
1961 Convention. 
61. The Board provides assistance to Governments in 
complying with their reporting obligations under the 
1961 Convention. In 2008, as in previous years, the 
Board provided to several Governments, at their 
request, explanations on issues regarding reporting 
requirements for narcotic drugs. Training material on 
the control of narcotic drugs and guidelines on 
reporting on those drugs for use by national competent 
authorities are available on the website of the Board 
(www.incb.org). Reporting requirements were 
discussed during an informal consultation on reporting, 
organized for selected Governments by the Board 
during the fifty-first session of the Commission on 
Narcotic Drugs, in March 2008. All Governments are 
encouraged to seek from the Board any information 
that they may consider useful regarding the control of 
narcotic drugs pursuant to the 1961 Convention, 
including reporting requirements. 
 
  Submission of estimates of requirements for 
narcotic drugs 
 
62. The system of estimates for narcotic drugs is a 
very important tool for international control of narcotic 
drugs. Governments need to ensure the full and proper 
application of the system of estimates, as it is a 
prerequisite for the functioning of the international 
control system for narcotic drugs. Estimates should be 
established at the levels that are adequate to ensure 
access to narcotic drugs for medical treatment and to 
prevent diversion into illicit channels. 
63. As at 1 November 2008, a total of 167 States and 
territories had submitted their estimates of 
requirements for narcotic drugs for 2009; that figure 
represents 79 per cent of the 211 States and territories 
required to furnish the annual estimates for 
confirmation to the Board. The rate of submission of 
estimates is similar to that for previous years. For those 
States and territories that did not submit their estimates 
in time for examination and confirmation, the Board 
established estimates in accordance with article 12, 
paragraph 3, of the 1961 Convention. The estimates 
established by the Board are based on estimates and 
statistics reported in the past by the respective 
Governments. If Governments have not provided 
estimates and statistics for several years, however, the 
estimates established by the Board may be set lower 
than the estimates furnished in the past by the 
respective Governments, as a precaution against 
diversion. Therefore, the Governments for which 
estimates were established by the Board are urged to 
examine closely their requirements for narcotic drugs 
for 2009 and provide their own estimates to the Board 
for confirmation, in order to prevent any possible 
difficulties in importing the quantities of narcotic drugs 
required for legitimate purposes. 
64. The estimates for all States and territories are 
published by the Board in its technical report on 
narcotic drugs. The updates of those estimates, which 
reflect, inter alia, supplementary estimates furnished 
by Governments, are made available on the website of 
the Board. 
65. The Board examines annual estimates received 
from Governments in order to limit the use of narcotic 
drugs to the amount required for medical and scientific 
purposes and to ensure adequate availability of those 
drugs for such purposes. Governments are requested to 
adjust their estimates or to provide explanations 
whenever the Board considers the estimates to be 
inadequate. In 2008, the Board was, for the most part, 
satisfied with the promptness of the responses from 
Governments that had been requested to adjust their 
estimates or provide clarifications. 
66. Supplementary estimates are an important tool to 
meet the shortfalls in availability of narcotic drugs. 
The Board requests all Governments to determine their 
annual estimates of requirements for narcotic drugs as 
accurately as possible, so that resorting to 
supplementary estimates is reserved for unforeseen 
circumstances or for when developments in medical 
treatment, including the use of new medications and 
scientific research, result in additional requirements for 
narcotic drugs.  
 
  Deficiencies in reporting statistics and estimates 
 
67. In analysing the statistics and estimates received 
from Governments, the Board brings inconsistencies in 
national reports to the attention of the Governments 
concerned and requests them to clarify the 
inconsistencies and resolve the problems that have led 
to those inconsistencies. Deficiencies in reporting may 
reflect problems in the implementation of the treaty 
provisions in those countries, such as lapses in national 
laws or administrative regulations or the failure by 
some operators to comply with their obligations 
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pursuant to national legislation, including their 
obligation to provide to the national authorities timely 
and accurate reports on their transactions involving 
narcotic drugs. The Board reiterates its request to all 
Governments concerned to identify the causes for 
deficiencies in reporting statistics and/or estimates to 
the Board, with a view to resolving those problems and 
ensuring adequate reporting.  
68. The Board notes that some Governments have 
submitted the same estimates for several years. The 
Board requests those Governments to regularly assess 
their requirements for narcotic drugs to ensure that the 
estimates furnished to the Board for confirmation 
reflect their actual needs for narcotic drugs during the 
year in question. The Board is at the disposal of all 
Governments for explanations regarding the system of 
estimates for narcotic drugs.  
 
 3. Prevention of diversion of narcotic drugs into 
the illicit traffic 
 
  Diversion from international trade 
 
69. The system of control measures laid down in the 
1961 Convention provides effective protection of 
international trade in narcotic drugs against attempts at 
their diversion into illicit channels. In 2008, as in 
recent years, no cases of diversion of narcotic drugs 
from licit international trade into the illicit traffic were 
detected.  
70. The effective control of international trade in 
narcotic drugs is, to a large extent, a result of the 
vigilance of exporting countries when authorizing the 
export of narcotic drugs. The vast majority of 
exporting countries strictly observe the limits set in the 
system of estimates for narcotic drugs for the 
importing countries. However, in 2008, as in previous 
years, a few cases were identified where a specific 
export of narcotic drugs was authorized in excess of 
the estimates of the respective importing countries, 
thereby contravening the provisions of article 31 of the 
1961 Convention. Such exports of quantities above the 
estimates set by the importing country may result in 
the diversion of narcotic drugs into illicit channels. The 
Board has therefore reminded the Governments 
concerned of their obligation to comply with the 
provisions of article 31 and has requested them, when 
authorizing exports of narcotic drugs in the future, to 
always consult the annual estimates of requirements for 
narcotic drugs for each importing country and territory, 
which are published by the Board. 
71. The Board notes an investigation in Denmark and 
Norway of a case involving the loss of a consignment 
of 15 kg of codeine phosphate that was shipped by air 
from Oslo to Singapore, via Copenhagen, but did not 
arrive at its destination. The Board encourages all 
Governments to ensure that traders and transporters of 
internationally controlled substances employ adequate 
safety and security measures when transporting such 
substances. In cases in which a consignment containing 
such substances is lost or stolen, there should be 
adequate investigation procedures in place to 
determine the circumstances of the loss.  
 
  Diversion from domestic distribution channels 
 
72. The diversion and abuse of pharmaceutical 
preparations containing narcotic drugs are taking place 
in an increasing number of countries. The narcotic 
drugs most often diverted and abused include codeine, 
dextropropoxyphene, dihydrocodeine, fentanyl, 
hydrocodone, methadone, morphine, oxycodone, 
pethidine and trimeperidine. According to information 
received from Governments, the most abused 
pharmaceutical preparations are usually those which 
are also the most available on the licit market. The 
Board calls on all Governments concerned to take 
effective measures to counter the diversion and abuse 
of pharmaceutical preparations containing narcotic 
drugs. 
73. The abuse of pharmaceutical preparations 
containing narcotic drugs is reported in many 
countries. In some countries, the extent of the abuse of 
those preparations has surpassed the extent of the 
abuse of illicitly manufactured or produced drugs. In 
the United States, the abuse of pharmaceutical 
preparations, in particular those containing oxycodone 
and hydrocodone, is higher than the abuse of any 
illicitly manufactured or produced drug except 
cannabis (see also paragraphs 445 and 446 below). 
74. Abusers of pharmaceutical preparations 
containing narcotic drugs often mistakenly consider 
those preparations to be not harmful. That 
misconception may be partly attributable to the fact 
that such preparations are often widely available. 
Governments need to pay increased attention to the 
diversion and abuse of pharmaceutical preparations 
containing narcotic drugs. In particular, Governments 
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should include such preparations in national surveys on 
drug abuse to obtain information on the nature and 
extent of the problem. The Governments concerned 
need to use their drug abuse prevention programmes to 
draw attention to the high risks associated with the 
abuse of pharmaceutical preparations containing 
narcotic drugs. 
75. The abuse of pharmaceutical preparations 
containing narcotic drugs constitutes a serious health 
risk. For example, death cases related to abuse of 
methadone have been observed in several countries. In 
certain states in the United States, methadone 
preparations are more frequently implicated than 
heroin in cases involving death. In the United Kingdom 
of Great Britain and Northern Ireland, methadone was, 
in the first half of 2007, implicated in cases involving 
death more often than any other psychoactive drug 
except heroin/morphine.  
76. The Board has repeatedly brought to the attention 
of Governments reports received from several 
countries about the abuse of fentanyl patches. In its 
annual report for 2007, the Board referred to the 
diversion and abuse of used and discarded patches, 
which contain significant quantities of fentanyl. While 
the Board recognized the medical usefulness of 
fentanyl patches in the treatment of pain, it 
recommended that specific measures be taken for the 
safe disposal of used fentanyl patches.53  
77. The Board calls upon the Governments of 
countries in which fentanyl patches are manufactured 
to investigate, in cooperation with the pharmaceutical 
industry, means to reduce the residual content in used 
fentanyl patches. The range of residual content in used 
patches is wide, and that large margin could allow 
pharmaceutical companies to invest in forms with 
lower residual content. In addition to the efforts of 
industry, Governments are requested to ensure that the 
disposal of such patches is carried out with adequate 
safety and security measures in order to prevent any 
diversion to illicit markets.  
78. In Belgium, Germany and Ireland, where fentanyl 
patches are manufactured, specific control measures 
have been introduced at the manufacturing stage to 
prevent any diversion of unused or remaining material 
to the illicit market. The Board encourages the 
Governments of all other countries in which fentanyl 
__________________ 
 53  Ibid., paras. 242-249. 
patches are manufactured and in which there is an 
interest in learning more about such control measures 
to contact the Board for further information. 
79. The abuse of pharmaceutical preparations 
containing narcotic drugs is not always caused by 
dependency on the narcotic drug contained in the 
preparation. For example, in Germany, pharmaceutical 
preparations containing tilidine were diverted and 
consumed by street gang members in order to raise 
their pain threshold in preparation for gang fights. 
Such specific, non-medical use of narcotic drugs 
constitutes abuse and may result in drug dependency. 
The Board invites all Governments to be vigilant with 
regard to this form of abuse of pharmaceutical 
preparations containing narcotic drugs and to take 
measures to prevent the diversion of those 
preparations.  
80. The Board also urges Governments to remain 
vigilant with regard to the abuse of pharmaceutical 
preparations containing substances that are not 
internationally controlled. For example, the abuse of 
dextromethorphan, a substance that was excluded from 
Schedule I of the 1961 Convention and is therefore not 
under international control, appears to be increasing. 
Since preparations containing dextromethorphan are 
available as over-the-counter medications, 
Governments may wish to consider whether additional 
control measures are not warranted (see also 
paragraph 467 below).  
 
 4. Misuse of poppy straw for illicit drug 
manufacture 
 
81. Until the mid-1990s, the abuse of poppy straw 
extracts containing alkaloids represented the most 
serious drug abuse problem in several countries in 
Central and Eastern Europe. In those countries, opium 
poppy was cultivated primarily for culinary purposes. 
The Board recommended that the Governments 
concerned should apply various measures to enhance 
national measures for the control of opium poppy 
cultivation, in accordance with their specific situation. 
The measures ranged from licensing opium poppy 
cultivation and promoting the cultivation of poppy 
varieties with low morphine content to totally 
prohibiting opium poppy cultivation, as envisaged in 
article 22 of the 1961 Convention.  
82. The Board has collected information regarding 
the misuse of poppy straw from countries where the 
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licit cultivation of opium poppy takes place. The Board 
notes that in most countries in Central and Eastern 
Europe various measures have been implemented to 
prevent the misuse of poppy straw, in accordance with 
the Board’s recommendations. As a consequence of 
those measures, the misuse of poppy straw for the 
illicit manufacture of alkaloids has declined in most 
countries in those subregions. The decline in the abuse 
of poppy straw extracts was, however, also attributable 
to an increase in the availability and abuse of other 
opioids, in particular heroin. 
83. The pattern of abuse of opioids may vary in the 
different parts of a country. According to the latest 
information provided by the Government of Poland, 
the share of drug abusers admitted to treatment in 
Warsaw who reported having abused poppy straw 
extracts within 30 days prior to admission for treatment 
declined from almost 35 per cent in 1995 to less than 
2 per cent in 2005; however, in the city of Krakow, the 
share was 20 per cent in 2005. 
84. In Ukraine, the abuse of poppy straw extracts 
continues to represent the most serious drug abuse 
problem. Such extracts are reportedly abused by 98 per 
cent of all injecting drug abusers in the country. The 
licit cultivation of opium poppy for culinary purposes 
has expanded in recent years in Ukraine, and poppy 
straw has been diverted from such licit cultivation for 
illicit use. The Board requests the Government of 
Ukraine to take effective measures against the misuse 
of poppy straw for illicit drug manufacture (see 
paragraphs 734-736 below). The Board encourages the 
Governments of all countries in the region to remain 
vigilant with regard to the illicit manufacture and 
abuse of poppy straw extracts.  
85. The misuse of poppy straw is extremely limited 
in the countries where opium poppy, with high 
morphine content, is cultivated for the extraction of 
alkaloids. That is because a system for licensing the 
cultivation of opium poppy has been introduced in 
most of those countries, and regulatory and law 
enforcement authorities control producers and 
industrial users of poppy straw in a coordinated 
manner, in conformity with the relevant 
recommendations by the Board.  
86. The technological progress in the cultivation of 
opium poppy for the extraction of alkaloids has 
resulted in significant increases in the concentration of 
alkaloids in opium poppy plants, which increases the 
potential for misuse. In some countries where poppy 
straw is produced for the extraction of alkaloids, a 
licensing system to control the cultivation of opium 
poppy has not yet been established and less strict 
control regimes continue to apply, such as a system for 
the registration of producers or a system of mandatory 
contracts between the producers and the company 
purchasing the poppy straw. The Board calls on the 
Governments of all countries where opium poppy is 
cultivated for the extraction of alkaloids to remain 
vigilant to the danger of narcotic drugs being diverted 
from such cultivation. The Board recommends to the 
Governments of producing countries that have not yet 
done so to establish a system for licensing the 
cultivation of opium poppy.  
 
 5. Control over trade in opium poppy seeds 
 
87. The Economic and Social Council, in its 
resolution 1999/32, called upon Member States to take 
the following measures to fight the international trade 
in opium poppy seeds from countries not permitting 
the cultivation of opium poppy: 
 (a) Poppy seeds should only be imported if they 
originated in countries where opium poppy was grown 
licitly in accordance with the provisions of the 
1961 Convention; 
 (b) Governments should be encouraged, to the 
extent possible and where national circumstances so 
required, to obtain an appropriate certificate from the 
exporting countries on the country of origin of opium 
poppy seeds as the basis for importation and should 
give notification of export of opium poppy seeds, as far 
as possible, to the competent authorities of the 
importing countries; 
 (c) Information on any suspicious transactions 
involving poppy seeds should be shared with other 
Governments concerned and with the Board. 
88. The Board has repeatedly encouraged 
Governments to implement Economic and Social 
Council resolution 1999/32 and has reported on the 
control over trade in opium poppy seeds in various 
countries.54 In its resolution 51/15, the Commission on 
Narcotic Drugs requested the Board to continue 
gathering information regarding the implementation of 
__________________ 
 54  Report of the International Narcotics Control Board for 
2005 …, paras. 76-78. 
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Council resolution 1999/32 by Member States and to 
share that information with Member States. To that 
end, the Board sent a questionnaire to the Governments 
of the countries most involved in the international 
trade in poppy seeds and the Governments of countries 
neighbouring those countries where opium poppy is 
illicitly cultivated. Several Governments have already 
responded to the questionnaire. The Board trusts that 
the other Governments concerned will also furnish the 
requested information. The Board will examine the 
information received from Governments and report on 
the results of the analysis in its report for 2009. 
 
 6. Ensuring the availability of narcotic drugs for 
medical purposes 
 
  Supply of and demand for opiate raw materials  
 
89. Pursuant to the 1961 Convention and relevant 
resolutions of the Commission on Narcotic Drugs and 
the Economic and Social Council, the Board examines 
on a regular basis developments affecting the supply of 
and demand for opiate raw materials. The Board 
strives, in cooperation with Governments, to maintain a 
lasting balance between supply and demand. A detailed 
analysis of the present situation with regard to the 
supply of opiate raw materials and demand for those 
materials worldwide is contained in the 2008 technical 
report of the Board on narcotic drugs.55  
90. To analyse the situation regarding supply and 
demand, the Board uses information from 
Governments of countries producing opiate raw 
materials, as well as from countries where those 
materials are utilized for the manufacture of opiates or 
substances not controlled under the 1961 Convention. 
The Board calls upon the Governments of countries 
producing and/or utilizing opiate raw materials to 
ensure that their estimates and statistics are of a high 
quality and to keep the Board informed of any new 
developments that may have an impact on future 
developments in the supply of and demand for those 
materials. 
91. Global stocks of opiate raw materials should 
cover global demand for about one year to ensure the 
availability of opiates for medical and scientific 
purposes.56 At the end of 2007, total stocks of opiate 
__________________ 
 55  Narcotic Drugs: Estimated Requirements for 2009; 
Statistics for 2007 … . 
 56  Report of the International Narcotics Control Board for 
raw materials rich in morphine were sufficient to cover 
global demand for more than 15 months. Total stocks 
of opiate raw materials rich in thebaine were sufficient 
to cover global demand for less than one year; 
however, that was compensated by the high level of 
stocks of thebaine and opiates derived from thebaine, 
which were sufficient at the end of 2007 to cover 
global demand for those opiates for almost 22 months.  
92. In 2008, production of opiate raw materials rich 
in morphine was less than planned in several producing 
countries due to adverse weather conditions. However, 
the global supply of opiate raw materials rich in 
morphine (production and stocks) remained fully 
sufficient to cover global demand. 
93. For 2009, Governments of producing countries 
are planning to extend the area cultivated with opium 
poppy rich in morphine to ensure that the production 
will be sufficient to cover demand during that year and 
to increase the stocks.  
94. For opiate raw materials rich in thebaine, 
information available to the Board indicates that global 
production exceeded global demand in 2008. 
According to the plans of the producing countries, 
global production will exceed global demand in 2009 
as well. The stocks of opiate raw materials rich in 
thebaine are therefore expected to increase to a level 
exceeding the demand for one year. The global supply 
of opiate raw materials rich in thebaine (production 
and stocks) will continue to be fully sufficient to cover 
global demand.  
95. Global demand continues to increase for both 
types of opiate raw materials: those rich in morphine 
and those rich in thebaine. It is anticipated that, as a 
result of the activities of the Board and WHO to ensure 
the adequate availability of opioid analgesics, global 
demand for opiates and opiate raw materials will 
continue to rise (see paragraphs 102 and 103 below).  
 
  Prevention of the proliferation of production of 
opiate raw materials 
 
96. Pursuant to the relevant resolutions of the 
Commission on Narcotic Drugs and the Economic and 
Social Council, the Board calls upon all Governments 
to contribute to the maintenance of a balance between 
the licit supply of and demand for opiate raw materials 
__________________ 
2005 …, para. 85. 
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and to cooperate in preventing the proliferation of 
sources of production of opiate raw materials. In its 
resolution 51/9, the Commission on Narcotic Drugs 
urged the Governments of all countries where opium 
poppy had not been cultivated for the licit production 
of opiate raw materials to refrain from engaging in the 
commercial cultivation of opium poppy, in order to 
avoid the proliferation of supply sites. The Board 
appeals to all Governments to comply with 
Commission resolution 51/9. 
 
  Cultivation and utilization of Papaver bracteatum 
as a raw material for the manufacture of opiates 
 
97. Papaver bracteatum is a variety of opium poppy 
for which no control provisions are contained in the 
1961 Convention as amended by the 1972 Protocol. In 
some countries, there has been an interest in 
conducting scientific research on the cultivation of 
Papaver bracteatum for the extraction of alkaloids, in 
particular thebaine. The Board addressed the issue of 
the cultivation and utilization of Papaver bracteatum 
in its report for 2007.57 
98. Several Governments provided the Board with 
their views on the possible impact of the commercial 
cultivation of Papaver bracteatum on the global supply 
of opiate raw materials and the steps to be taken in that 
connection to ensure a lasting balance between the 
supply of and demand for opiate raw materials. Those 
Governments agreed with the view of the Board that 
the cultivation of Papaver bracteatum and the resulting 
production of poppy straw, if undertaken for 
commercial purposes, must be taken into consideration 
when balancing the supply of and demand for opiate 
raw materials. The Governments also supported the 
view of the Board that Papaver bracteatum should be 
placed under international control in case of its 
commercial cultivation.58  
99. Commercial cultivation of Papaver bracteatum 
has not yet been reported by any Government. The 
Board requests all Governments to keep it informed of 
any plans in their countries to begin cultivating 
Papaver bracteatum for commercial purposes. The 
Board wishes to remind all Governments that the 
__________________ 
 57  Report of the International Narcotics Control Board for 
2007 …, paras. 91-95. 
 58  Demand and Supply of Opiates for Medical and 
Scientific Needs (United Nations publication, 
Sales No. E.82.XI.4), paras. 357-358. 
Commission on Narcotic Drugs, in its resolution 2 
(XXIX), urged parties engaged in the cultivation of 
Papaver bracteatum for the production of thebaine or 
thebaine derivatives to voluntarily report to the Board 
statistics on the area cultivated and production. 
 
 7. Consumption of narcotic drugs 
 
100. Global consumption of opioid analgesics for the 
treatment of moderate to severe pain (expressed in 
defined daily doses for statistical purposes) increased 
by more than two and one half times during the past 
decade. The increase in consumption has taken place 
mainly in countries in Europe and North America. Of 
the opioids under international control, fentanyl, 
morphine and oxycodone are those most frequently 
used as analgesics for the treatment of moderate to 
severe pain. In 2007, countries in those two regions 
together accounted for almost 96 per cent of global 
consumption of fentanyl, 89 per cent of global 
consumption of morphine and 98 per cent of global 
consumption of oxycodone.  
101. Although the overall level of consumption of 
opioid analgesics for the treatment of pain is relatively 
high in Europe, higher consumption levels have been 
reported by countries in the western and northern parts 
of that region rather than in the other parts. However, 
over the past decade, several countries in central, 
eastern and southern Europe have significantly 
increased their consumption of opioid analgesics. For 
example, in the Czech Republic, Greece, Hungary, 
Italy, Poland and Spain, the average level of 
consumption of opioid analgesics for the treatment of 
moderate to severe pain was more than five times 
higher in 2007 than it was 10 years earlier. That 
increase is mainly the result of a steady rise in the 
consumption of fentanyl in those countries. 
102. Although there is sufficient supply of opiate raw 
materials worldwide, Governments need to take 
specific measures to ensure adequate access to opioid 
analgesics for the populations in their countries. The 
consumption of opioid analgesics for the treatment of 
pain in many developing countries remains low. While 
several developing countries more than doubled their 
level of consumption of opioid analgesics during the 
past decade, their original level of consumption was 
very low. The Board again urges all Governments 
concerned to identify the impediments in their 
countries to adequate use of opioid analgesics for the 
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treatment of pain and to take steps to improve the 
availability of those narcotic drugs for medical 
purposes, in accordance with the pertinent 
recommendations of WHO. 
103. The Board trusts that the Access to Controlled 
Medications Programme, the framework of which was 
prepared by WHO in cooperation with the Board, will 
provide effective assistance to Governments in that 
regard. Activities of the programme are expected to 
address various impediments to adequate availability 
of opioids, focusing on regulatory, attitude and 
knowledge impediments. The Board will provide 
expertise to WHO in those areas of the programme 
related to its mandate. The Board urges all 
Governments and the international entities concerned, 
such as UNODC, to cooperate with WHO in the 
implementation of the programme. The Board again 
calls upon Governments to provide resources to WHO 
for the implementation of the programme. 
104. Governments should be aware that increased 
availability of narcotic drugs for legitimate medical 
purposes may raise the risk of diversion and abuse of 
those drugs. In the United States, the most frequently 
diverted and abused pharmaceutical preparations are 
those containing hydrocodone and oxycodone. In 2007, 
the United States accounted for over 99 per cent of 
global consumption of hydrocodone and 83 per cent of 
global consumption of oxycodone. The medical use of 
hydrocodone reached 19 defined daily doses for 
statistical purposes (S-DDD) per 1,000 inhabitants per 
day, and the medical use of oxycodone reached 
5 S-DDD per 1,000 inhabitants per day. The Board 
wishes to remind all Governments of the need to 
closely monitor trends in the consumption of 
pharmaceutical products containing narcotic drugs and 
to adopt measures to counter their diversion and abuse, 
as necessary. 
105. Global consumption of methadone has increased 
more than three times over the past decade. Methadone 
is used in several countries for the treatment of pain, 
but the sharp upward trend in its consumption is 
mainly attributable to its growing use in maintenance 
treatment related to opioid dependency. Countries in 
North America (Canada and the United States) and in 
Europe (Germany, Italy and Spain) continue to report 
the highest levels of consumption of methadone. 
However, in recent years, consumption has also 
increased significantly in some countries in other 
regions, in particular in China and Iran (Islamic 
Republic of). The Board requests the authorities of 
those and other countries where methadone is used for 
medical purposes to be vigilant with regard to cases 
involving methadone diversion, trafficking or abuse 
and to take effective countermeasures, if necessary. 
 
 
 B. Psychotropic substances 
 
 
 1. Status of adherence to the Convention on 
Psychotropic Substances of 1971 
 
106. As at 1 November 2008, the number of States 
parties to the Convention on Psychotropic Substances 
of 1971 stood at 183. Of the 11 States that have yet to 
become parties to the 1971 Convention, there are two 
in Africa (Equatorial Guinea and Liberia), one in the 
Americas (Haiti), one in Asia (Timor-Leste) and seven 
in Oceania (Cook Islands, Kiribati, Nauru, Samoa, 
Solomon Islands, Tuvalu and Vanuatu). The Board 
calls on those States which have not yet become parties 
to the 1971 Convention, particularly those in Oceania, 
where the number of non-parties is highest, to accede 
to that Convention without further delay.  
 
 2. Cooperation with Governments 
 
  Submission of statistical data 
 
107. Under the 1971 Convention, parties are obliged to 
furnish to the Board annual statistical reports on 
psychotropic substances. In addition, the Economic 
and Social Council, in its resolutions 1985/15 and 
1987/30, requested Governments to voluntarily provide 
to the Board information on the countries of origin of 
imports and the countries of destination of exports of 
substances listed in Schedules III and IV of the 
1971 Convention. Details of the statistical data 
received, including the status of reporting by 
Governments, and the analysis of such data are 
reflected in the technical report of the Board on 
psychotropic substances.59 
108. The majority of States regularly comply with the 
above reporting requirements by submitting the 
__________________ 
 59  Psychotropic Substances: Statistics for 2007; 
Assessments of Annual Medical and Scientific 
Requirements for Substances in Schedules II, III and IV 
of the Convention on Psychotropic Substances of 1971 
(United Nations publication, Sales No. E/F/S.09.XI.3). 
 E/INCB/2008/1
 
 21 
 
mandatory and voluntary statistical reports, and most 
of the reports are submitted in a timely manner. As at 
1 November 2008, a total of 157 States and territories 
had submitted to the Board annual statistical reports on 
psychotropic substances for 2007 in conformity with 
the provisions of article 16 of the 1971 Convention. 
That accounts for 74 per cent of the States and 
territories required to furnish such statistics. A total of 
130 Governments voluntarily submitted details on the 
countries of origin of imports and countries of 
destination of exports of substances listed in 
Schedules III and IV of the 1971 Convention. In 
addition, for the year 2007, 108 Governments 
submitted voluntarily all four quarterly statistical 
reports on imports and exports of substances listed in 
Schedule II. 
109. Late submission of mandatory annual statistical 
reports creates difficulties for the international control 
of psychotropic substances. The Board regrets that 
some countries, including major manufacturing and 
exporting countries such as Israel, the Netherlands and 
the United Kingdom, have continued to experience 
difficulties in submitting the annual statistical report 
on psychotropic substances before the deadline 
(30 June). In addition, some Governments have not 
provided information on the countries of origin of 
imports or countries of destination of exports of 
substances in Schedules III and IV of the 
1971 Convention, pursuant to Economic and Social 
Council resolutions 1985/15 and 1987/30. Incomplete, 
late or no reporting may indicate deficiencies in the 
national control system. Incomplete or inaccurate 
information on exports and imports hinder the 
identification of discrepancies in trade statistics, 
thereby jeopardizing international drug control efforts. 
The Board urges the Governments concerned to 
identify the reasons that prevented them from 
submitting on time accurate statistical reports to the 
Board and to take all measures necessary to ensure 
their compliance with the provisions of the 
1971 Convention.  
 
  Assessments of requirements for psychotropic 
substances 
 
110. Governments are requested to provide to the 
Board assessments of annual domestic medical and 
scientific requirements for psychotropic substances 
pursuant to Economic and Social Council 
resolution 1981/7 with respect to substances in 
Schedule II of the 1971 Convention and pursuant to 
Council resolution 1991/44 with respect to substances 
in Schedules III and IV of that Convention. The 
assessments are communicated to all States and 
territories to assist the competent authorities of 
exporting countries when approving exports of 
psychotropic substances. As at 1 November 2008, the 
Governments of all countries had submitted to the 
Board at least once their assessments of annual medical 
requirements for psychotropic substances.  
111. The Board recommends that Governments review 
and update the assessments of their annual medical and 
scientific requirements for psychotropic substances at 
least every three years. In January 2008, all 
Governments were asked to review and, if necessary, 
update the assessments of their annual medical and 
scientific requirements for psychotropic substances. As 
at 1 November 2008, 93 Governments had submitted to 
the Board a full revision of the assessments of their 
requirements for psychotropic substances and an 
additional 41 had submitted modifications to 
assessments for one or more substances.  
112. However, 22 Governments have not submitted a 
revision of their legitimate requirements for 
psychotropic substances for at least three years. That is 
a matter of concern to the Board, as the assessments 
valid for those countries and territories may no longer 
reflect their actual medical and scientific requirements 
for psychotropic substances. When assessments are 
lower than the actual legitimate requirements, the 
importation of psychotropic substances needed for 
medical or scientific purposes may be delayed. When 
assessments are significantly higher than legitimate 
needs they may increase the risk of psychotropic 
substances being diverted into illicit channels. The 
Board encourages all Governments to review and 
update their assessments on a regular basis and to keep 
it informed of all modifications.  
 
 3. Prevention of diversion of psychotropic 
substances into the illicit traffic 
 
  Diversion from international trade 
 
113. Licit international trade in psychotropic 
substances in Schedule I of the 1971 Convention is 
limited to sporadic transactions involving no more than 
a few grams per year, since, under the provisions of the 
1971 Convention, those substances may only be used 
for scientific and very limited medical purposes. As a 
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result, there have hardly been any attempts to divert 
such substances from international trade. The last 
attempt to divert a substance in Schedule I took place 
in December 2000, and it was unsuccessful. No 
diversion of a substance in Schedule I from licit 
international trade has ever been reported. 
114. With regard to the substances in Schedule II of 
the 1971 Convention, the situation is similar. While, in 
the past, diversion of those substances from licit 
international trade was one of the main means used to 
supply illicit markets, cases involving the diversion of 
such substances from international trade have become 
rare, thanks to the introduction of additional voluntary 
control measures at the national and international 
levels.  
115. Fenetylline, a substance in Schedule II of the 
1971 Convention, was one of the substances most 
frequently diverted from international trade during 
the 1980s (several hundred kilograms per year) and 
abused in the form of Captagon preparations. After the 
licit manufacture of Captagon preparations was 
stopped in 1985, international control measures and 
vigilance in manufacturing and trading countries 
increased. No diversion of the licitly manufactured raw 
material fenetylline has been reported since 1998. 
However, as the demand for Captagon on the illicit 
market has continued, counterfeit Captagon tablets 
continue to be manufactured illicitly, using illicitly 
manufactured fenetylline or amphetamines. Nowadays, 
most of the seized tablets contain amphetamines, as 
well as stimulants not under international control. The 
countries most affected by trafficking in counterfeit 
Captagon tablets are in West Asia. The counterfeit 
Captagon tablets seized in the various countries 
number in the millions. Most of the seized tablets were 
en route to countries on the Arabian peninsula. The 
Board urges the countries affected by trafficking in 
counterfeit Captagon tablets to collaborate with other 
countries in the region in order to establish a network 
for the exchange of information and the promotion of 
cooperation between law enforcement authorities, in 
particular with a view to establishing profiles for 
determining the countries of origin of seized tablets. 
116. Among the substances in Schedule II of the 
1971 Convention, only amphetamines and 
methylphenidate are manufactured and traded for licit 
purposes in large quantities, mostly for the treatment of 
attention deficit disorder (ADD); in addition, 
amphetamines are used in large quantities for industrial 
processes. Since 1990, no diversion of those substances 
from licit international trade has been identified. This 
positive development is attributable to the control 
measures set forth in the 1971 Convention for 
substances in Schedule II, notably the import and 
export authorization system, which is supplemented by 
additional voluntary control measures recommended by 
the Board and endorsed by the Economic and Social 
Council, such as assessments by countries of their licit 
requirements for psychotropic substances and the 
quarterly reporting of trade statistics. 
117. A similar decline has been observed in cases 
involving diversion from international trade of 
substances in Schedules III and IV, although licit 
international trade in those substances is widespread, 
involving thousands of individual exports each year 
and most of the countries in the world. This positive 
development is attributable to the additional voluntary 
control measures over international trade 
recommended by the Board, endorsed by the Economic 
and Social Council and adopted by the majority of all 
countries, notably the requirement of import and export 
authorizations for trade in substances in Schedules III 
and IV and the assessment by countries of their licit 
requirements for psychotropic substances. 
118. Since 1 November 2007, there has been only one 
case involving the attempted diversion from 
international trade of substances in Schedule III and in 
that case the diversion was prevented with the 
assistance of the Board. The case involved the 
attempted diversion of 25 kg of flunitrazepam from the 
Netherlands to Guinea-Bissau. The competent 
authorities of the Netherlands requested the assistance 
of the Board in verifying the legitimacy of an import 
certificate and other supporting documentation that 
appeared to have been falsified. The Board was able to 
determine that the related import certificate and other 
supporting documentation had been falsified, and the 
planned export was stopped. Flunitrazepam continues 
to be one of the most frequently abused 
benzodiazepines. In 1995, after it was demonstrated 
that preparations containing flunitrazepam, notably 
Rohypnol, were frequently diverted and abused, 
flunitrazepam was transferred from Schedule IV of the 
1971 Convention to Schedule III. Although the illicit 
market for flunitrazepam appears to be supplied mainly 
through the diversion of the substance from domestic 
distribution channels, attempts at diverting the 
 E/INCB/2008/1
 
 23 
 
substance from international trade continue to take 
place. The Board notes that many countries, including 
the main countries manufacturing and importing the 
substance, have, in close cooperation with the 
pharmaceutical industry, adopted strict control policies 
on flunitrazepam. The Board calls upon all 
Governments that have not yet done so to follow that 
example. 
119. With regard to substances in Schedule IV, two 
attempts at the diversion of alprazolam were prevented 
with the assistance of the Board. One involved the 
attempted diversion of 2 million tablets containing 
alprazolam (totalling 4 kg of the substance) from India 
to the Dominican Republic, and the other involved the 
attempted diversion of 30,000 alprazolam tablets from 
Austria to Serbia. In both cases, the method used was 
falsification of the import authorizations. Thanks to the 
vigilance of the national competent authorities, the 
implementation by Governments of the treaty 
provisions for substances in Schedule IV of the 
1971 Convention and the enforcement of additional 
controls over international trade, it was possible to 
thwart both of those attempts at diversion. The Board 
urges all countries that have not yet done so to 
introduce mandatory import authorizations for all 
substances in Schedules III and IV of the 
1971 Convention, as that measure has proved to be 
particularly effective in the identification of diversion 
attempts. The Board also urges all exporting countries 
to use the assessments of requirements of psychotropic 
substances, which are published by the Board on a 
regular basis, to verify the legitimacy of placed orders. 
Trade transactions identified as suspicious because the 
import orders exceed the established assessments 
should be verified with the Board prior to approving 
the export of those substances or brought to the 
attention of the importing country. 
 
  Diversion from domestic distribution channels 
 
120. While most cases involving the diversion of 
psychotropic substances from domestic channels, 
particularly at the retail level, involve relatively small 
quantities, the total quantity being diverted to illicit 
markets may not be negligible. The substances diverted 
most often are stimulants (especially methylphenidate), 
benzodiazepines (especially flunitrazepam and 
diazepam) and the analgesic buprenorphine. 
121. The non-medical use of prescription drugs 
containing psychotropic substances remains a serious 
and growing problem in many countries. For instance, 
according to information provided by United States 
authorities, prescription drugs containing controlled 
substances are one of the most commonly abused 
groups of substances, ranked second only to cannabis 
and above cocaine, heroin and methamphetamine. 
During the four-year period 2004-2007, over 175,000 
benzodiazepine drug items were analysed by forensic 
laboratories in the United States. It was found that the 
most frequently abused benzodiazepines in that period 
were alprazolam, clonazepam and lorazepam, in that 
order. 
122. In recent years, the diversion (from licit 
distribution channels) and abuse of preparations 
containing the analgesic buprenorphine have been a 
cause for concern. The abuse of the substance has been 
increasing above all in countries where buprenorphine 
is used for the treatment of opioid addicts. Preparations 
containing buprenorphine have been smuggled between 
those countries and have also been smuggled out of 
those countries and into countries in other regions.60  
123. With a view to identifying possible gaps in the 
control measures applied to buprenorphine that might 
facilitate those diversions, the Board continues to 
request the governments of countries and territories 
authorizing licit consumption of buprenorphine to 
inform it of details of the control measures applicable 
to buprenorphine in their respective territory. Judging 
from the information received, it appears that 
buprenorphine is subject to the same control measures 
applied to narcotic drugs in 47 per cent of the 
49 countries and territories responding to the request 
by the Board. In an additional 20 per cent of the 
countries and territories, some of the controls for 
narcotic drugs are applied to the distribution of 
buprenorphine when it is used for the treatment of 
opiate addicts. Moreover, over 90 per cent of the 
countries and territories trading in buprenorphine apply 
the import and export authorization system to orders 
involving that substance in accordance with the 
relevant Economic and Social Council resolutions.  
__________________ 
 60  See, for example, Report of the International Narcotics 
Control Board for 2006 (United Nations publication, 
Sales No. E.07.XI.11), paras. 190-192, and Report of the 
International Narcotics Control Board for 2007…, 
para. 114. 
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124. The Board calls upon all Governments to increase 
their vigilance regarding trafficking in and abuse of 
preparations containing buprenorphine and to consider 
enhancing existing control measures applied to the 
domestic distribution of such preparations and the use 
of such preparations for the treatment of addicts, as 
necessary. The Board requests Governments to monitor 
the consumption levels of prescription drugs 
containing psychotropic substances, with a view to 
identifying possible diversions, and to raise public 
awareness about the consequences of the abuse of such 
drugs.  
125. The Board notes that the diversion of 
preparations containing controlled psychotropic 
substances through illegally operating Internet sites 
continues unabated. Significant amounts of those 
substances are abused, not only in the countries in 
which they are diverted, but also in the countries into 
which they are smuggled. There are indications that 
mail is used for drug trafficking to a considerable 
extent in many countries and that improved 
cooperation between postal, customs and police 
authorities at the national and international levels is 
required to deal with that problem effectively.  
 
 4. Control measures 
 
  Assistance to Governments in verifying the 
legitimacy of import transactions 
 
126. The Governments of many exporting countries 
continue to request the assistance of the Board in 
verifying the legitimacy of import authorizations for 
psychotropic substances. The Board maintains a 
collection of samples of official certificates and 
authorizations used for importing narcotic drugs, 
psychotropic substances and precursor chemicals. 
Those samples may be compared with questionable 
import documents, thus assisting Governments in the 
verification of the authenticity of such documents. As 
at 1 November 2008, 116 Governments (57 per cent of 
those requested to do so) had provided the Board with 
a copy of the import authorization currently used by 
their authorities when authorizing imports of controlled 
substances into their countries. The Government of 
every major trading country except Ireland and 
Singapore has provided such a sample. However, the 
Board is concerned that many smaller trading countries 
and territories have not yet done so, which might result 
in the undue delay of legitimate imports. The Board 
calls on the Governments of all countries that have not 
yet provided such samples to the Board to do so 
without further delay. 
127. The Board notes that some responses to its 
requests for confirmation of the legitimacy of import 
orders are received after considerable delay. The Board 
would like to draw the attention of the Governments 
concerned to the importance of responding in a timely 
manner. Failure to confirm the legitimacy of import 
orders may hinder the investigation of diversion 
attempts and/or may cause delays in legitimate trade in 
psychotropic substances and impede the availability of 
psychotropic substances for legitimate purposes. 
 
  National control measures regarding international 
trade 
 
128. Experience has shown that the import and export 
authorization system is the most effective tool for 
preventing the diversion of controlled substances from 
international trade. The Board notes with appreciation 
that in 2007 the Governments of Algeria, Iran (Islamic 
Republic of), Montenegro, Papua New Guinea, the 
Philippines, the Republic of Korea, Singapore and 
Uruguay extended the system of import and export 
authorizations to include some substances that had 
previously not been covered. At present, export and 
import authorizations are required by law for 
substances in Schedules III and IV in more than 
160 countries and territories.  
129. The Board again calls on the Governments of all 
countries that do not yet control the import and export 
of all psychotropic substances using the system of 
import and export authorizations, regardless of whether 
or not they are parties to the 1971 Convention, to 
introduce such controls. Experience has shown that 
countries that are centres of international commerce 
but do not have such controls are at particular risk of 
being targeted by traffickers. The Board therefore 
urges the Governments of countries that are major 
importers and exporters of psychotropic substances to 
extend such controls to all substances in Schedules III 
and IV of the 1971 Convention. 
130. Governments are encouraged to consider revising 
the table showing the countries in which national 
legislation requires the issuing of import authorizations 
for substances in Schedules III and IV of the 
1971 Convention, which is circulated twice a year to 
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all Governments, and to inform the Board of any 
revisions of the requested information. 
131. In addition to the import and export authorization 
system, the system for the assessment of medical and 
scientific needs of psychotropic substances, established 
by the authorities of each country and territory, is the 
most important control measure applied to 
international trade in psychotropic substances. 
Experience has shown that the diversion of 
psychotropic substances can be prevented if exporting 
countries verify whether the quantities ordered by 
importing countries are within the assessments 
established to cover their medical and scientific needs. 
The Board appreciates the cooperation of authorities of 
exporting countries who contact the Board when they 
receive import authorizations for imports of 
psychotropic substances in excess of the assessed 
legitimate requirements. During 2007, the authorities 
of seven countries issued import authorizations for 
substances in Schedule III or IV of the 
1971 Convention without having established 
assessments for those substances. In addition, the 
authorities of 29 countries and 1 territory issued import 
authorizations for substances in Schedule II, III or IV 
in quantities that significantly exceeded their 
assessments. The Board notes with appreciation that 
Governments have become more vigilant when issuing 
import authorizations for psychotropic substances as 
those figures have been decreasing over recent years. 
The Board reiterates its request to Governments that 
have not yet done so to establish a mechanism for 
ensuring that their assessments correspond to their 
actual legitimate needs and not to authorize imports in 
quantities exceeding their assessments. 
 
 5. Consumption of psychotropic substances  
 
132. As noted by the Board in previous reports, the 
consumption levels of psychotropic substances 
continue to differ widely depending on the country and 
region, reflecting cultural diversity in medical practice 
and related variations in prescription patterns. 
However, high and low levels of drug consumption are 
matters of concern to the Board. Increased availability 
of psychotropic substances that is not medically 
justified may lead to the diversion and abuse of the 
substances in question, as shown in the examples 
below. Very low levels of consumption of psychotropic 
substances in some countries may reflect the fact that 
those substances are almost inaccessible to certain 
parts of the population. In response to the demand 
among those segments of the population, those 
substances, or counterfeit medicaments allegedly 
containing the substances, may be offered on 
unregulated markets. The Board reiterates its 
recommendation to all Governments to compare the 
consumption patterns in their countries with those in 
other countries and regions, with a view to identifying 
unusual trends requiring attention and taking remedial 
action, where necessary.  
 
  Stimulants in Schedule II of the 1971 Convention 
that are used for the treatment of attention deficit 
disorder 
 
133. Methylphenidate, amphetamine and 
dexamphetamine, substances in Schedule II of the 
1971 Convention, are used mainly for the treatment of 
ADD (primarily in children) and narcolepsy. Those 
substances have traditionally been used much more 
extensively in the Americas than elsewhere.  
134. Of the stimulants in Schedule II of the 
1971 Convention, methylphenidate is the one most 
widely used. The manufacture and use of 
methylphenidate for the treatment of ADD continue to 
grow. The sharp rise in global manufacture and use of 
methylphenidate reflect mainly developments in the 
United States, where the substance is frequently 
publicized, including in advertisements directed at 
potential consumers. Although calculated consumption 
of methylphenidate in the United States declined 
considerably in 2007, that country continued to 
account for nearly 80 per cent of the calculated global 
consumption of methylphenidate in the years 2005-
2007. The use of the substance for the treatment of 
ADD has increased (albeit to a much lower level) in 
the rest of the world as well, rising sharply in many 
countries. The countries reporting a significant 
increase in the consumption of methylphenidate during 
the last five years include Iceland, Norway, Sweden, 
Belgium, Germany and Canada, in that order.  
135. The Board reiterates its concern that the diversion 
and abuse of stimulants in Schedule II of the 
1971 Convention have taken place in some countries, 
in particular in countries with high prescription levels 
for those substances. The Board requests all 
Governments to ensure that the control measures 
foreseen in the 1971 Convention are applied to 
stimulants in Schedule II and calls on the Governments 
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concerned to increase their vigilance with regard to the 
diversion of, trafficking in and abuse of those 
substances. The Board invites Governments to inform 
it of any new development in that area.  
 
  Buprenorphine 
 
136. Buprenorphine, listed in Schedule III of the 
1971 Convention since 1989, belongs to the family of 
opioids used mainly as analgesics. Since the late 
1990s, however, buprenorphine has increasingly been 
used in the detoxification and substitution treatment of 
opioid addicts and new preparations containing high 
doses of buprenorphine (Subutex®) or buprenorphine 
with naloxone (Subuxone®) have been introduced in 
several countries for the treatment of drug addicts. As a 
result, global manufacture of buprenorphine has 
increased substantially and increasing use of 
buprenorphine has been reported in many countries. 
For instance, the manufacture of buprenorphine 
increased more than 10-fold during the period 1998-
2007, from 460 kg in 1998 to 5 tons in 2007. During 
the same period the number of countries reporting 
imports of buprenorphine increased from 10 to 60. 
Currently, the majority of those countries use the 
substance for the treatment of opioid addiction.  
137. The increased use of buprenorphine for medical 
purposes has been accompanied by increased diversion 
of buprenorphine preparations. As stated in the report 
of the Board for 2006,61 in many countries 
buprenorphine that has been diverted from domestic 
distribution channels or smuggled is used to meet 
demand for the substance on illicit markets. The Board 
reiterates its requests to all Governments to monitor 
closely the distribution of buprenorphine, including 
pharmaceutical products containing buprenorphine, 
and to strengthen the controls applied to that substance, 
where necessary, in order to stop the diversion of that 
substance from the supply chain. 
 
  Stimulants in Schedule IV of the 1971 Convention 
that are used as anorectics 
 
138. The stimulants in Schedule IV of the 
1971 Convention are mainly used as anorectics. The 
most frequently used stimulant in Schedule IV is 
phentermine, followed by fenproporex, amfepramone, 
__________________ 
 61  Report of the International Narcotics Control Board for 
2006 …, paras. 190-192. 
phendimetrazine and mazindol. The Board follows 
closely developments in the consumption of those 
substances to identify consumption levels that may be 
inappropriate for medical purposes and might therefore 
lead to the diversion and abuse of the substances in 
question.  
139. Throughout the 10-year period 1998-2007, 
calculated consumption levels of stimulants in 
Schedule IV of the 1971 Convention were highest in 
the Americas. During the period 2005-2007, average 
calculated consumption of stimulants in Schedule IV 
was 11 S-DDD per 1,000 inhabitants per day in the 
Americas (compared with 2 S-DDD in Europe and 
Oceania, 1 S-DDD in Asia and 0.2 S-DDD in Africa). 
Argentina, Brazil and the United States (in that order) 
continue to be the countries with the highest calculated 
per capita consumption of the stimulants in 
Schedule IV. The Board is pleased to note that in 2006 
Brazil started to apply stricter control measures to the 
stimulants listed in Schedule IV and that, since then, 
the calculated consumption level for those substances 
has declined in that country compared with previous 
years. In 2007, the consumption level for those 
substances declined also in Argentina and the United 
States. However, Argentina, Brazil and the United 
States together accounted in 2007 for 78 per cent of 
global calculated consumption of those stimulants, 
expressed in S-DDD.  
140. In 2007, calculated consumption of stimulants in 
Schedule IV of the 1971 Convention declined in some 
countries in Asia, such as the Republic of Korea and 
Singapore, where in the past the level of consumption 
of those stimulants had been high. In the period 2005-
2007, the average consumption level in those two 
countries was about half of that calculated for the 
Americas. Average calculated consumption levels for 
the stimulants in Schedule IV have been decreasing in 
recent years in Asia as a whole, and in Europe and 
Oceania as well.  
141. The Board encourages Governments reporting 
high levels of consumption of stimulants in 
Schedule IV of the 1971 Convention to monitor the 
situation closely with a view to identifying possible 
overprescribing of anorectics or any other 
unprofessional practice by the medical profession and 
to ensure that domestic distribution channels are 
adequately controlled.  
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 C. Precursors 
 
 
 1. Status of adherence to the United Nations 
Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988 
 
142. As at 1 November 2008, 182 States had become 
parties to the 1988 Convention. The Board again urges 
Equatorial Guinea, the Holy See, Kiribati, the Marshall 
Islands, Namibia, Nauru, Palau, Papua New Guinea, 
Solomon Islands, Somalia, Timor-Leste and Tuvalu to 
implement the provisions of article 12 and ratify the 
Convention without further delay. While all States that 
are major manufacturers, exporters and importers of 
scheduled chemicals are parties to the 
1988 Convention, nearly half of the States in Oceania 
have not ratified the Convention. During 2008, 
attempted diversions of precursors occurred in that 
region, underlining the urgent need for all States to 
become parties to the 1988 Convention.62  
 
 2. Cooperation with Governments 
 
  Submission of statistical data on seizures 
 
143. Article 12 of the 1988 Convention requires all 
parties to submit each year information on chemical 
substances used in the manufacture of illicit drugs. As 
at 1 November 2008, 133 States and territories, 
including the European Commission (on behalf of the 
member States of the European Community), had 
submitted that information. The Board notes that 
Honduras, the Libyan Arab Jamahiriya, the Niger, the 
Sudan and Togo, which had failed to submit that 
information in previous years, have resumed providing 
such information to the Board. The Board notes that 
Serbia has submitted that information for the first time. 
144. Although Angola, Burundi, Gabon and the 
Gambia are States parties to the 1988 Convention, 
those States have never submitted the required 
information. The Board wishes to remind those States 
__________________ 
62  For a comprehensive report on recent developments 
related to precursors, see Precursors and Chemicals 
Frequently Used in the Illicit Manufacture of Narcotic 
Drugs and Psychotropic Substances: Report of the 
International Narcotics Control Board for 2008 on 
the Implementation of Article 12 of the United 
Nations Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988 (United 
Nations publication, Sales No. E.09.XI.4). 
of their obligation under the Convention to report such 
information and of the importance of reporting to the 
Board. 
145. While 50 Governments reported seizures of 
precursor chemicals in 2007, only a few of them 
provided the Board with supplementary information on 
non-scheduled chemicals, methods of diversion and 
stopped shipments. The Board urges the Governments 
of all countries, especially major importing and 
exporting countries such as China, Japan and Pakistan, 
to provide comprehensive information on 
investigations related to seizures and intercepted 
shipments of precursors, since that information is 
crucial in identifying new and emerging trends in illicit 
drug manufacturing and trafficking in precursors. 
 
  Annual submission of information on the licit 
trade in and uses of substances in Tables I and II 
of the 1988 Convention 
 
146. The Board wishes to emphasize that it is 
important for Governments to provide it with 
information on licit trade in, uses of and requirements 
for substances in Tables I and II of the 
1988 Convention. That information has proved to be 
useful in identifying suspicious transactions and 
enabling authorities to prevent the diversion of 
precursor chemicals. Since 1995, the Board has been 
requesting Governments to voluntarily provide that 
information, pursuant to Economic and Social Council 
resolution 1995/20. 
147. By 1 November 2008, 112 States and territories 
had submitted data for 2007 on the licit trade in 
precursors. In addition, 104 Governments had provided 
information for 2007 on licit uses of and requirements 
for those substances. The European Commission has 
also supplied such information for its member States. 
Considering that those efforts have been undertaken on 
a voluntary basis, the Board expresses its appreciation 
to all Governments that have submitted information on 
the licit movement of precursor chemicals and invites 
all Governments to adhere to that practice. 
 
 3. Control measures 
 
148. It is essential for Governments to have in place 
effective measures for controlling the movement of 
precursor chemicals at the national level. Those 
measures, when appropriately enforced, allow 
Government authorities to carefully monitor trade in 
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precursor chemicals and prevent the diversion of such 
chemicals. The Board notes that new legal measures 
were introduced to strengthen precursor control in 
Australia, Belize, China, El Salvador, Honduras, 
Mexico, Nicaragua and South Africa.  
149. There is evidence that because of the successes 
achieved in monitoring international trade in 
precursors over the past few years, traffickers are 
having to look for new distribution channels. To obtain 
precursor chemicals for their illicit drug laboratories, 
most traffickers divert the chemicals from domestic 
trade or smuggle them across national borders. That 
applies, for example, to chemicals used in the illicit 
manufacture of heroin in Afghanistan and in the illicit 
manufacture of cocaine in countries in South America. 
The Board therefore urges Governments to pay due 
attention to their domestic measures for precursor 
control.  
 
  Estimates of legitimate requirements for 
precursors 
 
150. The Commission on Narcotic Drugs, in its 
resolution 49/3, requested member States to provide to 
the Board annual estimates of their legitimate 
requirements for 3,4-methylenedioxyphenyl-2-
propanone (3,4-MDP-2-P), 1-phenyl-2-propanone 
(P-2-P), ephedrine and pseudoephedrine and, to the 
extent possible, estimated requirements for imports of 
preparations containing those substances that could be 
easily used or recovered by readily applicable means. 
As at 1 November 2008, the Governments of 
109 States had provided their annual estimates of those 
legitimate requirements. Those estimates have been 
published in the reports of the Board on the 
implementation of article 12 of the 1988 Convention 
since 2006. In addition, the Board continues to publish 
updated annual estimates of countries’ legitimate 
requirements for precursors of amphetamine-type 
stimulants on its website (www.incb.org). That 
information has assisted Governments in identifying 
shipments with the potential for diversion. Therefore, 
given the usefulness of the data, the Board encourages 
all Governments to continually revise the estimates of 
their requirements and to provide accurate information 
on that subject in a timely manner. In the meantime, 
the Board is in the process of analysing best practices 
in national methodologies for establishing estimates for 
annual estimates of legitimate requirements for 
precursors of amphetamine-type stimulants. 
 4. Online system of pre-export notifications 
 
151. Pre-Export Notification Online (PEN Online), the 
online system for the exchange of pre-export 
notifications, has already had an impact on the control 
of international shipments of precursor chemicals. By 
1 November 2008, 98 countries and territories had 
registered to use the PEN Online system. Since its 
introduction in March 2006, approximately 20,000 pre-
export notifications have been sent to 179 countries 
and territories through the PEN Online portal. The 
Board is pleased to note that an increasing number of 
Governments of importing countries have authorized 
access to the Web-based application. The Board 
welcomes Security Council resolution 1817 (2008), in 
which the Council, inter alia, urged the Governments 
that had not yet done so to register with and utilize the 
PEN Online system. 
152. PEN Online has established itself as an important 
means of communication that can be used for 
strengthening precursor control, giving Governments 
of importing countries an opportunity to instantly 
provide initial feedback on the legitimacy of suspicious 
shipments. Nevertheless, the Board has noted that 
many of the Governments registered with the 
PEN Online system do not use all of the functions 
available in the system, particularly the one that allows 
for the provision of feedback. For example, particular 
attention should be paid to the time frame set by 
Governments of exporting countries for providing 
feedback on pre-export notifications. In order to reduce 
unnecessary delays in legitimate trade, the Board 
strongly encourages Governments to utilize all of the 
functions available in the PEN Online system, 
including the provision of feedback to the Government 
of the exporting country, where necessary.  
 
 5. Prevention of diversion of precursors into the 
illicit traffic 
 
153. The Board continues to support Project Cohesion 
and Project Prism. Both initiatives have yielded results 
identifying trafficking in non-scheduled substances, 
weaknesses in control mechanisms and diversion 
methods and routes. Between 2 January and 
30 September 2008, Project Prism conducted activities 
focusing on trade in ephedrine and pseudoephedrine 
(including pharmaceutical preparations and ephedra 
and identifying shipments), P-2-P and phenylacetic 
acid in Africa, the Americas, West Asia and Oceania. 
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As a result of those activities, a total of 37.1 tons of 
ephedrine and pseudoephedrine (enough to 
manufacture 23.4 tons of methamphetamine) were 
prevented from reaching illicit drug laboratories. The 
intended destination of the precursor chemicals was, in 
most cases, in North America, but the chemicals were 
being diverted through Africa, West Asia and Central 
America, using Europe as a trans-shipment area.  
154. While in some countries mechanisms for 
controlling and monitoring trade in ephedrine and 
pseudoephedrine have been strengthened, traffickers 
have been exploring new means of supplying their 
illicit drug laboratories. New substances are being used 
as precursors in the manufacture of illicit drugs and 
new distribution routes are being utilized. In addition, 
traffickers are placing orders through licit 
pharmaceutical companies and using such companies 
to divert preparations containing ephedrine and 
pseudoephedrine, particularly in Africa and West Asia. 
In Africa, for example, the Democratic Republic of the 
Congo, Ethiopia, Nigeria, South Africa, Uganda, the 
United Republic of Tanzania and Zambia were among 
the countries targeted by traffickers for operations 
involving the diversion or attempted diversion of those 
substances. 
155. Measures introduced by the Government of 
Mexico to prohibit the import of ephedrine and 
pseudoephedrine continue to have an impact on the 
movement of precursors in Central America, where 
imports of those substances have increased 
significantly. Trafficking networks are obtaining 
precursors in Central America and South America and 
establishing illicit drug laboratories. While in some 
countries new legislation is being adopted, legislative 
provisions need to be implemented at a faster pace. 
The Board therefore encourages the Governments of 
countries in Central America and South America to 
strengthen their mechanisms for monitoring precursor 
chemicals and to work together with the Board in 
providing information to help identify all the stages of 
the illicit manufacture of amphetamine-type stimulants. 
156. A time-bound activity was carried out within the 
framework of Project Cohesion from 1 April to 
30 September 2008. The activity focused on the 
exchange of information related to seizures, diversion 
attempts and suspicious shipments of acetic anhydride, 
as well as other chemicals used in the illicit 
manufacture of heroin. During the activity, 20 cases 
involving seizures, diversions and attempted diversions 
of precursors were reported to the Board. 
157. The Board welcomes the positive results achieved 
in the period 2007-2008 in preventing the diversion of 
some of the acetic anhydride destined for Afghanistan. 
The efforts of the international community to counter 
trafficking in chemicals in Afghanistan increased 
noticeably in the period 2007-2008. A number of 
relevant international meetings took place, such as the 
International Conference in Support of Afghanistan, 
held in Paris on 12 June 2008. During 2008, within the 
framework of Project Cohesion, the Board was 
informed of significant seizures of acetic anhydride in 
Afghanistan, Hungary, India, Iran (Islamic Republic 
of), Pakistan, the Republic of Korea, Slovenia and 
Turkey.  
158. The diversion and smuggling of chemicals for use 
in the illicit manufacture of heroin in Afghanistan 
continue to pose problems, and the Board is concerned 
that the control mechanisms currently in place in the 
country may not be sufficient. The Board urges the 
Government of Afghanistan to take additional 
measures, such as strengthening precursor control 
measures, investigating and reporting to the Board all 
seizures of chemicals effected in the country. 
Moreover, the Board wishes to remind all Governments 
of Security Council resolution 1817 (2008), in which 
the Council invited all Member States, in particular 
those producing precursor chemicals, Afghanistan, 
neighbouring countries and all countries on the 
trafficking routes to increase their cooperation with the 
Board, notably by fully complying with the provisions 
of article 12 of the 1988 Convention, in order to 
eliminate loopholes utilized by criminal organizations 
to divert precursor chemicals from licit international 
trade (see also paragraph 224 below). 
159. The Board continues to be concerned about the 
origins of the diverted potassium permanganate in 
South America, as well as the methods used to divert 
the substance. The number of identified or prevented 
diversions of shipments containing chemicals used in 
the illicit manufacture of cocaine from international 
trade continues to decrease. Nevertheless, there is no 
shortage of those chemicals. There are indications that 
traffickers have found ways to obtain the precursor 
chemicals they need by diverting the chemicals from 
domestic trade or smuggling the chemicals across 
national borders within the region. The Board urges 
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Governments to continue to strengthen their controls 
over domestic distribution channels and invites the 
Governments of countries in the Americas to take 
advantage of the experience acquired during Project 
Cohesion, focusing on acetic anhydride, and to design 
similar strategies to combat the diversion of chemicals 
used in the illicit manufacture of cocaine. 
 
 
 D. Promoting universal application of the 
international drug control treaties 
 
 
160. In discharging its mandate under the international 
drug control treaties, the Board maintains an ongoing 
dialogue with Governments through various forms, 
such as regular consultations and country missions. 
That dialogue has been instrumental in the Board’s 
efforts to assist Governments in complying with the 
provisions of the international drug control treaties. 
 
 1. Evaluation of overall treaty compliance by 
selected Governments 
 
161. The Board reviews, on a regular basis, the drug 
control situation in various countries and 
Governments’ compliance with the provisions of the 
international drug control treaties. The review covers 
different aspects of drug control, including the 
functioning of national drug control administrations, 
the adequacy of national drug control legislation and 
policy, measures taken by Governments to combat drug 
abuse and illicit trafficking, and Governments’ 
fulfilment of their reporting obligations under the 
international drug control treaties. The findings of the 
review, as well as the Board’s recommendations for 
remedial action, are conveyed to the Governments 
concerned for consideration.  
162. The Board, as a result of the review, adopts, when 
necessary, positions on particular drug control issues. 
Those positions, which are based on the Board’s 
interpretation of the provisions of the international 
drug control treaties, are communicated to the 
Governments concerned and, when appropriate, made 
public through its annual report.  
163. In 2008, the Board reviewed the drug control 
situation in Brazil, Haiti, Myanmar and the 
Netherlands, as well as measures taken by the 
Governments of those countries to implement the 
international drug control treaties. In doing so, the 
Board paid particular attention to new developments in 
drug control in those countries.  
 
  Brazil 
 
164. The Board has taken note of information recently 
received from the Government of Brazil regarding 
enhanced regulation of the trade in and distribution and 
consumption of psychotropic substances, in particular 
stimulants. The Board notes that the consumption of 
stimulants in Brazil has recently started to decline. In 
addition, the Board has received information on the 
control measures taken by the Government to prevent 
the diversion of precursor chemicals into illicit 
channels.  
165. The Board, while noting the above positive 
developments, remains concerned that drug abuse in 
Brazil has increased substantially; over-prescription of 
stimulants controlled under the 1971 Convention has 
been widespread, and the consumption of stimulants in 
Schedule IV of the Convention continues to be high; 
the diversion of pharmaceutical preparations 
containing controlled substances into illicit markets 
has increased; and the availability of opioid analgesics 
for pain relief continues to be inadequate, well below 
the needs estimated for the population of Brazil. 
Although seizures of precursor chemicals continue to 
be made, the quantity seized is still small. 
166. Since its mission to Brazil in 2003, the Board has 
maintained a close dialogue with the Government, 
through regular communications, as well as meetings, 
with Government officials. In 2006, the Board sent 
another mission to Brazil to review, together with the 
competent national authorities, the measures taken and 
progress made by the Government in the area of drug 
control. The Board’s objective has been to promote the 
Government’s compliance with the international drug 
control treaties.  
167. The Board notes that a new law adopted in Brazil 
in September 2006 represents a significant shift in the 
national drug control policy. According to the new law, 
drug abusers, while remaining subject to penalties, are 
not to be punished exclusively with imprisonment, 
whereas drug traffickers are subject to more stringent 
penalties. The Board views the new law as a positive 
development and urges the Government to provide 
adequate facilities as part of its efforts to address the 
growing drug abuse problem, including treatment, 
counselling and rehabilitation facilities for drug 
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abusers. The Board stresses that it is important to 
strengthen measures aimed at drug abuse prevention, in 
view of the significant challenges that the Government 
is facing in addressing the drug problem. 
168. The Board trusts that the Government of Brazil 
will continue strengthening its efforts in drug control. 
The Board stands ready to continue its dialogue with 
the Government and to provide necessary assistance 
when required.  
 
  Haiti 
 
169. In recent years, Haiti has experienced increasing 
problems involving trafficking in and abuse of drugs, 
particularly cannabis and cocaine. The Board notes that 
national drug control efforts in Haiti have been 
undermined by a lack of coordination within the 
Government and inadequate legislation. The country 
also suffers from insufficient law enforcement and 
judicial capacity, and rule of law is practically non-
existent.  
170. The Board is concerned that Haiti continues to be 
the only country in the Americas that is not yet a party 
to the 1971 Convention. Furthermore, the Board notes 
that new drug control legislation, which was drafted in 
the early 2000s, has yet to be adopted. The Board urges 
the Government of Haiti to take steps to accede to the 
1971 Convention and adopt the new legislation as soon 
as possible.  
171. The Board notes that, despite the existence of a 
national drug control commission in Haiti, the 
Government has yet to approve a long-term national 
drug control strategy. The Board remains concerned 
about the continued lack of information on drug 
trafficking and seizures in Haiti, particularly in view of 
the fact that its geographical position makes the 
country vulnerable to trafficking in drugs, particularly 
cocaine.  
172. The Board recognizes the considerable 
difficulties that the Government of Haiti is facing in its 
efforts to improve the overall economic and social 
situation, particularly in the light of the recent natural 
disasters, which have caused additional suffering 
among the population. However, the Board remains 
concerned that there is little or no information 
available on the measures taken by the Government to 
counter drug abuse and drug trafficking, and that 
makes it difficult for the Board to evaluate the 
situation. 
173. The Board urges the Government of Haiti to take, 
as a matter of priority, measures to strengthen drug 
control and calls on members of the international 
community, particularly the United Nations, to provide 
Haiti with the assistance necessary to address the 
situation.  
 
  Myanmar 
 
174. Myanmar is in a region that, for many years, was 
used as the world’s main area for the illicit cultivation 
of opium poppy. Since 1999, the Government of 
Myanmar has been implementing a 15-year drug 
control plan calling for the elimination of all illicit 
drug production and trafficking by 2014, and sustained 
efforts by the Government to ensure the eradication of 
opium poppy have, over the years, achieved significant 
results. Between 1999 and 2006, an estimated 85 per 
cent of the total area under illicit opium poppy 
cultivation was eradicated, with some international 
assistance.  
175. The Board is concerned, however, about the fact 
that illicit opium poppy cultivation in Myanmar 
increased by 29 per cent in 2007, and potential opium 
production increased by 46 per cent due to a higher 
yield. That was the first time since 2000 that illicit 
opium poppy cultivation had increased considerably 
over the previous year, and there are indications that 
such cultivation might have increased again in 2008.  
176. The Board notes that in Myanmar the provision 
of legitimate alternative livelihoods for farming 
communities engaged in illicit opium poppy cultivation 
continues to pose challenges. The Board, while 
acknowledging the efforts of the Government of 
Myanmar in the eradication of illicit opium poppy 
cultivation, encourages the Government to work with 
the international community to address that problem 
and to take adequate measures to provide legitimate 
alternative livelihoods for those farming communities. 
177. Many communities that were previously engaged 
in illicit opium poppy cultivation have switched to the 
illicit manufacture of methamphetamine, which takes 
place on a large scale in Myanmar and fuels the abuse 
of that substance in many countries in East and South-
East Asia. While recognizing the difficulties the 
Government of Myanmar has faced in expanding its 
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control over areas in the country where illicit drug 
activities take place, the Board urges the Government 
to continue strengthening its efforts to address the 
illicit manufacture of methamphetamine, in 
cooperation with the Governments of neighbouring 
countries.  
 
  Netherlands 
 
178. The Board has longstanding concerns regarding 
certain policies adopted by the Government of the 
Netherlands, in particular the policy that allows small 
amounts of cannabis to be sold and abused in so-called 
“coffee shops”. The Board is also concerned about the 
operation of so-called “drug consumption rooms”, 
facilities where drug addicts can abuse illicit drugs. 
The medical prescription of cannabis and the heroin 
maintenance programme in the Netherlands are also 
issues that the Board is monitoring closely.  
179. The Board has maintained an ongoing dialogue 
with the Government of the Netherlands on those and 
other issues over the years. Some progress has been 
made: in 2003, the Government informed the Board 
that it was terminating its “pill-testing” programme (in 
which persons at clubs and other venues could have 
illicit drugs tested for their “safety”), as it had realized 
that the programme gave young persons the wrong 
message about drug abuse. The Board welcomed that 
decision and urged other Governments conducting 
similar programmes to follow suit.  
180. Furthermore, in August 2004, the Government of 
the Netherlands informed the Board of an important 
change in its policy on cannabis. In an inter-ministerial 
policy paper on cannabis, the Government 
acknowledged that “coffee shops” were “not 
blameless” in the maintenance of the illicit drug trade 
and were not satisfactory in terms of suppressing drug-
related crime. Pursuant to that policy change, the 
Government has been taking measures towards 
reducing the number of “coffee shops” located near 
schools and in border areas and has been taking action 
against uncontrolled outlets. The Board notes that 
those measures have not yet been fully implemented, 
and will continue to closely monitor the situation. The 
Government has also conducted campaigns informing 
the public, in particular young persons, of the dangers 
of cannabis abuse.  
181. The Board notes that drug control is an issue of 
high priority in the Netherlands and that the 
Government continues to spend considerable resources 
in that field. The control of licit activities related to 
narcotic drugs, psychotropic substances and precursor 
chemicals in the Netherlands is strict and effective, and 
the Government has cooperated closely with the Board 
on most issues. The Government has continued to 
strengthen law enforcement efforts to address 
the problem of illicit manufacture of 
amphetamine-type stimulants, in particular 
methylenedioxymethamphetamine (MDMA), and to 
cooperate with the Board in joint operations to improve 
precursor control. 
182. The Board welcomes the shift in the policy of the 
Government of the Netherlands regarding “coffee 
shops”, which is an important step towards full 
compliance with the provisions of the international 
drug control treaties. The Board trusts that the 
Government will also review its policy on “drug 
consumption rooms” and urges the Government to take 
the measures necessary to terminate the operation of 
such facilities. The Board notes that the Government 
has commissioned an independent evaluation of the 
national drug control policy. The Board trusts that the 
evaluation, to be conducted in 2010, will provide an 
opportunity for the Government to reconsider the 
above-mentioned aspects of its policy and to comply 
fully with its international obligations under the 
international drug control conventions.  
183. At the invitation of the Board, a high-level 
delegation from the Government of the Netherlands 
attended the ninety-third session of the Board, in 
November 2008, to discuss and exchange views with 
the Board on issues related to the Government’s 
implementation of the international drug control 
conventions. The Board appreciates the detailed 
information presented by the delegation regarding the 
drug control situation in the Netherlands and looks 
forward to continuing its ongoing dialogue with the 
Government regarding the compliance of the 
Netherlands with the international drug control 
conventions and on other drug control issues.  
 
 2. Evaluation of the implementation by 
Governments of recommendations made by the 
Board following its country missions 
 
184. As part of its ongoing dialogue with 
Governments, the Board conducts, on a yearly basis, an 
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evaluation of the implementation of its 
recommendations pursuant to its missions to countries.  
185. In 2008, the Board invited the Governments of 
the following six countries to provide information on 
the implementation of its recommendations pursuant to 
its missions to those countries in 2005: Bangladesh, 
Ghana, Lesotho, Mexico, Russian Federation and Saudi 
Arabia. The Governments of those countries were 
requested to provide information on the 
implementation of the Board’s recommendations, 
including any achievements made and difficulties 
encountered.  
186. The Board appreciates the timely submission of 
information by the Governments of Bangladesh, 
Ghana, Mexico and the Russian Federation. The 
information received enabled the Board to assess the 
drug control situation in those countries and the 
Governments’ compliance with the international drug 
control treaties. Information provided by the 
Government of Lesotho was received too late for 
review by the Board and will therefore be presented in 
the report of the Board for 2009.  
187. The Board regrets that, despite its repeated 
requests, no information was received from the 
Government of Saudi Arabia. The Board urges the 
Government to provide the requested information 
without further delay.  
 
  Bangladesh 
 
188. The Board notes that the Government of 
Bangladesh has been making efforts to strengthen drug 
control since the mission of the Board to that country 
in 2005. In particular, the Board notes that additional 
resources have been allocated to the Department of 
Narcotics Control of Bangladesh and that the National 
Narcotics Control Board, the inter-ministerial body 
responsible for coordinating drug control policy in the 
country, has resumed its activities. Bangladesh has also 
improved its cooperation with neighbouring countries, 
particularly India, in the field of law enforcement.  
189. At the same time, the Board is concerned that 
much work remains to be done in Bangladesh in 
strengthening the control at the retail level of 
pharmaceutical preparations containing controlled 
substances. Though legislation and regulations in this 
area are by and large adequate, the Government of 
Bangladesh has been unable to ensure adequate 
compliance, and it is often possible to obtain those 
preparations without a prescription. The Board requests 
the Government to take urgent measures in that area to 
ensure that the distribution of controlled substances at 
all levels is closely monitored and that such substances 
are used only for medical and scientific purposes.  
190. The Board continues to be concerned about the 
inadequate measures for reducing illicit drug demand 
in Bangladesh. The availability of facilities for the 
treatment of drug abuse continues to be limited, and 
there is a lack of reliable data on the drug abuse 
situation in the country. The Board notes that the 
Government is taking measures to strengthen its 
capacity in those areas through, for example, the 
establishment of centres for the treatment of drug 
abuse throughout the country. The Board encourages 
the Government to continue its demand reduction 
efforts.  
 
  Ghana 
 
191. The Board notes that some progress in drug 
control has been made by the Government of Ghana 
since the mission of the Board to that country in 2005. 
Following major restructuring in the field of drug 
control, including the introduction of a number of 
measures to strengthen coordination among the 
relevant Government agencies, the Narcotics Control 
Board, the main coordinating body for drug control in 
the country, resumed its activities in December 2007. 
The Narcotics Control Board has established an inter-
agency committee on demand reduction. It has also 
developed a strategic plan for the period 2008-2010 to 
strengthen drug law enforcement, control of the licit 
trade in scheduled substances and drug abuse 
prevention.  
192. The Government of Ghana has acted on the 
Board’s recommendation on complying with the 
reporting obligations under the international drug 
control treaties and, as a result, substantial progress has 
been made in that area in recent years. The 
Government has also acted upon the Board’s 
recommendations on demand reduction. Since its 
establishment in January 2007, the Demand Reduction 
Directorate has actively conducted awareness-raising 
activities in schools and has initiated programmes for 
the training of medical doctors in the principles of 
rational prescription of opioids, as well as programmes 
for the rehabilitation and reintegration of drug abusers. 
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The Board encourages the Government to conduct a 
rapid assessment survey of the drug abuse situation in 
the country, in order to address the problem of drug 
abuse in a more effective manner.  
193. The Board notes that little progress has been 
made in ensuring the availability of narcotic drugs for 
medical purposes in Ghana. The availability of opiates 
for the treatment of pain in medical institutions 
continues to be inadequate. The Board requests the 
Government to examine the current situation and take 
the steps necessary to ensure that narcotic drugs, 
particularly opiates, are made available for medical 
purposes.  
194. In addition, lack of legislation on precursor 
control and the absence of a designated competent 
authority for the implementation of the provisions of  
article 12 of the 1988 Convention continue to be areas 
that the Government of Ghana needs to address. The 
Board urges the Government to make additional efforts 
so that progress is made in those areas. The Board 
trusts that the Government will continue its efforts to 
comply fully with the international drug control 
treaties.  
 
  Mexico 
 
195. The Board notes that, since its 2005 mission to 
Mexico, the Government has taken measures to 
implement the recommendations of the Board. Progress 
has been made in certain areas of drug control.  
196. Shortly after the Board’s last mission to Mexico, 
the Government formally invoked article 12 of the 
1988 Convention regarding pre-export notifications for 
the importation of all precursors. The Government has 
also strengthened controls over ephedrine and 
pseudoephedrine, introducing additional control 
mechanisms such as regulations on the prescription of 
preparations containing pseudoephedrine and on 
limiting the quantities of the two substances that can be 
imported. The Government, while eradicating the illicit 
cultivation of opium poppy and cannabis, has 
continued carrying out alternative development 
projects covering 75 per cent of the areas where such 
illicit cultivation takes place. The Government has also 
taken concrete steps towards addressing the problem of 
corruption.  
197. The Board, while acknowledging those positive 
developments, notes that there remain significant 
challenges for the Government of Mexico. Though the 
Government continues to make considerable efforts, 
corruption remains a serious obstacle in drug control 
activities at the national, state and local levels, and 
organized criminal organizations wield considerable 
power in some areas of the country. Despite the 
concrete steps taken by the Government, the abuse of 
drugs remains high, particularly among school children 
and the young population. There continues to be 
substantial illicit cultivation of opium poppy and 
cannabis, and drug trafficking continues to pose 
serious problems. 
198. The Board notes that there continue to be 
weaknesses in the inspection of retail outlets in Mexico 
for pharmaceutical preparations containing controlled 
substances. There is also a need to provide training for 
pharmacists in ensuring that the dispensing of 
controlled substances is closely monitored and that 
such substances are used only for medical purposes. 
The Board encourages the Government to continue its 
efforts to ensure the adequate availability of opiates for 
medical purposes, following the adoption in 2006 of 
the guidelines on normative standards for the diagnosis 
and administration of palliative medicines.  
199. The Board acknowledges the commitment of the 
Government of Mexico to drug control and trusts that 
continued measures will be taken against illicit crop 
cultivation, illicit drug manufacture and trafficking, the 
diversion of controlled substances and drug abuse in 
the country.  
 
  Russian Federation 
 
200. Drug trafficking and abuse have increased 
substantially in the Russian Federation since the 1990s, 
following the breakup of the Soviet Union. The abuse 
of opiates, in particular heroin, is a matter of major 
concern, drug abuse by injection being the main factor 
behind the rapidly growing HIV epidemic. The 
Government has recognized that the drug problem 
poses a major threat to national security and has 
continued taking measures in various areas of drug 
control to address the problem.  
201. The Board notes that steps have been taken by the 
Government of the Russian Federation to implement 
the recommendations made pursuant to the Board’s 
mission to that country in 2005. In particular, the 
Government has strengthened administrative structures 
in drug control to improve national coordination, 
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including by creating the State Anti-Drug Committee. 
The recently created Committee is comprised of a wide 
range of government agencies, including those 
responsible for issues related to the media and culture. 
The Board welcomes that effort to ensure that drug 
control involves all segments of society.  
202. The Government of the Russian Federation has 
continued taking steps to strengthen supply reduction 
and law enforcement. Measures have been taken to 
strengthen border control: new equipment has been 
purchased and training has been provided to the border 
control agencies and, as a result, there has been an 
increase in drug seizures. The Government has also 
changed the approach of law enforcement, from one 
targeting individual drug abusers to one with an 
emphasis on combating organized crime. Furthermore, 
the Government has acted upon the Board’s 
recommendation on reporting obligations and 
improved the timeliness of its statistical reports 
submitted to the Board pursuant to the international 
drug control treaties.  
203. One of the Board’s key recommendations 
following its 2005 mission was that the Government of 
the Russian Federation should maintain a balanced 
approach to drug control, not only continuing to 
strengthen its efforts in supply reduction, but also 
making more efforts in the area of demand reduction. 
The Board notes that the Government has taken 
measures in that area since the 2005 mission. The 
Board trusts that the Government will continue to 
make progress towards ensuring a comprehensive 
approach to addressing the drug abuse problem in the 
country.  
204. The Board notes that there is still no possibility 
for non-violent drug offenders in the Russian 
Federation to receive alternative sentences in lieu of 
imprisonment. The Board notes the provisions of the 
international drug control conventions on this issue, in 
particular article 3, paragraph 4 (b) and (c), of the 1988 
Convention, according to which States parties may 
provide measures such as treatment, education, 
aftercare, rehabilitation or social reintegration in 
appropriate cases. The Board encourages the 
Government of the Russian Federation to adopt such 
measures.  
*** 
205. The Board has received information from the 
Governments of Indonesia, Pakistan and Thailand on 
the implementation of the Board’s recommendations 
pursuant to its missions to those countries in 2004. As 
that information was received too late to be included in 
its report for 2007, the Board has published the 
outcome of its review in the present report.  
 
  Indonesia 
 
206. The Board notes that progress has been made by 
the Government of Indonesia in some areas of drug 
control, following its mission to that country in 2004. 
In particular, the Government has taken considerable 
measures in the area of precursor control, including the 
adoption of regulations to strengthen import and export 
licensing of precursors used for both pharmaceutical 
and industrial purposes. The Government has also 
adopted a second national action plan on precursor 
control, covering the period 2006-2010. The action 
plan includes the revision of legislation to enhance 
controls on precursors and the establishment of 
provincial and municipal task forces for precursor 
control. The Board welcomes those measures and trusts 
that the Government will fully implement the national 
action plan.  
207. The Board also notes that the Government of 
Indonesia has continued its efforts in demand 
reduction, for example through the development of 
facilities for the treatment of drug abuse and 
community-based prevention programmes. The Board, 
in view of the worsening situation of drug abuse in 
Indonesia, urges the Government to further strengthen 
its efforts in that area. In particular, the Board 
encourages the Government to conduct a nationwide 
assessment of the drug abuse situation and to take all 
necessary measures, in accordance with the 
international drug control treaties, to address the 
problem. 
208. The Board notes that there appears to be a lack of 
progress in several other areas, including the 
strengthening of coordination among national 
ministries and agencies involved in drug control, and 
the ensuring of adequate availability of narcotic drugs 
for medical needs, particularly pain management. The 
Board trusts that the Government of Indonesia will 
take the measures necessary to ensure that progress is 
made in those areas as well.  
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  Pakistan 
 
209. The Board notes that efforts have been made by 
the Government of Pakistan in the implementation of 
the Board’s recommendations following its mission to 
that country in 2004. The Government has allocated 
considerable resources in addressing the problem of 
drug abuse in the country, with its ongoing efforts in 
the areas of prevention, treatment and rehabilitation of 
drug addicts. In 2005, the Government established two 
model addiction treatment and rehabilitation centres in 
the country, with the active involvement and 
contribution of non-governmental organizations in that 
area. In 2006, the Government conducted a national 
assessment of drug abuse in the country, with the 
assistance of UNODC. The Board encourages the 
Government to continue its efforts in the area of 
demand reduction, in particular in strengthening 
systems for the collection of data on trends in drug 
abuse in the country. 
210. While welcoming the above positive 
developments in drug control, the Board is concerned 
that its recommendations to strengthen the control of 
pharmaceutical preparations containing controlled 
substances have not yet been implemented and that 
there is significant abuse of those preparations in the 
country. The Board urges the Government to expedite 
the process of making new regulations for effective 
control of those substances in order to prevent their 
diversion from licit distribution channels and their 
abuse.  
211. Furthermore, the Government has yet to put in 
place efficient control mechanisms for precursor 
chemicals passing through Pakistan destined for 
Afghanistan and to take law enforcement measures 
against the illegal distribution of pharmaceutical 
preparations containing controlled substances through 
Internet pharmacies located in the country. Measures 
should also be taken to address the resurgence of illicit 
opium poppy cultivation in the country. The Board 
trusts that the Government will continue its efforts in 
drug control, particularly in those areas where progress 
is lacking, to ensure that the provisions of the 
international drug control treaties are fully 
implemented in Pakistan. 
 
  Thailand 
 
212. The Board sent a mission to Thailand in 2004 to 
review the drug control situation in the country, 
including measures taken by the Government as part of 
the “war on drugs”. The “war on drugs” was a national 
campaign conducted by the Government in early 2003, 
when Thailand had the highest rate of abuse of 
amphetamine-type stimulants (specifically 
methamphetamine) in the world. The “war on drugs” 
resulted in a large number of killings, many in what 
could only be described as suspicious circumstances.  
213. The mission found that independent committees 
had been established to examine every killing that had 
taken place during the national campaign and, if 
necessary, to bring charges against any official 
implicated. Pursuant to the findings of the mission, the 
Board has requested the Government of Thailand to 
keep it informed of any developments with regard to 
those investigations. Since then, the Board has been in 
close contact with the Government on that issue.  
214. The Board notes that, according to information 
recently received from the Government of Thailand, a 
total of 55 law enforcement officers are to be 
prosecuted for possible involvement in killings during 
the “war on drugs”. The Government has also informed 
the Board that it does not intend to recommence the 
“war on drugs” and that any measure taken by the 
Government against drug trafficking will be in 
accordance with human rights principles. The Board 
notes that current efforts of the Government to counter 
drug trafficking and abuse are aimed at, among other 
things, increasing community involvement in 
combating drug problems, at least partially to monitor 
Government measures and ensure that legal bounds are 
respected. 
215. The Board also recommended that the 
Government ensure greater availability of opiates for 
pain management in Thailand. The Board notes that the 
availability of those substances remains low in the 
country and encourages the Government once again to 
evaluate its procedures in that area. 
 
 3. Promoting dialogue with Governments  
 
216. Pursuant to the international drug control treaties, 
the Board invites, when appropriate, Government 
delegations to its sessions with a view to promoting 
dialogue with Governments on treaty compliance. In 
2008, the Board invited delegations from Bolivia, the 
Netherlands (see paragraph 183 above) and 
Switzerland. 
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  Bolivia 
 
217. At the invitation of the Board, a high-level 
Government delegation from Bolivia attended the 
ninety-third session of the Board, in November 2008, 
to discuss and exchange views with the Board on 
issues related to the country’s implementation of the 
international drug control conventions. The Board 
appreciates the detailed information presented by the 
delegation on the drug control situation in Bolivia and 
on measures taken by the Government in drug control.  
218. While noting the explanations provided by the 
delegation, the Board continues to be concerned about 
certain aspects of drug control policy in Bolivia that 
contravene the international drug control conventions. 
National legislation allows the cultivation and 
consumption of coca leaf for non-medical purposes, in 
particular coca leaf chewing. That is contrary to the 
provisions of the 1961 Convention, in particular 
article 4 of the Convention, which obligates States 
parties to “limit exclusively to medical and scientific 
purposes the production, manufacture, export, import, 
distribution of, trade in, use and possession of drugs”. 
219. The Board notes that the Government of Bolivia 
is currently reviewing national drug control legislation, 
with a view to allowing the use of coca leaf for 
traditional purposes and for a wide range of industrial 
products, some of which are for export. The Board 
urges the Government to ensure that any measure 
adopted complies with Bolivia’s obligations under the 
1961 Convention. 
 
  Switzerland 
 
220. A high-level Government delegation from 
Switzerland was invited to the ninety-second session of 
the Board, in May 2008, to discuss and exchange views 
with the Board on issues related to Switzerland’s 
implementation of the international drug control 
treaties. The Board appreciates the detailed information 
presented by the delegation regarding the drug control 
situation in Switzerland and measures taken by the 
Government against drug trafficking and abuse. 
221. The Board notes, in particular, that the plan to 
propose the decriminalization of cannabis has been 
rejected and that the Government has recently 
informed the Board of its decision to establish a 
national cannabis agency, pursuant to article 28 of the 
1961 Convention. The Board welcomes those positive 
developments in drug control in Switzerland. 
222. The Board, while noting the explanations given 
for the operation of “drug consumption rooms” in 
Switzerland, urges the Government to provide adequate 
treatment facilities to drug addicts in accordance with 
the provisions of the international drug control treaties. 
The Board will maintain its dialogue with the 
Government of Switzerland and looks forward to 
continued close cooperation with the Government in 
that and other drug control matters. 
 
 
 E. Measures to ensure the implementation 
of the international drug control 
treaties 
 
 
 1. Action of the Board taken pursuant to article 14 
of the 1961 Convention and article 19 of the 
1971 Convention 
 
223. Article 14 of the 1961 Convention as amended by 
the 1972 Protocol and article 19 of the 
1971 Convention set out measures that the Board may 
take to ensure the execution of the provisions of those 
conventions. The Board has invoked such measures 
vis-à-vis a limited number of States for their persistent 
failure to bring their control measures into conformity 
with the conventions. Most of those States have taken 
remedial measures, which has led to the Board’s 
decision to terminate action under article 14 of the 
1961 Convention and article 19 of the 
1971 Convention.  
 
 2. Consultation with the Government of 
Afghanistan pursuant to article 14 of the 
1961 Convention 
 
224. In 2008, the international community continued 
its efforts towards rebuilding Afghanistan and 
addressing drug-related problems in that country. The 
Security Council adopted resolution 1817 (2008), in 
which it called upon all Member States to increase 
international and regional cooperation in order to 
counter the illicit drug production and trafficking in 
Afghanistan, including by strengthening the 
monitoring of the international trade in chemical 
precursors and to prevent attempts to divert the 
substances from licit international trade for illicit use 
in Afghanistan. In addition, the International 
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Conference in Support of Afghanistan was held in 
Paris in June 2008, resulting in a significant amount of 
funds being pledged for assistance for the Government 
of Afghanistan. The Board welcomes those important 
events and, as an independent treaty body, will 
continue to monitor the drug control situation in 
Afghanistan to ensure that progress is made by the 
Government pursuant to article 14 of the 
1961 Convention.  
225. The Board invoked article 14 of the 
1961 Convention against Afghanistan in 2000. The 
Board’s action was based on its assessment that the 
Government’s inability to stop the illicit cultivation of 
opium poppy was seriously endangering the aims of 
the 1961 Convention. In 2001, the Board called the 
attention of the international community, in particular 
the Commission on Narcotic Drugs and Economic and 
Social Council, to the situation in Afghanistan.  
226. Over the past few years, the Board has made 
interventions vis-à-vis the Government and the 
international community as appropriate. In particular, 
the Board has maintained close contact with the 
Government of Afghanistan, including by sending 
high-level missions to the country and inviting the 
Government to send delegations to its sessions for 
discussion. The Board has also provided technical 
assistance to Afghanistan, for example in the form of 
training for Afghan authorities in the implementation 
of the international drug control treaties.  
227. The Board notes with concern that Afghanistan 
remains the source of over 90 per cent of all the 
illicitly cultivated opium poppy in the world. In 2008, 
the area under illicit opium poppy cultivation in 
Afghanistan totalled over 157,000 hectares (ha), and 
the country’s opium production, estimated at 7,700 
tons, was the second largest in history. The Board, 
while noting that in 2008 illicit opium poppy 
cultivation decreased by 19 per cent and opium 
production decreased by 6 per cent, urges the 
Government and the international community to 
continue their efforts to eliminate illicit opium poppy 
cultivation in Afghanistan. 
228. About 98 per cent of the illicit opium poppy 
cultivation in Afghanistan takes place in seven 
provinces in the southern and south-western parts of 
the country, where security remains problematic. That 
underlines the fact that the situation cannot truly be 
reversed without the Government exercising effective 
control over all areas of the country. That fact is 
evidenced by the limited progress made in the opium 
poppy eradication campaign carried out in 2008. Only 
5,017 ha of illicitly cultivated opium poppy were 
eradicated that year, compared with 19,047 ha in 2007 
and 15,300 ha in 2006. The total area of opium poppy 
eradicated in 2008 represented only 10 per cent of the 
target set for that year.  
229. The illicit cultivation of opium poppy is not the 
only drug control problem in Afghanistan. The Board 
notes with concern that the illicit cultivation of 
cannabis plants in the country has increased 
significantly over the past few years. In 2008, illicit 
cannabis cultivation was reported in 14 provinces, not 
only in areas in which opium poppy is illicitly 
cultivated but also areas that have been declared free of 
opium poppy. Farmers have been switching from 
opium poppy cultivation to cannabis cultivation, as 
cannabis cultivation is becoming increasingly lucrative 
in Afghanistan and no action has been taken by the 
Government to prevent such cultivation. The Board 
strongly urges the Government to take measures to 
address the situation. The Board calls upon the 
international community to provide assistance to the 
Government of Afghanistan to facilitate its efforts to 
eliminate all illicit drug activity on its territory, 
including the illicit cultivation of cannabis plants.  
230. The Board notes that, although there has been no 
legitimate use for acetic anhydride in Afghanistan, 
orders for that substance to be sent to Afghanistan have 
continued to be placed in some countries in Asia and 
Europe. During 2007 and 2008, the Board was 
informed of significant seizures of acetic anhydride in 
countries in West Asia, including Afghanistan, and of 
deliveries totalling several hundred tons of acetic 
anhydride being prevented in a number of countries 
outside that region. Most of the acetic anhydride seized 
had been diverted from domestic distribution channels.  
231. As discussed in more detail in paragraphs 677-
678 below, the control mechanisms currently being 
applied, particularly those for precursor chemicals, are 
not sufficient to prevent the flow of diverse chemicals 
into Afghanistan and their diversion for use in the 
illicit manufacture of heroin. The Board urges the 
Government of Afghanistan to strengthen precursor 
control in Afghanistan, to increase the interdiction and 
investigation capacity of the national law enforcement 
authorities and to report to the Board on any seizures 
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of chemicals effected on its territory. The Board wishes 
to remind all Governments, in particular the 
Governments of Afghanistan and of the countries 
neighbouring Afghanistan, of the importance of 
implementing Security Council resolution 1817 (2008) 
(see the 2008 report of the Board on the 
implementation of article 12 of the 1988 Convention).  
232. The Board notes with concern that excessive and 
easy availability of illicit drugs in Afghanistan has 
contributed to an increase in drug abuse in the country. 
A drug abuse survey in Afghanistan conducted by 
UNODC in 2005 indicated growing problems 
involving the abuse of opiates and cannabis, as well as 
significant abuse of pharmaceutical preparations. To 
address those problems, the Government adopted in 
2008 an action plan on demand reduction covering the 
period 2008-2012. The Board welcomes that 
development and urges the Government to take the 
steps necessary to ensure its implementation. The 
Board urges the Government to ensure that adequate 
measures are taken to address drug abuse among 
particularly vulnerable groups in the country, including 
women.  
233. As pointed out by the Board in its annual reports, 
drug-related corruption in Afghanistan is a widespread 
and deep-seated problem that has seriously impeded 
the Government’s efforts to address other drug-related 
problems. The Board notes with concern that corrupt 
officials allow drug traffickers to continue to operate 
with impunity, while officials attempting to address the 
situation are often subjected to harassment, violence or 
death threats. The Board wishes to reiterate that 
success in addressing drug-related corruption requires 
strong political will and firm action by the Government 
and that clear, measureable results are needed in this 
area. The Board urges the Government to take effective 
measures against corrupt officials at any level of 
government who are involved in illicit drug activities 
and to make public the outcome of any such measures. 
234. Afghanistan is a party to the three international 
drug control treaties. However, despite the serious drug 
control problems in the country, it remains one of the 
very few countries that has yet to become party to the 
1972 Protocol amending the 1961 Convention. The 
Board calls on the Government of Afghanistan to 
accede to that legal instrument as a matter of priority.  
 
 
 F. Special topics 
 
 
 1. Follow-up to the twentieth special session of the 
General Assembly  
 
  Preparations for the high-level segment of the 
fifty-second session of the Commission on 
Narcotic Drugs  
 
235. As part of the follow-up to the twentieth special 
session of the General Assembly, the Board conducted 
in 2007 an evaluation of the worldwide implementation 
of the international drug control treaties, based on 
information submitted by Governments through a 
questionnaire. Consequently, a report on the findings 
of the evaluation was submitted to the Commission on 
Narcotic Drugs at its fifty-first session, in March 2008, 
for consideration by Governments.  
236. A report on the follow-up to the Twentieth 
Special Session has been published by the Board.63 
The report outlines the activities undertaken by the 
Board and progress made in following up the twentieth 
special session of the General Assembly. The report 
also identifies the significant challenges that remain 
and presents the Board’s recommendations on further 
action to be taken by Governments and relevant 
international organizations in the area of drug control.  
237. Furthermore, pursuant to Commission on 
Narcotic Drugs resolution 51/4, the Board has been 
actively involved in the preparations for the high-level 
segment of the fifty-second session of the Commission 
on Narcotic Drugs, related to the follow-up to the 
twentieth special session of the General Assembly. The 
Board participated in and contributed substantively to 
the five open-ended intergovernmental expert working 
groups. In particular, the Board provided the expert 
working groups with papers on five topics: (a) drug 
demand reduction; (b) supply reduction; (c) countering 
money-laundering and promoting judicial cooperation; 
(d) international cooperation on the eradication of 
illicit drug crops and on alternative development; and 
(e) control of precursors and of amphetamine-type 
stimulants.  
__________________ 
 63  Report of the International Narcotics Control Board on 
Follow-up to the Twentieth Special Session of the 
General Assembly (United Nations publication, 
Sales No. E.09.XI.7). 
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238. The papers provided to the working groups 
reflect the views of the Board on the different topics 
under discussion, outlining progress made and 
challenges in those areas, as well as recommendations 
of the Board. The Board notes that its views have been 
reflected in the deliberations of the working groups and 
in the final outcome of the process of reviewing the 
follow-up to the twentieth special session of the 
General Assembly.  
239. The Board wishes to underline that the goals set 
for 2008 by the General Assembly at its twentieth 
special session continue to be as relevant and as 
important as they were in 1998 and that new challenges 
to international drug control have emerged. The Board 
calls upon Governments and the entire international 
community to continue their efforts to achieve further 
progress in addressing the world drug problem. The 
Board will continue to work closely with Governments 
and relevant international organizations towards the 
adoption at the high-level segment of the fifty-second 
session of the Commission on Narcotic Drugs, to be 
held in March 2009, of a political declaration and 
action plans for future action. 
 
  Important role of civil society in drug control 
 
240. The Board takes note of the declarations and 
resolutions adopted at “Beyond 2008”, a forum of non-
governmental organizations held in Vienna from 7 to 
9 July 2008. The Board has always believed that, with 
their knowledge and experience, members of civil 
society, including non-governmental organizations, 
play an important role in international drug control. In 
this regard, the Board may use relevant information in 
its assessment of the drug control situation in various 
countries and of Governments’ compliance with the 
international drug control treaties. 
 
  The first World Forum against Drugs 
 
241. The first World Forum against Drugs was held in 
Stockholm from 8 to 10 September 2008. The main 
theme of the Forum was 100 years of drug prevention. 
More than 600 participants representing 82 countries 
attended the Forum. The President of the Board 
participated in the Forum. The Forum presented an 
opportunity to bring together researchers and 
representatives of organizations dealing with illicit 
drug problems in all parts of the world. The Forum 
concluded by adopting a resolution against the non-
medical use (abuse) of narcotic drugs. The Forum 
marked the start of a global network of organizations 
united in their support of the international drug control 
treaties. 
 
 2. Cocaine trafficking in West Africa 
 
242. In recent years, there has been a marked increase 
in the smuggling of cocaine consignments from South 
America through West Africa into Europe. Drug 
traffickers target countries with weak governmental 
structures that have limited capacity to defend 
themselves against drug trafficking and its 
consequences, such as corruption and drug abuse. The 
Board has serious concerns that drug trafficking will 
undermine political, economic and social structures in 
those countries, weakening the control of Governments 
over their territories and institutions. 
243. It is estimated that about 27 per cent (40 tons) of 
the cocaine abused each year in Europe was smuggled 
through West Africa. Drugs are smuggled through 
almost all the countries in West Africa: Cape Verde, 
Ghana, Guinea, Guinea-Bissau, Liberia, Mali, 
Mauritania, Nigeria, Senegal and Sierra Leone. 
Governments of countries in the region reported 
seizures of cocaine totalling about 3 tons in 2006 and 
over 6 tons in 2007; in previous years, the total 
quantity seized was significantly lower.  
244. The increase in seizures is a welcome 
development, indicating that there is a growing 
awareness among law enforcement authorities in those 
countries about cocaine trafficking and that the 
political will to address the problem exists. However, 
cocaine seizures in West Africa are often haphazard, 
and law enforcement and judicial capacity to 
investigate and prosecute drug traffickers is inadequate 
in many countries in West Africa. Many countries also 
have serious problems involving corruption, making 
them prime targets for drug trafficking organizations.  
245. As cocaine trafficking has increased, the abuse of 
the drug has also increased in West Africa, although the 
level still remains low compared with that of other 
regions. The rise in cocaine abuse is a matter of serious 
concern, particularly in view of the fact that, in many 
of those countries, law enforcement and judicial 
capacity is inadequate, and demand reduction 
programmes have yet to be developed.  
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246. Increased cocaine trafficking through West Africa 
will have a significant impact on the drug control 
situation not only at the national level, but also at the 
regional and international levels. The situation needs to 
be urgently addressed by the Governments concerned, 
as well as by the international community. 
247. The Board notes that the international community 
has responded actively to the surge in cocaine 
trafficking in West Africa. Following a call by the 
Security Council for the leaders of Guinea-Bissau to 
take action against drug trafficking, the international 
community committed funds to support drug control 
efforts in that country. The Board calls upon the 
international community, particularly the United 
Nations, to provide Governments of countries in West 
Africa with all the assistance necessary to address the 
problem (see paragraphs 298 to 300 below). 
 
 3. Distribution of internationally controlled 
substances in the unregulated market 
 
248. The Board welcomes the adoption of Commission 
on Narcotic Drugs resolution 51/13, in which the 
Commission requested Member States and the 
international community to take appropriate measures 
to deal with the continuing problem of distribution of 
internationally controlled substances in unregulated 
markets. The Board shares the concern of the 
Commission over the fact that the distribution of those 
substances in the unregulated market is increasingly 
characterized by the involvement of organized criminal 
networks and by the expansion of the range of products 
containing narcotic drugs or psychotropic substances 
on the market. The consumption of medicaments 
containing internationally controlled substances found 
in unregulated markets, regardless of whether they 
have been diverted from legitimate channels or are 
counterfeit drugs, has exposed patients to serious 
health risks, including dependence, and can sometimes 
have lethal consequences.  
249. In its report for 2006, the Board drew the 
attention of Governments to the widespread practice of 
selling internationally controlled drugs in the 
unregulated market and recommended measures to be 
taken by all affected Governments to counter that 
problem. In particular, the Board emphasized the need 
for all the parties concerned to strictly enforce the 
applicable control requirements and the need for 
Member States to enforce existing legislation. 
Governments must further ensure that narcotic drugs 
and psychotropic substances are not illegally 
manufactured, imported or exported and are not 
diverted to the unregulated market. Furthermore, 
Governments should conduct inspections of 
manufacturers, exporters, importers and distributors 
and assess their requirements of narcotic drugs and 
psychotropic substances in a systematic manner to 
ensure sufficient supplies to meet legitimate demand.64 
The Board appreciates that the Commission on 
Narcotic Drugs, in its resolution 51/13, requested 
Member States to give consideration to implementing 
the recommendations of the Board to address the 
problem of the unregulated market. The Board appeals 
to all Governments to take all steps necessary to 
implement the international drug control regime, 
including the related resolutions of the Economic and 
Social Council65 and measures recommended by the 
Commission66. 
250. The Board believes that the elimination of the 
unregulated market must be done through a concerted 
effort involving Governments and relevant parties such 
as the pharmaceutical industry, professional 
associations and international organizations. The Board 
welcomes the forty-first report of the WHO Expert 
Committee on Specifications for Pharmaceutical 
Preparations,67 published in 2007, which provides 
guidance to Governments in combating problems of 
counterfeit and substandard medicines. The Board 
appreciates the measures taken by the International 
Medical Products Anti-Counterfeiting Taskforce 
(IMPACT) of WHO with a view to preventing the trade 
in and distribution of counterfeit products or 
medicaments of poor quality.  
251. The Board notes that, in response to the 
recommendations made in its report for 200668 and 
pursuant to Commission on Narcotic Drugs 
resolution 51/13, UNODC, in cooperation with WHO, 
is exploring ways to provide technical assistance to 
__________________ 
 64 Report of the International Narcotics Control Board for 
2006 …, para. 38. 
 65 In particular, Council resolutions 1991/44 and 1996/30.  
 66 In particular, Commission resolutions 48/5 and 50/11. 
 67  WHO Expert Committee on Specifications for 
Pharmaceutical Preparations: Forty-first Report, WHO 
Technical Report Series, No. 943 (Geneva, World Health 
Organization, 2007). 
 68 Report of the International Narcotics Control Board for 
2006 …, para. 39. 
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Member States that require such support in order to be 
able to deal more effectively with problems associated 
with the unregulated market.  
 
 4. Guidelines for Governments on preventing the 
illegal sale of internationally controlled 
substances through the Internet 
 
252. The illegal sale and purchase through the Internet 
of pharmaceutical preparations containing 
internationally controlled substances have been a 
matter of concern to the Board for a number of years. 
The Board has drawn the attention of Governments to 
developments in that area and has called upon 
Governments to pay adequate attention to the detection 
and investigation of such illegal transactions, to 
implement legislative and regulatory provisions to 
counteract those transactions and to raise the 
awareness of customers of Internet pharmacies about 
the potential health risks involved. The Board has 
repeatedly called on Governments to fully cooperate 
with one another in investigative efforts and to increase 
the awareness of law enforcement, regulatory and drug 
control authorities about the need to counter the illegal 
selling of internationally controlled substances by 
Internet pharmacies.  
253. The Board has over the years collected from 
national authorities information on their experience in 
addressing the problem of the illegal sale of 
pharmaceuticals through the Internet and on the 
measures taken to counteract such transactions. The 
information received from Governments indicates that 
most countries do not have sufficient legislation, 
administrative regulations and cooperative mechanisms 
to counter those activities. The Board therefore decided 
to develop guidelines on matters related to Internet 
pharmacies for use by competent national authorities.  
254. The Guidelines for Governments on Preventing 
the Illegal Sale of Internationally Controlled 
Substances through the Internet have been developed 
by the Board with the help of national experts, experts 
from relevant international organizations (such as 
UNODC, Universal Postal Union (UPU), International 
Criminal Police Organization (INTERPOL), World 
Customs Organization), Internet service providers, 
financial services and pharmaceutical associations. The 
Guidelines, which are sent to all Governments and are 
available on the Board’s website (www.incb.org), are 
intended to provide assistance to Governments in 
formulating national legislation and policies for 
prescribers, pharmacists, law enforcement authorities, 
regulatory authorities and the public, with regard to the 
use of the Internet for dispensing, purchasing, 
exporting and/or importing internationally controlled 
substances.  
255. The Guidelines include recommendations for 
action to be taken at international and national levels 
and are divided into three parts: legislative and 
regulatory provisions; general measures; and national 
and international cooperation. The Guidelines are 
intended to help each Government to identify the 
control measures most appropriate for its country. 
Some of the recommendations, particularly those 
relating to the provisions of the international drug 
control treaties, should be implemented in all 
countries. To ensure concerted international action, 
basic requirements for information exchange and 
cooperation should also be implemented in all 
countries.  
256. The Board invites all Governments to use the 
Guidelines and to inform the Board of their experience 
in implementing the Guidelines. The Board hopes that 
the Guidelines will serve as a starting point for 
successful international cooperation and, in the long 
term, will lead to an international agreement in that 
area.  
257. The Commission on Narcotic Drugs and the 
Economic and Social Council share the Board’s 
concern regarding the illegal sale of internationally 
controlled substances through the Internet. In its 
resolution 50/11, the Commission encouraged Member 
States to notify the Board, in a regular and 
standardized manner, of seizures of licit substances 
under international control ordered via the Internet and 
delivered through the mail, in order to enable the 
Board to fully assess trends relevant to that issue. In 
the same resolution, the Commission encouraged the 
Board to continue its work with a view to raising 
awareness of and preventing the misuse of the Internet 
for the illegal supply, sale and distribution of 
internationally controlled licit substances. 
258. The Board has developed a format to be used by 
countries to report in a standardized manner on 
seizures of narcotic drugs and psychotropic substances 
illegally sold through the Internet and delivered 
through the mail. The format will be brought to the 
attention of Governments in early 2009. The Board 
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invites all Governments to use the format in reporting 
the relevant information to the Board. The Board also 
invites Governments to continue to inform the Board 
of national legislation related to the sale of 
internationally controlled substances through the 
Internet, national cooperative mechanisms and 
practical experience in the control of such sales, as 
well as details of national focal points for activities 
related to illegal Internet pharmacies.  
 
 5. Smuggling of drugs by courier services 
 
259. In the past two years, the Board has collected 
information from Governments on the misuse of 
courier services by drug traffickers. The information 
received shows that the misuse of courier services for 
drug trafficking has occurred in all regions. Drug 
traffickers have realized that using courier services is a 
relatively secure method of illegal drug transportation. 
Some Governments have identified the use of courier 
services as a major modus operandi for drug 
smuggling.  
260. The actual extent of the problem may not be 
known in all countries, as several Governments have 
indicated that they are not in a position to determine its 
extent. However, in countries where law enforcement 
has been sensitized to the problem of smuggling drugs 
through courier services, a significant number of such 
incidents have been detected.  
261. The drugs smuggled through courier services 
include illicitly manufactured drugs, as well as 
pharmaceutical preparations containing narcotic drugs 
and psychotropic substances that have been diverted 
from licit distribution channels. The most commonly 
smuggled drugs are heroin, cocaine, cannabis, MDMA 
(commonly known as “ecstasy”), lysergic acid 
diethylamide (LSD) and amphetamines. Smuggled 
pharmaceutical preparations include psychotropic 
substances such as benzodiazepines and narcotic drugs 
such as codeine. Although relatively small amounts of 
drugs are smuggled in individual letters or parcels, 
they add up to significant quantities, which reflects the 
importance attached by drug trafficking organizations 
to that smuggling method.  
262. It was reported that the use of courier services for 
drug smuggling was increasing because, with courier 
services: (a) drugs could be concealed with ease; (b) it 
was possible to send small quantities of drugs 
frequently; (c) the operational costs were low; (d) it 
was possible to send consignments from one location 
to various destinations; and (e) it was difficult to verify 
whether information provided by the sender was valid. 
263. Most Governments that have recorded drug 
smuggling incidents involving the use of courier 
services are of the opinion that, though the illicit 
activity is carried out without the complicity of the 
courier company, it constitutes misuse of the company 
services, sometimes with the involvement of an 
individual company employee. In such cases, the safety 
and control provisions of courier companies have been 
found to be insufficient. No courier services, including 
the larger courier services, are secure from drug 
smuggling attempts. However, reports from some 
countries indicate that small courier companies are 
more frequently targeted than large ones, since large 
ones routinely require details about shipments and 
utilize a tracking system, which facilitates monitoring 
of the movement of the shipment from the sender to 
the consignee.  
264. The Board notes that in many countries there is 
no need to introduce specific control measures for 
courier services. Existing postal control measures and 
regulations, if fully applied to courier services, are 
sufficient to counter the smuggling of narcotic drugs 
and psychotropic substances. The Board encourages all 
Governments that have not yet done so to establish 
legislative and administrative measures ensuring 
adequate safeguards against the misuse of postal and 
courier services for the purpose of drug trafficking. 
Governments are invited to take similar measures 
against the shipment of cannabis seeds and drug 
paraphernalia such as equipment specifically intended 
for the illicit cultivation and abuse of cannabis.  
265. The import and export of internationally 
controlled substances by courier services are subject to 
all control provisions required for international trade in 
such substances, including the issuance of 
authorizations or permits. It should be routine 
procedure for a sender to be required to have a copy of 
the authorization ready for inspection and for courier 
services to request the sender to present the 
authorization when sending a letter or parcel. Courier 
services should also ensure that shipment delivery 
agreements include information about prohibited and 
controlled substances.  
266. Legislative provisions and administrative 
regulations with respect to security measures for the 
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transport of controlled substances are crucial to 
limiting the risk of theft or loss. Some Governments 
have issued special regulations for the transport of 
narcotic drugs and psychotropic substances. Courier 
services should comply with those regulations.  
267. The Board notes that in most countries courier 
services are responsible for checking parcels and 
alerting the authorities of suspicious transactions. 
Before accepting consignments, the details of the 
sender and the recipient should be obtained and 
recorded. Those details should be verified against 
reliable identity documents and should accompany the 
parcel. All parcels for which proper identification is 
not possible should be opened and examined. If a 
courier company employee picks up a parcel from a 
given address, the address should be kept on record.  
268. The Board recognizes the importance of 
providing adequate training for employees of postal 
and courier services. Special training and regular 
information exchange, including alerts, should be used 
to sensitize the employees of those services to the risks 
of drug smuggling. Such training needs to be provided 
regularly to inform the employees about new attempts 
to use postal and courier services for drug smuggling. 
It may be useful to provide employees of courier 
services with guidelines on identifying suspicious 
shipments.  
269. Governments should strengthen institutions 
responsible for the control of postal and courier 
services and establish channels for the exchange of 
information between regulatory authorities, law 
enforcement authorities, the judiciary, postal 
administration and courier services to enable the rapid 
investigation of drug trafficking cases. Regular 
meetings between law enforcement authorities and 
postal and courier services could be used to provide 
information on current trends in drug trafficking, 
modus operandi of drug trafficking syndicates and 
concealment methods, such as common types of 
packaging.  
270. Appropriate checking techniques such as random 
checks, as well as checks after profiling (based on risk 
indicators and intelligence), have proved to be useful 
in preventing drug smuggling. Information made 
available prior to the arrival of international shipments 
by courier services facilitate the identification and 
speed up the selection of suspicious consignments for 
inspection by the customs.  
271. Governments should cooperate in preventing the 
misuse of courier services for drug smuggling. The 
technique of controlled delivery was reported by 
several Governments as being the most effective way 
to counter the smuggling of drugs through courier 
services. Controlled delivery allows authorities to 
identify the smuggling method and the recipient of the 
contraband and to collect evidence essential to 
dismantling the criminal organization involved in the 
smuggling. The Board encourages all Governments 
concerned to use the technique of controlled delivery 
when appropriate and to cooperate with other 
Governments in that regard. 
272. The Board encourages regional and international 
cooperative efforts to counteract the misuse of courier 
services for drug smuggling. In this respect, the Board 
notes that the Tripoli Action Plan adopted at the Arab 
Regional Symposium on Counteracting Drug 
Trafficking and Money-Laundering using the Mail, 
organized with the help of UNODC in November 2007 
(see paragraph 303 below), which includes specific 
measures on cooperation and information-sharing. 
273. Governments should observe existing 
international agreements and use them to further 
cooperation against the misuse of courier services for 
drug smuggling. The Universal Postal Convention 
regulates the international shipments of mail by state 
postal services. The Board encourages Governments to 
apply the provisions of that Convention to private 
courier services and amend their national legislation 
accordingly. The Board invites UPU to extend the 
relevant provisions of the Convention applicable to 
state postal services so that they are also applicable to 
private courier services. 
274. The Board requests all Governments to increase 
their vigilance with regard to cases involving the 
misuse of courier services for drug smuggling and to 
adopt measures to effectively counter that illicit 
activity. The Board invites all Governments concerned 
to continue to provide the Board with pertinent 
information on that subject.  
 
 6. Abuse of cough syrups containing narcotic 
drugs 
 
275. There is evidence that cough syrups containing 
narcotic drugs, such as codeine, dihydrocodeine, 
ethylmorphine, hydrocodone and pholcodine, have 
been diverted and abused in some countries. However, 
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data on the extent of the diversion and abuse of such 
cough syrups have been limited. Therefore, the Board 
sent a questionnaire in 2008 to the Governments of 
about 50 countries in all regions to obtain information 
on the diversion and abuse of cough syrups containing 
narcotic drugs, including details on the main cough 
syrups abused, the extent of their abuse and the supply 
sources for abusers, as well as the measures taken by 
Governments to counter such diversion and abuse. In 
addition, information was obtained from reports by 
Governments and relevant international organizations 
to complement the data obtained through the 
questionnaire. 
276. The abuse of cough syrups containing narcotic 
drugs was reported by several Governments. While the 
extent of abuse of cough syrups is limited in most 
countries, in some countries it represents a significant 
problem. According to a survey conducted in 
Bangladesh, 4.3 per cent of patients seeking drug 
addiction treatment in 2007 indicated cough syrups 
containing codeine as their primary drug of abuse. In 
the Islamic Republic of Iran, according to a 
Government estimate, about 100,000 persons abuse 
cough syrups containing codeine, frequently in 
combination with benzodiazepines. In the United 
States, the abuse of cough syrups containing narcotic 
drugs is reported as common in some states such as 
Texas, where law enforcement authorities identified 
cough syrups containing hydrocodone and codeine as 
the most commonly abused pharmaceutical drugs in 
2006. 
277. Cough syrups are mainly abused by teenagers and 
young adults. Abusers of cough syrups are often 
polydrug users. In most countries, drug abusers obtain 
cough syrups containing narcotic drugs, in particular 
codeine, through purchases in pharmacies and other 
licit distribution outlets, since a prescription is not 
required by law for some of those preparations. In 
countries where a prescription is required, abusers 
obtain cough syrups through illegal purchases from 
pharmacies without a prescription or purchases in the 
illicit market. Illicit markets are supplied by cough 
syrups diverted from licit distribution channels, in 
particular through illegal purchases from wholesalers 
and through theft from wholesalers, pharmacies and 
hospitals. 
278. Cough syrups are diverted in some countries for 
subsequent smuggling into other countries. For 
example, cough syrups containing codeine are 
smuggled out of India and into Bangladesh, Nepal and 
Thailand. The Board calls on the Governments 
concerned to take measures against the diversion and 
smuggling of cough syrups.  
279. Several Governments have reported on certain 
measures that proved effective in preventing the 
diversion and abuse of cough syrups in their countries. 
The measures included introducing stricter control and 
supervision of the channels of distribution of cough 
syrups and programmes for drug abuse prevention 
among youth to increase awareness of the risks 
associated with inappropriate use of cough syrups. 
280. Cough syrups containing narcotic drugs are an 
effective medication for many patients and are 
important in medical practice and health care. 
However, the Board calls on all Governments to be on 
the alert for problems involving the abuse of cough 
syrups and to adopt, if necessary, measures to 
effectively prevent the diversion and abuse of cough 
syrups.  
 
 7. Ketamine 
 
281. Since 2004, the Board has drawn the attention of 
Governments to the problem of trafficking in and abuse 
of ketamine, a substance currently not under 
international control.69 Ketamine is abused in a 
number of countries, particularly in the Americas, East 
and South-East Asia, South Asia and Oceania. 
282. In March 2006, ketamine was subject to critical 
review by the WHO Expert Committee on Drug 
Dependence. The Committee concluded that the 
information presented to it was not sufficient to 
warrant international scheduling of ketamine at that 
time. However, the Committee requested the secretariat 
of WHO to produce an updated version of the critical 
review document, to be submitted to the Committee at 
its next meeting.  
__________________ 
 69 Report of the International Narcotics Control Board for 
2004 (United Nations publication, Sales No. E.05.XI.3), 
para. 390; Report of the International Narcotics Control 
Board for 2005 …, paras. 385, 431, 471 and 641; Report 
of the International Narcotics Control Board for 
2006 …, paras. 199-204 and 457-458; and Report of the 
International Narcotics Control Board for 2007 …, 
paras. 222-225. 
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283. In order to enable Governments to take 
appropriate measures against the diversion and abuse 
of ketamine, the Commission on Narcotic Drugs, in 
March 2006, adopted resolution 49/6, in which it called 
upon Member States to consider controlling the use of 
ketamine by placing it on the list of substances 
controlled under their national legislation, where the 
domestic situation so required. In March 2007, the 
Commission adopted resolution 50/3, in which it 
encouraged Member States to consider adopting a 
system of precautionary measures for use by their 
Government agencies to facilitate the timely detection 
of the diversion of ketamine.  
284. The Board, in view of the fact that the abuse of 
and trafficking in ketamine had been occurring in a 
large number of countries for many years, welcomed 
the adoption by the Commission on Narcotic Drugs of 
its resolutions 49/670 and 50/371 and called on all 
Governments to implement them without delay. In 
addition, the Board decided to request all Governments 
to provide it with information on the specific legal or 
administrative measures adopted pursuant to 
Commission resolution 49/6, including information on 
measures to control ketamine and on ketamine imports, 
exports, seizures, abuse and trafficking. In line with 
that decision, a questionnaire was sent to all 
Governments in August 2008.  
285. As at 1 November 2008, the Board had received 
the requested information from 63 countries and 
4 territories, of which 34 reported that ketamine had 
already been placed on the list of substances controlled 
under national legislation, pursuant to Commission on 
Narcotic Drugs resolution 49/6, and 32 countries 
reported that legal provisions or administrative 
measures had been adopted to implement that 
resolution. Of the countries and territories that had not 
yet placed ketamine under control, 9 reported that their 
domestic situation would require doing so, mainly 
because of the extent of abuse of the substance.  
286. With regard to the control of licit international 
trade in ketamine, 35 of the countries responding to the 
questionnaire had introduced the requirement of import 
and export authorization for imports and exports of 
__________________ 
 70 Report of the International Narcotics Control Board for 
2006 …, para. 203.  
 71 Report of the International Narcotics Control Board for 
2007 …, para. 222. 
ketamine, and one country was in the process of doing 
so; two other countries had introduced the requirement 
of import authorizations only. The vast majority 
(78 per cent) of the responding countries and territories 
were in a position to provide precise information on 
total manufacture, imports and exports of ketamine per 
year. 
287. Twenty-one countries and territories provided 
details on the abuse of and illicit trafficking in 
ketamine, including information on seizures of 
ketamine. While most reported many seizures 
involving small quantities of ketamine, some reported 
having seized large quantities of the substance. 
Australia reported having seized the largest quantity of 
ketamine (15.2 tons during the period 2007-2008). The 
other countries were China (1 ton in 2006), followed 
by Germany, Malaysia, Philippines and Thailand.  
288. In line with its past practice of conveying all 
relevant information on ketamine trafficking and abuse 
to WHO, the Board has communicated the above-
mentioned information to WHO for use in its critical 
review of ketamine in 2009. The Board again requests 
all Governments to continue to provide it and WHO 
with all information available on the abuse of ketamine 
in their countries in order to assist the WHO Expert 
Committee on Drug Dependence in its efforts to assess 
ketamine for possible inclusion in one of the schedules 
of the international drug control conventions.  
289. In order to facilitate the verification, by 
Governments, of the legitimacy of imports and exports 
of ketamine, the Board is publishing information on 
measures introduced by Governments for the control of 
ketamine, notably information on the national 
requirements already in place in individual countries 
for import and export authorizations for ketamine. The 
Board requests all Governments that have not yet done 
so to furnish it with updated information on their 
national regulatory control measures for ketamine. The 
Board encourages all Governments to consult that 
information before authorizing imports or exports of 
ketamine.  
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III. Analysis of the world situation 
 
 
 A. Africa 
 
 
 1. Major developments 
 
290. Cocaine consignments destined mainly for illicit 
markets in Europe are increasingly being smuggled 
through Africa. An increasing number of cocaine 
seizures have been effected on the high seas of the 
Gulf of Guinea and on the African mainland, which 
indicates that West Africa has become one of the 
world’s major hubs for smuggling cocaine from South 
America into Europe. Reports point to increasing 
levels of abuse of cocaine in some countries affected 
by such trafficking. Reports also indicate the spread of 
cocaine trafficking through landlocked countries in the 
Sahel area. The Board is seriously concerned about 
those developments and welcomes the Security 
Council’s interest in the problem, which poses a 
serious threat to stability and development in that 
subregion, in particular in countries emerging from 
conflict and civil strife. 
291. Cannabis production, trafficking and abuse 
continue to represent major challenges in Africa. 
Cannabis is the main drug of abuse in Africa: it is 
estimated that the substance is abused by over 
42 million people in the region. Cannabis is illicitly 
cultivated and is then smuggled within Africa and 
beyond, mainly into Europe and North America. Africa 
accounts for an estimated 26 per cent of global 
cannabis production. While cannabis herb is illicitly 
produced in countries throughout Africa, Morocco has 
remained one of the world’s largest producers of 
cannabis resin. 
292. East Africa is the major conduit for smuggling 
heroin from South-West Asia into Africa, mainly 
through the major airports of Addis Ababa and Nairobi. 
From East Africa, the heroin is smuggled into Europe 
and North America, either directly or indirectly 
through countries in West Africa (especially 
Côte d’Ivoire, Ghana and Nigeria) and, to a lesser 
extent, through countries in North Africa. The abuse of 
heroin has become a matter of concern in some East 
and Southern African countries, in particular Kenya, 
Mauritius, South Africa and Zambia.  
293. Illicitly manufactured pharmaceutical 
preparations or prescription drugs containing narcotic 
drugs and psychotropic substances that had been 
diverted from licit distribution channels continue to be 
available on the unregulated markets in many countries 
in Africa. The situation remains unresolved because of 
the inadequate legislative frameworks, ineffective 
administrative mechanisms and insufficient resources 
for the proper enforcement of controls such as 
licensing and the inspection of distribution channels. 
294. In recent years, Africa has emerged as a major 
area targeted for the diversion of ephedrine and 
pseudoephedrine to be used in the illicit manufacture 
of methamphetamine in the Americas and elsewhere. 
During 2008, numerous suspicious shipments of those 
precursors were stopped en route to Africa and almost 
30 tons of ephedrine and pseudoephedrine were 
prevented from being diverted to or through Africa.  
 
 2. Regional cooperation 
 
295. Drug control issues continue to remain high on 
the agenda of the African Union. In December 2007, 
the Ministerial Conference of the African Union 
endorsed the Revised African Union Plan of Action on 
Drug Control and Crime Prevention (2007-2012), 
which was subsequently adopted at the meeting of the 
Heads of State of the African Union held in Addis 
Ababa from 30 January to 2 February 2008. A number 
of priority areas were identified in the Revised Plan of 
Action, including enhanced and effective policy 
formulation, coordination and collaboration in drug 
control to address drug trafficking, organized crime 
and corruption at the regional, subregional and national 
levels; institutional capacity-building for law 
enforcement, criminal justice and forensic service 
systems on drug control and crime prevention; 
mainstreaming drug and crime concerns into 
development strategies; and capacity-building and 
human resource development for the prevention of 
drug abuse and the treatment and rehabilitation of drug 
abusers. The Board encourages the Governments of 
African countries to take all the steps necessary to 
ensure the successful implementation of the Revised 
Plan of Action. 
296. The Board notes that the threats posed by the 
rapidly increasing transit traffic in drugs through some 
countries in West Africa are becoming a matter of 
concern to the international community. In June 2008, 
E/INCB/2008/1  
 
48  
 
the Security Council voiced concern at the major threat 
posed by drug trafficking and organized crime to the 
consolidation of peace in Guinea-Bissau and warned of 
the danger that the illicit drug trade posed for a country 
struggling to make political and economic progress. 
The Board welcomes the call by the Council to the 
international community to continue to provide 
assistance to Guinea-Bissau. The Board urges all 
Governments to extend their support to that country to 
enable it to meet its obligations under the international 
drug control treaties (see also paragraph 247 above). 
297. Within the framework of the Economic 
Community of West African States (ECOWAS), the 
Governments of West African countries are involved in 
joint efforts to combat the rapidly increasing transit 
traffic in drugs, in particular cocaine from Latin 
America passing through West Africa to Europe. 
During the seventeenth session of the Commission on 
Crime Prevention and Criminal Justice, held in 
April 2008, a special informal meeting of the ministers 
of justice, the interior and security of Burkina Faso, 
Cape Verde, Chad, Ghana, Guinea, Mali, Mauritania, 
the Niger, Senegal and Togo, as well as representatives 
of Côte d’Ivoire and Nigeria, was held to pave the way 
for a high-level conference on cocaine trafficking 
through West Africa that would develop a concerted 
approach to improving the responses of national 
security sectors to the new threats of drug trafficking 
by transnational organized criminal groups (see also 
paragraph 247 above). 
298. That high-level conference, the ECOWAS 
Conference on Drug Trafficking as a Security Threat to 
West Africa, was convened jointly by ECOWAS, 
UNODC and the United Nations Office for West Africa 
in Praia in October 2008. Participants included the 
ministers of justice and the ministers of the interior of 
the 15 member States of ECOWAS, and representatives 
of major international development partners and of 
major Latin American partners in the drug control 
effort, such as Austria, Brazil, France, Italy, 
Luxembourg, Portugal, Spain, Switzerland, the United 
Kingdom, the United States and Venezuela (Bolivarian 
Republic of). Important international entities 
participated as well, including the Department of 
Peacekeeping Operations of the Secretariat and other 
United Nations entities, the African Union, the 
European Commission, the European Police Office 
(Europol), INTERPOL and the World Customs 
Organization. The Conference adopted two documents 
to be endorsed by Heads of States in December 2008, 
namely, a political declaration on the prevention of 
drug abuse, drug trafficking and organized crime in 
West Africa and a regional action plan listing regional 
initiatives to be undertaken by the ECOWAS 
Commission with the aim of complementing national 
drug control plans, strategies and programmes of 
action, including specific commitments for assistance 
by external partners. 
299. The Eighteenth Meeting of Heads of National 
Drug Law Enforcement Agencies, Africa, was hosted 
by the Government of Côte d’Ivoire in Yamoussoukro 
in September 2008. The Meeting was attended by 
representatives of national drug law enforcement 
agencies from 25 African countries, as well as by 
10 observers. The participants examined the current 
situation with respect to regional and subregional 
cooperation in countering drug trafficking and 
developed strategies to address trafficking in cannabis, 
amphetamine-type stimulants and precursor chemicals 
in Africa.  
300. To assist the Governments of countries in West 
Africa in their efforts to combat the smuggling of drugs 
through their territory, UNODC in 2007 launched a 
two-year programme on law enforcement and 
intelligence cooperation against cocaine trafficking 
between West Africa and Latin America and the 
Caribbean. The programme, which is financed by the 
European Commission, aims at enhancing the 
exchange of information and intelligence between law 
enforcement agencies in the two areas by providing an 
electronic communications platform, training and 
mentoring on the collection, collation and analysis of 
intelligence. The countries participating in the 
programme are: in West Africa, Cape Verde, the 
Gambia, Ghana, Guinea-Bissau, Senegal and Togo; 
and, in Latin America and the Caribbean, Bolivia, 
Brazil, Colombia, the Dominican Republic, Ecuador, 
Jamaica, Peru and Venezuela (Bolivarian Republic of). 
301. An expert round-table meeting for East Africa 
was organized in Nairobi in September 2008 in the 
framework of the Paris Pact Initiative, a UNODC-led 
international partnership to counter traffic in and abuse 
of Afghan opiates. The meeting brought together senior 
experts on drug law enforcement and drug demand 
reduction from East Africa and neighbouring countries, 
as well as from Paris Pact partners in the subregion. 
The objective of the meeting was to assess the drug 
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abuse situation in East Africa, with particular emphasis 
on the abuse of opiates, to identify good practices, 
current challenges, priority actions and targets in the 
field of drug demand reduction and to develop 
appropriate measures at the national and regional 
levels to counter the smuggling of Afghan opiates into 
and through East Africa. 
302. Cooperation in drug control matters among 
countries in the subregion of Southern Africa is 
organized in the framework of the Southern African 
Development Community (SADC) and the Southern 
African Regional Police Chiefs Cooperation 
Organization (SARPCCO). In April 2008, the 
Government of Malawi hosted a regional SADC 
workshop on drug trafficking and the cultivation, 
production and eradication of cannabis plants. The 
workshop, attended by senior officials of the drug 
control police from Botswana, Lesotho, Malawi, 
Mauritius, Namibia, South Africa, Swaziland, Zambia 
and Zimbabwe, as well as by representatives of 
INTERPOL, agreed on an operational strategy on drug 
interdiction in the subregion, cross-border operations 
and new initiatives to prevent the diversion of 
precursor chemicals. Also, SARPCCO heads of 
forensic science institutions held a meeting in 
Livingstone, Zambia, in April 2008 to improve 
technical cooperation activities in the subregion and to 
develop a subregional network of forensic laboratories. 
In August 2008, the thirteenth annual general meeting 
of SARPCCO was held in Windhoek. The meeting, 
which was hosted by the Government of Namibia, 
adopted measures for building the capacity of police 
and forensic services in Southern Africa and joint 
cross-border initiatives against transnational crime. 
303. The Board notes that a number of African States 
have undertaken additional initiatives against drug 
trafficking and money-laundering. In November 2007, 
the Arab Regional Symposium on Countering Drug 
Trafficking and Money-Laundering using the Mail, 
held in Tripoli, adopted the Tripoli Action Plan on 
Countering Drug Trafficking and Money-Laundering 
using the Mail. The Action Plan foresees measures to 
combat drug trafficking and money-laundering through 
the international mail, such as cooperation and 
information-sharing, developing human resources, 
awareness-raising and the role of the media in 
combating drug trafficking through the mail. The 
symposium was attended by representatives of the 
League of Arab States, UPU, INTERPOL and UNODC, 
as well as by representatives of entities in the private 
sector dealing with mail services (see also 
paragraph 272 above). 
304. In April 2008, a subregional seminar on 
combating money-laundering and the financing of 
terrorism was held for member States of the Central 
African Economic and Monetary Community and the 
Economic Community of Central African States in 
Gabon. About 30 officials from Burundi, Cameroon, 
the Central African Republic, Chad, the Congo, the 
Democratic Republic of the Congo, Gabon and Sao 
Tome and Principe attended the seminar. The 
participants adopted recommendations on 
strengthening the legal and institutional frameworks 
against money-laundering and the financing of 
terrorism, on asset forfeiture mechanisms and on inter-
agency and international cooperation. 
305. In August 2008, at the eighth meeting of the 
Council of Ministers of the Eastern and Southern 
Africa Anti-Money Laundering Group,72 held in 
Mombasa, Kenya, the second three-year strategic plan, 
covering the period April 2009-March 2012, was 
adopted. The plan sets out nine strategic objectives to 
combat money-laundering and financing of terrorism, 
including policy formulation, regional cooperation, 
capacity-building, training, awareness-raising and 
advisory services to member States. 
 
 3. National legislation, policy and action 
 
306. In response to the urgent problems confronting 
the Government of Guinea-Bissau in combating 
cocaine trafficking through its territory, UNODC and 
the Ministry of Justice of Guinea-Bissau have prepared 
an integrated multidisciplinary programme aimed at 
combating drug trafficking and organized crime in that 
country (see also paragraph 247 above). The 
programme, which began in April 2008, will support 
the Government of Guinea-Bissau in its efforts to 
reform its security sector, to stabilize the peace process 
and protect the social development of the country, with 
activities in the fields of law enforcement 
__________________ 
 72  The Eastern and Southern Africa Anti-Money 
Laundering Group is a Financial Action Task Force 
(FATF)-style regional body for East and Southern Africa 
established in 1999. Current members are Botswana, 
Kenya, Lesotho, Malawi, Mauritius, Mozambique, 
Namibia, Seychelles, South Africa, Swaziland, Uganda, 
the United Republic of Tanzania, Zambia and Zimbabwe. 
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capacity-building, institutional reform and nationwide 
training. The programme will allow a more effective 
response to recommendations made by the Security 
Council on Guinea-Bissau. Similar programmes are 
planned by UNODC for other countries in the 
subregion, including Liberia, Mali, Mauritania, the 
Niger and Sierra Leone.  
307. A new law adopted by the parliament of Senegal 
in December 2007 provides for a significantly 
increased penalty for drug trafficking: 10-20 years of 
hard labour, which is double the previous penalty. 
Senegal has recently been targeted by massive 
smuggling of cocaine from Latin America into Europe, 
as illustrated by two major seizures of cocaine in that 
country in June 2007. In Nigeria, draft legislation is 
before parliament that will provide for stricter and 
more effective penalties for major drug traffickers. 
Furthermore, updated drug control legislation is being 
drafted in Sierra Leone, with the assistance of 
UNODC.  
308. The Government of Ghana has taken a number of 
legislative and administrative measures to address the 
increase in drug trafficking through its territory. 
Legislation to control maritime activities are being 
updated, a national drug control strategy for the 
period 2008-2010 has been developed and the 
Narcotics Control Board of Ghana has been 
restructured and provided with additional resources. 
With technical cooperation from the Government of the 
United Kingdom, security at the international airport at 
Accra has been strengthened. The Joint Port Control 
Unit, comprising police and customs and established in 
Ghana in 2007 under the UNODC-World Customs 
Organization Global Container Project, continues to 
operate at the port of Tema. 
309. The Government of Ethiopia has taken steps to 
address drug trafficking through the international 
airport at Addis Ababa. With technical cooperation 
from UNODC, a joint airport control team was 
established at the airport in 2007. The strategic 
geographical location of Ethiopia in the Horn of Africa 
and the extensive flight routes of Ethiopian airlines 
have made the airport at Addis Ababa one of the major 
hubs for drug trafficking in Africa, especially for 
smuggling heroin from Asia into West Africa and 
Europe. 
310. The National Drug Law Enforcement Agency of 
Nigeria has strengthened its control measures at 
several airports, including those at Lagos and Kano, 
which provide direct international flights to European 
and West Asian countries. The Agency has also 
introduced a visa clearance programme to curb drug 
trafficking by Nigerian nationals abroad. That 
programme, voluntarily supported by Governments 
with embassies in Nigeria, makes it an additional 
requirement for visa applicants to obtain a certificate 
of drug trafficking reporting clearance from the 
Agency. 
311. The Board notes the efforts of the National 
Agency for Food and Drug Administration and Control 
(NAFDAC) of Nigeria in combating counterfeit drugs 
in that country. In recent years, NAFDAC has 
strengthened the regulatory framework, improved the 
drug registration processes and closed down many 
companies importing counterfeit medicines destined 
for unregulated markets in Nigeria and beyond. In 
May 2008, NAFDAC seized a 20-foot container 
containing counterfeit pharmaceutical products on a 
vessel in Lagos. Since 2005, NAFDAC has been 
spearheading the work of the West African Drug 
Regulatory Agencies Network, a platform for 
interacting and exchanging strategies against 
counterfeit medicines. 
312. In April 2008, the Government of South Africa 
strengthened its precursor control legislation by 
including ephedrine and pseudoephedrine in its 
Medicines and Related Substances Act of 1965. The 
South African parliament is currently considering new 
legislation on the prevention and treatment of drug 
abuse. The Prevention of and Treatment for Substance 
Abuse Bill, which replaces the Prevention and 
Treatment of Drug Dependency Act of 1992, will 
regulate the establishment, registration and 
management of treatment centres, inpatient and 
outpatient services and community-based services and 
will define the mandate of the Central Drug Authority, 
whose responsibility it is to monitor and oversee the 
implementation of the national drug control master 
plan.  
313. The Board is concerned about the alarming 
increase in Côte d’Ivoire in the number of facilities, 
locally dubbed fumoirs, where drugs obtained from 
illicit sources are abused. The Board acknowledges the 
efforts of the Ivorian law enforcement authorities, 
which led to the successful dismantling of 29 such 
facilities during 2007 and the seizure of substantial 
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quantities of cannabis, heroin, cocaine and 
psychotropic substances from those facilities, and 
encourages the Government of Côte d’Ivoire to 
continue to accord priority to combating drug abuse in 
its country. 
314. The Board is pleased to note that a major 
awareness-raising campaign against drug abuse among 
youth was conducted jointly by UNODC, the police of 
United Arab Emirates and Right Start International 
Foundation in a number of countries and areas in North 
Africa and West Asia73 during March and April 2008. 
The campaign was organized in schools, universities, 
youth clubs and public places popular among youth. In 
the course of the five-week campaign, 5,000 events, 
including concerts, school conferences and 
programmes on satellite channels, took place. Also, 
train-the-trainer sessions were conducted for 
1,800 volunteers. A total of 7,390 drug abusers 
registered for treatment and rehabilitation, of whom 
1,592 were actually admitted to treatment centres. 
315. The Board also notes the efforts made by some 
Governments of African countries with regard to the 
treatment and rehabilitation of drug abusers. In 
Algeria, preparations are under way for the launch, in 
2009, of a national network of facilities for providing 
treatment and aftercare for drug abusers. The facilities 
will include 15 new detoxification centres, 
53 outpatient centres and 185 reception and orientation 
units for drug addicts. In Kenya, an outreach and 
treatment programme established in 2005 has provided 
treatment to over 3,100 patients in Nairobi and 
Mombasa. Programmes for the treatment of drug 
dependence are also being run in other countries, such 
as Seychelles and Uganda. An opiate substitution 
treatment programme has been operating successfully 
in Mauritius since 2007. 
316. The Board welcomes the steps being taken by a 
number of Governments of African countries to 
counter money-laundering. Since November 2007, new 
legislation to counter money-laundering has been 
passed in Burundi, Ghana, Lesotho and Rwanda. In 
2008, the Government of Namibia adopted regulations 
for enforcing the country’s Financial Intelligence Act 
of 2007. In the United Republic of Tanzania, a 
financial intelligence unit has been established under 
__________________ 
 73  Algeria, Egypt, Jordan, Morocco, Qatar, Saudi Arabia, 
Tunisia, the United Arab Emirates, Yemen and Palestine. 
the Ministry of Finance, and a similar unit is expected 
to be set up soon in Rwanda. The Government of 
Kenya has recently submitted to parliament draft 
legislation to counter money-laundering, and a 
comprehensive law against money-laundering is being 
drafted in Ethiopia, for submission to parliament in 
2008. The Comoros has become an observer to the 
Eastern and Southern Africa Anti-Money Laundering 
Group. The Democratic Republic of the Congo, which 
enacted legislation against money-laundering in 2004, 
is now also seeking admission as an observer to the 
Group. 
 
 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
317. Africa remains the world’s second largest 
producer of cannabis herb after the Americas, 
accounting for 22 per cent (or 8,900 tons) of global 
cannabis production in 2006.74 Cannabis herb is 
illicitly produced in many countries throughout Africa. 
The largest producer countries include: in Southern 
Africa, South Africa, Malawi, Swaziland, Zambia and 
the Democratic Republic of the Congo, in that order; in 
West Africa, Nigeria, Ghana, Guinea, Côte d’Ivoire, 
Benin and Togo; in North Africa, Egypt and Morocco; 
and, in East Africa, the United Republic of Tanzania. 
Most of the cannabis herb produced in Africa is abused 
locally. However, cannabis herb produced in a limited 
number of African countries, mainly Ghana, Morocco, 
Nigeria and South Africa, is also smuggled to 
destinations outside of Africa, notably in Europe and, 
to a lesser extent, East Asia. In 2006, 1,217 tons of 
cannabis herb were seized in Africa, as the region 
accounted for 23 per cent of global cannabis herb 
seizures in that year. The largest seizures were reported 
in South Africa (359 tons, or 7 per cent of global 
seizures), Malawi (272 tons), the United Republic of 
Tanzania (225 tons), Nigeria (192 tons) and Egypt 
(101 tons). 
318. According to UNODC data,75 Morocco remains 
the world’s largest producer of cannabis resin, 
supplying the illicit markets in Western Europe and 
__________________ 
 74  The year 2006 is the latest year for which aggregate 
UNODC data on global production, manufacture, 
trafficking and abuse are available. 
75 World Drug Report 2008 (United Nations publication, 
Sales No. E.08.XI.1), p. 99. 
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North Africa. In 2005, the available data had suggested 
a decline in the country’s cannabis production, and the 
extent of cannabis cultivation was reported to have 
been reduced to 76,400 ha during that year. Those 
developments were attributed to an intensified 
campaign by the Government of Morocco to eradicate 
the illicit cultivation of cannabis plants, which was 
corroborated by a decline in reported seizures of 
cannabis resin and cannabis herb. In 2007, however, 
owing to intensified interdiction efforts by the 
Government, seizures of both cannabis resin and 
cannabis herb increased again, with cannabis resin 
seizures increasing from 89 tons in 2006 to 118 tons in 
2007 and cannabis herb seizures increasing from 
60 tons in 2006 to 209 tons in 2007. The seizures 
continued to increase during the first half of 2008, as 
several multi-ton seizures of cannabis resin and 
cannabis herb were made by Moroccan authorities. No 
further survey on the extent of illicit cannabis 
cultivation has been undertaken in Morocco since 
2005. However, accurate data on the actual extent of 
illicit cannabis cultivation are essential for effective 
measures to be taken against such cultivation. The 
Board therefore encourages the Government of 
Morocco to update the data on the extent of illicit 
cannabis cultivation on its territory within the 
framework of its ongoing discussions with UNODC. 
319. North Africa accounted for 12 per cent of the 
1,025 tons of cannabis resin seized globally in 2006. 
Most of the cannabis resin from Morocco destined for 
Europe is trafficked through Spain, as well as France 
and Italy. In addition, cannabis resin destined to 
Europe or West Asia passes through Mauritania, Mali, 
the Niger, the Libyan Arab Jamahiriya and Chad to 
Egypt. In addition to Morocco, large seizures were 
reported for 2006 in the Libyan Arab Jamahiriya 
(14.8 tons), Algeria (10 tons), Senegal (8.4 tons) and 
Egypt (5.1 tons). It is likely that the growing 
trafficking in cannabis through North Africa will foster 
the development of illicit markets in the countries 
affected by such trafficking. 
320. According to UNODC estimates, about 
42 million people in Africa abuse cannabis. The annual 
prevalence rate for cannabis abuse among persons aged 
15-64 years in Africa is 8 per cent. The highest annual 
prevalence rates for cannabis abuse in Africa are found 
in West and Central Africa (12.6 per cent), where 
States have reported large increases in such abuse, 
followed by Southern Africa, where the annual 
prevalence rate is 8.4 per cent. In 2006 as in previous 
years, most of the demand for drug-related treatment in 
Africa (63 per cent) continued to be associated with 
cannabis abuse. 
321. Although cocaine is not manufactured in Africa, 
the rapid increase in seizures of cocaine in the region 
in the past few years, especially in West Africa, shows 
that Africa is becoming an important transit and 
stockpiling area for cocaine consignments from Latin 
America destined for Europe (see paragraphs 242-246 
above and 512 below). Prior to 2005, the total amount 
of cocaine seized in Africa was barely 1 ton. Between 
2005 and 2007, however, at least 33 tons of cocaine 
were seized en route to Europe from West Africa, 
especially off the coast of the Canary Islands, Cape 
Verde and Guinea-Bissau, as well as in various 
countries along the Gulf of Guinea, including Benin, 
Côte d’Ivoire, Ghana, Nigeria, Togo and, further west, 
Guinea, Liberia, Mauritania, Senegal and Sierra Leone. 
According to UNODC estimates, about 27 per cent (or 
40 tons) of the cocaine abused annually in Europe has 
passed through West Africa. 
322. Cocaine trafficking through Africa continued 
unabated in 2008, with significant seizures of cocaine 
being made in the first 10 months of the year. In 
Ghana, 399 kg of cocaine were seized in a motor 
vehicle coming from Guinea. In Sierra Leone, 700 kg 
of cocaine were seized on an aircraft arriving from the 
Bolivarian Republic of Venezuela. Furthermore, the 
French navy seized 2.5 tons of cocaine on board a 
Liberian fishing vessel off the coast of Liberia in 
January 2008 and 3 tons of cocaine on a Panamanian 
vessel en route from Brazil to Algeria in 
February 2008. 
323. Cocaine is mostly transported to West Africa in 
large quantities on board sea vessels, often concealed 
in containers. In West Africa, the cocaine is stockpiled, 
repackaged into smaller consignments and transported 
to countries in Europe and to the United States, usually 
by air couriers swallowing and carrying as much as 
1 kg in their stomachs, or through checked-in luggage 
containing very large quantities of cocaine. Drug 
trafficking organizations have begun using what is 
called the “shotgun approach”, whereby a large number 
of couriers are dispatched on the same flight, thereby 
making it difficult for law enforcement agencies to 
identify and arrest all couriers on the same flight. 
 E/INCB/2008/1
 
 53 
 
324. The emergence of West Africa as a transit area for 
cocaine trafficking may have several causes. The 
geographical location of West Africa makes it an ideal 
staging post for trans-shipping cocaine consignments 
from Latin America to the growing cocaine markets in 
Europe. By using West Africa for their transit posts, the 
traffickers try to circumvent the increased surveillance 
and effective interdiction units put in place along the 
classic smuggling routes by the national law 
enforcement agencies of the United States and 
countries in Europe. Traffickers also exploit loopholes 
in law enforcement in many West African countries. 
325. Cocaine consignments transiting West Africa are 
also smuggled through East Africa, as indicated by 
seizures effected in some ports and airports in East 
Africa and on flights to Europe and elsewhere 
originating in East Africa. The airport at Addis Ababa 
has recently emerged as a transit point for cocaine 
consignments destined for Turkey. In 2008, five 
seizures of cocaine totalling 6 kg were made at the 
airport at Istanbul and in all cases the cocaine had been 
smuggled by West African nationals arriving by air 
from Addis Ababa. There is also evidence that cocaine 
is being transported by both land and air from West 
Africa to North Africa before being smuggled into 
Europe by sea or air. In addition, some cocaine 
continues to be smuggled into countries in Southern 
Africa, mainly through Angola into South Africa. 
South Africa remains the only African country 
reporting a relatively high level of annual cocaine 
seizures. 
326. The increase in cocaine trafficking in Africa has 
resulted in increased abuse of the drug in the region, 
which is particularly noticeable in the countries in 
West and Southern Africa and along the Atlantic coast 
of North Africa. According to current UNODC 
estimates, about 1.1 million people in Africa abuse 
cocaine, and the annual prevalence rate for persons 
aged 15-64 years is 0.2 per cent, which is below the 
global average of 0.37 per cent. Increasing abuse of 
cocaine and/or crack cocaine has been reported in some 
Southern African countries, such as Namibia and South 
Africa. South Africa has reported demand for treatment 
for cocaine abuse at a level considerably higher than 
the African average. Cocaine abuse may soon spread 
rapidly in West Africa if the problem of transit 
trafficking through the subregion is not addressed 
decisively. 
327. Illicit cultivation of opium poppy continues on 
the Sinai peninsula in Egypt. In 2007, there was a 
considerable increase in the eradication of illicitly 
cultivated opium poppy in Egypt, the total area 
eradicated being 98 ha, almost twice the area 
eradicated in 2006 (51 ha). The opium derived from 
that cultivation is reportedly consumed locally and not 
used for the illicit manufacture of heroin. The 
Government of Algeria has reported that, as a result of 
intensified law enforcement and interdiction measures, 
it eradicated illicitly cultivated opium poppy in small 
areas in the north of the country: over 74,000 poppy 
seedlings were eradicated in 2007, and almost 
80,000 were eradicated in the first nine months of 
2008. The Board notes the efforts of the Government 
of Algeria and encourages it to continue identifying 
and eradicating any illicit opium poppy cultivation in 
its territory. 
328. Heroin from South-West Asia continues to enter 
the African region through East Africa. The strategic 
location of East Africa, on a long and established 
trading route between Europe and South-West Asia, 
and the extensive flight routes of Kenyan and 
Ethiopian airlines linking East Africa to the principal 
heroin source countries in Asia, as well as West Africa 
and Europe, have created favourable conditions for 
smuggling heroin from Asia into West Africa and 
Europe. The international airports at Addis Ababa and 
Nairobi have emerged as major entry and transit points 
for the whole of Africa and beyond. From East Africa, 
large quantities of heroin are transported across the 
continent to countries in West Africa, especially 
Côte d’Ivoire, Ghana and Nigeria, and from there to 
countries in Europe and to the United States. Seizures 
of heroin continue to be made in Côte d’Ivoire, Kenya, 
Mauritius, Nigeria and the United Republic of 
Tanzania. Most of the heroin is smuggled using air 
couriers, but commercial air cargo and express courier 
mail services are also increasingly being used for 
heroin trafficking. In addition, heroin trafficking 
through Tripoli has increased recently. Some of the 
heroin trafficked and temporarily stored in East Africa 
has spilled over into the local illicit market. Heroin 
from East Africa is also smuggled into countries in 
Southern Africa, notably Mauritius and South Africa, 
where it is abused. 
329. According to UNODC statistics, about 
1.4 million people in Africa (or 0.3 per cent of persons 
aged 15-64 years) are abusing opiates, mostly heroin. 
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Egypt constitutes the largest market for opiates (some 
330,000 people) in Africa. Increased abuse of opiates 
has been reported in most countries in East and 
Southern Africa. The annual prevalence rate of such 
use is highest in Mauritius (2 per cent), followed by 
Egypt (0.7 per cent). According to the South African 
Community Epidemiology Network on Drug Use, 
demand for treatment for heroin abuse in South Africa 
has increased. Recent statistics show that Cape Town is 
one of the areas in the country with the largest number 
of heroin abusers (over 15,000). In South Africa, 
heroin is mostly smoked; injecting heroin abuse is 
stable or declining. 
 
  Psychotropic substances 
 
330. One matter of major concern to the Board is the 
abuse of pharmaceutical products containing 
psychotropic substances, which are sold without 
medical prescription or in the street. That practice has 
been observed in many countries in West and Central 
Africa. The Board calls upon the drug regulatory 
authorities of those countries to address the concerns 
of the Board in a serious manner. Attempts at diverting 
psychotropic substances from international trade into 
illicit channels in order to supply those unregulated 
markets continue to be made. For instance, in 
November 2007, an attempted diversion of 25 kg of 
flunitrazepam from the Netherlands to Guinea-Bissau 
was prevented with the assistance of the Board. 
331. Illicit manufacture of amphetamines occurs in 
South Africa and, on a small scale, in Egypt. 
Methcathinone (“cat”) is manufactured clandestinely 
and is widely available in South Africa. The growing 
abuse of crystal methamphetamine (locally dubbed 
“tik”) in the Cape Town area has become a cause for 
concern for the authorities. It appears that the illicit 
demand for methamphetamine is met from 
methamphetamine smuggled into or manufactured in 
South Africa. During 2007, the South African police 
dismantled 30 clandestine drug laboratories, most of 
which manufactured methamphetamine or 
methcathinone. In August 2008, 54 kg of crystal 
methamphetamine en route from Lagos were seized at 
the international airport at Johannesburg. 
332. The abuse of amphetamines across Africa has 
been increasing slowly over the past few years, with 
much of the growth being fuelled by the increasing 
methamphetamine abuse in South Africa. The number 
of amphetamine abusers in Africa is estimated by 
UNODC at 2.3 million, accounting for about 9 per cent 
of the world total. The average annual prevalence rate 
of abuse of amphetamines in Africa is estimated at 
0.4 per cent of the population aged 15-64 years, the 
highest annual prevalence rates in the region being 
reported in Nigeria and some other West African 
countries, Egypt and South Africa. 
333. Methaqualone (Mandrax) illicitly manufactured 
in China or India continues to enter South Africa, 
mainly through Mozambique, Swaziland and 
Zimbabwe. Methaqualone is also manufactured in 
clandestine laboratories in Southern Africa. From 
South Africa, which is regarded as the largest illicit 
market for methaqualone in the world, some of the 
drug is smuggled into countries in the subregion, where 
it is also abused. Methaqualone is abused mostly in 
combination with cannabis, a form of drug abuse 
known as the “white pipe”. The Board notes the 
successful interception of methaqualone consignments 
by the South African law enforcement authorities. In 
February 2008, the South African police detected and 
seized 1,363 kg of methaqualone during a routine 
search of a truck at a border crossing between South 
Africa and Zimbabwe. 
 
  Precursors  
 
334. Africa continues to be a major area used for the 
diversion of certain precursor chemicals, notably 
ephedrine and pseudoephedrine.76 Traffickers have 
been trying to take advantage of weaknesses in 
precursor control mechanisms in place in many African 
countries to divert ephedrine and pseudoephedrine to 
be used in the illicit manufacture of methamphetamine 
elsewhere, notably in the Americas. During the 
period 2007-2008, numerous suspicious shipments of 
ephedrine and pseudoephedrine to Africa were 
identified and stopped. Forged import permits were 
used for most of the identified diversion attempts. The 
countries targeted in that period were Botswana, the 
Democratic Republic of the Congo, Ethiopia, Nigeria, 
Togo, Uganda, the United Republic of Tanzania and 
Zambia. During that period, a total of 12.5 tons of 
those precursors were seized in Ethiopia alone. 
__________________ 
76 See also Precursors and Chemicals Frequently Used in 
the Illicit Manufacture of Narcotic Drugs and 
Psychotropic Substances: Report of the International 
Narcotics Control Board for 2008 … . 
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335. Altogether, almost 30 tons of ephedrine and 
pseudoephedrine were prevented from being diverted 
to or through Africa during the period 2007-2008. That 
amount represents a sharp decline compared with the 
period 2006-2007, during which over 75 tons of 
ephedrine and pseudoephedrine were prevented from 
being diverted to or through African countries, in 
particular the Democratic Republic of the Congo 
(23 tons). The Board is concerned that, in spite of those 
attempted diversions, hardly any seizures of ephedrine 
or pseudoephedrine have been reported in countries in 
Africa. For instance, between 2000 and 2008, 
ephedrine and pseudoephedrine seizures in Africa 
totalled only 242 kg, with South Africa accounting for 
most of those seizures.  
336. The recent decrease in the total amount of 
ephedrine and pseudoephedrine involved in identified 
attempts at diverting to Africa could be due to a 
number of factors, which may include traffickers 
placing orders for consignments of smaller amounts of 
ephedrine and pseudoephedrine to avoid suspicion and 
follow-up investigations by the authorities of exporting 
and importing countries. The Board therefore calls 
upon all Governments of exporting and transit 
countries to verify the legitimacy of all shipments of 
ephedrine and pseudoephedrine destined for Africa, 
including shipments of pharmaceutical preparations 
containing those substances. The Board also calls upon 
the Governments of all countries in Africa that have 
not yet done so to establish appropriate mechanisms 
for control over ephedrine and pseudoephedrine, 
including preparations containing those substances, 
that will enable them to respond in a timely manner to 
pre-export notifications and enquiries of exporting 
authorities about the legitimacy of any transactions.  
 
  Substances not under international control 
 
337. In 2008, the Government of Namibia placed 
N-benzylpiperazine (BZP) under national control and 
introduced a prescription requirement for it. BZP is a 
piperazine-derived compound that is currently not 
under international control.77 
__________________ 
 77  In March 2007, the Board requested WHO to consider 
reviewing piperazine-derived compounds for possible 
scheduling under the 1971 Convention. Furthermore, the 
Board in its report for 2007, urged all Governments to 
provide to WHO and the Board any information on the 
abuse of and trafficking in such compounds (Report of 
338. In view of the increasing abuse of khat78 in 
Madagascar, the Government of that country prohibited 
the cultivation, sale and consumption of khat as of 
January 2008. Khat is grown mainly in East Africa and 
on the Arabian peninsula and is abused locally. While 
khat is currently not under international control, its 
cultivation has been prohibited in a number of 
countries in East Africa, including Eritrea, Rwanda and 
the United Republic of Tanzania. 
339. According to the World Customs Organization, 
the total amount of khat seized globally has increased 
significantly in recent years, amounting to almost 
44 tons in 889 cases in 2007. The largest seizures in 
2007 were made by Canada (13 tons), Germany 
(7 tons), Sweden (6 tons), Denmark (1.6 tons) and 
Switzerland (1.4 tons). In those countries, khat is 
abused mainly by expatriates with origins in East 
Africa and the Arabian peninsula. The Board notes that 
seizures of dried khat have risen in recent years, since 
dried khat no longer has to be shipped and distributed 
to consumers within 48 hours. 
 
 5. Missions 
 
340. A mission of the Board visited Ethiopia in 
March 2008. The Board appreciates the steps taken by 
the Government in recent years to increase its capacity 
to deal with the drug problem, including the creation of 
the Drug Administration and Control Authority, the 
strengthening of the drug control capacity of the police 
and the modification of the Penal Code. The 
Government has initiated several activities in the area 
of primary prevention of drug abuse. 
__________________ 
the International Narcotics Control Board for 2007…, 
para. 734, recommendation 22). 
 78  Khat refers to the leaves and young shoots of the plant 
Catha edulis. Khat has been considered and reviewed on 
two occasions by the WHO Expert Committee on Drug 
Dependence. During the last review, in 2006, the 
Committee concluded that the potential for abuse and 
dependence was low and that the level of abuse and 
threat to public health was not significant enough to 
warrant international control. Therefore, the Committee 
did not recommend the scheduling of khat. The 
Committee recognized that social and some health 
problems resulted from the excessive use of khat and 
suggested that national educational campaigns should be 
adopted to discourage use that might lead to those 
adverse consequences (WHO Expert Committee on Drug 
Dependence: Thirty-fourth Report, WHO Technical 
Report Series, No. 942 (Geneva, 2006), pp. 11-12). 
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341. The mission examined with the authorities steps 
against the illicit cultivation and abuse of cannabis in 
Ethiopia. Also discussed were measures against drug 
trafficking, including the transit traffic through the 
international airport in Addis Ababa. The Board 
encourages the Government to carry out periodic 
studies on the prevalence of drug abuse and to 
strengthen its capacity for the treatment of drug 
addicts. The Board invites the Government to promote 
the rational use of opioid analgesics, in accordance 
with the guidelines issued on the subject by WHO. 
342. The Board sent a mission to Mauritius in 
October 2008. Mauritius is a party to all of the 
international drug control treaties and has adopted 
comprehensive drug control legislation. The Board 
encourages the Government to set up a mechanism for 
sharing information, as well as coordinating 
machinery, involving all bodies, services and agencies 
involved in drug control activities. With respect to the 
smuggling of buprenorphine (Subutex®) to Mauritius, 
the Board invites the Government to continue to 
cooperate with European countries in an effort to 
address that problem effectively. 
343. The abuse of drugs, particularly heroin, by 
injection is a problem in Mauritius. The Board 
commends the Government for offering a large variety 
of drug demand reduction services to drug abusers. The 
Board recommends that more psychosocial support be 
provided to drug abusers and trusts that measures taken 
to prevent the spread of HIV/AIDS will not promote or 
facilitate drug abuse. 
 
 
 B. Americas 
 
 
  Central America and the Caribbean 
 
 
 1. Major developments 
 
344. Trafficking in controlled substances containing 
ephedrine and pseudoephedrine is increasing in Central 
America. Since Mexico strengthened its regulations to 
prevent the diversion of those precursors, criminal 
organizations have been taking advantage of the lax 
control of sales near the southern border of Mexico to 
acquire drugs containing ephedrine and 
pseudoephedrine and establishing methamphetamine 
laboratories in the subregion. 
345. The region of Central America and the Caribbean 
continues to be a major trafficking route for illicit 
drugs originating in South America and destined for 
North America and Europe. Despite the authorities’ 
efforts to combat the problem, there are indications 
that drug trafficking is increasing in areas in Central 
America and in the Dominican Republic and Haiti. As 
a result of growing drug trafficking, drug abuse is on 
the rise in the Dominican Republic and crime has also 
escalated in the country. 
346. The Board acknowledges the increasing number 
of regional cooperation activities organized by 
Governments, the Inter-American Drug Abuse Control 
Commission (CICAD) and UNODC, as well as the 
increasing assistance from countries outside the region 
of Central America and the Caribbean. The Board 
welcomes the declaration of the eighteenth Ibero-
American Summit, held in San Salvador in 
October 2008, in which members of the Organization 
of Ibero-American States for Education, Science and 
Culture (OEI) agreed to strengthen the role of 
education as a tool for development in the region and 
to enhance technical cooperation to combat organized 
crime. 
347. In Central America, maras (street gangs) continue 
to be associated with international drug trafficking 
networks. About 5,000 gangs from El Salvador, 
Guatemala and Honduras operate in Mexico, where 
some of them have become involved in criminal 
operations with Mexican drug trafficking 
organizations. According to Mexico and countries in 
Central America, organized criminal groups based in 
Mexico have been recruiting gang members from 
El Salvador and Guatemala since 2007.  
348. The increase in deportations in the United States 
during the past three years has forced more gang 
members to return to countries such as El Salvador, 
Guatemala, Honduras and Nicaragua. Seventy-five per 
cent of the gangs in Central America have links with 
other gangs and criminal groups in the United States. 
The deported gang members usually attempt to return 
illegally to the United States. Those who succeed 
extend and reinforce their operational networks in 
activities such as drug smuggling, thus strengthening 
international criminal associations.  
349. Corruption, poorly funded judiciary systems, lack 
of public trust and weak law enforcement have 
undermined efforts to strengthen drug control policy in 
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Central America and the Caribbean. Money-laundering 
has had an impact on criminal activity at the national 
and regional levels. In Caribbean countries, measures 
are being taken to counter money-laundering and, in 
some cases, to ensure the seizure of proceeds of drug-
related crime. However, national legislation needs to 
be updated and implemented at a faster pace. The 
Board encourages the authorities of countries in the 
region that have not done so to pass legislation 
introducing civil forfeiture and anti-corruption 
programmes to strengthen financial institutions and to 
expand and continue activities in the field of drug 
control. 
 
 2. Regional cooperation 
 
350. In August 2007, CICAD, with the assistance of 
the Government of Spain and UNODC, organized a 
mock investigation in Antigua, Guatemala, focusing on 
an actual case involving money-laundering. The 
purpose of the investigation was to improve 
coordination between law enforcers, prosecutors and 
intelligence analysts. The participants included experts 
from Costa Rica, El Salvador, Guatemala, Honduras, 
Nicaragua and Panama. 
351. CICAD, in partnership with a strategy centre 
based in the United States, began to implement a pilot 
programme in Costa Rica on the culture of lawfulness, 
a school curriculum for teenage students to promote 
respect of law. In Guazapa, El Salvador, technical and 
financial support was provided to a youth outreach 
centre that provides job training, family counselling 
and intervention, as well as resources, to prevent drug 
abuse and violence. By the end of 2007, CICAD had 
trained 500 counsellors in drug abuse treatment in 
El Salvador and 150 in Guatemala. 
352. The CICAD demand reduction programme 
initiated in 2008 a professional certificate programme 
at the Université Quisqueya in Haiti. The CICAD 
Lions prevention programme, developed by the Lions 
Clubs International Foundation, is a school-based drug 
abuse prevention programme based on teaching life 
skills that has been operating in different member 
States of the Organization of American States (OAS) 
since 2005. The programme was launched in the 
Dominican Republic in the period 2007-2008 under the 
auspices of CICAD. Antigua and Barbuda, Dominica, 
the Dominican Republic and Panama received 
technical assistance from CICAD for the drafting of 
their national drug control plans and strategies. In 
addition, Caribbean countries received training on 
methodology for project management to strengthen 
human resources in national drug control commissions. 
353. In 2007, CICAD celebrated the tenth anniversary 
of the Multilateral Evaluation Mechanism (MEM), an 
instrument designed to measure the progress of 
Government action using evaluations. Implemented by 
CICAD, MEM has, during the past 10 years, proved to 
be an effective tool for use by countries in Central 
America and the Caribbean in addressing the drug 
problem. MEM reports are published periodically on 
the CICAD website. During the second half of 2007, 
MEM members visited Panama to promote the 
Mechanism in that country and to provide training for 
national institutions active in the field of drug control. 
MEM representatives participated in a meeting of 
Caribbean drug observatories held in Grenada in 
September 2007. The meeting was organized in 
partnership with the Caribbean Community 
(CARICOM). The purpose of the meeting was to 
review research and practice regarding drug abuse 
policy. MEM representatives also held a training 
workshop in Haiti for national institutions working 
with the Mechanism (see paragraph 478 below). 
354. The first interregional forum of CICAD and the 
European Union twin-city initiative was held in Santo 
Domingo in April 2008. The twin-city initiative teams 
up European cities with cities in Latin America and the 
Caribbean to find joint solutions to improve strategies 
for drug abuse treatment. Twenty-four cities in Latin 
America and the Caribbean sent representatives and 
18 delegations from European cities attended the forum 
about public policy on drug abuse.  
355. In 2007, CICAD worked with organizations, 
councils and centres based in the Caribbean, including 
the Caribbean Customs Law Enforcement Council in 
Saint Lucia and the Regional Drug Law Enforcement 
Training Centre in Jamaica, to establish programmes 
and initiatives aimed at helping member States to 
reduce illicit drug manufacture, distribution and 
availability. In April 2008, 16 law enforcement officers 
from Jamaica and 18 others from other Caribbean 
countries attended a two-week training course in 
Kingston on topics related to precursor control. The 
course was a collaborative effort involving the 
Government of Jamaica, OAS and CICAD, as well as 
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the Government of Canada (in the form of support 
from the Royal Canadian Mounted Police). 
356. In September 2007, the Governments of Jamaica 
and the United States signed an agreement modifying 
and amending the 2001 counter-narcotics agreement 
between the two Governments. As part of the 
agreement, Jamaica is to receive an additional 
US$ 35 million from the United States to fight the 
illicit trade in narcotic drugs. A total of US$ 14 million 
will go towards training, equipment and vehicles to 
enhance air and seaport security. 
357. The “Cuscatlán joint group” is a task force 
created by authorities from El Salvador and 
Guatemala, with the assistance of the United States, to 
enable vessel registration, surveillance and air and sea 
patrols to intercept illicit drug consignments on the 
coast of El Salvador. The Executive Secretariat of the 
Commission against Addictions and Illicit Drug 
Trafficking of Guatemala signed an agreement with the 
non-governmental organization Anti-Drugs Foundation 
of El Salvador (FUNDASALVA) to provide a one-year 
training programme in treating drug abuse for 
38 specialists in El Salvador, with the support of the 
United States.  
358. As part of the Merida Initiative, an initiative of 
the presidents of Mexico and the United States that was 
incorporated into law in June 2008, the Government of 
the United States will provide US$ 65 million to the 
Governments of the Dominican Republic and Haiti, as 
well as the Governments of countries in Central 
America, for 2008. The funds are mostly to be used for 
equipment and training in several areas of drug control. 
In addition, the programme includes funds to support 
the drug demand reduction efforts of CICAD (see 
paragraph 421 below). 
359. In June 2007, the OAS General Assembly 
adopted a resolution to promote cooperation, including 
at the regional level, in addressing the problem of 
criminal gangs. In the resolution, the Assembly 
resolved to instruct the Permanent Council to establish 
a contact group of member States concerned about the 
phenomenon of criminal gangs and to hold a special 
meeting with member States, other inter-American 
agencies, international organizations and 
representatives of civil society to analyse the criminal 
gang problem using a multidisciplinary approach.  
360. From 1 January to 31 July 2007, investigators, 
prosecutors and judges from the Dominican Republic 
participated in the UNODC Legal Advisory 
Programme for Latin America and the Caribbean, 
which included training on trial techniques, case 
management, circumstantial evidence and special 
investigative techniques. The International Association 
of Drug Treatment Courts, which is promoting the drug 
treatment court approach in the region, was also 
involved in the training. 
361. The Government of Honduras participated in a 
project on substance control involving the Meso-
American Control Group on Narcotics, Psychotropics 
and Precursor Chemicals, implemented in Central 
America by UNODC with the support of the 
Government of Mexico and the Permanent Central 
American Commission for the Eradication of the Illicit 
Production, Traffic, Consumption and Use of Narcotic 
Drugs and Psychotropic Substances (and agreed to by 
the Governments of Costa Rica, El Salvador, 
Guatemala, Honduras, Nicaragua and Panama). The 
Commission held a meeting in Panama City in 
January 2008 to draft a regional action plan for the 
period 2009-2013. 
362. Coordination and cooperation between forensic 
science institutes in a number of countries in Central 
America, including Costa Rica, Guatemala and 
Honduras, were enhanced through their representation 
at the Ibero-American network of forensic science 
institutes (the Latin American Academy of 
Criminalistics and Forensic Studies (AICEF)) and 
through the exchange of expertise with forensic science 
institutes in other Latin American countries, Portugal 
and Spain. 
363. At a meeting held in Belize in June 2007, the 
Presidents of Belize and Mexico agreed to strengthen 
the rule of law in the common border and to enhance 
cooperation in fighting common threats such as drug 
trafficking, terrorism and contraband. Both Presidents 
declared their commitment to reinforcing cooperation 
against international crime through a treaty on mutual 
legal assistance in criminal matters. 
364. In Trinidad and Tobago, capacity-building 
projects have been taking place under the auspices of 
the Dublin Group. The projects, which are aimed at 
supporting the Special Anti-Crime Unit of Trinidad and 
Tobago, focus on law enforcement and target lawyers, 
prosecutors and judges.  
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365. A Regional Summit on Drugs, Security and 
Cooperation was held in Santo Domingo in 
March 2007. Representatives of Colombia, the 
Dominican Republic, Haiti and Trinidad and Tobago 
participated in the summit. The meeting dealt with 
issues such as cooperation and exchange of 
information related to drug control.  
366. CARICOM member States strengthened 
cooperation mechanisms for security and recognized 
drug trafficking as a major threat. As part of the 
security support for a major sporting event in 2007 (the 
Cricket World Cup), access to the INTERPOL 
document database was expanded to include offices in 
ports and a framework was established for the sharing 
of subregional information on maritime matters.  
 
 3. National legislation, policy and action 
 
367. In Central American countries, measures are 
being taken to reduce the participation of youth gangs 
in international drug trafficking organizations. In 2007, 
the Nicaraguan Police had identified 21 gangs and 
48 criminal groups associated with gangs. The 
Directorate of Young People’s Affairs of Nicaragua 
sent multidisciplinary teams to work where those gangs 
were operating. As a result, 11 gangs with a total of 
about 800 members were dismantled in 2007. The 
Board notes with concern that, in spite of those efforts, 
the involvement of Nicaraguan gangs in criminal 
activity is increasing. 
368. The Government of Honduras has addressed the 
youth gang problem through educational programmes. 
During the first half of 2007, almost 9,000 children, 
teenagers and parents participated in programmes on 
countering violence and preventing gang-related 
problems. The programmes were organized by 
members of the Preventive Police. Other courses were 
organized for judges, attorneys and law enforcement 
officers.  
369. In addition, Governments, religious associations 
and other non-governmental organizations and 
charitable groups in Central American countries, such 
as Bienvenido a Casa and Homies Unidos in 
El Salvador, continue to work through existing 
programmes to help former gang members to 
reintegrate into society in their home countries 
following their deportation from the United States. 
370. In August 2008, Guatemalan law enforcement 
authorities launched special operations to patrol their 
country’s border with Mexico to detect illegal activities 
such as drug trafficking and arms trafficking. In 
May 2008, Guatemalan authorities started working on 
a new national drug prevention plan, targeting persons 
between 16 and 35 years old, which is the age group 
most affected by drug abuse and drug trafficking. In 
addition, the Government of Guatemala has established 
an office to provide legal assistance in cases involving 
corruption. 
371. On 19 June 2008, the Ministry of Health of 
Belize issued a ministerial decree to strengthen 
controls over ephedrine. According to the new 
legislation, special authorization is required to trade in 
ephedrine and pre-export notifications must be sent to 
importing countries. The legislation also prohibits the 
importation or exportation of pseudoephedrine in bulk 
quantities and in pharmaceutical doses. On 13 August 
2008, the Government of El Salvador issued a 
regulation on the handling and control of 
pseudoephedrine as a raw material and in 
pharmaceutical products. Furthermore, manufacturers 
of pharmaceutical preparations in El Salvador have 
been given 12 months to find a substitute for 
pseudoephedrine in medicines sold over the counter. In 
2007, the Government of Nicaragua included ephedrine 
and pseudoephedrine in the list of substances 
controlled by the law on medicaments and pharmacies. 
The Board strongly encourages the Governments of all 
countries in Central America and the Caribbean to 
adopt and implement legislation to control the 
increasing diversion of precursors in the region. 
372. To build the capacity of forensic services in 
Guatemala, a forensic science institute (the Instituto 
National de Ciencias Forenses) was created in 2006. 
The institute officially began its work in July 2007, 
with significant assistance from various donors, 
including Germany and the European Commission. It 
is currently guided by a scientific committee of 
forensic experts from Colombia and Spain, as well as 
Puerto Rico. 
373. The Government of Honduras set up a task force 
in the Mosquita area, an area used for cocaine 
trafficking by sea and air. Within 18 months, the task 
force seized 11 tons of cocaine. The Counter-Narcotics 
Directorate, attached to the Ministry of Public 
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Prosecution of Honduras, has set up a special division 
to investigate maritime drug trafficking. 
374. In 2008, a pilot project developed by a CICAD 
task force was started to estimate drug abuse among 
prisoners in Costa Rica. During the past three years, 
Costa Rica has successfully implemented a 
comprehensive model for the treatment of drug 
addiction. 
375. In July 2008, the President of the Dominican 
Republic launched a strategic plan for national drug 
control for the period 2008-2012. The plan includes 
guidelines to strengthen institutions, revise the legal 
framework, implement public policy and create a 
national information and research institute. In addition, 
the Government implemented a plan for the security of 
citizens. A presidential decree was issued to create a 
national council for the security of citizens.  
376. The Government of the Dominican Republic also 
established a special military unit to tackle trafficking 
in human beings, drugs and firearms in border areas. 
The unit, called Cuerpo Especializado de Seguridad 
Fronteriza, began operations in September 2007, when 
200 soldiers were deployed along the country’s border 
with Haiti. In addition, the Government of the 
Dominican Republic provided eight aircraft for 
fighting drug trafficking.  
377. In order to ensure that information related to pre-
export notifications of controlled substances was well 
managed, the directorate general of customs in the 
Dominican Republic initiated a process to implement 
the electronically operated single customs declaration 
procedure. The directorate general will invest more 
than US$ 20 million in the development of an 
electronic processing system. The project, which 
includes the provision of new equipment, computer 
programs and training for personnel, is supported by 
the Economic Development Cooperation Fund of the 
Republic of Korea.  
378. The Government of the Dominican Republic 
launched in 2006 an operation to fight corruption 
among drug control authorities. According to reports of 
the Government, 5,000 persons have been reprimanded 
and expelled from the National Drug Control 
Directorate as a result of the operation. Some of those 
persons have been charged with drug trafficking, 
although the operation also targeted indiscipline and 
incompetence. The Board notes the efforts of the 
Dominican Republic to combat corruption, drug 
trafficking and violence. 
379. In Haiti, security remains fragile in part because 
of the continuous trafficking in drugs and firearms. In 
its resolution 1780 (2007), the Security Council, inter 
alia, invited Member States, in coordination with the 
United Nations Stabilization Mission in Haiti 
(MINUSTAH), to engage with the Government of Haiti 
to address cross-border trafficking in illicit drugs and 
arms and other illegal activities.  
380. Efforts are under way in Trinidad and Tobago 
to eradicate illicitly cultivated cannabis. In 
November 2007, Government officials and 
representatives of non-governmental organizations 
participated in a workshop to finalize the drafting of a 
national drug control plan for the period 2008-2012.  
381. In 2008, the Government of Saint Kitts and Nevis 
passed legislation aimed at increasing the efficiency of 
the Financial Services Commission, empowering it to 
impose sanctions on financial institutions involved in 
money-laundering. 
382. In Jamaica, after years of stalling in Parliament, 
the Proceeds of Crime Act was approved by the Senate. 
The Act, in effect since May 2007, incorporates 
elements of previous legislation against money-
laundering and allows for the recovery of assets linked 
to criminal activity. The Government has pledged to 
reform the current justice system. In May 2007, the 
Jamaican Justice System Reform Task Force published 
a preliminary report and provided guidelines for 
improvement in areas such as accountability and 
transparency. To address the new threat posed by the 
use of the Internet as a means of advertising and 
acquiring controlled drugs, members of the Jamaica 
Constabulary Force have received training by experts 
on Internet investigations. The Jamaica Constabulary 
Force opened a new base of operations in Saint 
Thomas in December 2007 to maintain security on the 
eastern coastline and protect it against trafficking in 
illicit drugs and firearms. 
383. The third anniversary of Operation Kingfish, a 
major initiative involving law enforcement agencies 
from Canada, Jamaica, the United Kingdom and the 
United States was celebrated in 2007. Through 
Operation Kingfish, over 2,000 operations have been 
conducted and more than 13 tons of cocaine and 
12 tons of cannabis have been seized. 
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 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
384. The geographical location of Central America and 
the Caribbean makes it an important transit and storage 
area for South American drug consignments en route to 
Mexico, including those consignments having the 
United States and countries in Europe as their final 
destination. Drug trafficking has had an impact on both 
drug abuse and drug-related crime in the region and 
has also led to increased money-laundering activities, 
especially in the Caribbean.  
385. Drug trafficking by land continues to pose a 
problem to national authorities in Central America. 
According to UNODC, 18 per cent of the cocaine 
smuggled into Mexico enters that country through 
Belize and Guatemala. There are indications that drug 
trafficking along that route is increasing and that 
Belize is being used as a trans-shipment area for 
cocaine consignments entering Europe via the West 
Africa route (see paragraph 324 above). 
386. According to the Government of Belize, Mexican 
criminal organizations are increasingly making use of 
Belizean territory for stockpiling illicit drugs and 
coordinating drug trafficking operations. As part of its 
regional strategy for Central America and the 
Caribbean, UNODC is currently working with the 
Government of Belize to strengthen the rule of law and 
fight organized crime. 
387. Since maritime drug trafficking routes are 
increasingly being monitored, drug traffickers have 
been using low-flying light aircraft, in addition to other 
aircraft. Speedboats continue to be used to smuggle 
drugs across the Caribbean. Illicit drug consignments 
are usually concealed in personal luggage, canned food 
or industrial containers. However, the use of “mules”, 
people who smuggle drugs by ingesting them, 
continues. 
388. Jamaica continues to be the main producer and 
exporter of cannabis in Central America and the 
Caribbean. Despite the eradication efforts and 
significant seizures and arrests, cannabis is illicitly 
cultivated in most parts of the country. Consignments 
of cannabis from Jamaica are sent through the 
Bahamas, the Dominican Republic and Haiti to 
countries in North America or Europe. Cannabis is 
produced for domestic consumption in other countries 
in the Caribbean, such as Barbados, Saint Vincent and 
the Grenadines and Trinidad and Tobago. According to 
the Government of Trinidad and Tobago, cannabis 
plants are illicitly cultivated on about 145 ha in the 
country.  
389. Guatemala is the only country in Central America 
and the Caribbean in which there is significant illicit 
opium poppy cultivation. According to the Government 
of Guatemala, the total amount of opium poppy 
eradicated in 2008 increased compared with the total 
amount eradicated in 2007, and illicit opium poppy 
cultivation also increased in 2008. The Board urges the 
Government to provide it with detailed information 
regarding the total area of illicit opium poppy 
cultivation in the country, as well as the total area 
eradicated. 
390. According to Guatemalan authorities, the amount 
of cocaine seized during the first quarter of 2008 was 
more than the amount seized in 2006 and 2007 
combined. In a single operation, the Guatemalan army 
and police seized 1,136 kg of cocaine in the area of 
San Andrés, Petén. The drug was found on a small 
aircraft headed towards Mexico. The Government of 
Guatemala reported that between January and 
April 2008, 1,511 kg of cocaine, over 59,000 cannabis 
plants and more than 161 million opium poppy plants 
were seized.  
391. In the first half of 2007, the authorities of Panama 
reported having seized 17,872 kg of cocaine, 1,221 kg 
of cannabis and about 31 kg of heroin. In a joint 
operation, the authorities of Costa Rica, Nicaragua and 
the United States seized 250 kg of cocaine in 
Nicaragua in November 2007.  
392. The authorities of Costa Rica have reported a 
marked increase in seizures of cocaine and heroin, 
mainly on maritime routes. Colombian drug traffickers 
continue to hire fishermen from Costa Rica and use the 
fishermen’s vessels in their operations. In 2007, 2 tons 
of cocaine were confiscated in Europe in a total of 
146 seizures involving consignments from Costa Rica. 
The majority of the seizures originating in Costa Rica 
were reported by Spain, followed by the Netherlands, 
Germany and Belgium. Most of the seizures involved 
mail shipments.  
393. There has been an increase in drug trafficking in 
Honduras principally in the north (Cortés, Colón, 
Atlántida) and along the border of Honduras with 
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Nicaragua. The largest amounts of drugs enter 
Honduras through the department of Gracias a Dios, 
usually by sea or by air. In March 2007, 1,350 kg of 
cocaine were seized on a small aircraft coming from 
the Bolivarian Republic of Venezuela and 3,200 kg of 
cocaine were seized on a fishing boat in May 2007.  
394. Haiti is used as a major trans-shipment area for 
consignments of South American cocaine bound for the 
United States. Drug trafficking has increased along the 
border of Haiti with the Dominican Republic. In 
May 2007, Haitian authorities and United Nations 
police (UNPOL) arrested 10 people, including 4 police 
officers, and seized almost 420 kg of cocaine, one of 
the largest cocaine seizures in that area in the past 
decade. 
395. Between January and October 2008, authorities in 
the Dominican Republic seized 2,467 kg of cocaine, 
220.1 kg of cannabis, 95.7 kg of heroin and 
15,949 units of “ecstasy”. During the same period 
17,378 people were arrested for drug-related offences.  
396. The Government of the Bahamas reported the 
seizure of 193,902 kg of cannabis and 189.5 kg of 
cocaine during 2007 as a result of Operation Bahamas, 
Turks and Caicos (OPBAT).  
397. In 2007, the Government of Cuba reported having 
seized 3,074.6 kg of narcotic drugs, of which 
2,126.9 kg was cannabis. Cannabis and cocaine are 
abused in small amounts, mainly in Havana. The 
Government addresses the problem of drug abuse 
through drug abuse prevention and treatment 
programmes under the supervision of the National 
Drug Commission, with the participation of political 
and civil organizations. 
398. The availability of drugs in the streets of the 
Dominican Republic is a growing problem, as 
indicated by the fact that drug abuse is on the rise. 
About 20 per cent of the narcotic drugs trafficked in 
the country are used to pay drug traffickers. Instead of 
receiving money, traffickers are paid in drugs, thus 
expanding the local drug trafficking networks and 
increasing local demand. The growing illicit drug 
market mainly affects the poorest segment of the 
population and is reflected in the increasing violence 
and criminal activity in the country. The homicide rate 
in the Dominican Republic increased by 66 per cent 
from 2000 to 2007. 
399. According to the latest available UNODC data, in 
2006, the annual prevalence rate of cocaine abuse 
among the population aged 15-64 in Haiti was 0.9 per 
cent. 
400. In 2007, the Ministry of Health and Environment 
of Saint Vincent and the Grenadines launched the 
Global School-based Student Health Survey to measure 
the abuse of alcohol, drugs and other substances, 
together with other indicators such as physical activity 
and mental health. The results showed that 19.9 per 
cent of students 13-15 years old had abused drugs at 
least once during their lives. 
401. In Trinidad and Tobago, cannabis is the most 
abused drug. Cannabis plants are mainly cultivated 
locally, although more potent varieties of cannabis are 
brought into Trinidad and Tobago from Saint Vincent 
and the Grenadines. According to the National Alcohol 
and Drug Abuse Prevention Programme, there are only 
a few cases of heroin abuse in the country. Several 
demand reduction initiatives are currently under way. 
Those initiatives include programmes in prisons, public 
awareness campaigns and school-based programmes. 
In addition, the Drug Abuse Resistance Education 
(DARE) programme in Trinidad and Tobago is being 
implemented. 
402. The DARE programme is also being implemented 
in the following other countries in Central America and 
the Caribbean: Barbados, El Salvador, Grenada, 
Nicaragua, Saint Kitts and Nevis, Saint Lucia and Saint 
Vincent and the Grenadines. 
403. The Board notes with concern the lack of 
published studies on drug abuse in Central America 
and the Caribbean. Therefore, the Board welcomes the 
initiative of the Inter-American Observatory on Drugs, 
which has announced that it is preparing a comparative 
report on drug abuse among school students in the 
Caribbean and a comparative study of the drug 
situation in Central America.  
 
  Psychotropic substances 
 
404. The Board notes with concern the increase in the 
abuse of MDMA (“ecstasy”) in countries in Central 
America and the Caribbean, particularly in El Salvador 
and Guatemala. MDMA abuse is also increasing in 
Jamaica, especially in the tourist areas of Negril and 
Montego Bay. The “ecstasy” found in the region 
continues to be smuggled from European countries or, 
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more recently, from Canada (see paragraphs 419-457 
below). 
405. According to the most recent data provided by 
UNODC, the Dominican Republic is the Caribbean 
country with the highest annual prevalence of abuse of 
amphetamines (excluding “ecstasy”): 1.1 per cent. 
During the first nine months of 2007, 18,347 “ecstasy” 
tablets were seized in that country. 
406. According to UNODC, in Barbados the annual 
prevalence of abuse of amphetamines (excluding 
“ecstasy”) among persons aged 15-64 was reported to 
be 0.2 per cent in 2007. The rate for abuse of “ecstasy” 
was reported to be 0.5 per cent among persons in the 
same age group.  
407. The authorities of Cuba have reported the abuse 
of psychotropic substances in that country; they have 
also noted that the level of abuse is decreasing due to 
new control measures. In Trinidad and Tobago, the 
National Alcohol and Drug Abuse Prevention 
Programme has reported evidence of the abuse of 
“ecstasy” in that country. 
408. There are reports indicating that 
methamphetamine laboratories are being established in 
Central America. Two clandestine laboratories for 
manufacturing “ecstasy” were seized and dismantled in 
Tegucigalpa in August 2008.  
 
  Precursors 
 
409. Recent measures adopted in Mexico to limit the 
availability of pseudoephedrine have had an impact on 
trafficking in precursors in Central America. Honduran 
law enforcement officers have reported an increase in 
demand for medicines containing pseudoephedrine that 
can be sold over the counter. In particular, nationals of 
other countries have been buying significant amounts 
of those medicines. In June 2008, Honduran authorities 
seized 1.2 million tablets of pseudoephedrine at the 
airport at Tegucigalpa. 
410. The authorities of El Salvador have also reported 
an increase in demand for pharmaceutical preparations 
containing pseudoephedrine. The authorities have 
reported that nationals of El Salvador and Guatemala 
have been allegedly supplying Mexican cartels with 
precursors. 
411. In 2007, Panama reported the seizure of 
10,000 kg of ephedrine and over 1,000 litres of 
hydrochloric acid. Costa Rica reported the seizure of 
2.8 kg of pseudoephedrine. In Belize, the health 
authorities have noted an increase in the importation of 
pharmaceutical preparations containing 
pseudoephedrine and are currently monitoring their 
distribution to prevent diversion.  
412. In Central American countries, measures are 
being taken to address the increasing diversion of 
precursors used in illicit drug manufacture; and some 
Caribbean countries, such as Antigua and Barbuda, 
Barbados and Grenada, have mechanisms for 
regulating the use and distribution of controlled 
chemicals. In the region as a whole, however, the 
movement of precursors is poorly monitored and 
regulated due to weak infrastructure and insufficient 
funding. The Board encourages the Governments of 
countries in Central America and the Caribbean to 
adopt and strengthen legislation and to establish a 
regional cooperation mechanism for preventing 
trafficking in and diversion of precursors. 
 
 
  North America 
 
 
 1. Major developments 
 
413. The major challenge in the region of North 
America is the domination of illicit drug production 
and trafficking by organized crime and the growing 
violence in fighting among drug cartels and between 
drug traffickers and law enforcement officers, 
particularly in Mexico. On the demand side, a 
significant shift of consumption patterns towards the 
abuse of prescription drugs can be observed in the 
United States. Canada has changed its role as a 
traditional importer and consumer of “ecstasy” to a 
major manufacturer and exporter of that drug.  
414. The Government of Mexico faces violent 
opposition by drug cartels to its attempts to fight 
organized crime and drug trafficking. The Government 
has deployed more than 12,000 military troops and has 
employed forces from seven Government agencies, 
spending more than US$ 2.5 billion in 2007 (an 
increase of 24 per cent over the spending level in 2006) 
to improve security and reduce drug-related violence. 
Drug cartels have responded with unprecedented 
violence and the number of homicide victims, 
including top-level federal police officers, in 2007 and 
2008 has more than doubled compared with previous 
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years, as federal intervention is taking place in states 
where corruption had allowed drug traffickers to 
operate relatively undisturbed.  
415. Organized criminal groups continue to control 
drug trafficking in North America, the strong presence 
of Mexican drug syndicates being felt in Mexico and 
the United States and the increasing influence of Asian 
drug trafficking organizations noticeable in Canada and 
the United States. Colombian drug trafficking 
organizations continue to focus their operations on 
cocaine and heroin trafficking, but Mexican syndicates 
have taken over from Colombian organized criminal 
groups the smuggling and distribution of heroin and 
cocaine from South America to the United States. In 
addition, Mexican drug trafficking organizations are 
heavily involved in the distribution of 
methamphetamine from Mexican-operated illicit drug 
manufacture and cannabis cultivation and trafficking 
within and into the United States. Asian drug 
trafficking organizations operating from Canada are 
involved in the illicit cultivation of high-potency 
cannabis in Canada and the United States and are 
illicitly manufacturing methamphetamine for the illicit 
market in Canada and the United States. 
416. In 2007, an estimated 35.7 million citizens in the 
United States, or 14.4 per cent of the population aged 
12 or older, had consumed illicit drugs (annual 
prevalence). One encouraging sign is the decline in 
overall illicit drug use among youth and young adults 
in the United States. Since 2001, there has been a 
decrease of 24 per cent in drug abuse among persons 
aged 12-17 years. That drop is mostly attributed to a 
decrease in the abuse of cannabis; however, there has 
also been a decrease in the abuse of almost all other 
drugs. Similarly, the abuse of drugs among young 
adults (persons aged 18-25 years) has decreased in all 
drug categories except pain relievers. 
417. The decrease in the abuse of cannabis in the 
United States is related to the perceived risks of 
smoking cannabis, which increased between 2002 and 
2007, and strong parental disapproval of drug abuse. 
The increase in the perceived risks may be attributed to 
educational campaigns in the United States. Despite 
that significant decline, the problem of substance abuse 
among United States teenagers continues to be 
widespread, as nearly half of United States students 
aged 17-18 (47 per cent) have tried an illicit drug by 
the time they have finished secondary school (lifetime 
prevalence).  
418. In Canada and Mexico, the abuse of cocaine, 
cannabis and methamphetamine has increased. 
Mexican authorities are concerned over the fact that 
the age of initiation of drug abuse has decreased to 
8-10 years and over the increased risk of drug abuse 
associated with the use of tobacco and alcohol at an 
early age (before reaching age 17). The abuse of 
prescription drugs is also a recognized abuse problem 
among senior citizens in Mexico. 
419. Canada has become the primary source of supply 
of MDMA (“ecstasy”) found on the illicit market in 
that country and the United States. There is wide 
availability and stable use of MDMA in Canada: past-
year prevalence is 4.4 per cent among youth and young 
adults (persons 15-24 years old). Canadian law 
enforcement authorities report continued smuggling of 
precursors from China into Canada for use in illicit 
drug manufacture in that country. Unprecedented 
quantities of Canadian “ecstasy” were seized in other 
countries, reflecting the increased significance of the 
country in “ecstasy” manufacture and trafficking.  
420. A recent household survey showed that in Mexico 
the accumulated incidence of cocaine doubled between 
2002 and 2008. The use of methamphetamine and 
“crack” cocaine (a cocaine derivative converted from 
cocaine hydrochloride), while showing a lower 
prevalence, has increased during the same period. The 
difference between the rates of male and female 
abusers has declined. 
 
 2. Regional cooperation 
 
421. For many years, cooperation projects have been 
carried out in the countries in North America. A new 
major step in regional cooperation in 2008 is the 
Merida initiative, an example of security cooperation 
involving Mexico and the United States, as well as the 
countries in Central America, to combat drug 
trafficking, transnational crime and terrorism (see 
paragraph 358 above). The initiative combines national 
efforts with regional cooperation and supports 
coordinated strategies to counteract the power of 
criminal organizations. The initiative will support 
border, air and maritime controls and improve the 
capacity of judicial systems to conduct investigations 
and prosecutions. The United States Congress 
approved in June 2008 US$ 465 million in assistance, 
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primarily for Mexico but also for Central American 
countries. 
422. Progress is also being made in other cooperation 
projects. United States law enforcement agencies are 
supporting their Mexican counterparts by providing 
training in precursor detection, investigative 
techniques and methamphetamine investigations in the 
main areas of illicit methamphetamine manufacturing 
in Mexico. Support in the form of specialized 
equipment, vehicles and computers is being provided 
to the new federal police corps and its special 
investigative units. In 2007, a multi-year effort was 
initiated in Mexico to help the Secretary of Public 
Security carry out reform. In addition, specialized 
training was provided to the new federal police in such 
areas as addressing cybercrime and handling 
explosives and incendiary devices and to the Mexican 
Navy. Since 2007, prosecutors from Colombia, Mexico 
and countries in Central America have strengthened 
their exchange of police and financial intelligence in 
judicial investigations and interception operations. 
423. Cooperation between Canada and the United 
States is progressing and bilateral forums, such as the 
Cross-Border Crime Forum and Project North Star, 
have increased information-sharing and joint training 
among law enforcement officers. Under the Border 
Enforcement Subgroup of the Forum, agreement is 
being sought on the Integrated Marine Security 
Operations programme, known as Shiprider. The 
Shiprider programme will allow officers from one 
country to operate from vessels (or aircraft) of another 
country, thereby permitting a single vessel to patrol 
both Canadian and United States waters. The pilot 
programme of the border enforcement security task 
force will complement the existing integrated border 
enforcement team initiative and enable comprehensive 
border control, not only between ports of entry but also 
at ports of entry. Canada has expanded its cooperative 
efforts in the transit zone from South America to 
North America and deployed “Maritime Patrol Assets” 
in support of the Joint Interagency Task Force South.  
424. As many samples of seized MDMA contain 
methamphetamine, United States law enforcement 
agencies and the Royal Canadian Mounted Police have 
stepped up their intelligence-sharing and coordinated 
law enforcement operations to fight criminal 
organizations manufacturing “ecstasy”. Canadian and 
United States law enforcement agencies are also 
enhancing their coordination through the National 
Methamphetamine Chemicals Initiative. 
 
 3. National legislation, policy and action 
 
425. The Government of Mexico has continued to take 
action against corruption, including by improving pay 
and benefits, introducing stricter criteria for the 
selection of new employees and using more modern 
investigative techniques. In Mexico, drug control 
operations have been launched in 11 states and the 
investment in security forces has been increased. 
Furthermore, the Government of Mexico, in 
cooperation with the Governments of Colombia and 
countries in Central America, has developed a regional 
security plan to improve drug control operations 
throughout the Americas.  
426. In Mexico, Congress approved legal and 
constitutional reforms unifying the federal police into 
one force and allowing proactive investigation, 
increasing the discretion of prosecutors and the 
modification of the code of criminal procedures.  
427. Complementary legislation on mandatory 
minimum prison sentences for convictions of serious 
drug-related crime was introduced in Canada. Such 
serious drug-related crime includes growing cannabis 
and manufacturing and dealing in “crystal” 
methamphetamine and “crack” cocaine. 
428. In order to respond to the increasing abuse of 
prescription drugs, several measures have been 
introduced in the United States, such as point-of-
purchase messages on prescription drugs with high 
abuse potential. Several states in the United States 
have introduced prescription monitoring programmes 
such as the Automated Rx Reporting System 
(OARRS), available via a secure website 24 hours a 
day, 7 days a week. Critics had feared that the 
introduction of the system would reduce the number of 
prescriptions issued, but that was not the case. In fact, 
physicians have stated that they find OARRS reports 
useful for the validation of information provided by 
patients. 
429. The Government of Canada launched its revised 
National Anti-Drug Strategy, which combines 
treatment and prevention, including public awareness 
campaigns, and stricter law enforcement measures 
targeting illicit drug manufacturers and traffickers. The 
new strategy in Canada provides 100 million Canadian 
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dollars for personnel dedicated to tackling the illicit 
production of cannabis and the illicit manufacture of 
amphetamine-type stimulants. In addition, it includes 
measures to strengthen precursor control and border 
control, as well as to improve cooperation with 
authorities of the United States. Resources allocated to 
prevention focus on youth and programmes in schools 
and resources allocated to treatment focus on the 
development of national benchmarks for evaluation 
and data collection, enhancing treatment for indigenous 
populations and youth offenders in the criminal justice 
system. The goal is to reduce illicit drug use among 
Canadian youth aged 10-24, including high-risk youth, 
focusing on risk and protective factors before drug use 
begins. 
430. The Board is concerned that distribution of “safer 
crack kits” has continued in several cities in Canada 
and that a Supreme Court of British Columbia issued a 
decision in May 2008 permitting a “drug injection 
room” in Vancouver, the first “drug injection room” in 
the Americas, to continue to operate. The Board views 
such programmes with great concern and considers that 
they violate the international drug control treaties.  
431. Canada is one of the few countries worldwide 
that allows cannabis to be prescribed by doctors to 
patients with certain illnesses. There are currently over 
2,200 patients in Canada for whom cannabis is 
prescribed. Initially, only state-run institutions could 
make cannabis available for medical purposes. 
However, subsequent regulations allowed patients to 
grow a small amount of cannabis for their own use and 
provided for private persons to obtain licences for 
growing cannabis to be used for medical purposes. 
According to current regulations, each of those private 
persons may supply cannabis to only one patient. In 
Canada, the Federal Court ruled in January 2008 that 
the provision that a supplier could only provide 
cannabis to one patient unduly restricted the patient’s 
access to cannabis used for medical purposes and 
unreasonably slanted the market in favour of the 
Government’s chosen supplier. The Government has 
appealed the ruling. Article 23 of the 1961 Convention 
stipulates specific requirements that a Government 
must fulfil if it is to allow the licit cultivation of 
cannabis, including the establishment of a national 
cannabis agency to which all cannabis growers must 
deliver their total crops. The Board encourages the 
Canadian authorities to respect the provisions of 
article 23 and fulfil those requirements.  
432. The Board is concerned that in the United States, 
the disagreement between the Government and several 
states regarding the use of “medical cannabis” 
continues. The question whether the “medical use” of 
cannabis should be made legal has been put to a 
referendum in several states (most recently in 
Massachusetts and Michigan). While the Government 
maintains that the consumption and cultivation of 
cannabis are illegal activities, several states have 
passed laws by referendum that ease or eliminate 
sanctions for the “compassionate/medical use” of 
cannabis. In California, for example, legislation allows 
the use of “medical cannabis” for a variety of 
indications, as well as the cultivation of the plant by 
designated growers of cannabis. That has led to a 
proliferation of cannabis cultivation in California and 
to the establishment of cannabis “vending machines” 
as well as other reported methods of abuse. The Board 
is concerned that that practice may lead to a further 
increase in cannabis abuse in the United States and 
may affect other states. The Board calls upon the 
authorities of the United States to continue its efforts to 
stop that practice, which is in contradiction to national 
law and is in violation of article 23 of the 
1961 Convention.  
433. The Government of Mexico has developed 
standards and norms to be followed for the treatment of 
drug abuse at the national, state and local levels. Those 
standards and norms are contained in the official norms 
for the prevention, treatment and control of addiction 
and the criteria of minimum standards of quality for 
the administration of treatment in medical and 
residential establishments. In Mexico, the National 
Council against Addictions (CONADIC) and the 
Secretariat of Health are both responsible for 
maintaining a national registry of services and 
treatment programmes and the names of the institutions 
permitted to conduct such programmes. A process is 
under way to create a national network of facilities for 
the treatment of drug abuse, comprising 300 new 
treatment centres (70 of which have already been built) 
in addition to the existing 96 programmes for 
outpatient treatment and 6 programmes for inpatient 
treatment. Both types of treatment programmes are 
public programmes available to the entire population 
for the treatment of drug abuse.  
434. The Government of Mexico has increased the 
share of the budget earmarked for reducing drug 
demand and, with the participation of the main 
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Government ministries, including the Ministry of 
Health, has launched a national programme. In 
addition, the national system for family development is 
supporting a national programme for drug abuse 
prevention in communities. The Ministry of Social 
Development is supporting, with the active 
involvement of the community and the assistance of 
the police, a social programme aimed at making public 
places in communities safer environments. 
Furthermore, the Ministry of Public Education, in close 
collaboration with the Attorney General’s Office and 
the police, has launched a new prevention programme 
as part of an integrated approach to dealing with the 
drug problem.  
435. In the United States, the number of persons aged 
12 or older receiving treatment at a facility specializing 
in the treatment of substance abuse in 2007 was 
2.4 million, or 1 per cent of population aged 12 or 
older. One cause for concern is that the share of the 
national drug control budget allocated to drug abuse 
prevention has continued to decline. According to the 
2009 budget summary of the National Drug Control 
Strategy, 11 per cent of the US$ 14.1 billion requested 
for the 2009 national drug control budget is allocated 
to prevention, compared with 20 per cent in 2001. 
Slightly less than 25 per cent of the budget is allocated 
to treatment. A major share of the budget is allocated to 
supply reduction. The Board encourages the authorities 
of the United States to seek an even balance between 
demand and supply reduction programmes and to 
provide adequate funding to demand reduction 
measures. 
 
 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
436. North America remains one of the main areas of 
cannabis illicit production and abuse, the largest 
producer country being Mexico (about 7,400 tons), 
followed by the United States (about 4,700 tons) and 
Canada (about 3,500 tons). Despite the efforts of the 
Government of Mexico to eradicate cannabis, the total 
area under illicit cannabis cultivation increased. In 
2007, the Mexican military took over from the 
Attorney General’s Office the sole responsibility for 
eradicating cannabis and opium poppy. Due to the 
realignment of responsibilities for aerial eradication 
efforts, the total eradicated area of illicitly cultivated 
cannabis declined (to 21,357 ha) in 2007 compared 
with the figure for 2006 (30,158 ha). 
437. In Canada, 61.4 per cent of youth and young 
adults (aged 15-24) have used cannabis at least once in 
their lives, 37 per cent have used it at least once in the 
past 12 months and 8.2 per cent have used it on a daily 
basis. Illicit cannabis growers utilize advanced 
methods of cultivation to meet the high demand for 
cannabis in Canada and on the illicit market in the 
United States. Annual cannabis production in Canada is 
estimated to range from 1,399 to 3,498 tons. One cause 
for concern is the very high THC content of a limited 
number of samples in Canada and the United States, 
proving that criminal organizations in both countries 
are able to produce high-potency cannabis. Illicit 
cannabis cultivation continues to thrive in Canada, 
partly because of the absence of laws providing strict 
punishment for such activity. The majority of the illicit 
cannabis growing operations in that country are carried 
out by organized criminal groups. 
438. In the United States, cannabis remains the most 
commonly abused drug: 25.1 million persons (or 
10.1 per cent of the population aged 12 or older) used 
cannabis in 2007. The illicit market for cannabis is 
supplied by an increasing number of domestic indoor 
and outdoor cannabis cultivation sites. Cannabis is also 
smuggled into the United States out of Canada, 
Colombia, Jamaica and Mexico. While most of the 
cannabis available in the United States has a lower 
potency and is produced in Mexico, United States 
authorities are concerned about the high potency of 
some cannabis grown indoors in Canada and the 
United States under hydroponic conditions. Largely as 
a result of those innovations, the average THC content 
of all cannabis samples tested in the United States 
increased to 8.77 per cent in 2006, nearly twice the 
figure obtained in 1996 (4.5 per cent). Individual 
samples may have an extremely high THC content: 
cannabis seized in Atlanta that had been grown indoors 
had a THC content of over 18 per cent. 
439. Cocaine continues to be easy to obtain on the 
illicit market in Canada, where 5.5 per cent of the 
population aged 15-24 years has abused cocaine in the 
past 12 months. The total amount of cocaine seized in 
Canada increased slightly from 2,556 kg in 2005 to 
2,676 kg in 2006. Most of the cocaine in Canada has 
been smuggled over land routes leading through 
countries in Central America, Mexico and the United 
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States. In addition, cocaine continues to be smuggled 
into Canada on direct flights from South America, as 
well as through various transit countries in the 
Caribbean, such as Antigua and Barbuda, the 
Dominican Republic and Trinidad and Tobago. 
Colombian drug traffickers have attempted to escape 
detection by routing cocaine consignments through 
countries neighbouring the countries of destination. 
Cocaine is also smuggled through Canada into other 
countries such as Australia. “Crack” continues to be 
abused throughout Canada. Cocaine laced with 
methamphetamine (to increase demand), has been 
identified as an emerging trend in Canada.  
440. In the United States, the annual prevalence of 
cocaine abuse in 2007 was 2 per cent among persons 
13-14 years of age, 3.4 per cent among persons 
15-16 years of age and 5.2 per cent among persons 
17-18 years of age, and the annual prevalence of 
“crack” cocaine among teenagers ranged from 1.3 to 
1.9 per cent. The annual prevalence of cocaine abuse 
among the general population in 2007 was 2.3 per cent 
(5.7 million cocaine abusers, compared with more than 
6 million in 2006). In 2007, domestic and international 
law enforcement efforts resulted in large cocaine 
seizures in the Eastern Pacific, which contributed to 
the cocaine shortage in the United States, which in turn 
contributed to the decline in the annual prevalence rate 
in that country for 2007. In addition, intensified efforts 
by the Mexican authorities to fight drug cartels 
resulted in a decline in cocaine deliveries across the 
border to the United States. Law enforcement reports 
indicated that, between January and September 2007, 
there was a sustained cocaine shortage in 38 cities in 
the United States with large illicit markets for cocaine, 
while the price of a gram of pure cocaine nearly 
doubled. The shortage of cocaine was also reflected in 
workplace drug testing and in a lower percentage of 
cocaine-related emergency room visits in 2007 
compared with the data for 2006. 
441. Notwithstanding the successful law enforcement 
activities mentioned above, the estimated amount of 
cocaine from South America smuggled into the 
United States remained significant. United States 
authorities estimate that 530-710 tons of cocaine left 
South America for the United States in 2006, an 
estimate similar to the estimate for 2005. About 90 per 
cent of the cocaine smuggled out of South America and 
into the United States has passed through the Central 
America corridor, the majority of it being shipped 
through the Eastern Pacific vector.  
442. In Canada, heroin abuse continues to be the least 
common form of drug abuse (lifetime prevalence: 
0.9 per cent). Heroin is mostly supplied by countries in 
South-West Asia; India continues to be the primary 
source or transit country. There have been no changes 
with regard to the availability and purity of heroin in 
Canada. Most of the heroin in Canada has been 
smuggled into the country by air passengers or through 
postal or courier services. In Canada, heroin abuse has 
been at least partly replaced by the abuse of 
prescription opiates. The total amount of opium seized 
increased considerably from 16 kg in 2005 to about 
124 kg in 2006. India was the primary source of the 
opium seized; however, the most significant individual 
seizures involved consignments transited through Iran 
(Islamic Republic of) and Turkey. In Canada, opium is 
mainly abused by older members of some ethnic 
groups.  
443. In the United States, heroin abuse is stable at a 
relatively low level (lifetime prevalence: 1.5 per cent), 
despite the fact that heroin is easily available in most 
large urban areas and in some suburban and rural areas, 
mostly in the north-eastern part of the country. 
However, there has been some increase in heroin abuse 
among young adults in suburban and rural areas. The 
concentration of heroin abuse in the north-east is partly 
the result of abusers of prescription opiates switching 
to heroin because of its lower cost and higher purity 
level. Heroin continues to be abused by youth in the 
United States: the annual prevalence of heroin abuse is 
currently 0.9 per cent, which is significantly below the 
peak level of 2000, when 1.5 per cent of all persons 
aged 17-18 reported having abused heroin during the 
previous year. However, United States authorities are 
concerned that the high level of abuse of prescription 
opiates may lead to increased heroin abuse among 
adolescents. In the United States, a combination of 
Mexican “black tar” heroin and over-the-counter 
medication containing diphenhydramine hydrochloride 
is being sold under the street name “cheese heroin”.  
444. Most of the heroin abused in the United States is 
illicitly manufactured in Colombia or Mexico. Mexico 
experienced a continuous decline in eradication levels, 
the total area eradicated dropping from 21,609 ha in 
2005 to 16,831 ha in 2006 and only 7,784 ha in 2007. 
That decline was partly the result of unfavourable 
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climate conditions and the realignment of 
responsibilities for aerial eradication in Mexico (see 
paragraph 436 above). 
445. In the United States, the number of persons who 
abuse prescription drugs is now greater than the total 
number of persons who abuse cocaine, heroin, 
hallucinogens, “ecstasy” and/or inhalants. Prescription 
drugs are the second most abused category of drugs, 
surpassed only by cannabis. In 2007, about 
16.3 million persons reported having abused 
prescription drugs in the previous year (6.6 per cent of 
the population aged 12 and above), compared with 
14.8 million in 2002. About 6.9 million of those who 
abused prescription drugs in the past year are “current 
users” (persons who abuse such drugs at least once a 
month). Most of those who abused prescription drugs 
in the past month are abusers of pain relievers: they 
numbered 5.2 million in 2007, compared with 
4.4 million in 2002. 
446. One matter of particular concern is the high rate 
of abuse of prescription drugs among youth. The non-
medical use of prescription pain relievers among young 
adults (aged 18-25) in the past month increased from 
4.1 per cent in 2002 to 4.6 per cent in 2007. About 
15 per cent of students aged 17-18 reported the non-
medical use of at least one prescription medication 
within the past year. The annual prevalence of abuse of 
narcotic drugs other than heroin among secondary 
school students is 9.2 per cent. More than 5 per cent of 
students aged 17-18 have tried oxycodone 
(Oxycontin®) at least once in the past year and nearly 
10 per cent have tried hydrocodone (Vicodin®), 7.5 per 
cent have tried amphetamines, 6.2 per cent have tried 
sedatives and 6.2 per cent have tried tranquillizers.  
447. According to the 2006 Partnership Attitude 
Tracking Study parents in the United States talk to 
their children less about the dangers of abusing 
prescription drugs than about the dangers of abusing 
heroin, cocaine, “crack”, MDMA, cannabis or alcohol, 
although a significant percentage of parents consider 
the abuse of prescription drugs to be a growing 
problem. Subsequently, a large portion of adolescents 
associate no particular risk with the non-medical use of 
pain relievers such as Vicodin® or Oxycontin®.  
448. Concerned with the increasing abuse of 
pharmaceutical preparations containing internationally 
controlled substances, the Board has, for a number of 
years, called on the competent authorities of the United 
States to investigate possible ways and means of 
preventing the advertisement of controlled substances 
to the general public, in conformity with the provisions 
of article 10, paragraph 2, of the 1971 Convention. In 
May 2008, a bill was introduced in the United States 
House of Representatives to amend the Federal Food, 
Drug, and Cosmetic Act with respect to drug and 
device advertising. The bill, once it becomes law, 
would establish limitations on advertising directed at 
potential consumers and would require the prominent 
display of the side effects of drugs in such 
advertisements. However, the Board notes that the bill 
would not prohibit the advertisement of controlled 
substances to the general public, as required by the 
provisions of article 10. Advertising through the United 
States media reaches consumers not only in the United 
States. Due to technological progress, such 
advertisements also reach the general public in all 
countries where such advertising is prohibited in line 
with article 10. The Board, therefore, reiterates its 
concern that direct-to-consumer advertising aimed at 
increasing the consumption of internationally 
controlled substances is not in line with article 10 of 
the 1971 Convention and may promote medically 
unjustified consumption of those substances in the 
United States, as well as in other countries.  
449. In the United States, the abuse of prescription 
drugs has caused a significant number of deaths among 
drug abusers. According to the Florida Medical 
Examiners Commission, autopsies conducted in 2007 
revealed that prescription drugs had caused death in 
three times as many cases as had all illicit drugs 
combined. The increase in the number of deaths caused 
by oxycodone was more than 2.5 times the increase in 
deaths caused by heroin. While legislation allowing 
prescription drug monitoring programmes has been 
adopted in 38 of the 50 states in the United States, 
Florida has still not adopted such legislation due to 
privacy concerns.  
450. In the United States, methadone-related deaths 
and overdoses increased sharply (by 390 per cent) from 
786 in 1999 to 3,849 in 2004, according to the most 
recent national-level data available. Data from states 
with a traditionally high number of methadone-related 
deaths suggest that that increasing trend has continued. 
The licit distribution of methadone to pharmacies, 
hospitals, teaching institutions and practitioners 
increased by nearly 500 per cent from 1999 to 2004.  
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451. The surge in the abuse of fentanyl in the United 
States, which resulted in the death of a large number of 
abusers, was reversed after a large clandestine 
laboratory manufacturing fentanyl in Mexico was 
dismantled in 2006. While the abuse of fentanyl has 
occurred periodically in the United States, the last 
large outbreak, which began in late 2005, was the most 
significant, geographically diverse and most long-
lasting one. By mid-2007, the number of fentanyl-
related deaths had decreased to the levels before 2005. 
452. In 2007, the Drug Enforcement Administration of 
the United States initiated 1,736 criminal and 
complaint investigations targeting trafficking in 
controlled pharmaceuticals, including by Internet 
companies. The Drug Enforcement Administration 
issued immediate suspension orders to 10 Internet 
pharmacies operating in the State of Florida that had 
illegally distributed millions of dosage units of 
hydrocodone throughout the United States. The number 
of Internet pharmacies selling controlled prescription 
drugs increased by 70 per cent, from 342 in 2006 to 
581 in 2007, the majority of them selling prescription 
drugs without the required prescription.  
453. In Canada, diverted prescription drugs are mostly 
obtained from domestic sources. The abuse of 
oxycodone remains a cause for concern in Canada, and 
oxycodone continues to be smuggled out of Canada 
and into the United States. However, there is some 
indication that pharmaceuticals smuggled into Canada 
may be contributing to the supply of pharmaceuticals 
to the illicit market.  
 
  Psychotropic substances 
 
454. Methamphetamine abuse remains a problem in 
Canada and traffickers continue to adulterate “ecstasy” 
and cannabis with methamphetamine in order to 
increase the illicit demand for methamphetamine. Most 
of the methamphetamine on the illicit market in 
Canada is supplied by laboratories in that country, 
which are increasingly being used as a source for illicit 
markets in other countries, including the United States. 
Significant seizures of methamphetamine of Canadian 
origin were effected in 2006 by authorities in Japan 
and New Zealand (see paragraph 755 below).  
455. In the United States, the abuse of 
methamphetamine in 2007 was slightly less than in 
previous years: 0.2 per cent of the population are 
current abusers. There has been a steady decline in the 
abuse of methamphetamine by youth at all age levels. 
The abuse of “crystal” methamphetamine (commonly 
called “ice”) among youth reached its lowest level 
since 1992.  
456. Mexico continues to be the primary source of the 
methamphetamine trafficked in the United States. In 
2007, Mexican authorities dismantled 26 clandestine 
laboratories for processing drugs, 9 of which were 
classified as methamphetamine “super laboratories” 
(that is, having the capacity to produce at least 
10 pounds (4.54 kg) of methamphetamine per 
processing cycle).  
457. Canada, traditionally an importer and consumer 
of MDMA, has become a major manufacturer and 
exporter of “ecstasy” (see also paragraphs 404 above 
and 755 below). The increased illicit manufacture and 
trafficking in MDMA in Canada is reflected in the 
unprecedented quantities of Canadian “ecstasy” seized 
in other countries, such as Australia and the United 
States. While the number of seized MDMA laboratories 
decreased slightly, the manufacturing capacity of the 
laboratories and their level of sophistication increased, 
indicating the involvement of organized criminal 
groups. The manufacture of all clandestine MDMA 
laboratories combined is estimated to exceed 2 million 
tablets per week. There is no requirement for the 
registration of tablet presses in Canada.  
458. Total seizures of MDMA illicitly manufactured in 
Canada increased significantly in the United States, 
from 1.1 million doses in 2004 to 5.2 million in 2006. 
A significant proportion of the samples of seized 
MDMA (more than 50 per cent) contained 
methamphetamine, increasing the danger of the doses. 
The abuse of MDMA has increased among secondary 
school students: the annual prevalence of abuse of 
MDMA among students aged 17-18 is 4.5 per cent. 
That development may be related to the decline in the 
perceived risk and the disapproval of MDMA abuse. 
Considering that changes in attitudes often indicate an 
imminent change in abuse patterns, United States 
authorities are concerned that the number of initiates to 
MDMA abuse will increase. 
459. As the smuggling of MDMA from Canada into 
the United States began to increase, the importance of 
European sources of MDMA decreased. In the United 
States, the illicit manufacture of MDMA within the 
country remains limited.  
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460. Gamma-hydroxybutyric acid (GHB) continues to 
be abused in Canada and is mostly supplied by 
clandestine laboratories in that country. However, 
small quantities of GHB are occasionally smuggled 
into the country.  
461. In the United States, LSD and psilocybin, 
supplied by clandestine laboratories within the country, 
continue to be abused. The annual prevalence of LSD 
abuse among youth is low. Psilocybin is the 
hallucinogen most widely abused in that country.  
 
  Precursors 
 
462. Organized criminal groups in Canada smuggle 
ephedrine, a precursor required for the manufacture of 
methamphetamine, from China and India into Canada. 
While the number of seizures of clandestine 
methamphetamine laboratories seized in Canada has 
continued to decline, the manufacturing capacity of 
those seized laboratories has increased. In response, in 
at least eight provinces in Canada, medications 
containing ephedrine and pseudoephedrine have been 
removed from grocery and convenience stores and 
have been made available only at the counter in 
pharmacies. The illicit manufacture of MDMA in 
Canada is supported by the smuggling of large amounts 
of the precursor 3,4-MDP-2-P from China. The 
precursor gamma-butyrolactone (GBL), used in the 
illicit manufacture of GHB, is obtained from sources 
within Canada or outside the country via the Internet or 
the postal system. 
463. In the Synthetic Drug Control Strategy of the 
United States, authorities in that country set the goal of 
reducing by the end of 2008 (using data for 2005 as a 
baseline) methamphetamine abuse by 15 per cent. The 
goal of reducing the number of incidents involving 
methamphetamine laboratories by 25 per cent was 
reached already in 2006, when the number of such 
incidents declined by 48 per cent. The significant 
decrease in the number of incidents involving such 
laboratories was attributed to the Combat 
Methamphetamine Epidemic Act of 2005, which 
established stricter national controls over the sale of 
products containing ephedrine and pseudoephedrine.  
464. Drug trafficking groups in Mexico have 
responded to the strong restrictions on the import and 
sale of precursors of methamphetamine in Mexico79 by 
smuggling those precursors using new routes leading 
from China and India, importing non-restricted 
chemical derivatives instead of those precursors and 
using alternative manufacturing methods. That has 
ensured a stable level of illicitly manufactured and 
smuggled methamphetamine in the United States.  
 
  Substances not under international control 
 
465. While the main transit countries used for 
smuggling khat into Canada remained the Netherlands 
and the United Kingdom, seizures of khat smuggled 
into Canada from other transit countries, such as 
France, Germany, Italy and the United States, increased 
slightly. In Canada, khat is mainly used by members of 
ethnic communities located throughout the country.  
466. Ketamine continues to be abused in Canada, 
where it has gained popularity as a new “club drug”. 
Ketamine is not only abused for its hallucinogenic 
effects, but has also been found to be an active 
ingredient in seized MDMA tablets. In Canada, 
ketamine is either diverted from licit distribution 
channels in the country or is smuggled into the country, 
where it is abused or trans-shipped to the United 
States. 
467. The over-the-counter cough and cold medicines 
abused in the United States mostly contain 
dextromethorphan. In 2007, the annual prevalence of 
abuse of those drugs was 4 per cent among students 
aged 13-14, 5.4 per cent among students aged 15-16 
and 5.8 per cent among students aged 17-18. Students 
may not recognize the potential dangers of the abuse of 
dextromethorphan, as the drug is available in more 
than 140 cough and cold medications without 
prescription. Several states and metropolitan areas in 
the United States are concerned about the abuse of 
dextromethorphan by youth and young adults, as the 
number of poison control calls related to the abuse of 
dextromethorphan continues to increase. 
468. The abuse of inhalants by youth has been rising 
in the United States since 2003. The highest annual 
prevalence of abuse of inhalants is among students 
aged 13-14: 8.3 per cent. United States authorities are 
__________________ 
 79  See also Precursors and Chemicals Frequently Used in the 
Illicit Manufacture of Narcotic Drugs and Psychotropic 
Substances. Report of the International Narcotics Control 
Board for 2008 … . 
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concerned about the decline in the perceived risk of 
abuse of inhalants. An average of 593,000 adolescents 
aged 12-17 use inhalants for the first time each year, 
the most frequently mentioned types of inhalants being 
glue, shoe polish, gasoline (petrol), lighter fluid and 
spray paint. 
 
 
  South America 
 
 
 1. Major developments 
 
469. In 2007, the total area of illicit coca bush 
cultivation increased in all three of the main countries 
in which coca bush is illicitly cultivated (Bolivia, 
Colombia and Peru) to 181,600 ha, 16 per cent more 
than in 2006. The potential illicit manufacture of 
cocaine in the region remained stable.  
470. According to UNODC, in Colombia, despite the 
continuation of eradication efforts, illicit cultivation of 
coca bush increased by 27 per cent. Moderate 
increases, not exceeding 5 per cent, were noted in 
Bolivia and Peru. Colombia accounted for 55 per cent 
of the total area under illicit coca bush cultivation in 
South America; that country was followed by Peru 
(29 per cent) and Bolivia (16 per cent). 
471. The overall increase in illicit coca bush 
cultivation in the Andean subregion in 2007 was offset 
in part by decreased yields of coca leaf in some of the 
areas of cultivation. As a result, potential global 
manufacture of cocaine increased over the previous 
year by only 10 tons, to 994 tons. The Board is 
concerned that the recent growth in illicit coca bush 
cultivation in the subregion may lead to further 
increases in illicit cocaine manufacture. 
472. The area of illicitly cultivated coca bush that was 
eradicated in the three main countries producing coca 
leaf in 2007 totalled 238,300 ha (5,500 ha more than in 
the past year): 153,100 ha were eradicated by aerial 
spraying and 85,200 ha by manual eradication. In 
Colombia alone, 220,000 ha of illicit coca bush were 
eradicated. Small areas under illicit coca bush 
cultivation were also eradicated in Ecuador. 
473. International criminal groups continued to use the 
Bolivarian Republic of Venezuela as one of the main 
departure areas for illicit drug consignments leaving 
the region of South America. According to UNODC, 
the smuggling of cocaine through that country has 
increased significantly since 2002. 
474. South American countries participated in the 
Drug Treatment City Partnership initiative, focusing on 
the establishment of a network between cities in Latin 
America and the Caribbean and in Europe to facilitate 
the exchange of information and best practices 
regarding drug control policies. The objective of the 
initiative, which is being funded by the European 
Commission and executed by CICAD, is to contribute 
to the improvement of treatment and rehabilitation 
programmes for drug abusers and demand reduction 
programmes for different groups of people in the 
participating countries. 
475. The Board appreciates the importance given by 
the Governments of South American countries to drug 
demand reduction programmes and preventive 
approaches in their national drug control strategies and 
policies. However, according to the latest Hemispheric 
Report of CICAD, in which progress in drug control 
was evaluated in countries in the western hemisphere 
in the period 2005-2006, the budget allocated by the 
Governments of some of those countries is insufficient 
to develop demand reduction activities.  
476. In 2008, Argentina, Bolivia, Chile, Ecuador, Peru 
and Uruguay presented a study on drug use in the 
southern part of South America entitled “Guiding 
elements for public policy on drugs in the subregion”, 
which was conducted in cooperation with UNODC and 
CICAD. As part of the study, for the first time, the 
same methodology was applied to determine different 
aspects of drug use among the general population 
(persons aged 15-64) in the region. According to the 
study, cannabis is the most abused drug in the countries 
surveyed. Past-year prevalence of cannabis abuse was 
4.8 per cent, higher than the global average of 3.8 per 
cent.  
477. Large quantities of precursor chemicals 
frequently used in the illicit manufacture of drugs 
continue to be seized in South America. For example, 
in 2007, Colombia seized 144 tons of potassium 
permanganate. The origin of seized chemicals often 
remains unknown. The Board reiterates its call to the 
Governments of countries in the region to urgently 
devise strategies to address the smuggling of precursor 
chemicals into areas in which cocaine is illicitly 
manufactured. 
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 2. Regional cooperation 
 
478. CICAD remains the main regional forum for 
coordinating drug control issues in the Americas. In 
2007, a decade after the creation of MEM, CICAD 
presented the report entitled Multilateral Evaluation 
Mechanism (MEM) Achievements, 1997-2007. The 
report summarizes the progress made by each country 
in the region, as well as advances in the region as a 
whole, regarding the development of policies and 
programmes to combat illicit drugs between 1997 and 
2007. As regards strengthening institutions, the report 
highlights the importance of established national drug 
control authorities and drug observatories that assist 
Governments in implementing their national drug 
control strategies. In terms of prevention, it points to 
progress in developing minimum treatment standards 
and drug control programmes that target different 
segments of society. The report also reflects the 
progress made in reducing illicit crops and tackling the 
demand side, as well as in implementing drug control 
measures.  
479. At the Seventeenth Meeting of Heads of National 
Drug Law Enforcement Agencies, Latin America and 
the Caribbean, held in Quito from 15 to 19 October 
2007, participants made recommendations on 
combating illicit cannabis cultivation and trafficking, 
money-laundering and trafficking in amphetamine-type 
stimulants in the region. During the meeting, experts 
from the Netherlands held a training workshop on the 
detection and dismantling of clandestine laboratories 
manufacturing amphetamine-type stimulants. 
480. The Government of Colombia hosted the Ibero-
American Workshop on Drug Policies in the Local 
Context in Cartagena de Indias from 29 October to 
2 November 2007. Workshop participants discussed 
experiences and best practices to increase the 
participation of subnational and local authorities in the 
planning and management of national drug control 
policies and activities. 
481. Representatives of the drug control and judicial 
authorities of Mexico and Peru held a preparatory 
working meeting on coordinated action in fighting 
drugs in Peru on 29 October 2007. The authorities 
discussed issues concerning the harmonization of legal 
documents related to synthetic drugs and mechanisms 
for sharing experiences and knowledge regarding drug 
trafficking organizations. 
482. The Tenth High-Level Specialized Dialogue on 
Drugs between the Andean Community and the 
European Union was held in Bogota on 1 and 
2 November 2007. Representatives of Bolivia, 
Colombia and Peru presented their national strategies 
for alternative development and eradication of illicit 
crop cultivation, while the representative of Ecuador 
reported on preventive alternative development 
programmes implemented in the northern areas of that 
country along its borders with Colombia. According to 
the Andean Community, although cannabis continued 
to be the most abused drug in the subregion, the abuse 
of coca base was increasing steadily. The meeting 
concluded that measures related to demand reduction 
and drug abuse needed to be strengthened further.  
483. On 8 and 9 November 2007, the Government of 
Uruguay hosted in Montevideo the Twelfth Meeting of 
the Specialized Drug Network of MERCOSUR 
Countries. The objective of the network is to promote 
activities and programmes of cooperation and 
prevention of drug abuse and treatment of drug 
abusers. The participants adopted the Declaration of 
the Presidents of MERCOSUR and Associated 
Countries, which stressed the importance of the shared 
responsibility of the countries in combating illicit 
drugs.  
484. In July 2007, UNODC launched a project on law 
enforcement and intelligence cooperation against cocaine 
trafficking from Latin America to West Africa. The aim of 
the project is to stimulate cooperation between the 
national law enforcement agencies of countries in 
South America (Bolivia, Brazil, Colombia Ecuador, 
Peru and Venezuela (Bolivarian Republic of)), the 
Caribbean (Trinidad and Tobago) and West Africa 
(Cape Verde, Ghana, the Gambia, Guinea-Bissau, 
Senegal and Togo) by gathering and sharing drug-
related intelligence (see paragraph 300 above).80 
485. At a meeting of the Intelligence Sharing Working 
Group held in Cartagena de Indias, Colombia, on 
13 and 14 November 2007, the participants, 
representing 22 countries and territories in Latin 
America and of 4 European Union member States, 
were informed of the above-mentioned UNODC 
project. The participants also reviewed recent drug 
trafficking routes leading from Latin America and the 
__________________ 
 80  See Report of the International Narcotics Control Board 
for 2007…, para. 299. 
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Caribbean through Africa and discussed the role of 
national forensic authorities in combating drug 
trafficking.  
486. Chile hosted the Ninth Meeting of the Expert 
Group on Drug Demand Reduction in Santiago from 
13 to 15 November 2007. The Meeting was attended by 
representatives of 22 countries, including Argentina, 
Bolivia, Brazil, Colombia, Ecuador, Paraguay, 
Suriname, Uruguay and Venezuela (Bolivarian 
Republic of). The Meeting, which focused on issues 
related to the abuse of drugs in the work environment, 
concluded that drug abuse worsened the work 
environment, reduced overall production capacity and 
was a cause of increased work-related accidents and 
absence from work. 
487. Corruption seriously affects many South 
American countries and reduces the impact of drug 
control efforts in the region. According to 
Transparency International’s Global Corruption Report 
2007, Chile and Uruguay are the only countries in the 
region with a corruption perceptions index of over 5.0. 
Countries that score under the index are considered to 
have a serious corruption problem. During the 
reporting period, South American countries launched a 
number of initiatives to address the problem. For 
example, 18 countries in Latin America and the 
Caribbean were represented in the Regional 
Conference on the Implementation of the United 
Nations Convention against Corruption held in La Paz 
in December 2007. 
488. At a workshop held in Lima on 6 and 7 December 
2007, Government representatives and experts from 
Bolivia, Colombia and Peru discussed their 
experiences in the field of alternative development and 
proposed guidelines to optimize the role of 
international cooperation in support of Government 
policies. 
489. In July 2008, Bolivia, Colombia, Ecuador and 
Peru, in cooperation with the European Union, 
launched a project to provide support to the Andean 
Community in the area of synthetic drugs, aimed at 
developing methodologies to obtain objective data on 
demand for and supply of synthetic drugs and their 
impact on society in the countries concerned. The data 
will help the Governments concerned to prepare their 
national strategies and programmes to combat 
trafficking in and abuse of synthetic drugs. 
490. High-level representatives of 25 countries of 
Central America, the Caribbean and South America 
met in Cartagena de Indias, Colombia, from 30 July to 
1 August 2008 at the Regional Summit on the World 
Drug Problem, Security and Cooperation. Participants 
adopted the Cartagena Declaration, in which they 
emphasized the importance of a balanced approach to 
implementing drug supply and drug demand strategies. 
In the area of drug supply reduction, the Declaration 
highlighted the importance of preventing the diversion 
of precursor chemicals by using the internationally 
established control mechanisms. In the area of drug 
demand reduction, it called for further enhancement of 
prevention, education, treatment, rehabilitation and 
social reintegration activities. 
491. On 1 August 2008, the National Council for 
Control of Narcotic Drugs and Psychotropic 
Substances (CONSEP) of Ecuador and the National 
Commission for Development and Life without Drugs 
(DEVIDA) of Peru signed an agreement providing a 
framework for joint activities and cooperation in the 
areas of prevention, interdiction and sustainable 
alternative development, including preventive 
alternative development programmes. 
 
 3. National legislation, policy and action 
 
492. In 2008, the Government of Bolivia initiated a 
study on coca leaf in Bolivia, the objective of which is 
to produce quantitative and qualitative data on the use, 
marketing and production of coca leaf in the country. 
The study is expected to be conducted over a period of 
18 months. The Board hopes that the results of the 
study will assist the Governments of Bolivia and the 
other countries concerned in the implementation of the 
provisions of the 1961 Convention as amended by the 
1972 Protocol, in particular the provisions on the 
production and use of coca leaf. 
493. The Brazilian authorities continued to participate 
in the Drug Abuse, HIV/AIDS and STD (Sexually 
Transmitted Diseases) Prevention Project, aimed at 
increasing access by the HIV/AIDS population to 
related health services and promoting prevention 
activities targeting vulnerable groups, including an 
estimated 193,000 persons who abuse drugs by 
injection. According to UNODC, the incidence of 
AIDS cases related to drug abuse by injection fell from 
23.6 to 9.3 per cent among men and from 12.6 to 
3.5 per cent among women between 1996 and 2006. 
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494. In November 2007, the Government of Colombia 
convened a national workshop in Bogota to examine 
procurement and distribution systems for opioid 
analgesics so as to facilitate patient access to those 
essential pain-relief medications in the country. The 
meeting was attended by representatives of the national 
regulatory authorities, and also of several international 
organizations, including WHO and the Pan American 
Health Organization. Later in 2008, the Government of 
Colombia adopted a resolution guaranteeing the 
availability of opioids 24 hours a day in at least one 
pharmacy in every department in the country. 
495. In 2007, the Government of Peru promulgated a 
series of laws aimed at strengthening the prevention, 
investigation and prosecution of organized crime, as 
well as strengthening the control of precursor 
chemicals, including Decree No. 928, which 
criminalizes activities that impede the eradication of 
illicit crops. In 2008, the Government also promulgated 
a new civil asset forfeiture law, aimed at seizing illicit 
assets of drug cartels and of those involved in forms of 
organized crime other than drug trafficking. A similar 
civil asset forfeiture law has been submitted to the 
Constitutional Assembly in Ecuador for its adoption. 
496. In 2008, the government of the region of Puno, 
Peru, passed a resolution declaring coca leaf a 
regional, cultural, medicinal and industrial heritage and 
a symbol of the Quechua-Aymara people and 
demanded a stop to forced eradication of coca bush in 
that part of the country. The Government of Peru 
referred the case to the Constitutional Court, which 
declared the resolution unconstitutional. 
497. A number of countries in South America devote 
special attention to problematic drug users. In 
December 2007, the competent authorities of Paraguay 
published a national programme for treatment of 
problematic drug users, which gathers experiences 
from different national and international institutions 
and experts involved in drug abuse prevention 
programmes, including programmes for the treatment 
and rehabilitation of drug abusers. 
498. According to the Government of the Bolivarian 
Republic of Venezuela, over 180 airstrips used for drug 
trafficking were detected in that country in 2007. 
Ninety of those airstrips were destroyed during the law 
enforcement activities. Pursuant to the national drug 
control plan for the period 2008-2013, the Government 
has initiated a series of measures aimed at protecting 
its territory and national air space from drug 
smuggling. Those measures include the destruction of 
non-authorized airstrips and the installation of a radar 
system for air traffic control, in particular in the areas 
of the country that are most affected by trafficking, 
such as the country’s border with Colombia. In 
addition, the Government imposed restrictions on the 
use of airports for private flights. The drug control 
strategy also includes measures to reinforce the 
participation of the community in combating drugs, 
including in prevention of diversion of precursor 
chemicals, in cooperation with the chemical industry. 
499. The Board notes that, in 2008, the Governments 
of Argentina, Bolivia, Brazil, Chile, Ecuador, Paraguay 
and Peru participated in Operation “Ice Block”, which 
focused on the monitoring of trade in precursors of 
amphetamine-type stimulants. The Board wishes to 
encourage the Governments of Latin American 
countries to remain vigilant with regard to shipments 
of precursor chemicals and to adopt further measures 
to enhance their controls.  
 
 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
500. According to UNODC, the annual illicit 
production of cannabis in South America is estimated 
at about 10,000 tons, almost 25 per cent of global illicit 
production in 2006. Paraguay, whose illicit production 
of cannabis is estimated at 5,900 tons, is the main 
country producing cannabis in the region. 
501. According to law enforcement agencies in South 
America, most illicit cannabis cultivation occurs in 
remote and inaccessible areas. The organized criminal 
groups established in the region take advantage of the 
lucrative cannabis trafficking operations and are often 
involved in other types of criminal activity. 
502. Brazil continues to report the largest seizures of 
cannabis in South America. In 2007, Brazilian 
authorities seized almost 200 tons of that narcotic drug. 
During 2007, Colombia seized 183.2 tons of cannabis, 
the largest amount of the substance seized in the 
country in the previous 10 years. In Peru, seizures of 
cannabis remained relatively stable between 2004 and 
2007, ranging from 1.1 to 1.5 tons. In the Bolivarian 
Republic of Venezuela, cannabis seizures have 
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gradually increased since 2003; in 2007, authorities in 
that country seized over 25 tons of cannabis. 
503. According to the first comparative study on drug 
abuse among the general population in six South 
American countries, the highest lifetime prevalence of 
abuse of cannabis, 27.1 per cent, was found in Chile 
and the lowest, 4.0 per cent, in Peru. In Chile, the past-
year prevalence of cannabis abuse was significantly 
lower (7.5 per cent) and was comparable with that 
found in Argentina (7.2 per cent). According to 
UNODC, in Uruguay, cannabis abuse, which had 
grown rather modestly in the 1990s, increased 
noticeably in the period 2001-2007: the annual 
prevalence of cannabis abuse among the general 
population quadrupled, from 1.3 per cent in 2001 to 
5.3 per cent in that country in 2007.  
504. According to UNODC, in Bolivia, the cultivation 
of coca bush increased slightly for the second 
consecutive year, amounting to 28,900 ha. The illicit 
cultivation was concentrated in the Yungas and 
Chapare regions, which accounted for 69 per cent and 
30 per cent, respectively, of the total illicit coca bush 
cultivation in the country. In most of the Chapare 
region, farmers cultivate coca bush on an area 
averaging one cato (0.16 ha), the largest area allowed 
according to an agreement reached between the 
Government and coca grower’s organizations in that 
region in 2004. In September 2008, the Government of 
Bolivia signed an agreement with coca bush growers of 
the Yungas allowing them to cultivate coca bush in that 
area. The Board expects that the Government, when 
addressing the existing cultivation of coca bush in the 
Yungas, will comply with its obligations under the 
treaties. 
505. According to the provisions of the 
1961 Convention, all coca bush cultivation is illicit 
unless it is destined for medical, scientific or specific 
industrial purposes. As that continues not to be the case 
in Bolivia, the Board urges the Government, when 
addressing the existing cultivation of coca bush in the 
country, to bear in mind the above and to do its utmost 
to comply with its obligations under the 
1961 Convention. 
506. A study of coca leaf yield conducted in the 
Yungas region in 2006 confirmed that farmers 
cultivating coca bush employed sophisticated 
agricultural techniques, such as the use of 
agrochemicals and mechanical irrigation, to improve 
the yield. In 2007, the Government of Bolivia reported 
the manual eradication of over 6,200 ha of coca bush, 
24 per cent more than in 2006. Ninety-five per cent of 
that eradication was carried out in the Chapare region. 
In Bolivia, potential cocaine manufacture in 2007 
increased by 9 per cent over the previous year, to 
104 tons.  
507. Colombia continues to be the world’s largest 
producer of coca leaf. In 2007, the illicit cultivation of 
coca bush increased there by 27 per cent, to 99,000 ha. 
Illicit coca bush cultivation increased above all in low-
yield areas, such as the Pacific region, which yields 
about 2,600 kg of fresh coca leaf per hectare each year. 
In regions in which production is high, such as Meta-
Guaviare, in which the coca leaf yield is about four 
times higher than in the Pacific region, the area under 
illicit coca bush cultivation has decreased slightly. As a 
result, in 2007, potential cocaine manufacture in 
Colombia did not increase; it amounted to 600 tons, 
10 tons less than in 2006. 
508. In 2007, about 67,000 ha of illicitly cultivated 
coca bush were eradicated manually in Colombia and a 
further 153,000 ha were subject to aerial spraying. The 
forced manual eradication was carried out by mobile 
eradication groups with the assistance of the police and 
the army. Those eradication efforts were hampered by 
violent attacks by armed and criminal groups using 
firearms and anti-personnel mines to protect illicit 
crops.  
509. According to UNODC the cultivation of coca 
bush in Peru increased in 2007 by 4 per cent, to 
53,700 ha. For three years, such cultivation increased 
in the areas bordering Bolivia. In 2007, estimated 
cocaine manufacture in Peru was 290 tons, and Peru 
accounted for 29 per cent of potential global 
manufacture of cocaine, a level 4 per cent higher than 
in 2006 and the highest level since 1999. 
510. According to DEVIDA, there has been an 
alarming increase since 2004 in attacks by armed 
groups and drug traffickers against workers eradicating 
illicit coca bush, in particular in areas without 
permanent police protection. In mid-2008, the 
Federation of Coca Farmers in Peru initiated a strike 
and demanded the suspension of the eradication of 
coca crops in the Upper Huallaga area. In 2007, 
eradication in Peru decreased by 5 per cent to 
12,072 ha, of which 8 per cent was eradicated 
voluntarily and 92 per cent was eradicated by force. In 
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the first half of 2008, a further 5,100 ha of illicitly 
cultivated coca bush were eradicated. 
511. The world’s main cocaine trafficking routes 
continue to run from countries in the Andean 
subregion, notably Colombia, to the United States. In 
the past few years, the amount of cocaine from South 
America smuggled via West Africa into Europe has 
increased dramatically (see also paragraphs 242-246 
above). 
512. According to Europol, drug trafficking networks 
in South America cooperate in temporary joint ventures 
established on an ad hoc basis, making use of 
specialists in all sectors of their criminal activities, 
ranging from chemists for processing the cocaine, 
skippers, pilots and trained couriers for the 
transportation of drugs to financial experts for the 
laundering of their criminal proceeds. The South 
American trafficking organizations also exploit the 
unstable social and economic situation and the weak 
drug control mechanisms in some African countries. 
They have established bases in West Africa and have 
set up a variety of businesses to justify their presence 
in that subregion and to conceal their criminal 
activities and their cooperation with African criminal 
groups. 
513. UNODC estimates that the global rate of 
interception of cocaine consignments is currently about 
40 per cent. In 2006, the South American countries 
accounted for 45 per cent of cocaine seizures 
worldwide. Large seizures continue to be concentrated 
in a few countries. In 2007, cocaine seizures increased 
in Bolivia, Brazil and Colombia and decreased in 
Ecuador and Peru. 
514. Drug seizures in Bolivia have followed an 
upward trend that started several years ago. In 2007, 
seizures of cocaine hydrochloride doubled over the 
level of the previous year, reaching 2.9 tons, and 
seizures of cocaine base tripled compared with 2002, 
amounting to 14.9 tons. In accordance with the 
national drug control strategy for the period 2007-
2010, which provides for further measures to combat 
drug trafficking, drug control operations in Bolivia 
have been further reinforced. In the first half of 2008, 
seizures of cocaine increased by one third compared 
with the same period in 2007. 
515. In 2007, seizures of cocaine hydrochloride and 
cocaine base in Colombia increased slightly, to 
181 tons, accounting for one fourth of potential 
manufacture of cocaine in the country. The Colombian 
authorities estimate that of the illicit drugs leaving 
their country about 80 per cent is smuggled by sea 
through the Mexico-Central American corridor, the 
Euro-African corridor and the Caribbean corridor, in 
that order. Most of the drugs are trafficked by sea on 
board speedboats capable of carrying a load of between 
1 and 1.5 tons. The use of submersible vessels for drug 
trafficking, which had been noted in the past, was 
reported in 2007 as well. More illicit drugs are 
trafficked by sea than by air. Drugs are smuggled 
across borders by air (on board aircraft) rather than by 
land. 
516. After an exceptionally large amount of cocaine 
was seized in Peru in 2005 and 2006, the amount 
seized in 2007 decreased to 8.1 tons, about half the 
amount seized in the previous year. The decrease in the 
amount of cocaine seized was offset in part by an 
increase in the amount of coca paste seized, which 
amounted to 6.3 tons. According to UNODC, about 
5 per cent of potential manufacture of cocaine 
hydrochloride in Peru is destined for use in that 
country. The remainder is smuggled into North 
America and, increasingly, Europe. Approximately 
40 per cent of that amount is smuggled by maritime 
routes and the rest mainly over the borders with 
Ecuador, Chile and Brazil, in that order. 
517. In Brazil, the competent national authorities 
seized a total of 18.2 tons of cocaine, including coca 
paste, in 2007. In Argentina, the smuggling of coca 
leaves from the southern part of Bolivia has increased. 
During 2007, Argentine police at the Bolivian border 
seized 44 tons of coca leaves and 3.3 tons of cocaine. 
518. Ecuador is affected by not only drug trafficking, 
but also drug stockpiling, the diversion of precursor 
chemicals and to some extent illicit drug production. In 
2007, more than 25 tons of cocaine base and cocaine 
hydrochloride were seized. According to the 
Ecuadorian authorities, drug trafficking and money-
laundering are accompanied by an increased level of 
other forms of serious crime, including robbery, 
extortion and kidnapping, which destabilize the 
national economy and undermine security. 
519. Between 2002 and 2007, the authorities of the 
Bolivarian Republic of Venezuela seized an average of 
35 tons of cocaine each year. In 2007, the amount of 
cocaine seized in that country totalled 31.8 tons. 
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European countries, in particular Spain, have been 
identified as the main countries of destination for some 
70 per cent of the drugs smuggled through the 
Bolivarian Republic of Venezuela. The number of 
persons arrested in the Bolivarian Republic of 
Venezuela in connection with drug trafficking 
increased from 809 to 4,150 between 2006 and 2007. 
520. Although Guyana and Suriname are not 
associated with significant production of illicit drugs, 
both countries are used as trans-shipment areas for a 
significant amount of cocaine en route to Europe and 
North America, partly through Africa. 
521. In Colombia, traditional use of coca leaf is 
marginal and statistically insignificant: virtually the 
entire coca leaf production is destined for illicit 
cocaine manufacture. It is estimated that Colombian 
farmers process half of their coca leaf production into 
cocaine base to gain a higher income per hectare of 
cultivated area. The last step in the process of 
manufacturing cocaine hydrochloride is usually carried 
out by traffickers in clandestine cocaine laboratories. 
Although several countries in South America regularly 
report on the number of laboratories manufacturing 
cocaine hydrochloride that have been destroyed on 
their territory, most of the destroyed laboratories are 
reported by Colombia. Of the 2,500 clandestine 
laboratories destroyed in Colombia in 2007, 11 per 
cent were processing cocaine hydrochloride and the 
rest were processing coca paste or cocaine base. 
522. The number of laboratories illicitly processing 
coca leaf identified in Bolivia has gradually increased 
in recent years. Between 2000 and 2007, the number of 
destroyed coca maceration pits increased from 790 to 
6,525 and the number of laboratories destroyed for 
processing coca paste and cocaine increased from 
628 to 4,087. The Bolivian authorities destroyed over 
4,000 laboratories for processing coca paste and 
cocaine in 2007 and 2,000 such laboratories in the first 
half of 2008. 
523. The destruction of 16 laboratories manufacturing 
cocaine hydrochloride in Peru in 2007, in addition to 
over 600 laboratories processing coca paste and 
cocaine base, confirms the capacity to manufacture 
cocaine hydrochloride in the country. In the first half 
of 2008, 12 more cocaine hydrochloride laboratories 
were destroyed in Peru. In the Bolivarian Republic of 
Venezuela, 13 laboratories illicitly manufacturing 
cocaine were dismantled in 2007 in the states of Zulia 
and Táchira, close to the Colombian border.  
524. In the past few years, most South American 
countries have reported increasing abuse of cocaine, 
probably a spillover effect of the drug trafficking 
throughout the region. Several countries in the 
southern part of South America previously used as 
transit areas by drug traffickers have been used more 
and more for drug processing. That shift has resulted in 
the increased availability of inexpensive semi-refined 
cocaine derivatives, such as cocaine base and coca 
paste, in the local markets. Changes in drug abuse 
patterns, including increased abuse of paco (coca 
paste), were reported, for example, by Argentina, 
Brazil, Chile and Uruguay. 
525. The first comparative study on drug use in six 
countries of South America has shown that the average 
past-year prevalence of cocaine abuse in those 
countries was 1.4 per cent, which is 0.3 per cent higher 
than the global average. The prevalence of cocaine 
abuse ranged from 0.1 to 2.7 per cent. The prevalence 
was highest in Argentina, followed by Uruguay, Chile, 
Bolivia, Peru and Ecuador. Argentina reported the 
lowest age of initiation for the abuse of cocaine among 
the surveyed countries: 25 per cent of cocaine abusers 
in Argentina are 16 years old or younger. Between 
42 and 46 per cent of cocaine abusers in Argentina, 
Ecuador and Peru showed signs of drug dependency. 
The higher level of cocaine abuse has resulted in 
increased demand in the region for treatment for 
cocaine abuse. According to UNODC, treatment for 
cocaine abuse accounted for 48 per cent of all 
drug-related treatment in 2005; that figure increased to 
54 per cent in 2006. 
526. Illicit cultivation of opium poppy in South 
America accounts for less than 1 per cent of illicit 
opium poppy cultivation worldwide. In Colombia, the 
main country of illicit cultivation of opium poppy in 
the region, such cultivation has declined 10-fold during 
the past decade. In 2007, the total area under illicit 
opium poppy cultivation in Colombia was about 
700 ha, or 1.4 tons of potential heroin manufacture. In 
the past, opium poppy was eradicated on small 
cultivation sites in Peru and Venezuela (Bolivarian 
Republic of). In 2007, Peruvian authorities eradicated a 
total of 28 ha of opium poppy. 
527. In 2007, two heroin laboratories were destroyed 
in Colombia. During 2007, the largest seizures of 
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heroin in South America occurred in Colombia (over 
500 kg), followed by Ecuador, the Bolivarian Republic 
of Venezuela and Brazil. There are indications that 
heroin found in South America could also be coming 
from West Asia. In 2008, the Government of Pakistan 
reported that traffickers were exchanging heroin for 
cocaine in that country. 
528. According to the latest UNODC data, the annual 
prevalence of abuse of opiates in South America is 
0.3 per cent, which is 0.1 per cent lower than the 
global average. The highest annual prevalence of abuse 
of opiates in the region was found in Brazil (0.5 per 
cent) and the lowest (less than 0.1 per cent) was 
recorded in Bolivia and Suriname. Most of the reported 
abuse of opiates in the region involves the abuse of 
opioids diverted from licit sources. The Board notes 
with concern that, contrary to the situation in other 
South American countries, in Uruguay the relative 
number of females who abuse drugs by injection is 
high; consequently, there is an increasing number of 
cases of HIV infection among pregnant women who 
abuse drugs by injection and among newborn babies of 
women who abused drugs by injection during 
pregnancy. 
 
  Psychotropic substances 
 
529. Several countries in South America reported an 
increase in the non-medical use of psychotropic 
substances, in particular sedatives and tranquillizers, in 
the past year. Those countries, including Argentina, 
expressed their concern at the increased abuse of 
so-called “date rape drugs”, which are often 
administered by criminals to victims of sexual assault 
or other types of crime. Use of such drugs, in particular 
in combination with alcohol, may result in rapid loss of 
resistance, impaired judgement and amnesia. GHB, 
flunitrazepam and ketamine (a substance not under 
international control) are among the substances most 
often used by criminals for such purposes. 
530. In 2007, the National Secretariat on Drug Policies 
(SENAD) of Brazil initiated a study on the use of 
alcohol and other psychoactive substances, including 
cannabis, cocaine, amphetamines and benzodiazepines, 
in road traffic accidents in Brazil. The aim of the study 
is to measure the impact of the abuse of those 
psychoactive substances on private and professional 
drivers in the country. 
531. In Argentina, the lifetime prevalence of abuse of 
stimulants and tranquillizers without medical 
prescription by people aged 15-64 was 1.6 and 3.6 per 
cent, respectively. According to the latest study relating 
drug abuse to emergency room admissions in 
Argentina, anxiolytics, sedatives and tranquillizers 
were together the third most frequently used 
psychoactive substances (after alcohol and tobacco) 
among patients treated in emergency rooms in public 
hospitals. Although some South American countries, 
including Argentina, Chile and Peru, reported 
increased abuse of MDMA (commonly known as 
“ecstasy”) in 2006, seizures of the substance continued 
to be low in the region. 
 
  Precursors 
 
532. Large-scale diversion of precursor chemicals 
continued to be reported in South America. In 2007, 
over 14,000 tons of chemicals were reported to have 
been seized in the region. Acetone and sulphuric acid 
were the most frequently seized precursor chemicals 
under international control. Between 2000 and 2007, 
global seizures of potassium permanganate, the key 
chemical used in the illicit manufacture of cocaine, 
totalled about 850 tons. Over 90 per cent of the 
seizures of potassium permanganate were made in 
Colombia. The Board is concerned that traffickers have 
found ways to circumvent international trade controls, 
for example, by illicitly producing potassium 
permanganate in Colombia, by diverting the substance 
from domestic trade and by smuggling within the 
region. The Board reiterates its request to the 
Governments of all countries in the Americas to 
urgently devise strategies to address the smuggling of 
precursor chemicals into the area in which cocaine is 
illicitly manufactured, utilizing, where appropriate, the 
experiences gained in the framework of Project 
Cohesion in targeting acetic anhydride in Central and 
West Asia. 
533. The Board notes that imports of ephedrine and 
pseudoephedrine in some South American countries, 
including Argentina, have significantly increased in the 
past several years. The Board is concerned that the 
increased imports may indicate increased interest 
among drug trafficking organizations in obtaining the 
key chemicals to meet the needs of the clandestine 
methamphetamine laboratories in countries in North 
America, in particular Mexico, as well as in South 
America. In 2007, seizures of pharmaceutical 
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preparations containing pseudoephedrine were reported 
in Peru. In July 2008, the Argentine authorities 
identified a case involving the diversion of ephedrine 
on a large scale and destroyed a methamphetamine 
laboratory in their country. The Board requests the 
Governments of all countries in South America to 
continue monitoring the licit trade in precursors of 
amphetamine-type stimulants, including ephedrine and 
pseudoephedrine traded as raw material or in the form 
of pharmaceutical preparations, in order to prevent the 
diversion of those precursors from licit channels. 
 
 
 C. Asia 
 
 
  East and South-East Asia 
 
 
 1. Major developments 
 
534. The Board noted the large-scale smuggling of 
illicit drugs into East and South-East Asia from outside 
the region, mainly from Canada and countries in West 
Asia. In 2007, Japanese law enforcement authorities 
reported a number of seizures involving consignments 
of drugs, including cannabis, methamphetamine and 
MDMA, hidden in sea and air freight originating in 
Canada. In October 2007, China reported its largest 
single seizure of drugs from West Asia, and law 
enforcement authorities in the Autonomous Region of 
Xinjiang seized heroin and cannabis that had been 
concealed in a shipment originating in Kazakhstan and 
destined for Canada. Also in 2007, Thailand reported 
that the amount of heroin from West Asia exceeded the 
amount from the Lao People’s Democratic Republic, 
Myanmar and Thailand. In March and April 2008, 
customs officers at Hong Kong International Airport 
seized a significant amount of heroin purportedly 
originating in West Asia, part of which was seized from 
passengers arriving from the Philippines and part of 
which was seized from passengers arriving from India 
and the United Arab Emirates. 
535. The Board notes that Governments of States in 
East and South-East Asia have continued to strengthen 
national drug control legislation and improved the 
provision of treatment and rehabilitation services for 
drug abusers. In particular, China has adopted a law 
that includes provisions on voluntary community-based 
treatment and rehabilitation for drug abusers. 
536. The unsafe practice of sharing needles among 
drug abusers remains one of the main causes of HIV 
transmission in many countries in South-East Asia. The 
Australian Agency for International Development 
launched the HIV/AIDS Asia Regional Program in 
Chiang Mai, Thailand, in April 2008, to help stop the 
spread of HIV/AIDS in South-East Asia through 
advocacy, knowledge-sharing and strategic 
partnerships. The Program, which is expected to last 
eight years, involves Governments, regional agencies, 
civil society organizations and drug abuse prevention 
networks in controlling the spread of HIV transmission 
associated with drug abuse in Cambodia, China, the 
Lao People’s Democratic Republic, Myanmar, the 
Philippines and Viet Nam. 
537. National authorities of countries in East and 
South-East Asia continued to report significant seizures 
of drugs smuggled through the postal system. Large 
amounts of benzodiazepines and cannabis were seized, 
but the most often seized drug was methamphetamine. 
In particular, in 2007, it was noted that illicit drugs 
from Thailand were being smuggled through the postal 
system into the United Kingdom. Traffickers also 
smuggled drugs from Canada, China and the United 
States into the Republic of Korea through the postal 
system. 
538. While heroin continued to be the most widely 
abused drug in China (including in the Hong Kong 
Special Administrative Region (SAR)), Malaysia and 
Viet Nam, a significant increase in the abuse of non-
controlled substances was also reported. Ketamine was 
reported to be the most commonly abused psychotropic 
substance in China (including in the Hong Kong SAR). 
In the Hong Kong SAR of China, ketamine is the drug 
of choice for 73 per cent of drug abusers under the age 
of 21. 
 
 2. Regional cooperation 
 
539. The Board notes with satisfaction that the 
countries in East and South-East Asia continued to 
cooperate in the field of drug control through bilateral, 
multilateral and regional organizations. 
540. During the thirteenth Summit of the Association 
of Southeast Asian Nations (ASEAN), held in 
Singapore in November 2007, ASEAN member States 
(Brunei Darussalam, Cambodia, Indonesia, the Lao 
People’s Democratic Republic, Malaysia, Myanmar, 
the Philippines, Singapore, Thailand and Viet Nam) 
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signed the ASEAN Charter, in order, inter alia, to 
strengthen regional cooperation in building a safe, 
secure and drug-free environment for the peoples of 
ASEAN. The Sixth ASEAN Ministerial Meeting on 
Transnational Crime was held in Bandar Seri Begawan, 
Brunei Darussalam, in November 2007. Participants 
agreed to enhance border control systems; to establish 
a dedicated national focal point and maximize the use 
of existing mechanisms for better coordination in 
combating transnational crime issues; and to enhance 
capacity-building, including by providing training in 
English and computer skills for law enforcement 
officials. The Fifth Meeting of the ASEAN Inter-
Parliamentary Assembly Fact-Finding Committee to 
Combat the Drug Menace was held in Singapore from 
22 to 25 June 2008. The participants agreed to continue 
to exchange information and cooperate to address 
common threats related to drug control. The eighth 
ministerial meeting of Signatory Countries of the 
1993 Memorandum of Understanding on Drug Control 
was held in Vientiane in June 2008. The participants 
agreed to continue to exchange information on regional 
drug demand reduction activities and the link between 
drug abuse and HIV/AIDS. At the fifteenth ASEAN 
Regional Forum, held in Singapore on 24 July 2008, 
participants adopted the Statement Promoting 
Collaboration on the Prevention of Diversion of 
Precursors into Illicit Drug Manufacture. In the 
Statement, the competent national authorities of the 
ASEAN Regional Forum were urged to work in 
cooperation with each other and with existing 
mechanisms to strengthen the control of precursors 
used in the illicit manufacture of drugs. In the 
framework of the ASEAN-Republic of Korea 
Knowledge-Transfer Programme on Narcotic Crimes, 
launched in 2007, the Lao People’s Democratic 
Republic became the first country to receive drug 
control assistance from the Republic of Korea. The 
purpose of the assistance is to strengthen the drug law 
enforcement capacity of the Lao National Commission 
for Drug Control and Supervision through the transfer 
of technology and provision of relevant equipment.  
541. The Twenty-eighth ASEAN Chiefs of Police 
Conference was held in Bandar Seri Begawan from 
25 to 29 May 2008. The participants resolved to 
enhance the exchange of information on syndicates 
involved in the illicit manufacture of and trafficking in 
narcotic drugs and psychotropic substances, including 
information on their trafficking routes and modus 
operandi, in order to facilitate coordinated operations 
and investigations. Participants also resolved to 
enhance the exchange of information on the movement 
of precursor chemicals and to enhance capacity in 
regulating precursor chemicals used in the illicit 
manufacture of drugs with a view to preventing the 
diversion of those chemicals. Participants further 
resolved to strengthen coordination, cooperation and 
collaboration through sharing intelligence in order to 
facilitate the identification, tracing, freezing, forfeiture 
or confiscation of assets derived from the proceeds of 
drug trafficking, in accordance with national law. 
Participants further resolved to enhance cooperation in 
regional training, sharing of best practices, personnel 
exchange programmes and other capacity-building 
efforts related to drug control.  
542. In Guangzhou, China, the Regional Intelligence 
Liaison Office for Asia and the Pacific of the World 
Customs Organization and Chinese customs authorities 
jointly organized in September 2007 a regional seminar 
on fighting drug trafficking. Participants discussed the 
drug trafficking situation in the region, cooperative 
regional drug law enforcement efforts, trends in drug 
smuggling, exchange of information and intelligence, 
specific cases and techniques for detecting suspicious 
shipments and cross-border cooperation. 
543. The Regional Amphetamine-Type Stimulants 
Forum was held in Manila from 29 to 31 August 2007. 
Representatives from ASEAN member States and 
China, as well as representatives from the ASEAN 
Secretariat, INTERPOL, WHO, the Australian National 
Council on Drugs and the Australian Federal Police, 
attended the Forum. The main objective of the Forum 
was to enable participants to identify options for 
responding to the problems of the illicit supply of and 
demand for amphetamine-type stimulants in East Asia. 
Participants discussed the latest regional data and 
examined examples of how data on the illicit supply 
and demand of such stimulants could be used for 
policymaking. The participants identified areas of 
priority, including: initiating measures to improve the 
sharing of forensic information and data on precursor 
seizures using existing mechanisms; expanding 
technical assistance for forensic capacity and improved 
information sharing; conducting impact studies on 
existing treatment and demand reduction programmes 
and developing mechanisms for integrating results into 
national policies; and initiating and expanding 
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technical assistance for carrying out prevalence studies 
and rapid assessments. 
544. The seventh meeting of drug control officials 
from Cambodia, the Lao People’s Democratic Republic 
and Viet Nam was held in Siem Reap, Cambodia, in 
December 2007. At the meeting, representatives of the 
three States agreed to cooperate in preventing the 
diversion of sassafras oil. Viet Nam agreed to assist in 
training law enforcement authorities in Cambodia and 
the Lao People’s Democratic Republic during 2008 and 
to build a centre for the treatment of drug abusers in 
Cambodia. The Third Thailand-Viet Nam Bilateral 
Meeting on Drug Control Cooperation was held in 
Da Nang, Viet Nam, in May 2008. At the meeting, the 
two States agreed to cooperate in promoting the 
treatment and rehabilitation of drug addicts and in 
combating drug-related crime. 
545. In November 2007, customs authorities from the 
Hong Kong SAR of China and the Republic of Korea 
reaffirmed their commitment to combating 
transnational offences, including drug trafficking, 
concerning customs authorities. Pursuant to the 
agreement, the two States will strengthen cooperation 
for the exchange of expertise and the organization of 
training courses. The customs authorities of the Hong 
Kong SAR of China and Japan signed similar 
agreements in January 2008, as did the authorities of 
the Macao SAR of China and Thailand. Myanmar and 
Thailand signed a memorandum of understanding in 
February 2008 to cooperate in eradicating illicit opium 
poppy crops and introducing an opium poppy crop-
substitution project in Myanmar. In March 2008, 
Cambodia and Singapore signed a memorandum of 
understanding against transnational crime. The 
signature of that agreement signals closer bilateral 
cooperation between the two States with regard to the 
exchange of expertise and information on a number of 
areas, such as countering drug trafficking. 
546. States in East and South-East Asia continued to 
share expertise by providing assistance in drug control. 
The Republic of Korea launched an eight-month 
project in 2008 to assist Viet Nam in raising public 
awareness about the dangers of drug abuse. 
547. In January 2008, customs authorities in the Hong 
Kong SAR of China launched the Drug Seizure 
Immediate Notification System, for East and South-
East Asia. Participating States include Cambodia, 
China (including the Hong Kong SAR and the Macao 
SAR), Japan, the Lao People’s Democratic Republic, 
Thailand and Viet Nam. The System allows 
participating States to exchange information on drug 
trafficking on the basis of cases of such trafficking 
detected at their airports. The System will be reviewed 
after the first six months of its operation. 
548. Regional initiatives, including meetings and 
training courses, to promote precursor control 
continued to provide opportunities for States to share 
expertise. The joint meeting of the International Forum 
on Control of Precursors for Amphetamine-Type 
Stimulants and the Asian Collaborative Group on Local 
Precursor Control was held in Tokyo in February 2008. 
At the meeting, the participants identified the main 
diversion threats, gaps and vulnerabilities in precursor 
control and the responses in East and South-East Asia. 
The participants endorsed a project proposal for a 
baseline study on non-controlled substances used in the 
illicit manufacture of amphetamine-type stimulants. A 
course on clandestine laboratory investigations was 
conducted by the International Law Enforcement 
Academy in Bangkok in January and February 2008. 
During the course, participants from 11 States in East 
and South-East Asia were introduced to methods of 
handling chemicals found at clandestine laboratories. 
 
 3. National legislation, policy and action 
 
549. In China, the Narcotics Control Law entered into 
force on 1 June 2008. The new law reaffirms that the 
China National Narcotics Control Commission is the 
body responsible for organizing, coordinating and 
guiding drug control efforts in the country. The law 
contains provisions on the role of preventive education, 
the importance of strengthening activities to facilitate 
the treatment and rehabilitation of drug abusers and to 
prevent illicit crop cultivation, as well as illicit drug 
manufacture, trafficking and abuse. The law also 
includes provisions on systems for licensing and 
inspecting the research, manufacture, delivery, use, 
storage and transportation of narcotic drugs and 
psychotropic substances, as well as on a system for 
licensing the manufacture of, trade in and shipment of 
precursor chemicals. 
550. In 2008, China strengthened controls over 
pharmaceutical preparations containing precursor 
chemicals by introducing the requirement of a 
prescription for nasal drops containing ephedrine 
hydrochloride. 
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551. China also strengthened its controls on online 
drug sales in 2008. The State Food and Drug 
Administration has made cracking down on false 
advertising of drug products online a priority for 2008 
and aims to increase its supervision of major Internet 
sites suspected of being involved in the false 
advertising (which includes the use of exaggerated or 
misleading information regarding the benefits of the 
drugs) or the mailing of counterfeit drugs to customers.  
552. In 2008, Japan launched its latest Five-Year Drug 
Abuse Prevention Strategy, covering the period 2008-
2013. The main objectives of the strategy are to reduce 
drug abuse among young people through awareness-
raising, to prevent relapse through the provision of 
treatment and rehabilitation, to take measures against 
organized crime and to strengthen border interdiction 
efforts and international cooperation. 
553. A decree was signed by the President of the Lao 
People’s Democratic Republic in 2008 to promulgate a 
new law on drugs that had been adopted by the 
National Assembly in 2007. The new drug law 
comprises 80 articles and will complement the existing 
criminal penal code. The new drug law further defines 
principles, regulations and measures related to drug 
control. 
554. In 2008, a law amending and supplementing the 
Law on Narcotic Drug Prevention and Suppression was 
promulgated by the Government of Viet Nam. The new 
law provides a detailed description of the 
responsibilities of relevant authorities, including 
police, maritime police, border authorities and customs 
authorities, with regard to drug abuse prevention and 
drug control. In particular, it modifies the procedures 
and terms of administrative detention for compulsory 
drug detoxification and management and includes 
provisions for opiate substitution therapy. 
555. The Macao SAR of China introduced a new bill 
in 2008 related to the illicit manufacture of, trafficking 
in and abuse of narcotic drugs and psychotropic 
substances. The bill calls for increasing from 12 to 
15 years the maximum sentence of imprisonment for 
those convicted of illicitly producing or smuggling 
drugs and for criminalizing the manufacture and 
possession of equipment and materials used in illicit 
drug manufacture. 
556. In 2008, China focused its efforts on combating 
drug abuse among youth. It launched a campaign to 
inform people about the abuse of psychotropic 
substances, foster a drug-free culture among youth and 
mobilize the community to prevent drug abuse. During 
2007, 6,900 drug abusers were rehabilitated in 
treatment and rehabilitation centres in the Lao People’s 
Democratic Republic. In 2008, the Government has 
continued to make the provision of treatment and 
rehabilitation for drug abusers a priority and has 
provided financial assistance to treatment and 
rehabilitation centres in 10 provinces. 
557. In 2007, law enforcement authorities in the Hong 
Kong SAR of China conducted a three-month 
operation targeting cross-border drug trafficking. The 
operation resulted in the seizure of cannabis, cocaine, 
heroin, ketamine and methamphetamine. 
558. In Thailand, the Independent Commission for 
Study and Analysis of the Formation and 
Implementation of Drug Suppression Policy released a 
report in 2008 on the findings of its six subcommittees 
regarding the “war on drugs”. According to the report, 
55 law enforcement officers were prosecuted as a result 
of the investigations (see also paragraphs 212-215 
above). 
559. HIV transmission in East and South-East Asia is 
driven by high-risk behaviour, such as needle-sharing 
among persons who abuse drugs by injection. Several 
States in East and South-East Asia, including China, 
Indonesia, Malaysia and Viet Nam, provide sterilized 
needles and opioid substitution therapy, for example, 
methadone to people who abuse heroin by injection. 
However, most of the programmes offering such 
services reach only a fraction of the people who 
require the services. In the Hong Kong SAR of China, 
a large-scale drug abuse programme has, for many 
years, helped to keep at a low level HIV prevalence 
among persons who abuse drugs by injection. 
560. According to the information contained in a 
report by the Commission on AIDS in Asia,81 drug 
abuse is illegal in many countries in East and South-
East Asia and drug abusers are often jailed, not only 
for their drug abuse, but also for crimes committed to 
finance their addictions. The challenges faced by 
countries such as Indonesia and Thailand in preventing 
the spread of HIV infection in prisons highlight the 
__________________ 
 81  Commission on AIDS in Asia, Redefining AIDS in Asia: 
Crafting an Effective Response (New Delhi, Oxford 
University Press, 2008). 
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importance of effective drug abuse prevention and 
treatment programmes in prisons to help limit the 
spread of HIV. 
 
 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
561. The illicit cultivation of cannabis plants has 
continued in countries in East and South-East Asia, 
including in Indonesia and Thailand. Viet Nam 
reported an increase in the illicit cultivation of 
cannabis plants in some northern and southern 
provinces during 2007 and 2008. 
562. States in East and South-East Asia continued to 
report significant seizures of cannabis. In 2007, the 
Lao People’s Democratic Republic seized 2.2 tons of 
cannabis, the highest amount reported in recent years. 
Thailand reported having seized 1.1 tons of cannabis in 
14 incidents in 2007; in most cases, the cannabis 
originated in the Lao People’s Democratic Republic 
and had been concealed in motor vehicles. In February 
and March 2007, 33 kg of cannabis were seized in the 
Hong Kong SAR of China in two incidents. In both 
cases, customs officers at Hong Kong International 
Airport seized the cannabis from passengers arriving 
from Johannesburg. Customs authorities of the 
Republic of Korea seized cannabis concealed in 
express delivery cargo at Incheon International Airport 
in May 2007. In July 2007, customs officers at the post 
office in Guangzhou, China, seized 4.2 kg of cannabis 
in four separate incidents; in two of the incidents, the 
parcels originated in Nigeria. In August 2007, Japanese 
customs authorities at the seaport at Osaka seized 
279 kg of cannabis from sea cargo originating in 
Vancouver, Canada. The Philippines also reported 
significant seizures of cannabis during 2007. In 
January 2008, customs authorities at Beungkam, 
Thailand, seized 242 kg of cannabis. In May 2008, law 
enforcement authorities in Viet Nam reported having 
seized 8.8 tons of cannabis concealed in a truck in 
Quang Ninh province; the consignment had originated 
in the Middle East and was en route to China. 
563. Preliminary data on the total area under illicit 
opium poppy cultivation in Myanmar indicate a slight 
increase in that area, from 27,700 ha in 2007 to 
28,500 ha in 2008. In 2007, authorities in Myanmar 
eradicated 3,598 of the 27,700 ha under illicit opium 
poppy cultivation. In the Lao People’s Democratic 
Republic, 779 of the 1,500 ha under illicit opium 
poppy cultivation were eradicated. The total area under 
illicit opium poppy cultivation in Thailand was 
estimated at 231 ha; most of the illicit cultivation 
occurred in remote areas in northern Thailand. In 2007, 
illicitly cultivated opium poppy was also eradicated in 
Thailand (220 ha) and Viet Nam (38 ha). The Lao 
People’s Democratic Republic reported having seized 
14.2 kg of opium during 2007. 
564. China reported having seized 4.6 tons of heroin in 
2007, much less than the 11 tons seized in 2004, as the 
decreasing trend in seizures of the substance in that 
country continued. The decrease in the availability of 
heroin in the illicit market was largely attributed to the 
efforts made by the drug control authorities in China. 
In the Lao People’s Democratic Republic, 23.8 kg of 
heroin were seized in 2007. 
565. In July 2007, customs officers in the Hong Kong 
SAR of China seized 160 kg of cocaine that had been 
concealed in vessels from Panama purportedly 
containing purified water. 
566. In February 2008, law enforcement authorities in 
China and the United States cooperated with one 
another to uncover a drug trafficking operation 
involving the shipment of express mail parcels from 
South America to China. In Jiangsu, China, cocaine 
was found in an express mail parcel originating in the 
Bolivarian Republic of Venezuela. 
567. Cambodia, Malaysia and the Philippines reported 
the highest annual prevalence of abuse of cannabis in 
East and South-East Asia. Cannabis was the second 
most commonly abused substance (after solvents) 
among persons aged 15 and older in Japan. The Lao 
People’s Democratic Republic reported a decrease in 
opium abuse in 2007 compared with 2006. The 
reported number of opium abusers in the 10 northern 
provinces of that country was 7,706, a decrease of 
31 per cent compared with 2006. The proportion of 
opium abusers in that country remained stable, at 
0.75 per cent of the total adult population. In China, 
Malaysia and Viet Nam, heroin continued to be the 
most commonly abused drug. In 2007, there were 
749,000 registered heroin abusers in China. In Viet 
Nam, there are over 170,000 drug abusers, 83 per cent 
of whom reportedly abuse heroin. In November 2007, 
drug abuse by injection and heroin abuse among ethnic 
minorities living in villages in remote areas were 
reported. 
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 Psychotropic substances 
 
568. An increase in the illicit manufacture of 
amphetamine-type stimulants was reported in countries 
in East and South-East Asia, in particular in China and 
Indonesia. In 2007, 75 laboratories illicitly 
manufacturing amphetamine-type stimulants were 
dismantled in China (compared with 53 in 2006), and 7 
such laboratories were dismantled in Indonesia 
(compared with 1 in 2006). The illicit manufacture of 
methamphetamine continued to be reported in 
countries in East and South-East Asia, including China, 
Indonesia, Myanmar and the Philippines. In 2007, 
nine laboratories involved in the illicit manufacture of 
methamphetamine were dismantled in the Philippines; 
precursor chemicals, including acetone, ephedrine and 
hydrochloric acid, were seized at those laboratories. In 
the Philippines four laboratories involved in the illicit 
manufacture of methamphetamine were dismantled in 
2006. In Myanmar, five clandestine facilities for 
processing methamphetamine were dismantled in 2007; 
all of the facilities were located in the eastern and 
northern parts of Shan State and in the Wa region, 
bordering China, the Lao People’s Democratic 
Republic and Thailand. In Myanmar, eight laboratories 
involved in the illicit manufacture of 
methamphetamine were dismantled in 2006. In some 
countries in East and South-East Asia, laboratories 
involved in the illicit manufacture of 
methamphetamine and MDMA were recently 
dismantled. 
569. In February 2008, a clandestine 
methamphetamine laboratory with an estimated 
monthly manufacturing capacity of 1 ton was 
dismantled in Zamboanga City, the Philippines. The 
laboratory had purportedly been operated by an 
international drug trafficking syndicate for an extended 
period of time and some of the methamphetamine 
manufactured in the laboratory may have been 
exported to Malaysia. In February 2008, Vietnamese 
police uncovered a clandestine laboratory in Hai Phong 
City, where 70,714 MDMA tablets and some ketamine 
were seized, as well as binding equipment and 
colouring substances. 
570. In East and South-East Asia, China (including the 
Hong Kong SAR), Japan, the Republic of Korea, 
Thailand and Viet Nam continued to report significant 
seizures of methamphetamine. During 2007, law 
enforcement authorities in Thailand seized 
155,949 methamphetamine tablets; most of the seized 
tablets were from the Lao People’s Democratic 
Republic, followed by Myanmar and Cambodia. In 
2007, Brunei Darussalam also reported 
methamphetamine seizures. In March 2007, customs 
authorities in Japan and the Republic of Korea reported 
a series of seizures of methamphetamine originating in 
China. In July 2008, about 800,000 methamphetamine 
tablets originating in the Lao People’s Democratic 
Republic were seized in Quang Binh province, 
Viet Nam. 
571. During 2007, there was an increase in seizures of 
amphetamine-type stimulants, mainly methamphetamine 
originating in China (including the Hong Kong SAR of 
China) and destined for Indonesia. In the first five 
months of 2007, 10 cases involving 26 kg were 
reported. In May 2007, customs authorities in the Hong 
Kong SAR of China reported a series of seizures of 
amphetamine-type stimulants, mainly methamphetamine 
and MDMA, at Hong Kong International Airport. 
In the Lao People’s Democratic Republic, 
1,272,815 tablets of amphetamine-type stimulants were 
seized in 2007. 
572. In August 2007, Japanese customs officers at the 
seaport of Osaka seized 154 kg of methamphetamine 
from a sea cargo shipment originating in Vancouver, 
Canada. In March 2008, law enforcement officers from 
Liaoning Province and Yunnan Province of China 
cooperated with their counterparts in Myanmar in the 
seizure of 2 kg of methamphetamine that had been 
smuggled on a route leading from Myanmar to China. 
In May 2008, 7 kg of methamphetamine from Japan 
were seized by law enforcement authorities in Fujian 
Province of China; the methamphetamine had been 
smuggled by sea. 
573. In East and South-East Asia, China (including the 
Hong Kong SAR), Japan and the Republic of Korea 
continued to report seizures of MDMA. In July 2007, 
law enforcement officers at Narita International Airport 
in Japan seized 18,290 MDMA tablets concealed in air 
freight originating in Canada. In August 2007, 
Japanese customs officers at Osaka seaport seized 
208 kg of MDMA from a sea cargo shipment 
originating in Vancouver, Canada. Later that same 
month, customs officers at Narita International Airport 
seized 2,013 MDMA tablets concealed in air freight 
originating in Canada. In November 2007, customs 
officers at Incheon International Airport in the 
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Republic of Korea seized a small amount of MDMA 
tablets found in an express mail package originating in 
the United States. In May 2008, law enforcement 
authorities in Fujian Province of China seized 4 kg of 
MDMA smuggled by sea from Japan. Singapore and 
Thailand also reported having seized MDMA in 2007. 
574. Thailand seized 124 kg of diazepam during 2007, 
most of which had been smuggled through the postal 
system and had been destined for Denmark or the 
United Kingdom. In August 2007, Thai customs 
authorities at a mail sorting centre reported having 
seized 8,000 diazepam tablets from a package destined 
for the United Kingdom. 
575. According to UNODC, the Philippines has the 
highest annual prevalence of abuse of amphetamines in 
the world (6 per cent). A number of other countries in 
East and South-East Asia, including Cambodia, the Lao 
People’s Democratic Republic, Malaysia and Thailand, 
also have a high rate of abuse of such substances. In 
the Lao People’s Democratic Republic, 5,780 abusers 
of amphetamines were identified in the province of 
Vientiane in 2008. Methamphetamine is the most 
commonly abused drug in Brunei Darussalam. 
 
  Precursors 
 
576. Countries in East and South-East Asia continued 
to report seizures of significant amounts of precursor 
chemicals. In October 2007, law enforcement 
authorities at Narita International Airport in Japan 
seized 131 kg of pseudoephedrine tablets from 
passengers arriving from the Hong Kong SAR of 
China; the passengers were attempting to smuggle the 
tablets into Mexico. In October 2007, law enforcement 
officers in Thailand seized 50 tons of sassafras oil at 
Laem Chabang seaport; the sassafras oil originated in 
Cambodia and had been destined for China and the 
United States. China reported having seized large 
amounts of precursor chemicals in 2007, including 
5.7 tons of acetic anhydride and 5.8 tons of ephedrine. 
During 2007, customs officers in the Philippines seized 
a shipment of acetone and toluene that was purportedly 
to be used in the clandestine manufacture of 
methamphetamine. In April 2008, Cambodian law 
enforcement authorities destroyed 33 tons of safrole-
rich oil. 
 
  Substances not under international control 
 
577. The illicit manufacture of ketamine was 
identified as a growing problem in China. In 
March 2008, law enforcement authorities in Sichuan 
Province of China, dismantled a laboratory for the 
illicit manufacture of ketamine and seized 196 kg of 
ketamine and some equipment. In June 2008, four 
clandestine ketamine laboratories were dismantled and 
400 kg of ketamine were seized in Guangdong 
Province of China. The Hong Kong SAR of China, 
Myanmar, the Philippines, Singapore and Taiwan 
Province of China continued to report significant 
seizures of ketamine. In 2007, 3,038 people were 
reported to have abused ketamine, 58.5 per cent of 
whom were under the age of 21. Ketamine trafficking 
and seizures were also reported in Viet Nam. The abuse 
of ketamine was reported in several provinces in 
Cambodia in 2008. 
 
 5. Missions 
 
578. The Board sent a mission to Japan in 
October 2008. The Board observed that in Japan the 
regulatory controls implemented for narcotic drugs, 
psychotropic substances and precursor chemicals and 
the monitoring of the movement of controlled 
substances were in line with the provisions of the 
international drug control system. The Government of 
Japan is committed to drug control, complies with the 
provisions of the three international drug control 
treaties and has an effective and comprehensive 
national drug policy. Efforts to prevent drug abuse 
have been particularly successful. According to the 
drug abuse surveys conducted regularly by the 
Government, the prevalence rates for substance abuse 
in Japan are among the lowest in the world. The Board 
invites the Government to share with the international 
community the measures carried out by governmental 
and non-governmental entities to prevent drug abuse, 
as well as the impact those measures have had on the 
population in Japan. At the same time, the Board calls 
upon the Government to remain vigilant and monitor 
all types of substance abuse, including the abuse of 
pharmaceutical preparations containing controlled 
substances, and recommends that the Government 
expand the services for treatment of drug abusers to 
cover all segments of the population for which such 
services might be needed, with a view to facilitating 
rehabilitation and social reintegration. 
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579. Law enforcement activities in Japan appear to be 
well coordinated, and the Government’s cooperation 
with many other Governments is functioning well. 
However, in view of the growing involvement of 
international criminal organizations in drug trafficking 
in Japan, collaboration with the national law 
enforcement agencies of other countries should be 
strengthened. 
 
 
  South Asia 
 
 
 1. Major developments 
 
580. There are signs of increased trafficking in 
amphetamine-type stimulants and their precursor 
chemicals throughout South Asia. Large seizures made 
in the region in recent years point to the emergence of 
an illicit market for those substances; however, those 
seizures could also indicate that South Asian countries 
are being used as transit areas between manufacturing 
hubs in East Asia and the rapidly growing illicit 
markets on the Arabian peninsula. There are fears that 
the widespread availability of amphetamine-type 
stimulants may fuel an increase in the abuse of those 
substances in South Asia. 
581. Recent survey data from several South Asian 
countries indicate that the HIV transmission rate is still 
high among persons who abuse drugs by injection. In 
India, the prevalence of HIV infection among such 
drug abusers in 2006 was estimated at a national 
average of 8.71 per cent, compared with 0.36 per cent 
in the general adult population. In Bangladesh, HIV 
prevalence among such drug abusers in the region of 
Dhaka rose from 1.4 per cent in 2000 to 7 per cent in 
2006. In Nepal, HIV prevalence among such drug 
abusers in Kathmandu in 2007 was still high, at 34 per 
cent, but had decreased from the peak of 68 per cent 
reported in 2003.  
 
 2. Regional cooperation 
 
582. Bangladesh, India and Nepal participated in the 
inter-country consultation on preventing HIV among 
persons abusing drugs by injection held in Kolkata, 
India, in April 2007. The aim of the consultation was to 
assist countries in intensifying the efforts to prevent 
the spread of HIV among drug abusers. Emphasis was 
placed on the need for regional cooperation in view of 
the cross-border nature of drug abuse and trafficking. 
Participants agreed that coverage of opioid substitution 
therapy was low within the region and needed to be 
improved. 
583. Treatment specialists from all six South Asian 
countries attended the Second Regional Training 
Programme on Drug Treatment, Rehabilitation and 
Aftercare, organized by the Drug Advisory Programme 
of the Colombo Plan with funding from the United 
States Department of State, in Bangkok from 10 to 
21 September 2007. The training provided participants 
with an overview of the treatment and rehabilitation of 
drug addicts and avenues for improving services. 
Participants reviewed the current status of their 
treatment and rehabilitation programmes to identify 
major shortcomings and common solutions. 
584. The second meeting of ministers of the interior of 
the member States of the South Asian Association for 
Regional Cooperation (SAARC) was held in New 
Delhi from 23 to 25 October 2007. Participants 
recognized the importance of improving information 
exchange among member States in order to combat 
cross-border crime. To that end, India committed itself 
to providing resources to strengthen the capacity of the 
Drug Offences Monitoring Desk of SAARC, located in 
Sri Lanka. A proposal to set up a regional police force 
was brought up for consideration, but a decision on the 
subject was deferred to give member States more time 
to examine the proposal.  
585. Representatives of Bangladesh, Bhutan, India and 
Sri Lanka attended the Thirty-First Meeting of Heads 
of National Drug Law Enforcement Agencies, Asia and 
the Pacific, held in Bangkok in November 2007. The 
three main topics on the agenda were the regional 
response to trafficking heroin, the growing significance 
of problems involving amphetamine-type stimulants in 
the region and inter-agency cooperation to combat drug 
trafficking. The meeting recommended that 
Governments strengthen national legislative and 
procedural controls over precursor chemicals so as to 
counteract their diversion, develop capacity to safely 
dismantle clandestine laboratories manufacturing 
amphetamine-type stimulants and promote cooperation 
and coordination between key agencies responsible for 
drug law enforcement. 
586. The Subcommission on Illicit Drug Traffic and 
Related Matters in the Near and Middle East held its 
forty-second session in Agra, India, in December 2007. 
The session was attended by representatives of the 
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23 member States, by observers for Australia, the 
United States and European countries, and by 
observers for INTERPOL and relevant United Nations 
bodies. Participants shared their experiences in 
regional and subregional collaborative efforts to tackle 
the problem of drug trafficking, with emphasis on 
specific operational and practical problems 
encountered by drug law enforcement authorities in the 
region. Governments were encouraged to engage in 
international cooperation in law enforcement 
operations aimed at countering cannabis production 
and trafficking, to support partnerships between law 
enforcement authorities and community-based 
organizations in implementing demand reduction 
strategies and to facilitate international law 
enforcement initiatives focusing on both illicit drugs 
and precursors. 
587. From 23 to 31 January 2008, the First Asian 
Consultation on the Prevention of HIV Related to Drug 
Use was held in Goa, India. The Consultation focused 
on various issues related to drug abuse in Asia, such as 
HIV prevention and treatment among persons abusing 
drugs by injection. By bringing together key 
stakeholders from governmental and non-governmental 
organizations throughout the region, the Consultation 
aimed at promoting collaborative efforts in developing 
and implementing strategies that had proved successful 
in the region. Recommendations from the meeting 
stressed the need to expand access to HIV treatment 
and prevention to at least 60 per cent of drug abusers 
and to enhance significantly the availability of opioid 
substitution treatment to address the AIDS epidemic 
effectively. Attention was also drawn to the importance 
of developing specific approaches to tackling the 
difficulties faced by female drug abusers in obtaining 
assistance and to the high rate of transmission of 
hepatitis C among persons abusing drugs by injection. 
588. The Sixth Asian Youth Congress, organized by 
the Drug Advisory Programme of the Colombo Plan in 
collaboration with the competent authorities of 
Indonesia, was held in Bali, Indonesia, from 4 to 
7 August 2008. The Congress was a drug demand 
reduction initiative of the Advisory Programme 
intended to create a forum for young leaders in Asia to 
learn from their peers about drug abuse prevention. 
Besides learning about the consequences of illicit drug 
abuse among youth, participants shared information 
about peer-led activities aimed at reducing drug abuse 
in schools and on campuses and worked together to 
identify community-based strategies to tackle drug 
abuse problems among young people.  
589. At the fifteenth summit meeting of SAARC, held 
in Colombo in August 2008, Heads of State and 
Government recognized the interlinkages between 
terrorism and trafficking in narcotic drugs and 
psychotropic substances and reiterated their 
commitment to fostering regional cooperation to 
combat those problems.  
 
 3. National legislation, policy and action 
 
590. A report entitled “Rapid Situation and Response 
Assessment (RSRA) on drugs and HIV in Bangladesh, 
Bhutan, India, Nepal and Sri Lanka” was issued by 
UNODC in June 2008. The study was conducted in 
2005 in Bangladesh, India, Nepal and Sri Lanka and in 
2006 in Bhutan by UNODC, in partnership with 
governmental and non-governmental agencies working 
in the drug and HIV sectors. Its objective was to assess 
the extent and nature of drug use in the target 
countries, with emphasis on drug abuse by injection. 
The report recommended that future programmes 
should also target drug abusers who do not inject drugs 
so as to prevent any switch-over to the abuse of opioids 
by injection. It also highlighted the need to increase the 
availability of treatment for drug dependence and to 
stem the increasing problem of abuse of 
pharmaceuticals in the region. 
591. The Second National Training Programme on 
HIV Prevention among Incarcerated Substance Users 
was conducted by UNODC in collaboration with the 
Department of Narcotics Control of the Ministry of 
Home Affairs of Bangladesh in Dhaka in January 2008. 
The Programme was attended by prison officers, police 
and staff of national drug control agencies, who 
received training in reducing HIV vulnerability among 
prison inmates. Similar training was given in Pokhara, 
Nepal, earlier in the year and in Maldives in 
December 2007.  
592. The Bhutan Narcotic Control Agency launched its 
website on 26 June 2008 to provide information on the 
implementation of the provisions of the Narcotic 
Drugs, Psychotropic Substances and Substance Abuse 
Act of 2005. The website also features information 
about offices and organizations providing assistance to 
persons with drug abuse problems. 
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593. “Wake Up”, a national public awareness 
campaign aimed at preventing drug abuse and 
promoting recovery from drug addiction, was launched 
in Maldives in December 2007. Young people and 
parents were the targets of the sensitization campaign 
in a country where persons under 18 years of age 
account for the majority of arrests in drug-related 
cases. A website created as part of the campaign 
provides both advice on drug abuse to parents and 
resources to assist in recovery from drug abuse. 
594. In March 2008, the Government of Maldives 
launched a four-year drug control master plan that will 
address both the demand and supply sides of the drug 
abuse problem. Planned strategies should increase 
awareness, promote coordination among key 
stakeholders from government and the community and 
improve the quality of treatment and rehabilitation for 
drug abusers. More resources will be directed at 
strengthening the capacity of law enforcement agencies 
to control points of entry into Maldives. 
595. Law enforcement personnel from the southern 
and western parts of India attended a training 
programme on precursor chemicals organized by 
UNODC in Mumbai in May 2008. The programme set 
out to sensitize law enforcement officers to the 
problem of trafficking in precursor chemicals in India 
and the control regime in place to prevent it. 
Participants also learned about methods for identifying 
precursor chemicals and discussed intelligence-
gathering techniques that could facilitate 
investigations.  
596. A bill to amend the Drugs and Cosmetics Act of 
1940 is under consideration in the Parliament of India. 
It aims to curb the manufacture of and trade in fake 
and adulterated drugs by significantly increasing the 
penalties for related offences. An important provision 
of the proposed amendment is the creation of a central 
drug authority with sole responsibility for granting 
drug manufacturing licences. By centralizing licensing 
for the manufacture and sale of drugs, currently under 
the control of individual state governments, the new 
measure should reduce the countrywide variance in 
surveillance and law enforcement that allows drug 
counterfeiting to thrive in India. 
597. In November 2007, the Parliament of Sri Lanka 
approved the Drug-Dependent Persons (Treatment and 
Rehabilitation) Act, No. 54, of 2007. The Act provides 
for the designation and establishment of licensed 
treatment centres under the administration of the 
National Dangerous Drug Control Board. It also 
includes provisions for the compulsory admission to 
those centres of persons identified as drug-dependent 
by a government medical officer. Under the new 
legislation, 12 prisons were declared designated 
treatment centres in 2007. 
598. Sri Lanka enacted the Convention against Illicit 
Traffic in Narcotic Drugs and Psychotropic Substances 
Act No. 1 of 2008 on 23 January 2008. The Act 
incorporates the provisions of the United Nations 
Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 and the Convention 
on Narcotic Drugs and Psychotropic Substances 
adopted by SAARC in 1990. A key provision of the 
new law is the establishment of a precursor control 
authority responsible for administering internationally 
controlled substances.  
599. Sri Lanka launched the “I decide” public 
awareness campaign on 26 June 2008. The campaign 
was designed to provide information on drug abuse 
that would allow youth and communities to make 
informed choices and decisions. 
 
 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
600. Pharmaceutical preparations diverted from licit 
manufacture in India continue to feed the widespread 
abuse of such products in South Asia. Drugs smuggled 
into countries neighbouring India include pethidine and 
codeine-based cough syrups. In 2007 drug control 
authorities in Bangladesh made a record seizure of 
more than 70,000 tablets containing codeine. Seizures 
of codeine-based cough syrup under the brand name 
Phensidyl, smuggled into Bangladesh out of India, 
decreased by 50 per cent, to about 146 litres, in 2007 
compared with 2006. 
601. The number of patients undergoing treatment for 
drug abuse in Bangladesh decreased from 13,300 in 
2004 to 4,878 in 2007. During that period, the majority 
of patients (68-80 per cent) reported heroin to be their 
primary drug of abuse. The percentage of patients 
reporting cannabis as the primary drug of abuse 
doubled from about 7.5 per cent in 2004 to 15 per cent 
in 2007. A rapid assessment survey of about 1,000 drug 
users conducted by UNODC in 2005 indicated the 
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following lifetime prevalence rates for the abuse of 
drugs: 96 per cent for abuse of cannabis, 97 per cent 
for heroin, 13 per cent for opium and 28 per cent for 
buprenorphine. 
602. Every year, Indian counter-narcotics forces 
eradicate areas in which opium poppy grows wild or is 
illicitly cultivated. On average, about 2,000 kg of 
opium derived from illicitly cultivated opium poppy 
are seized annually in India. However, the proportion 
of the seized opium that is of Indian origin is unclear, 
since opium is still smuggled out of neighbouring 
countries where opium poppy is illicitly cultivated. The 
Board encourages the Government of India to continue 
its efforts to eradicate opium poppy in areas where it 
grows wild or is illicitly cultivated. 
603. Heroin and morphine continue to be among the 
substances most commonly abused in India. Significant 
seizures of heroin, each averaging about 1,000 kg, are 
made each year in that country. A significant portion of 
the heroin seized in India originates in its neighbouring 
countries in South-West Asia in which opium poppy is 
illicitly cultivated. In contrast to the stability in the 
average size of heroin seizures in India, the total 
quantity of morphine seizures declined steadily, from 
about 100 kg in 2003 to 43 kg in 2007. 
604. India is one of the largest illicit producers of 
cannabis and cannabis resin in South Asia. Although 
law enforcement authorities in India regularly eradicate 
large areas of illicitly cultivated cannabis plants, a 
significant amount of cannabis still finds its way onto 
the illicit market in that country. In 2007, about 284 ha 
of cannabis plants were destroyed. Seizures of 
cannabis in India have averaged about 150 tons over 
the three-year period 2004-2006, and about 108 tons of 
cannabis herb were reported seized in 2007. Since 
2003, the total amount of cannabis resin seized in India 
each year has averaged about 4 tons. 
605. In recent years, there have been reports of small 
quantities of cocaine being smuggled into India. In 
2007, some 8 kg of cocaine were seized in that country. 
Investigations into seizures made in 2008 suggest that 
the cocaine entering India is still being smuggled out 
of West Africa.  
606. According to UNODC, the prevalence of abuse of 
cannabis in India was 3.2 per cent in 2000 and the 
prevalence of abuse of opiates was 0.4 per cent in 
2001. More recent information can be found in reports 
of patterns of drug use among patients undergoing 
treatment for drug abuse in 2004 and 2005; of about 
82,000 patients, 61 per cent underwent treatment for 
the abuse of opiates, 15.5 per cent for cannabis abuse 
and 1.5 per cent for cocaine abuse. However, the Board 
notes the lack of up-to-date information on nationwide 
patterns of drug abuse in India. The Board encourages 
the Government of India to regularly monitor 
countrywide patterns of drug abuse as it represents an 
important element of an effective drug abuse 
prevention strategy. 
607. Maldives has witnessed an increase in the amount 
of heroin smuggled into the country in recent years. 
Heroin in quantities of up to 1 kg was intercepted by 
the Customs Service each year in 2004 and 2005. In 
contrast, in 2006, seizures of heroin totalling 8.9 kg 
were reported; the majority of that heroin was seized at 
the airport from passengers entering the country, in 
most cases from India. In 2007, a passenger was 
arrested at the airport while trying to smuggle 7.8 kg of 
heroin into Maldives. The increase in the quantity of 
heroin seized may indicate that the country is 
becoming an important transit area for drug smuggling 
operations. 
608. Nepal is the most important producer of cannabis 
resin in South Asia. The increase in seizures of 
cannabis resin in Nepal accounted for the fact that the 
amount of cannabis resin seized in the entire region of 
South Asia in 2006 was twice the amount seized in 
2003. In addition to being abused locally, cannabis 
resin in Nepal is smuggled into other countries in Asia 
and the Pacific. The main destination of cannabis resin 
from Nepal appears to be India, where 40-50 per cent 
of the cannabis resin seized in recent years originated 
in Nepal. Seizures of cannabis resin from Nepal are 
also regularly reported in China, the Hong Kong SAR 
of China, Japan and Thailand. 
609. Cannabis remains the most widely abused drug in 
Sri Lanka and is illicitly cultivated in the eastern and 
southern provinces of the country. In 2003, about 
74 tons of cannabis were seized in Sri Lanka. From 
2004 to 2007, the quantity of cannabis seized annually 
fluctuated between 30 and 40 tons. 
610. Heroin continues to be widely abused in 
Sri Lanka. Heroin is not manufactured locally but is 
brought into the country from India and Pakistan. 
Small quantities of heroin are smuggled into Sri Lanka 
from India by airline passengers and on fishing boats 
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coming from the west coast of India. In the period 
2003-2006, the quantity of heroin seized in Sri Lanka 
fluctuated between 50 and 80 kg. In 2007, about 30 kg 
of heroin were seized in the country. 
611. In Sri Lanka, cannabis currently accounts for the 
majority of drug-related arrests. The number of 
cannabis-related arrests increased steadily from 
9,566 cases in 2003 to 33,848 cases in 2007, 
corresponding to 43 per cent and 78 per cent of the 
total number of drug-related arrests, respectively. The 
number of prison admissions related to cannabis also 
increased; in 2003, about 13 per cent of drug-related 
prison admissions were related to cannabis 
(1,307 cases) compared with 44 per cent (5,065 cases) 
in 2007.  
612. In Sri Lanka, the number of drug-related arrests 
linked to heroin decreased from 12,488 cases in 2003 
to 9,428 cases in 2007, corresponding to 57 per cent 
and 21 per cent of the total number of drug-related 
arrests, respectively. In the same period, the number of 
prison admissions related to heroin also decreased; in 
2003, about 87 per cent of drug-related prison 
admissions were related to heroin (9,076 cases), 
compared with 56 per cent (6,386 cases) in 2007.  
613. In Sri Lanka, the vast majority of people arrested 
for drug-related offences are male; in 2006, about 4 per 
cent of the 47,298 people arrested for such offences 
were female. This gender difference is also reflected in 
the proportion of men and women imprisoned for 
narcotic-related offences; in 2006, about 2 per cent of 
the 10,384 detainees were women. Furthermore, of the 
2,738 patients treated for drug abuse in 2006, only 5 
were women. The Board notes that under the Sri Lanka 
National Policy for the Prevention and Control of Drug 
Abuse, treatment providers are encouraged to exercise 
gender balance in providing their services to patients. 
The Board encourages the Government of Sri Lanka to 
focus more attention on this issue in the light of the 
severe disparity between the proportion of men and 
women receiving treatment for drug abuse.  
 
  Psychotropic substances 
 
614. A popular form of methamphetamine abused in 
Asia is a tablet known as “yaba”, containing a mixture 
of caffeine and about 30 per cent methamphetamine. 
Increasingly large seizures of “yaba” tablets have been 
reported in Bangladesh, where the drug has gained 
popularity among young people. Most of the “yaba” 
circulating in Bangladesh is smuggled out of 
neighbouring countries such as Myanmar. According to 
UNODC, 1.2 million methamphetamine tablets 
originating in Myanmar were seized in Bangladesh in 
2007. 
615. Several seizures of LSD were reported in India in 
2007. The largest amount was seized in 
December 2007 from a tourist in Goa who was arrested 
for possession of about 2,000 units of LSD, weighing 
about 35 grams.  
616. Since the start of 2008, several seizures of 
amphetamine-type stimulants have been made in India. 
In March 2008, customs officers seized about 
3,700 tablets of methamphetamine, purported to 
originate in Myanmar, from an airline passenger, while 
about 70 kg of amphetamine was reported to have been 
seized in June 2008. 
617. In recent years, 0.2 per cent of patients 
undergoing drug-related treatment in India were 
admitted for the abuse of amphetamine-type 
stimulants. There are fears, however, that such abuse is 
increasing, facilitated by the fact that amphetamine-
type stimulants are illicitly manufactured in India and 
smuggled into the country from South-East Asia. The 
Board encourages the authorities concerned to develop 
strategies to monitor the prevalence of abuse of 
amphetamine-type stimulants in the country. 
618. In spite of efforts by law enforcement authorities 
to curb the clandestine manufacture of methaqualone in 
India, seizures of the drug are reported 
every year. The total quantity of methaqualone seized 
each year fluctuates greatly: in 2006 about 4,500 kg 
were seized, compared with 1 kg in 2007. The seizure 
in February 2008 of about 230 kg of tablets containing 
methaqualone underscores the persistent problem of 
clandestine manufacture of that drug in India. South 
Africa, where methaqualone is widely abused, 
continues to be a frequent destination of consignments 
of Indian methaqualone (see paragraph 333 above). 
619. According to UNODC, in June 2008, 1.8 kg of 
crystalline methamphetamine were seized at the 
international airport of Kathmandu. The shipment was 
bound for Doha and could be an indication that Nepal 
is being used as a new transit area for consignments of 
amphetamine-type stimulants destined for the 
increasingly lucrative illicit markets in countries on the 
Arabian peninsula. 
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620. Nepal remains a common destination for 
consignments of pharmaceutical preparations smuggled 
out of India. In 2007, law enforcement authorities 
seized more than 90,000 injections containing 
psychotropic substances such as buprenorphine and 
diazepam, a 10-fold increase over 2005. A rapid 
assessment survey carried out in Nepal by UNODC in 
2005 revealed that the lifetime prevalence of abuse of 
buprenorphine was 77 per cent among the 1,322 drug 
users surveyed. 
 
  Precursor chemicals 
 
621. A survey of the trade in chemicals that could be 
used as precursors in the illicit manufacture of narcotic 
and psychotropic drugs was carried out by the 
competent national authorities of Bhutan in 2008. Only 
six of the precursor chemicals under international 
control are imported into Bhutan, and they are used 
mainly in industry for laboratory tests and in 
educational institutions for teaching purposes. There 
has been no reported theft or diversion of such 
precursor chemicals in the country in the last three 
years. 
622. Some of the acetic anhydride licitly produced on 
an industrial scale in India is subject to diversion for 
the illicit manufacture of methaqualone and heroin. 
Since 2005, seizures of acetic anhydride of less than 
300 kg have been reported every year. In 2008, there 
was a sharp increase in seizures of acetic anhydride: 
over 1,500 kg of the chemical had been seized by the 
middle of the year. 
623. The diversion of ephedrine, pseudoephedrine and 
norephedrine, precursor chemicals used in the 
manufacture of amphetamine-type stimulants, is a 
matter of concern in India, the world’s third largest 
manufacturer of such precursor chemicals. In 
December 2007, law enforcement authorities 
uncovered a clandestine laboratory in Mumbai, India, 
equipped to extract pseudoephedrine from licit 
pharmaceuticals. About 290 kg of pseudoephedrine 
were seized in the operation. The pseudoephedrine was 
intended for export to Australia for use in the illicit 
manufacture of amphetamine-type stimulants. In India, 
about 400 kg of ephedrine were seized in 2007 and 
about 820 kg of norephedrine were seized in 
June 2008. 
 
 
  West Asia 
 
 
 1. Major developments 
 
624. The Government of Afghanistan and the 
international community have made some progress in 
addressing the problem of illicit opium poppy 
cultivation in that country. Illicit opium poppy 
cultivation in Afghanistan dropped from its record 
level of 193,000 ha in 2007 to 157,000 ha in 2008. The 
number of provinces free of opium poppy also 
increased, from 13 to 18. About 98 per cent of the 
illicit opium poppy cultivation in the country takes 
place in just seven provinces.  
625. Despite those successes, Afghanistan continues to 
account for by far the largest share of the world’s illicit 
opium poppy cultivation. Due to the higher crop yield, 
actual opium production dropped by only 6 per cent, 
from 8,200 tons in 2007 to 7,700 tons in 2008. The 
lack of security in Afghanistan has severely hampered 
Government efforts to eradicate illicit opium poppy: a 
total of 78 persons involved in those eradication efforts 
lost their lives in 2008, a sixfold increase over the 
previous year. The increase in the illicit cultivation of 
cannabis in Afghanistan is also a worrying 
development. The Board urges the Government of 
Afghanistan and the international community to 
continue their efforts to implement the international 
drug control treaties and to ensure that farming 
communities involved in illicit crop cultivation are 
provided with sustainable, legitimate livelihoods.  
626. The Security Council, in its resolution 1817 
(2008), called upon all Member States to increase 
cooperation in order to counter illicit drug production 
and trafficking in Afghanistan, including by 
strengthening the monitoring of the international trade 
in precursor chemicals, notably but not limited to 
acetic anhydride. In the same resolution, the Council, 
acknowledging the leading role played by the Board in 
the implementation of the international drug control 
conventions and the international control of precursors, 
invited all Member States, in particular those 
producing precursor chemicals, Afghanistan, 
neighbouring countries and all countries on the 
trafficking routes, to increase their cooperation with 
the Board. 
627. Afghan opiates are smuggled mainly through Iran 
(Islamic Republic of), Pakistan and countries in 
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Central Asia into countries in Eastern and Western 
Europe (such as the Russian Federation). That large-
scale smuggling of Afghan opiates has resulted in a 
wide range of social ills, including organized crime, 
corruption and high illicit demand for opiates. For 
example, the Islamic Republic of Iran has, for a 
number of years, had the highest rate of abuse of 
opiates in the world. In the countries in Central Asia, 
the rate of abuse of opiates continues to increase and 
HIV/AIDS transmission through the sharing of needles 
among persons who abuse drugs by injection continues 
to be a problem. The countries in the southern 
Caucasus are increasingly being used as trans-shipment 
areas for illicit consignments of drugs, mainly opiates 
from Afghanistan, and drug abuse continues to increase 
in those countries as well.  
628. Despite the fact that trafficking through Central 
Asia remains at a high level, cooperation among the 
Governments of Central Asian countries is improving, 
with more joint efforts against trafficking taking place 
on both a bilateral and multilateral basis. The Board 
urges the Governments of countries in Central Asia to 
continue strengthening their coordination efforts, 
including through the establishment of the Central Asia 
Regional Information and Coordination Centre.  
629. Illicit opium poppy cultivation also takes place in 
Pakistan, though on a much smaller scale than in 
Afghanistan (1,698 ha of opium poppy were illicitly 
cultivated in Pakistan in 2007). Cannabis is illicitly 
cultivated in many countries in Central Asia. The illicit 
cultivation of both cannabis and opium poppy appears 
to be increasing in the Bekaa valley of Lebanon.  
630. New routes for trafficking in drugs, including 
heroin from countries outside of West Asia, appear to 
be opening through countries on the Arabian peninsula. 
The new routes lead through countries such as Jordan, 
the Syrian Arab Republic and the United Arab 
Emirates.  
631. Many countries on the Arabian peninsula also 
continue to be faced with a longstanding problem of 
abuse of amphetamine-type stimulants, in particular 
counterfeit Captagon tablets. Captagon was originally 
the trade name of a pharmaceutical preparation 
containing fenetylline, but drug traffickers have now 
resorted to producing counterfeit Captagon tablets 
containing mainly amphetamine. The world’s largest 
seizures of counterfeit Captagon take place in Saudi 
Arabia, where 12.3 tons of the substance were seized in 
2006, accounting for 28 per cent of global 
amphetamine seizures. Captagon seizures in Saudi 
Arabia increased further in 2007, to 13.9 tons.  
632. Cocaine trafficking is spreading in West Asia. 
Seizures of the drug in Turkey totalled only 3 kg in 
2003 but increased to 40 kg in 2005, 77 kg in 2006 and 
114 kg in 2007. In May 2008, Israeli police authorities 
conducted a large-scale law enforcement operation in 
which they seized 104 kg of cocaine in the northern 
port of Haifa. 
 
 2. Regional cooperation 
 
633. The international community continued to 
provide support and assistance to Afghanistan under 
the umbrella of the Afghanistan Compact,82 adopted at 
the conclusion of the London Conference on 
Afghanistan, held from 29 January to 1 February 2006. 
The Compact expresses the shared commitment of the 
Government and the international community to build 
a democratic State that provides security and livelihood 
opportunities to all citizens. Recognizing the 
interdependence of security, governance and 
development challenges, the Compact focuses on three 
mutually reinforcing pillars: security; governance, the 
rule of law and human rights; and economic 
development. The Compact includes benchmarks to be 
used to measure achievement over five years, aligned 
with the Millennium Development Goals and covering 
all aspects of the State-building process.  
634. The Afghanistan National Development Strategy 
was finalized in April 2008, and was submitted to 
international financial institutions as a poverty 
reduction strategy paper. The Strategy covers the 
five-year period 2008-2013 and outlines the steps to be 
taken by the Government to achieve the Afghanistan 
Compact benchmarks regarding security, governance 
and development. The Strategy was presented to the 
International Conference in Support of Afghanistan, 
held in Paris on 12 June 2008. The Board hopes that 
the international community will provide the 
Government of Afghanistan with adequate assistance, 
including but not limited to financial assistance, for the 
tasks required.  
__________________ 
 82 “Letter dated 9 February 2006 from the Permanent 
Representative of Afghanistan to the United Nations 
addressed to the President of the Security Council” 
(S/2006/90), annex. 
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635. Governments of countries in West Asia have 
continued to take joint measures against drug 
trafficking. In particular, Governments of countries in 
Central Asia have increased their bilateral and 
multilateral cooperation in areas such as reduction of 
illicit drug supply and demand, precursor control, 
border management, countering the spread of 
HIV/AIDS and fighting organized crime and money-
laundering. They have also participated in various 
regional projects and international operations under the 
auspices of the Board, UNODC, the Commonwealth of 
Independent States (CIS), the Collective Security 
Treaty Organization (CSTO), the Shanghai 
Cooperation Organization and the 1996 Memorandum 
of Understanding on Subregional Drug Control 
Cooperation. 
636. Joint efforts to counter drug trafficking have 
produced some results. For example, in February 2008, 
law enforcement agencies of Kazakhstan, the Russian 
Federation, Tajikistan and Uzbekistan launched 
Operation Typhoon, a joint operation targeting one of 
the largest drug trafficking groups in Central Asia. As a 
result of that operation, more than 800 kg of heroin and 
100 kg of opium were seized in Kazakhstan, the 
Russian Federation and Uzbekistan. Operation 
Channel, conducted under the auspices of CSTO since 
2003, has also contributed to efforts to counter drug 
trafficking in West Asia. Operation Channel resulted in 
the seizing of over 28 tons of drugs and precursors in 
2007. CSTO member States actively involve States 
from outside the region, as well as international 
organizations, in their operations, adding to their 
effectiveness. In 2007, the Drug Control Agency of 
Tajikistan held 53 joint operations with law 
enforcement agencies in other CIS member States, as 
well as Afghanistan and China, resulting in significant 
seizures of drugs. (For more information on joint 
operations undertaken under the CSTO umbrella, see 
paragraph 694 below.) 
637. Notwithstanding the above, greater collaboration 
is needed for more sustained results. The Board is 
concerned that the lack of coordination and 
information-sharing among the various actors is at 
least partially responsible for the inability of the 
Government of Afghanistan to achieve its goals on the 
eradication of illicitly cultivated opium poppy. The 
Board calls on the Government and on the international 
community to give the highest priority to cooperation 
and intelligence-sharing, in order to ensure the 
effectiveness of joint efforts against drug trafficking in 
Afghanistan. 
638. The Governments of Azerbaijan, Kazakhstan, 
Kyrgyzstan, the Russian Federation, Tajikistan, 
Turkmenistan and Uzbekistan continued to cooperate 
towards the establishment of the Central Asia Regional 
Information and Coordination Centre. The pilot phase 
of the institution has already contributed to the 
improvement of coordination, the sharing of 
information and the strengthening of the capacity of 
Governments of countries in Central Asia. The Board 
urges the Governments involved, in particular the 
Government of the Russian Federation, the only State 
that has not yet ratified the agreement on the 
establishment of the Centre, to establish the Centre as 
soon as possible. The Board also urges the 
Governments involved to consider including in that 
initiative Governments of other countries in West Asia 
and the Caucasus, in order to ensure greater 
cooperation in collecting, exchanging and analysing 
drug-related intelligence, organizing and coordinating 
joint international operations and carrying out other 
supply reduction efforts and training in West Asia.  
639. Countries in West Asia are working to establish 
the Gulf Centre for Criminal Intelligence in Doha. The 
Centre will serve as a focal point for international 
cooperation in the collection of information and 
development of intelligence to counter drug trafficking 
and other serious forms of organized crime. 
640. In a meeting held in Dubai, United Arab 
Emirates, the heads of drug control agencies from 
countries on the Arabian peninsula, as well as the 
Council of Arab Ministers of the Interior, adopted the 
Dubai statement on strategic planning and cooperation 
in the field of drug control, in which they expressed 
their commitment to more effective cooperation and 
coordination of drug control activities. 
641. Representatives of Afghanistan, Iran (Islamic 
Republic of) and Pakistan, the three countries of the 
Triangular Initiative, a framework for stopping drug 
trafficking from Afghanistan, held a meeting in Tehran 
in May 2008. The participants agreed to appoint border 
liaison officers on each of their countries’ borders to 
plan joint operations targeting the smuggling of opiates 
out of Afghanistan. The participants also announced 
that they would strengthen efforts to counter the illicit 
trade in precursor chemicals used in processing opium 
in and around Afghanistan. 
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642. Representatives of countries on the Arabian 
peninsula and in other subregions adopted the Tripoli 
action plan on combating trafficking in drugs and 
money-laundering through the mail. The action plan 
includes joint measures taken to combat drug 
trafficking and money-laundering through the 
international mail, as well as to develop human 
resources, awareness-raising and the role of the media 
in combating drug trafficking through the mail. 
Cooperation in carrying out the action plan was sought 
from private companies dealing with mail services. 
(For more information on this action plan, see 
paragraph 303 above.) 
643. With the assistance of UNODC, Israeli and 
Palestinian officials continued to explore methods of 
improving cooperation. A series of meetings of 
policymakers was held to review possibilities for 
cooperation within the framework of a declaration 
agreed upon in Cairo at the end of 2005. Arrangements 
and procedures have been established for strengthening 
joint efforts in the investigation of drug trafficking and 
related crimes. 
644. A meeting hosted by the Government of 
Turkmenistan led to the initiation of two international 
projects against drug trafficking in West Asia: the 
Caspian Sea initiative and the Turkmen border 
initiative. In particular, the Caspian Sea initiative aims 
to involve the entire region of West Asia in regional 
and international efforts focusing on strengthening 
analytical capacity, intelligence-sharing and 
information exchange in the region.  
645. Though most regional cooperation focused on 
law enforcement, there have been some important 
initiatives in demand reduction in West Asia. Demand 
reduction authorities from several countries in West 
Asia met with their counterparts from countries in 
Europe, WHO and the Pompidou Group of the Council 
of Europe, to develop a network linking national 
institutions to European centres of best practices in 
demand reduction. Within that framework, national 
workplans on drug abuse prevention, the treatment and 
rehabilitation of drug abusers, substitution treatment 
for opioid dependence, and drug abuse and HIV 
prevention and care in prison settings are being 
developed. UNODC organized study tours to enable 
authorities from Afghanistan, Jordan, Lebanon and 
several countries from outside of West Asia to view 
prevention services in prisons in the Islamic Republic 
of Iran. 
 
 3. National legislation, policy and action 
 
646. In March 2008, the Afghan parliament confirmed 
the appointment of a new Minister of Counter 
Narcotics, a post that had been vacant for seven 
months. 
647. Efforts to eradicate illicitly cultivated opium 
poppy in Afghanistan have continued to encounter 
difficulties. The main obstacle has been the lack of 
security. A total of 78 persons involved in the 
eradication efforts lost their lives during the harvesting 
season 2007/2008, a sixfold increase over the previous 
figure. The harvest season 2007/2008 also differed 
from previous ones in that most of the violence was 
caused by insurgent forces instead of farmers. In 2008, 
over 98 per cent of illicit opium poppy cultivation in 
Afghanistan took place in the southern and south-
western provinces, over which the Government has 
little control. In 2007, the figure was 85 per cent. 
However, though cultivation is limited to a small 
number of areas, the illicit drug trade is a nationwide 
scourge in Afghanistan.  
648. Corruption continues to be a serious problem in 
Afghanistan, hampering efforts to eradicate illicit 
opium poppy cultivation and to combat the illicit drug 
trade in general. The Government ratified the United 
Nations Convention against Corruption83 in December 
2007, and a new governmental body to oversee the 
implementation of the national anti-corruption strategy 
has been created. Some members of the Afghan 
security forces have been arrested for drug-related 
offences. There continue to be reports that even senior 
officials in the Government may be involved in the 
illicit drug trade. The Board urges the Government to 
take strong measures to fight corruption. 
649. The Board notes with concern that the operation 
of the Counter-Narcotics Trust Fund, which was 
created to conduct development programmes in 
provinces free of opium poppy or provinces in which 
opium poppy cultivation has decreased, remains 
problematic. The Board urges the Government and the 
international community to ensure that there is an 
adequate mechanism for funding the provision of 
__________________ 
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alternative, legitimate livelihoods for farming 
communities.  
650. The Government of Afghanistan has strengthened 
drug abuse prevention efforts, conducting awareness, 
motivation and counselling programmes for drug 
abusers and the general public. Drug abuse messages 
have also been incorporated into the curricula of 
schools, even primary schools. The Government, with 
the support of a number of organizations, has 
established 40 centres specialized in the treatment and 
rehabilitation of drug abusers in seven provinces. In 
spite of those efforts, illicit drugs are widely available 
and, as a result, drug abuse is on the rise. Strengthened, 
more concentrated efforts are necessary.  
651. The Islamic Republic of Iran, one of the countries 
most affected by the illicit trade in Afghan opiates, 
increased by nearly 50 percent the resources available 
for drug control in the year starting on 20 March 2008 
and, in particular, increased nearly fourfold the 
resources appropriated for drug abuse prevention. The 
Government has also continued to strengthen border 
control through the deployment of additional personnel 
and the erection of barriers and other border structures. 
652. The Governments of other countries in West Asia 
have also continued to strengthen their drug control 
efforts through the adoption of comprehensive plans 
and new legislation. The Government of Pakistan 
adopted a new drug control master plan covering the 
period 2008-2012. The master plan takes into account 
the impact of the worsening drug situation in 
Afghanistan and outlines both supply and demand 
reduction measures to be taken. On 30 November 
2007, the Government of Tajikistan approved a new 
national programme against drug abuse and trafficking, 
covering the period 2008-2012. The programme was 
developed by the Tajik Drug Control Agency together 
with other relevant Government ministries and 
agencies. On 30 April 2008, the National Assembly of 
Armenia adopted amendments to the Law of the 
Republic of Armenia on Narcotic Drugs and 
Psychotropic Substances, with a view to increasing the 
ability of law enforcement agencies to combat drug 
trafficking. 
653. A task force on demand reduction was established 
in Jordan, ensuring involvement of all the ministerial 
offices involved in formulating the community-based 
treatment and rehabilitation strategy in the country. 
The task force has secured a long-term commitment to 
the development and implementation of a national 
action plan and strategy to improve the capacity of 
community services and facilitated a mechanism for 
ensuring full coordination and participation of the 
relevant authorities and sectors. A national task force 
on opiate substitution therapy has also been established 
by the Government of Lebanon.  
654. The Government of Turkmenistan established the 
State Drug Control Service, a specialized drug control 
agency, in January 2008. The Board welcomes that 
move, which is in response to one of the 
recommendations of the Board following its last 
mission to that country in 2003. Turkmenistan was also 
granted observer status (a first step towards full 
membership) with the Financial Action Task Force on 
Money Laundering in late 2007. 
 
 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
655. There is a strong link between security conditions 
and illicit opium poppy cultivation. In the southern 
provinces of Afghanistan, security is weak and the 
overwhelming majority of villages are involved in 
illicit opium poppy cultivation. UNODC estimates that 
the Taliban armed opposition group has an annual 
revenue of between US$ 200 million and 300 million 
from a surcharge levied on the illicit drug trade.  
656. The eradication efforts in Afghanistan are being 
hampered by lack of security, poor planning and 
inadequate equipment and funding. Though the initial 
target for eradication had been set at 50,000 ha, the 
Government remained unable to provide adequate 
security for eradication efforts and eventually only 
5,480 ha were eradicated. Although the lack of security 
and capacity remain the main reasons for that drop in 
eradication, there has been an increase in the number 
of provinces that have become free of opium poppy 
and there have been more voluntary eradication efforts 
by farmers.  
657. Inadequate security, ineffective Government 
control and problems in ensuring the rule of law are 
major factors contributing to illicit crop cultivation in 
other countries in West Asia as well. Illicit opium 
poppy cultivation takes place in Pakistan. Though such 
cultivation in Pakistan is on a much smaller scale than 
in Afghanistan, it appears to be increasing. The 
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Government of Pakistan remains determined to 
eradicate illicit opium poppy cultivation, but most of 
that cultivation takes place in remote areas near the 
Afghan border, where the Government has difficulties 
in enforcing national laws.  
658. Illicit opium poppy cultivation in the Bekaa 
valley in Lebanon is also increasing, at least partly 
because of the unstable political and security situation 
that the country has been facing for several years.  
659. Another concern of the Board is the situation in 
West Asia with regard to the illicit cultivation of 
cannabis plants. Afghanistan is becoming an important 
producer of illicit cannabis; according to UNODC, 
70,000 ha of cannabis were illicitly cultivated in 
Afghanistan in 2007, compared with 50,000 ha in 2006 
and 30,000 ha in 2005. In June 2008, Afghan 
authorities seized 260 tons of cannabis resin in a single 
operation in the southern province of Kandahar. 
Cannabis plants are also illicitly cultivated in the 
Occupied Palestinian Territory, and such cultivation 
appears to be increasing in the Bekaa valley. Cannabis 
plants are also illicitly cultivated in many countries in 
Central Asia, and such cultivation is increasing in some 
countries. 
660. Significant drug seizures were made in 
Afghanistan, though those seizures were small in 
comparison with the amount of illicit drug production 
in the country. For example, police in the eastern 
Nangarhar province confiscated 4.7 tons of opium in a 
single operation in April 2008, and the Afghan border 
security agency seized 28 tons of opium in Afghanistan 
in 2007. Nevertheless, significant challenges remain, 
largely due to the security situation. For example, there 
is no border police in Helmand province, where most 
of the drugs are being trafficked. 
661. More opiates are seized in the Islamic Republic 
of Iran than in any other country in the world. Total 
drug seizures in that country in 2007 increased by 
51 per cent compared with 2006. The Government of 
the Islamic Republic of Iran estimates that 2,500 tons 
of opiates enter its territory from Afghanistan each 
year, 700 tons of which are destined for abuse in the 
Islamic Republic of Iran. The police manage to seize 
approximately 500 tons of opiates every year.  
662. Pakistan continues to be used as a major transit 
area for Afghan opiates, though to a lesser extent than 
the Islamic Republic of Iran. According to the 
Government of Pakistan, 35 per cent of opiates of 
Afghan origin are smuggled through its territory. In 
February 2008, authorities in Pakistan seized 4 tons of 
opium in a single operation in a mountainous area of 
the Pishin district.  
663. Official drug seizure data for Central Asian 
countries for the period 2000-2007 show that the peak 
in heroin seizures recorded in the period 2003-2004 
was followed by a relatively gradual downward trend. 
In 2007, a total of 3.3 tons of heroin were seized in the 
Central Asian countries. That constitutes only 3 per 
cent of the 128 tons believed to have been smuggled 
through Central Asia. Compared with 2006, total 
heroin seizures decreased slightly (by 9 per cent) in 
2007, in particular because of the significant decrease 
in heroin seizures in Tajikistan and Uzbekistan. In 
contrast, in Kyrgyzstan and Turkmenistan heroin 
seizures increased substantially in 2007, by over 60 per 
cent compared with 2006 in each country. Seizures of 
opium have increased significantly in many countries 
in Central Asia, indicating a possible shift in 
trafficking patterns. 
664. Jordan and the Syrian Arab Republic are used as 
trans-shipment points for drug trafficking. Cannabis 
from Lebanon is smuggled into Jordan, heroin is 
smuggled through the Syrian Arab Republic and then 
Jordan on its way to Israel and counterfeit Captagon 
tablets are smuggled through the Syrian Arab Republic 
and then Jordan on their way to countries on the 
Arabian peninsula.  
665. It appears that trafficking organizations are 
increasingly exploiting the situation in Iraq to smuggle 
drugs, mainly into countries on the Arabian peninsula. 
Seizures by the Government of Jordan near the Iraqi 
border have risen significantly in recent years, and 
there has been an overall increase in the smuggling of 
cannabis resin and opiates from Afghanistan through 
Iraq into Jordan. Drug trafficking in Yemen also 
appears to be increasing, as evidenced by more 
drug-related offences and seizures of illicit drugs, 
mainly cannabis. In August 2008, the authorities of the 
United Arab Emirates seized 202 kg of heroin, in what 
was the largest seizure of that drug on the Arabian 
peninsula. 
666. Cannabis continues to be the most commonly 
seized type of drug in Central Asia. This is partly 
attributable to the fact that cannabis plants grow wild 
in Kazakhstan and Kyrgyzstan. A total of 870 kg of 
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cannabis resin was seized in Central Asia in 2007, an 
increase of 30 per cent compared with 2006. The 
largest total amount of cannabis seized was reported in 
Kazakhstan and Kyrgyzstan.  
667. Reports indicate that, though cocaine is still 
abused only in small quantities, cocaine abuse may be 
making headway among members of the more affluent 
segments of society in some countries in West Asia. In 
2007, the law enforcement authorities in Kazakhstan 
seized a consignment of 555 grams of cocaine, the 
largest cocaine seizure ever made in that country. The 
cocaine had apparently been brought into the country 
from Germany, Lithuania and Poland via the Russian 
Federation.  
668. The large amount of opiates from Afghanistan in 
countries in West Asia continues to cause major drug 
abuse problems in those countries. Nearly all the 
countries neighbouring Afghanistan have a high rate of 
drug abuse; the Islamic Republic of Iran, for example, 
has the world’s highest rate of abuse for opiates; in that 
country, the estimated prevalence of abuse of opiates is 
2.8 per cent. Pakistan also has a high rate of abuse for 
opiates: the estimated prevalence of such abuse among 
the general population is 0.7 per cent. Many countries 
in Central Asia have a similar level of drug abuse, 
heroin abuse having replaced cannabis and opium 
abuse as the main drug problem.  
669. Despite high estimates of drug abuse, the 
Governments of many countries in West Asia, 
including the Islamic Republic of Iran, have not 
collected comprehensive data on drug abuse for some 
years. The Board encourages those Governments to 
conduct comprehensive surveys and rapid assessments 
of the drug abuse situation in their countries and to 
take effective measures in the area of demand 
reduction.  
670. One Government that has recently conducted 
such a survey is that of Pakistan. The results of the 
survey, which was conducted with the assistance of 
UNODC and reflects data collected in 2006, shows that 
there are some 640,000 persons in Pakistan who 
regularly abuse opioids (0.7 per cent of the adult 
population). Of those persons, 484,000, or 77 per cent, 
are believed to abuse heroin. The Board notes that, 
despite the massive increase in illicit opium production 
and heroin manufacture in neighbouring Afghanistan, 
the rate of abuse of heroin has remained relatively 
stable in Pakistan. However, that has been offset by the 
increase in the abuse of opium and other opiates in the 
country. The increase in drug abuse by injection is also 
a matter of concern; there are currently an estimated 
130,000 persons abusing drugs by injection in 
Pakistan, twice the number in 2000. There is an HIV 
epidemic among persons who abuse drugs by injection, 
the infection rate being approximately 11 per cent. 
671. Drug abuse in the Central Asian countries 
continues to increase. The prevalence of the abuse of 
opioids is estimated at 1.03 per cent in Kazakhstan, 
0.8 per cent in Kyrgyzstan, 0.6 per cent in Tajikistan 
and 0.8 per cent in Uzbekistan. Heroin is the main drug 
of abuse, injection being the main method used. The 
HIV/AIDS problem in Central Asia is growing faster 
than anywhere else in the world, needle-sharing among 
persons abusing drugs by injection being one of the 
key driving forces of the problem. Drug abuse by 
injection accounts for more than 60 per cent of total 
registered HIV cases in Central Asia. Reported HIV 
prevalence among persons abusing drugs by injection 
is highest in Uzbekistan (21 per cent), followed by 
Tajikistan (14.7 per cent), Kazakhstan (9.2 per cent), 
and Kyrgyzstan (8 per cent).  
672. Drug abuse remains a serious concern in 
Afghanistan, where an estimated 1.4 per cent of the 
population abuses opioids. The number of drug addicts 
in at least some provinces in Afghanistan, including 
provinces where opium poppy is no longer cultivated, 
continues to rise. Drug abuse by injection is increasing. 
HIV prevalence among persons abusing drugs by 
injection is reported to be 3 per cent. The lack of 
economic opportunities, the volatile security situation 
and the fact that many returning refugees became 
addicted to drugs in their host countries (Iran (Islamic 
Republic of) and Pakistan) have contributed to the 
worsening of the drug abuse situation in Afghanistan.  
673. The Government of the United Arab Emirates is 
strengthening its efforts in treatment, building more 
centres for the treatment and rehabilitation of drug 
abusers, particularly in the capital city. There are very 
little data on drug abuse in the United Arab Emirates, 
but the abuse of cannabis and heroin is an ongoing 
problem in that country. The Board encourages the 
Government to collect adequate data on trends in drug 
abuse and to strengthen its demand reduction efforts.  
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  Psychotropic substances 
 
674. Large amounts of counterfeit Captagon tablets 
continue to be smuggled into countries on the Arabian 
peninsula. Seizures of amphetamines have risen 
sharply in Saudi Arabia, suggesting a surge in the 
abuse of illicit stimulants in the country. Saudi Arabia 
accounted for 28 per cent of global seizures of 
amphetamines (all amphetamine-type stimulants 
excluding MDMA) in 2006, the latest year for which 
global data are available.  
675. The amount of Captagon seized in Turkey rose 
significantly in 2007 in comparison with 2005 and 
2006. Seizures of MDMA in Turkey decreased by 
nearly 30 per cent compared with 2006 – though the 
Government has indicated that the decrease may be 
partly attributable to inadequate cooperation with law 
enforcement agencies in neighbouring countries. The 
Government has reported a slight decrease in the abuse 
of MDMA in Turkey, largely as a result of information 
campaigns to increase public awareness of the harmful 
nature of the drugs.  
676. The Board is concerned about information on 
possible smuggling of methamphetamine through 
Afghanistan. There have been isolated reports in recent 
years of Iranian law enforcement authorities seizing 
methamphetamine near their country’s border with 
Afghanistan. Though there is no evidence yet to 
suggest that methamphetamine is being illicitly 
manufactured in Afghanistan, the Board urges the 
Government of Afghanistan and the international 
community to be on the alert for indications of such 
activity.  
  Precursors 
 
677. It appears that the illicit manufacture of heroin in 
Afghanistan has continued to increase. Authorities in 
the eastern province of Nangarhar announced in March 
2008 that, besides having seized more than 40 tons of 
opiates in 2007, they had also dismantled 
11 laboratories illicitly manufacturing heroin. The 
Board is seriously concerned that, though recent 
increases in the price of acetic anhydride on illicit 
markets in Afghanistan suggest that international 
precursor control efforts are having some impact, 
precursor chemicals, acetic anhydride in particular, 
continue to be available for the illicit manufacture of 
heroin in Afghanistan. All Governments are reminded 
that Afghanistan has no legitimate need for acetic 
anhydride. (For more information on international 
efforts in this area, see the 2008 report of the Board on 
the implementation of article 12 of the 
1988 Convention.)  
678. More than 3 tons of precursor chemicals used to 
manufacture heroin, including the chemicals 
ammonium chloride and sodium carbonate, were seized 
in Afghanistan in July 2008, within the framework of 
the UNODC-supported Targeted Anti-trafficking 
Regional Communication, Expertise and Training 
initiative. Five tons of acetic anhydride were also 
seized by the Government of the Islamic Republic of 
Iran in the southern city of Bandar Abbas. In 
March 2008, Pakistan authorities seized 14 tons of 
acetic anhydride at Karachi port; that seizure led to the 
seizure in the Republic of Korea of another 12 tons of 
the chemical near Seoul in July 2008. In March 2008, 
over 5,000 kg of sulphuric acid were seized in 
Kyrgyzstan. 
679. The total amount of acetic anhydride seized in 
Turkey increased nearly threefold in 2007 compared 
with 2006, though that increase was mainly attributable 
to a single controlled delivery operation that resulted in 
the seizure of over 12,000 litres of the substance.  
680. The Board is concerned that several countries in 
West Asia, in particular the United Arab Emirates, have 
become trans-shipment areas for large consignments of 
ephedrine destined for Africa and North America. The 
Board urges the Government of the United Arab 
Emirates to continue strengthening its efforts to 
address that problem, in particular by strengthening 
controls in the free trade zones in the country. 
 
 5. Missions  
 
681. The Board sent a mission to the United Arab 
Emirates in January 2008 to review with the 
Government its implementation of the international 
drug control treaties.  
682. The Board is concerned that the implementation 
of controls over drugs and precursor chemicals in the 
free trade zones in the United Arab Emirates continues 
to be met with difficulties. The Board reminds the 
Government of its obligations under the international 
drug control conventions and urges it to take adequate 
measures against drug trafficking in all areas under its 
jurisdiction, including the free trade zones. As the 
United Arab Emirates is a major exporting and 
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trans-shipping area for chemicals scheduled under the 
1988 Convention, the Government of that country is 
also encouraged to use the PEN Online system without 
further delay and to introduce controls over 
pharmaceutical preparations containing ephedrine or 
pseudoephedrine.  
683. The Board also notes that there are no 
comprehensive activities aimed at identifying the drug 
abuse situation in the United Arab Emirates. The Board 
recommends that the Government take specific 
measures to collect data on the extent and nature of the 
drug problem in the country.  
684. The Board appreciates the will of the Government 
of the United Arab Emirates to fight drug abuse and 
trafficking, and it notes in particular the progress 
achieved by the Government in the implementation of 
some of the recommendations made by the Board after 
its 1995 mission to that country. The Board encourages 
the Government to continue its efforts to strengthen 
drug control.  
 
 
 D. Europe 
 
 
 1. Major developments 
 
685. Cannabis is the most widely abused drug in 
Europe. According to the European Monitoring Centre 
for Drugs and Drug Addiction, about 71 million people 
aged 15-64 years have tried cannabis in their lifetime 
and about 7 per cent have used it in the past year.  
686. Europe remains the second largest market for 
cocaine in the world. Large consignments of the drug 
from South America are smuggled into Europe by sea, 
often through West African countries (see 
paragraphs 242-246 and 321-326 above). The 
smuggling of cocaine through Eastern European 
countries has significantly increased in the past few 
years. The total amount of cocaine seized in Eastern 
Europe increased dramatically in 2007, primarily as a 
result of one major seizure of 480 kg made by customs 
officers in the former Yugoslav Republic of 
Macedonia. The increasing number of shipments of 
cocaine from South America to countries in Eastern 
Europe is part of a new development in cocaine 
trafficking: more and more cocaine arriving in Western 
Europe is transported to Eastern Europe and then 
transported back to illicit markets in Western Europe 
via the Balkan route, the route traditionally used for 
trafficking in opiates.  
687. The heroin available on illicit markets in Europe 
originates in Afghanistan and has been smuggled into 
Europe along one of two major routes: the Balkan 
route; or the so-called “silk route”, via Central Asia 
into the Russian Federation and from there to countries 
in Europe. The Balkan route continues to be the main 
route used for smuggling heroin into Eastern Europe 
and onwards to Western Europe. The so-called northern 
Balkan route, passing through Turkey, Bulgaria, 
Romania, Hungary and then Austria, was used more 
frequently in 2007, as evidenced by the more than 
2.5 tons of heroin seized on that route. The so-called 
southern Balkan route, leading through Greece, 
Albania and then the former Yugoslav Republic of 
Macedonia to Italy, appears to have been used less 
often for drug trafficking in 2007 than in previous 
years.  
688. Europe remains the region with the second largest 
illicit market for opiates. In Eastern Europe, the illicit 
market for opiates has continued to expand. According 
to UNODC estimates, there are about 2 million abusers 
of opiates in Eastern Europe. The abuse of opiates 
remained stable or declined in Central Europe and 
Western Europe but was reportedly increasing in the 
Russian Federation and other countries in Eastern 
Europe, as well as in countries in South-Eastern 
Europe along the Balkan route. It appears that the 
abuse of heroin has become more widespread among 
younger drug abusers in Western Europe.  
689. Treatment for heroin abuse in residential 
facilities, formerly the predominant treatment for such 
abuse in many European countries, is less common 
today. Most treatment for drug abusers takes place on 
an outpatient basis. The enlargement of outpatient 
treatment networks has continued in recent years in 
Bulgaria, Estonia, Finland, Greece, Lithuania and 
Romania. About 53 per cent of the outpatient treatment 
clients are treated for the abuse of opiates and the rest 
are treated for the abuse of other drugs, in particular 
cannabis (22 per cent) and cocaine (16 per cent). The 
number of people seeking treatment for the abuse of 
drugs, in particular opiates, is higher in Eastern Europe 
than in Western Europe.  
690. The illicit manufacture of synthetic drugs in 
Central Europe and Eastern Europe continued to rise. 
According to UNODC, in 2006 the largest number of 
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dismantled laboratories illicitly manufacturing 
amphetamine was reported by the Russian Federation, 
accounting for 57 per cent of all the illicit drug 
laboratories dismantled in Europe. The majority of the 
laboratories illicitly manufacturing methamphetamines 
in the region were uncovered in the Czech Republic. 
Several other Eastern European countries, including 
Bulgaria, Lithuania, the Republic of Moldova,84 
Slovakia and Ukraine, also reported having dismantled 
laboratories that had been illicitly manufacturing 
synthetic drugs.  
691. The subregions of South-Eastern and Eastern 
Europe continued to be used as transit areas for 
consignments of acetic anhydride destined for 
Afghanistan, where it is used in the illicit manufacture 
of heroin. It is estimated that almost 80 per cent of the 
acetic anhydride required for illicit laboratories in 
Afghanistan is smuggled through countries in South-
Eastern and Eastern Europe (see paragraphs 157-158 
and 230-231 above). The Board encourages 
Governments to fully implement Security Council 
resolution 1817 (2008) in which the Council called on 
all Member States to increase cooperation in order to 
counter illicit drug production and trafficking in 
Afghanistan, including by strengthening the 
monitoring of the international trade in precursor 
chemicals, notably acetic anhydride.  
 
 2. Regional cooperation 
 
692. The Paris Pact expert round table for the Black 
Sea area was held in Bucharest from 9 to 11 July 2008. 
Participants in the round table discussed ways and 
means of actively supporting and utilizing existing 
communication and information networks (such as 
INTERPOL, the World Customs Organization, 
Europol, MAR-Info (the maritime traffic information 
system), the Black Sea Economic Cooperation 
Organization, GUAM and the Southeast European 
Cooperative Initiative Center) to achieve maximum 
law enforcement coverage of the routes used for 
trafficking in opiates originating in Afghanistan. The 
round table requested UNODC and other international 
entities to continue providing to law enforcement 
operations technical assistance utilizing the expertise 
and instruments already available.  
__________________ 
 84 Since 9 September 2008, “Republic of Moldova” has 
replaced “Moldova” as the short name used in the 
United Nations. 
693. In September 2008, the European Commission 
proposed a new European Union Drugs Action Plan for 
2009-2012, in which the following priorities are 
identified: (a) reducing the demand for drugs and 
raising public awareness; (b) mobilizing European 
citizens to play an active part; (c) reducing the supply 
of drugs; (d) improving international cooperation; and 
(e) improving the understanding of the problem. 
Following discussion with European Union member 
States, the European Council is expected to endorse the 
Action Plan by December 2008.  
694. Building on the success of the series of 
operations known as “Operation Channel” conducted 
since 2004, CSTO and the Federal Drug Control 
Service of the Russian Federation carried out the 
second stage of operation Channel 2007 in November 
and December 2007, with the participation of Armenia, 
Belarus, Kazakhstan, Kyrgyzstan, the Russian 
Federation, Tajikistan and Uzbekistan. The goal of the 
operation was to build a system of enhanced collective 
security to prevent trafficking in drugs from 
Afghanistan. During the operation, new drug 
trafficking routes leading from Central Asia to CSTO 
member States and to Europe were detected. 
Representatives of law enforcement agencies of 
Azerbaijan, China, Estonia, Iran (Islamic Republic of), 
Latvia, Lithuania, Turkmenistan, Ukraine, the United 
States and Uzbekistan participated in the operation as 
observers. The operation resulted in the seizure of 
27,815 kg of narcotic drugs, psychotropic substances 
and precursor chemicals, including 1,157 kg of heroin, 
8,573 kg of opium, 6,196 kg of cannabis resin, 
5,567 kg of cannabis herb, 709 kg of poppy straw, 
15 kg of cocaine and 35 kg of synthetic drugs, as well 
as over 2 tons of precursor chemicals. 
695. In Bulgaria, a new regional office of the 
European Cities against Drugs (ECAD) was opened in 
late 2007 in the city of Burgas. The aim of the office is 
to assist the member cities in the Balkan area in 
exchanging information and best practices regarding 
drug abuse prevention.  
696. In Bosnia and Herzegovina, the fifth Regional 
Conference of the ECAD Balkan network entitled 
“Local community in fight against drug abuse” was 
held in Sarajevo on 15 and 16 November 2007. 
Participating in the conference were officials from 
eight countries in the Balkan area, as well as national 
and international experts in scientific areas and in the 
E/INCB/2008/1  
 
102  
 
areas of social policy and law enforcement. The 
conference adopted a declaration in which it called for 
improved coordination between local authorities in 
drug abuse prevention, the treatment of addiction and 
the civil sector.  
697. The Board welcomes the holding of the Synthetic 
Drug Enforcement Conference in Nunspeet, the 
Netherlands, from 28 to 30 November 2007. The 
conference was hosted by the Government of the 
Netherlands. Represented at the conference were 
Australia, Belgium, China, France, Germany, the 
Netherlands, Romania, the Russian Federation, 
Sweden, the United Kingdom and the United States. 
Europol and the European Commission were also 
represented at the conference.  
698. The Board welcomes the activities of Experience 
and Mutual Assistance (EXASS Net), a European 
network of partnerships between stakeholders at the 
frontline level responding to drug problems, providing 
experience and assistance for intersectoral cooperation. 
EXASS Net is part of activities of the Pompidou Group 
of the Council of Europe. The third meeting of EXASS 
Net, held in Frankfurt, Germany, in May 2008, 
included visits to various institutions in the Frankfurt 
system for providing assistance to drug abusers, such 
as a heroin distribution clinic, a methadone clinic and a 
crisis centre.  
 
 3. National legislation, policy and action 
 
699. The Board is concerned that the Government of 
Bosnia and Herzegovina has still not established a 
body at the national level to coordinate the fight 
against illicit drugs, pursuant to the Law on Prevention 
and Suppression of the Abuse of Narcotic Drugs, 
which entered into force in 2006. The law calls for the 
creation of a national inter-ministerial committee and a 
national agency to develop, oversee and coordinate the 
national drug control strategy. The Board urges the 
Government to take the necessary measures without 
further delay to ensure that the inter-ministerial 
committee and the national agency are established and 
functioning properly and that the national drug control 
strategy is developed and implemented.  
700. In the Netherlands a ban on tobacco smoking in 
the catering industry went into effect in July 2008. The 
ban also affects the so-called “coffee shops”, where the 
sale and abuse of cannabis is tolerated, but not the 
smoking of tobacco. The Government of the 
Netherlands has informed the Board that the “coffee 
shops” are being provided with information for visitors 
about the risks of cannabis use and about ways to 
obtain help when cannabis use becomes a problem.  
701. The Board notes that the Home Secretary of the 
United Kingdom has recommended that cannabis 
should be reclassified, which would mean that cases 
involving cannabis would be subject to stricter law 
enforcement and harsher penalties. The decision 
reflects the fact that highly potent forms of cannabis 
(such as “skunk”) have become dominant in the illicit 
drug market of the United Kingdom. If approved by 
Parliament, reclassification would take effect from 
early 2009. In addition, the first edition of the new 
drug strategy of the United Kingdom was released in 
February 2008. While maintaining a single focus on 
illicit drugs, the new strategy places more emphasis 
than the previous 10-year strategy on families and 
communities. Priority will be given to providing 
effective treatment for those who are causing the most 
harm to community and family members, such as 
parents whose drug use may be putting their children at 
risk.  
702. In Ukraine, a new law on drug trafficking and 
abuse entered into force in January 2008. The new law 
defines the structure of legislation, principles of 
Government policies, general regulations on the 
control and distribution of licit drugs. In addition, the 
new legislation regulates a wide range of items, such as 
licensing requirements, lists of substances used in 
veterinary practice, the maximum allowed substance 
content in doses of medication, the quality of drugs 
crossing borders, manufacturing methods, the use of 
equipment, transport and the required documentation. 
The new law is expected to strengthen further control 
of the movement of narcotic drugs, psychotropic 
substances and precursors within the country.  
703. In November 2007, the Government of Finland 
adopted a resolution on cooperation regarding national 
drug policy for the period 2008-2011, which outlines 
measures the Government intends to undertake to 
address drug abuse. The measures are related to 
preventive work and early intervention; combating 
drug-related crime; the treatment of drug addiction and 
the “reduction of harm” from drug abuse; and 
intensifying the treatment of drug abuse in connection 
with criminal sanctions. 
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704. In France, a new Government plan for fighting 
illicit drugs and addiction was adopted in July 2008. 
The plan includes an outline of the priorities of the 
Government for the period 2008-2011. The current 
plan is based on the evaluation of the previous plan 
(covering the period 2004-2008) and is comprised of 
193 measures: 38 measures on prevention and 
communication, 41 on law enforcement, 69 on 
treatment and reduction of risks associated with drug 
abuse, 30 on training and research and 15 at the 
international level. A total of 87.5 million euros will be 
required to implement the plan over the four-year 
period 2008-2011.  
705. In January 2008, the Government of Italy adopted 
a new action plan on drugs that covers five areas: 
coordination; demand reduction; supply reduction; 
international cooperation and information; and 
training, research and evaluation. The plan includes 
66 measures to be implemented in 2008 and will be 
followed by a plan for the four-year period 2009-2012. 
706. In the Republic of Moldova, the national plan of 
action to prevent drug abuse and drug smuggling in the 
period 2007-2009 was adopted. The plan covers 
activities under the responsibility of the Ministry of the 
Interior and the Ministry of Health. In addition, the 
Penal Code, the Penal Procedural Code and the Code 
on Administrative (Minor) Offences have been 
amended by the Parliament to include judicial 
measures against drug trafficking and abuse, in 
conformity with the provisions of the 
1988 Convention.  
707. The Board welcomes the publication of the 
European Commission Eurobarometer survey on 
attitudes and perceptions about drug issues, involving 
more than 12,000 persons aged 15-24 in the European 
Union member States. The survey, published in 
May 2008, shows, inter alia, that while more than 
80 per cent of young people recognize the health risks 
associated with the use of heroin, cocaine and 
“ecstasy”, only 40 per cent of young people recognized 
the health risks associated with cannabis use. In the 
Czech Republic, young people believe that tobacco and 
alcohol use pose a slightly higher risk than cannabis 
use.  
708. The Board welcomes the publication of the Home 
Office Cannabis Potency Study 200885 in the United 
Kingdom in May 2008, which provides important 
information about the market share of different types 
of cannabis available and their potencies. The study 
shows that the share of all drug seizures accounted for 
by cannabis herb seizures has increased markedly in 
recent years. Most of the cannabis seized on the street 
by law enforcement authorities is cannabis herb. There 
appears to have been a decline in the prevalence of 
cannabis resin. 
709. The Board notes that in the evaluation of a 
project to establish a “drug injection room” in Norway 
it is stated that there is no evidence that the scheme has 
resulted in a reduction in drug overdose rates or 
fatalities. Also mentioned in the evaluation are 
important issues such as the fact that the drug injection 
room may contribute to the perpetuation of drug abuse 
and that health authorities might be perceived as 
condoning drug use. The Government has decided that 
the temporary act relating to a trial scheme for drug 
consumption rooms will remain in force until 
December 2009. The Board urges all Governments to 
refrain from establishing “drug consumption rooms” 
and to pursue alternative ways to increase access to 
health and social services, including services for the 
treatment of drug abusers.  
710. The Board notes the results of a new survey on 
the prevalence of drug abuse in Ireland and in Northern 
Ireland (in the United Kingdom), published in 2008. 
The survey shows that the proportion of adults 
(persons aged 15-64 years) who reported having used 
an illicit drug in their lifetime increased from 19 per 
cent in the period 2002-2003 to 24 per cent in the 
period 2006-2007. The proportion of young adults 
(persons aged 15-34 years) who reported having used 
an illicit drug in their lifetime also increased by 5 per 
cent, from 26 per cent in the period 2002-2003 to 
31 per cent in the period 2006-2007. More men than 
women reported having used an illicit drug in their 
lifetime. The prevalence of use at least once in a 
lifetime, as well as use in the past month, increased for 
both cannabis and cocaine. 
__________________ 
 85  Sheila Hardwick and Leslie King, Home Office Cannabis 
Potency Study 2008 (Sandridge, St. Albans, Home 
Office, 2008). 
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711. In the Netherlands, a new policy document 
entitled “Follow-up strategy on synthetic drugs from 
2007” has been adopted by the Government. The 
policy document calls for, among other things, the 
continuation of a drug abuse prevention project entitled 
“Nightlife and drugs”, coordinated at the national level 
by the Netherlands Institute of Mental Health and 
Addiction (Trimbos Instituut). The project targets 
clubbers and nightlife districts: a group of people and a 
type of district both known for the large-scale use of 
synthetic drugs. The project aims to limit the risks of 
drug use among clubbers by working with local 
authorities and “nightspots”.  
712. In July 2008, a task force aimed at reducing the 
large-scale cultivation of cannabis was launched in the 
Netherlands. The objective of the task force is to set up 
a programme that will achieve by 2011 a measurable 
reduction in the large-scale cultivation of cannabis in 
the Netherlands. In addition, the task force is to 
provide more information about the criminal 
organizations behind the illicit cultivation of cannabis, 
their operating procedures and their profits. The 
establishment of the task force was announced in the 
policy programme on strengthening the approach to 
organized crime that was submitted to the parliament 
in December 2007. 
713. The Government of Belarus and UNODC signed 
a memorandum of understanding on drug control and 
crime prevention in January 2008. The agreement sets 
out strategic areas of cooperation in fighting 
international crime and trafficking in illicit drugs and 
establishes a basis for the expansion of UNODC 
activities in Belarus.  
 
 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
714. The illicit cultivation of cannabis continues to be 
reported in many countries in Western Europe, such as 
Germany, where large-scale cannabis cultivation areas 
have been seized. In Eastern and Central Europe, most 
of the cannabis herb originates in Albania, 
Montenegro, the Republic of Moldova, Serbia, the 
former Yugoslav Republic of Macedonia and Ukraine. 
Reports from Albania indicate that cannabis plants are 
being cultivated on public land. Europe is the region 
with the largest illicit market for cannabis resin. The 
amount of cannabis resin seized in Europe increased in 
2007 after having declined in 2006. In 2007, as in the 
previous year, more cannabis resin was seized in Spain 
than in any other country in the world. A large amount 
of cannabis resin was also seized in Belgium, France 
and Portugal.  
715. Cannabis continues to be the most widely abused 
drug in Europe. In European countries, lifetime 
prevalence of cannabis abuse ranges from 2 to 37 per 
cent, the lowest rates being in Bulgaria, Malta and 
Romania and the highest rates being in Denmark, 
France, Italy and the United Kingdom. The prevalence 
of cannabis abuse in the past year is about 7 per cent 
among European adults (persons aged 15-64). National 
estimates of the prevalence of cannabis abuse in the 
past year range from 1 to 11 per cent, the lowest rates 
being in (listed in ascending order) Bulgaria, Greece 
and Malta and the highest rates being in (listed in 
ascending order) the Czech Republic, Spain and Italy. 
The prevalence of cannabis abuse is disproportionately 
high among young people. Lifetime prevalence of 
cannabis abuse among schoolchildren aged 15-16 is 
highest in (listed in ascending order) Belgium, the 
Czech Republic, Ireland, Spain, France and the United 
Kingdom, where the rate ranges from 30 to 44 per cent 
and is lowest in (listed in ascending order) Norway, 
Sweden, Romania, Cyprus and Greece, where the rate 
is less than 10 per cent.  
716. There are indications that the abuse of cannabis is 
stabilizing or declining at a fairly high level. In the 
United Kingdom, the prevalence of cannabis abuse 
among pupils in England decreased significantly 
between 2001 (13.4 per cent) and 2007 (9.4 per cent). 
Between 2004 and 2007, lifetime prevalence of 
cannabis abuse fell in Germany as well; however, the 
number of cannabis abusers was estimated at 600,000 
in 2007, a significant increase compared with the 1997 
figure. In France, about 1.2 million persons abuse 
cannabis on a regular basis (at least 10 times a month). 
717. In Europe, the total amount of cocaine seized 
continues to be high. Europe’s share of global cocaine 
seizures rose from less than 3 per cent in 1980 to 
17 per cent in 2006. It is likely that less cocaine will be 
reported to have been seized in 2007, as Portugal, one 
of the main gateways for cocaine entering Europe, has 
reported a significant decrease in cocaine seizures. 
Similarly, effective action taken to prevent the use of 
couriers in cocaine trafficking at the international 
airport at Amsterdam, once a major gateway for 
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cocaine entering the region, has resulted in fewer 
seizures of that substance. According to the 
Government of the Netherlands, 9,084 kg of cocaine 
were seized by customs authorities in 2006. In 2007, a 
single seizure of 480 kg of cocaine originating in the 
Bolivarian Republic of Venezuela was made in the 
former Yugoslav Republic of Macedonia. Another large 
seizure of 118 kg of cocaine from Colombia was made 
by Polish customs authorities. The increased number of 
shipments of cocaine from South America to countries 
in Eastern Europe in recent years is part of a new 
development: cocaine arriving in Western Europe is 
increasingly being smuggled into Eastern Europe and 
then back into Western Europe via the Balkan route.  
718. Cocaine abuse has become more prevalent in 
some parts of Western Europe. Lifetime prevalence of 
cocaine in France is 2.6 per cent among the adult 
population (persons aged 15-64) and has more than 
doubled over the past 10 years. Lifetime prevalence of 
cocaine abuse is highest (4.1 per cent) among young 
adults (persons aged 25-34). Annual prevalence of 
cocaine abuse tripled between 2000 and 2005 among 
the general population: the number of people who 
abuse cocaine is currently estimated at 250,000. In 
Spain, however, results of a national survey of drug 
abuse among students show that the lifetime, annual 
and monthly prevalence of cocaine abuse among 
students in secondary schools has decreased 
significantly.  
719. Almost all the heroin available on the illicit drug 
markets in Europe originates in Afghanistan. The 
traditional (northern) Balkan route, passing through 
Turkey, Bulgaria, Romania, Hungary and then Austria, 
was used more frequently in 2007, as evidenced by the 
fact that more than 2.5 tons of heroin were seized on 
that route. The alternative (southern) Balkan route, 
leading through Greece, Albania, and then the former 
Yugoslav Republic of Macedonia to Italy, appears to 
have been used less often for drug trafficking in 2007 
than in previous years. With opium production shifting 
towards the southern provinces of Afghanistan, it has 
become less convenient for traffickers to ship opiates 
via the so-called “silk route”; therefore, drug 
trafficking along that route has declined. In 2007, less 
than 1 ton of heroin was identified as having been 
smuggled into Europe on the “silk route”; that 
represents a decrease compared with the amounts 
seized in previous years. Train connections between 
the Russian Federation and its western neighbouring 
countries Belarus, Poland and Ukraine are increasingly 
being used for smuggling heroin into Western Europe. 
Reports indicate that heroin is increasingly being 
trafficked by air from countries in Eastern and Central 
Europe to countries in Western Europe.  
720. In Europe, major seizures of heroin were reported 
in Bulgaria (more than 1 ton), the Russian Federation 
(934 kg) and Serbia (225 kg). An increase in heroin 
seizures was reported in some countries in Western 
Europe such as Germany and Spain. 
721. Most of the laboratories illicitly producing 
opiates continue to be located in Eastern Europe. 
According to the Government of the Russian 
Federation, of the 3,717 laboratories illicitly producing 
and processing narcotic drugs and psychotropic 
substances dismantled in that country in 2006, 
186 were used for the illicit production of acetylated 
opium from limited quantities of locally produced 
poppy straw. In Moldova,86 112 laboratories illicitly 
producing opiates were dismantled in 2006. 
722. For several years, the abuse of heroin and other 
opiates has been stagnant or declining in Western 
Europe. In Italy, for example, heroin abuse has 
continually declined since 2001. However, it now 
appears that heroin abuse could become more 
widespread. In the Netherlands, the lifetime prevalence 
of heroin abuse increased between 1997 and 2005, 
indicating greater interest in experimenting with the 
drug. In France, the abuse of heroin has begun to 
emerge among younger and more socially integrated 
segments of the population. The methods used for 
heroin abuse tend to vary: sniffing is more common 
and polydrug abuse is very frequent. Increasing 
trivialization of the consequences of heroin abuse 
appears to play a part in the abuse as the real dangers 
of the drug are poorly understood. Rising levels of 
abuse of opiates have been reported in countries in 
Eastern Europe, particularly in CIS member States and 
in countries in South-Eastern Europe along the Balkan 
route. According to UNODC, the number of people in 
Eastern Europe who abuse opiates is estimated to be 
about 2 million, or about 1.4 per cent of the population 
aged 15-64.  
__________________ 
 86  Since 9 September 2008, “Republic of Moldova” has 
replaced “Moldova” as the short name used in the 
United Nations. 
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723. According to the Government of the Russian 
Federation, in 2007 the number of persons newly 
registered for drug abuse treatment was 37,560; 
87.7 per cent of the total number of patients were 
registered for treatment for the abuse of opiates. In 
2007, of the total number of patients in treatment for 
drug abuse, 11.9 per cent were infected with HIV, a 
slight increase compared with the figure for 2006 
(11.8 per cent). Drug abuse by injection continues to be 
the main route of transmission of HIV infection in the 
Russian Federation. 
724. The Russian Federation is the largest illicit 
market for opiates in Europe. According to the 
UNODC World Drug Report 2008, as many as 
1.65 million people in the Russian Federation abuse 
opiates.87 The second largest illicit market for opiates 
in Eastern Europe is in Ukraine, where more than 
300,000 people abuse opiates. 
725. The increased drug trafficking and abuse in 
Eastern Europe in recent years have led to an increase 
in the spread of HIV/AIDS. According to UNAIDS, 
nearly three out of four (73.8 per cent) of the registered 
drug addicts in the Russian Federation abuse drugs by 
injection, which is also the main mode of HIV 
transmission in the country. In the Russian Federation, 
the proportion of persons who abuse drugs by injection 
among the general population (persons aged 15-44) is 
estimated at 2 per cent. According to UNAIDS, in 2007 
about two thirds (66 per cent) of newly registered HIV 
cases were attributable to drug abuse by injection. 
726. The HIV/AIDS epidemic in Ukraine is now more 
severe than in any other country in Europe: the 
prevalence of HIV/AIDS infection among the adult 
population is estimated to be 1.63 per cent. The 
number of reported cases of HIV infection among 
persons who abuse drugs by injection has continued to 
increase in Ukraine in the past few years. The most 
serious drug abuse problem in Ukraine is the abuse by 
injection of concentrate of poppy straw (called 
“shyrka”): it is used by 98 per cent of all persons who 
abuse drugs by injection. Needle-sharing, a common 
practice among drug abusers, has contributed to the 
spread of HIV/AIDS infection. According to estimates 
of the Government of Ukraine, there are more than 
500,000 registered drug abusers in the country, 
__________________ 
 87  World Drug Report 2008 … . 
including about 300,000 persons who abuse opiates by 
injection.  
727. Estonia has the second highest prevalence of HIV 
infection in Europe: it is estimated that 1.4 per cent of 
the adult population is infected with HIV. The HIV 
epidemic in that country is mainly driven by drug 
abuse by injection, a behaviour that is widespread 
among the prison population. In 2007, more than 
12 per cent of all prison inmates in Estonia were HIV 
positive.  
 
  Psychotropic substances  
 
728. Western Europe continues to be a major source of 
amphetamine-type stimulants, particularly MDMA. 
According to UNODC, Belgium and the Netherlands 
are the main countries exporting amphetamine and 
substances in the MDMA group. However, as MDMA 
is increasingly being illicitly manufactured in other 
parts of the world, seizures of MDMA in Western 
Europe have declined. In Western Europe, most 
seizures of MDMA are reported in France, Germany, 
the Netherlands and the United Kingdom. The main 
source of methamphetamine illicitly manufactured in 
Western Europe is the Czech Republic, which also 
reported the largest number of dismantled laboratories 
illicitly manufacturing that substance. The United 
Kingdom has the largest illicit market for 
amphetamine. However, annual prevalence of 
amphetamine abuse among the general population 
(persons aged 16-59) decreased significantly, from 
3.2 per cent in 1996 to 1.3 per cent in 2006. Similarly, 
Sweden has witnessed a significant decrease in 
amphetamine abuse over the past 20-30 years with the 
annual prevalence rate at 0.2 per cent, less than half the 
European average. Past-year prevalence of abuse of 
MDMA among young adults has remained largely 
stable over the past five years in the European Union.  
 
  Precursors 
 
729. Countries in Eastern Europe continued to be used 
as transit areas for consignments of acetic anhydride 
destined for Afghanistan, where the substance is used 
in the illicit manufacture of heroin. It is estimated that 
almost 80 per cent of the precursor chemicals required 
for illicit drug laboratories in Afghanistan is smuggled 
through countries in South-Eastern and Eastern 
Europe.  
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730. Seizures of precursors of amphetamine in Eastern 
European countries have increased in the past few 
years. According to UNODC, in 2006, major seizures 
of the precursor P-2-P were reported in Poland 
(1,085 litres), the Russian Federation (402 litres), 
Estonia (51 litres) and Bulgaria (32 litres).  
 
 5. Missions 
 
731. A mission of the Board visited Romania in 
October 2008. The Board notes that there has been 
some improvement and greater commitment by the 
Government in its efforts to fulfil the objectives of the 
international drug control treaties. Progress has been 
made in the Government’s efforts to address the drug 
problem in the country, and the Government’s 
cooperation with the Board has improved since the 
2002 mission of the Board to that country. The Board 
notes that Romania has taken some steps in recent 
years to strengthen its drug control efforts, but a 
number of problems continue to exist in that area. 
732. In particular, the Board notes that in Romania the 
existing mechanism for the monitoring and control of 
internationally controlled substances is neither 
sufficient nor functioning adequately. The Board 
requests the Government to take steps to put in place 
legislation, as well as to provide resources and trained 
personnel, to enable all drug regulatory authorities, 
especially the Ministry of Health, to perform their 
control functions. Moreover, with regard to efforts by 
the Government to address the challenge of the 
smuggling of drugs through its territory, the Board 
encourages the Government to further strengthen 
customs and border control activities to prevent such 
trafficking, for example, through capacity-building and 
increasing the allocation of resources to such activities. 
733. The Board notes that the availability of opioids 
for the treatment of pain does not appear to meet the 
requirements of the population in Romania. The Board 
urges the Government to accurately determine the 
national medical and/or scientific requirements for 
narcotic drugs and psychotropic substances and to take 
all steps necessary, including the provision of 
education and training to staff, to ensure that those 
substances are available for medical purposes. 
734. A mission of the Board visited Ukraine in 
May 2008. The Board notes the commitment of the 
Government to the objectives of the international drug 
control conventions. Progress has been made in the 
Government’s efforts to address the drug problem. 
Administrative steps have been taken to ensure the 
implementation of the provisions of the conventions. 
Ukraine has adopted comprehensive drug control 
legislation and developed a national drug control 
strategy. Although a mechanism has been established to 
coordinate efforts to fight drug trafficking, problems 
continue to exist, largely because of lack of 
cooperation among authorities involved in drug 
control.  
735. The transit traffic in heroin and cocaine poses 
serious drug control problems for Ukraine, particularly 
with regard to the increasing influence of organized 
transnational crime on drug trafficking both in and 
through Ukraine. The Board is of the opinion that that 
development requires effective inter-ministerial 
coordination at the policy level, as well as at the 
operational level. The Board recommends that the 
Government should clearly define the lines of 
responsibility between the various law enforcement 
agencies and improve the coordination of their 
activities.  
736. The intravenous abuse of acetylated opium made 
of locally produced poppy straw is the most serious 
drug abuse problem in Ukraine. As needle-sharing is 
practised among drug abusers, it has contributed to the 
increase in HIV/AIDS infection in Ukraine. The Board 
urges the Government to prevent the diversion of 
poppy straw from farms licensed for cultivating opium 
poppy. The Board encourages the authorities of 
Ukraine to develop, if necessary with the help of WHO 
and UNODC, a consolidated approach towards drug 
abuse prevention and treatment programmes. Long 
waiting lists and the increasing rate of HIV/AIDS 
infection indicate that the treatment programmes 
presently offered are not sufficient and that the 
treatment facilities urgently need to be expanded to 
respond to those problems. 
 
 
 E. Oceania 
 
 
 1. Major developments 
 
737. A recent increase in drug smuggling from Canada 
to Australia has been noted. Australian law 
enforcement officials reported having seized cocaine, 
MDMA and methamphetamine from a sea cargo 
consignment originating in Canada. Law enforcement 
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authorities in the United States also seized cocaine, 
MDMA and methamphetamine from a sea cargo 
consignment originating in Canada and destined for 
Australia. While the source country for the majority of 
seizures of methamphetamine in New Zealand 
continued to be China, a recent increase in trafficking 
in that substance from Canada was also noted. 
738. While comprehensive seizure data for Australia 
and New Zealand are available, limited data are 
available for other countries in Oceania. However, 
illicit substances including cannabis, cocaine, heroin 
and precursor chemicals were seized in Fiji, Papua 
New Guinea and Vanuatu during 2007, confirming 
concerns that countries in Oceania other than Australia 
and New Zealand are also vulnerable to drug 
trafficking. 
739. Australia reported a significant increase in 
seizures of cocaine in the period 2006-2007, compared 
with the period 2005-2006. Australia also reported an 
increase in seizures of paramethoxyamphetamine 
(PMA): six seizures were reported in 2007, compared 
with only two confirmed seizures prior to that year. In 
addition, a clandestine PMA laboratory was dismantled 
in the Australian State of New South Wales in 2007. 
 
 2. Regional cooperation 
 
740. The Pacific Islands Forum continued to bring 
countries in Oceania together to address drug control 
issues. Australia and New Zealand remained active in 
supporting capacity-building initiatives in drug control 
in the region. 
741. At the thirty-eighth Pacific Islands Forum, held in 
Nuku’alofa in October 2007, participants directed 
relevant national and regional organizations and 
regional law enforcement secretariats to strengthen the 
collection and exchange of law enforcement 
information to combat national and transnational 
organized crime, including drug trafficking. The annual 
meeting of the Regional Security Committee of the 
Pacific Islands Forum was held in Suva in June 2008. 
742. The Micronesia Regional Transnational Crime 
Unit, an initiative involving Australia, the Micronesia 
(Federated States of) and the United States, was 
launched in April 2008. The Unit, located in Pohnpei, 
Federated States of Micronesia, focuses on issues such 
as drug trafficking and will allow regional law 
enforcement authorities to share intelligence. The Unit 
is linked to a network of transnational crime units in 
Fiji, Papua New Guinea, Samoa, Tonga and Vanuatu. 
Cooperation under that network has led to the seizure 
of 55 kg of cannabis that were being smuggled 
between Fiji and Tonga. 
743. Law enforcement authorities in Australia and 
New Zealand provided ongoing support to a 
programme of sniffer dogs, trained to detect drugs, in 
Samoa. In an effort to combat the growing drug 
problem in Samoa, Australia and New Zealand each 
provided a sniffer dog to their Samoan counterparts in 
May 2007. In Australia from February to April 2007, 
Samoan law enforcement authorities were given 
specialized training on handling sniffer dogs and on 
safely handling drugs. Sniffer dog teams were trained 
to search people, baggage and cargo at the international 
airport, seaport and post office in Apia. 
744. The third regional workshop of the Pacific Drug 
and Alcohol Research Network was held in Suva in 
July 2008. Participants discussed collaborative 
research opportunities among health, law enforcement 
and social research professionals in Oceania and shared 
experiences in the use of rapid assessment 
methodologies for collecting data on drug abuse. 
 
 3. National legislation, policy and action 
 
745. In May 2008, the Government of Australia 
endorsed the national strategy on amphetamine-type 
stimulants, which encompasses a comprehensive 
approach to addressing problems associated with the 
abuse of amphetamine-type stimulants and 
recommends action in the areas of prevention, supply 
reduction and improved access to treatment. The 
Government also endorsed a National Corrections 
Drug Strategy for the period 2006-2009, which 
provides a framework for coordinated, integrated 
action to address drug-related issues for adults and 
juveniles in correctional facilities. The objective of the 
strategy is to promote and enforce laws, policies and 
practices that detect and reduce the smuggling of drugs 
into correctional and community-based facilities and 
services, prevent and reduce drug abuse among adult 
and juvenile offenders and increase access to a range of 
prevention and treatment services for adult and 
juvenile offenders. 
746. In Australia in February 2008, the Parliament of 
Queensland enacted the Drugs Misuse Amendment Act 
2008, which amends the Drugs Misuse Act 1986 and 
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the Drugs Misuse Regulation 1987. MDMA and PMA 
were rescheduled, so that the maximum penalty for the 
unlawful possession and supply of and trafficking in 
those drugs was increased from 20 to 25 years of 
imprisonment. Ephedrine was also rescheduled; as a 
result, the maximum penalty for the unlawful 
possession and supply or trafficking increased to 
20 years of imprisonment from two years of 
imprisonment for possession and five years for the 
unlawful supply of or trafficking in that substance. The 
illicit manufacture and supply of substances such as 
pseudoephedrine or methamphetamine were included 
in the 2008 act as new offences, as was the possession 
of equipment, such as tablet presses, used in the illicit 
production of drugs.  
747. The Australian customs authorities established 
Project Stridor as a pilot project in 2006 and 2007 to 
test the benefits of having a multidisciplinary law 
enforcement team involved in combating the emerging 
threat of precursor chemicals in Australia. Australian 
customs officers involved in intelligence, 
investigations and enforcement activities were brought 
together to monitor and track the trade in selected 
commodities through the Internet. The Australian 
customs authorities cooperated with their counterparts 
in the United Kingdom and utilized software developed 
by the customs authorities of the Netherlands. As a 
result of the exercise, two significant consignments of 
precursor chemicals were detected. 
748. In January 2008, 100 people formerly involved in 
the illicit cultivation, sale and use of cannabis in Simbu 
Province, Papua New Guinea, gave public testimony of 
how they became involved in such illicit activities and 
promised to assist law enforcement authorities in 
preventing others from becoming involved in such 
activities. 
 
 4. Cultivation, production, manufacture, 
trafficking and abuse 
 
  Narcotic drugs 
 
749. Cannabis continued to be illicitly cultivated 
throughout Oceania. According to UNODC, Australia 
is the largest producer of cannabis herb in the region.88 
750. Fiji reported a significant decrease in the number 
of cannabis plants that were eradicated during 2007, 
__________________ 
 88 World Drug Report 2008 … . 
when 1,353 plants were eradicated compared with 
8,542 plants in 2006. 
751. In June 2007, the Australian customs authorities 
at Perth Airport seized 3.5 kg of heroin from a 
passenger arriving from Malaysia. In December 2007, 
Australian customs officers seized heroin from two 
passengers arriving from Dubai, United Arab Emirates. 
In February 2008, Australian law enforcement 
authorities found 28 kg of heroin in a sea cargo 
consignment that had arrived in Sydney; and in 
August 2008, customs officers at Melbourne Airport 
reported having seized 2 kg of heroin from a passenger 
arriving from Thailand.  
752. States in Oceania continue to report seizures of 
cocaine. Australia reported the seizure of 634 kg of 
cocaine in the period 2006-2007, compared with 46 kg 
in the period 2005-2006. An additional 610 kg of 
cocaine were seized at the Australian border in the 
period 2006-2007, more than seven times the amount 
seized in the period 2005-2006 (83 kg). Although 
parcel post continued to be the preferred method of 
smuggling cocaine into Australia, a recent increase in 
smuggling by sea cargo was noted. In March 2008, 
Australian law enforcement authorities in Sydney 
reported having seized 250 kg of cocaine concealed in 
a sea cargo container originating in South-East Asia. In 
July 2008, law enforcement authorities in Australia 
seized 150 kg of cocaine hidden in a shipping container 
that had arrived in Melbourne. In June 2008, Australian 
law enforcement authorities reported having seized 
124 kg of cocaine that had been concealed in a sea 
cargo consignment originating in Canada. 
753. Cannabis continued to be the most abused drug in 
Oceania. A particularly high incidence of abuse was 
reported in Australia, Micronesia (Federated States of), 
New Zealand and Papua New Guinea. According to a 
recent study carried out by the National Centre for 
Education and Training on Addiction89 of Australia, 
cannabis is the most commonly abused illicit drug 
among schoolchildren aged 12-17 years in Australia; 
3.4 per cent of all students surveyed regularly abused 
cannabis. Nonetheless, the annual prevalence of 
cannabis abuse among the Australian population aged 
14 and above has gradually decreased from its high 
__________________ 
 89 Ann M. Roche and others, Drug Testing in Schools: 
Evidence, Impacts and Alternatives (Canberra, 
Australian National Council on Drugs, 2008). 
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level of 17.9 per cent in 1998 to 12.9 per cent in 2001, 
11.3 per cent in 2004 and 9.1 per cent in 2007. In 
contrast, the annual prevalence of cocaine abuse in 
Australia for the same age group increased from 
0.5 per cent in 1993 to 1.6 per cent in 2007,90 the 
highest prevalence recorded for that substance in all 
surveyed years. 
 
  Psychotropic substances 
 
754. In Australia and New Zealand, amphetamine-type 
stimulants continued to be supplied predominantly by 
clandestine manufacturers operating in those countries. 
However, the fact that methamphetamine and tablets 
made of a combination of MDMA and 
methamphetamine were also regularly seized at those 
countries’ borders indicates that amphetamine-type 
stimulants are also being smuggled into Oceania. 
755. In 2007, the Australian customs authorities seized 
4 kg of amphetamine from a postal shipment 
originating in Thailand. In August 2007, customs 
authorities in New Zealand seized 17 kg of 
methamphetamine. In November 2007, New Zealand 
law enforcement authorities at the Port of Tauranga 
reported having seized 32 kg of methamphetamine that 
had been concealed in a sea cargo consignment 
originating in China. In January 2008, Australian law 
enforcement authorities in Sydney reported having 
seized 28 kg of amphetamine that had been hidden in 
an air cargo consignment originating in Lithuania. In 
June 2008, Australian law enforcement authorities 
reported having seized 66 kg of methamphetamine that 
had been concealed in a sea cargo consignment 
originating in Canada.  
756. Significant quantities of MDMA continued to be 
seized in Oceania. In a single seizure in 2007, 4.4 tons 
of MDMA were seized from a shipping container that 
had arrived in Melbourne, Australia. That was almost 
the same as the total amount of MDMA seized 
worldwide in 2006: 4.5 tons. In June 2008, Australian 
law enforcement authorities reported having seized 
121 kg of MDMA that had been concealed in a sea 
cargo consignment originating in Canada. In 
May 2008, customs authorities in Perth, Australia, 
reported having seized, in a clandestine laboratory, 
__________________ 
 90 Australian Institute of Health and Welfare, 2007 
National Drug Strategy Household Survey: First Results, 
Drug Statistics Series No. 20 (Canberra, April 2008). 
45 kg of MDMA and equipment for manufacturing 
tablets. In February 2007, the Australian customs 
authorities at Brisbane Airport reported having seized 
80,000 MDMA tablets in parcels originating in the 
United Kingdom. Following an investigation that 
lasted 12 months, law enforcement authorities in 
Australia uncovered an international drug smuggling 
syndicate, leading to the arrest of 22 persons.  
757. While the incidence of abuse of amphetamines 
among the Australian population aged 14 and above 
declined from 3.7 per cent in 1998 to 2.3 per cent in 
2007,91 abuse of MDMA surpassed that of other 
amphetamine-type stimulants, making it the second 
most abused substance in Australia and New Zealand. 
In contrast to the general decline in drug abuse in 
Australia, the annual prevalence of abuse of MDMA 
among persons in the same age group increased from 
0.9 per cent in 1995 to 3.5 per cent in 2007. The annual 
prevalence of abuse of MDMA among persons aged 
15-45 years in New Zealand was 2.6 per cent. 
 
  Precursors 
 
758. States in Oceania continued to report seizures of 
ephedrine and pseudoephedrine, substances frequently 
used in the illicit manufacture of amphetamine-type 
stimulants. Traffickers attempted to smuggle large 
amounts of the substances in air and sea cargo and 
smaller amounts through the postal system. In 
July 2008, Australian law enforcement authorities 
seized 850 kg of pseudoephedrine, one of the largest 
seizures of the substance reported in that State to date. 
The substance was concealed in three sea cargo 
consignments that had arrived in Port Botany, Sydney, 
from Thailand. During 2007, reported seizures of 
ephedrine tablets totalled 167 kg in Australia and 
0.5 kg in New Zealand, and reported seizures of 
pseudoephedrine totalled 266 kg in Australia and 
155 kg in New Zealand. 
759. In December 2007, the customs authorities at the 
New Zealand International Mail Centre reported 
having seized 14.9 kg of ephedrine concealed in two 
packages originating in India and 2.1 kg of 
pseudoephedrine concealed in a parcel originating in 
Singapore.  
760. While most of the pseudoephedrine continued to 
be smuggled into Australia and New Zealand from East 
__________________ 
 91 Ibid. 
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Asia and South-East Asia, in June 2008 law 
enforcement authorities at Sydney Airport seized 45 kg 
of pseudoephedrine that had been concealed in an air 
cargo consignment originating in Lebanon. In 
November 2007, law enforcement authorities at the 
Port of Tauranga, New Zealand, reported having seized 
127 kg of pseudoephedrine that had been concealed in 
a sea cargo consignment originating in China. In 
December 2007, the Australian customs authorities at 
Sydney seized 105 kg of pseudoephedrine that had 
been hidden in an air cargo consignment originating in 
Cambodia. In December 2007, law enforcement 
authorities in New Zealand seized 44.8 kg of 
pseudoephedrine that had been concealed in a sea 
cargo consignment originating in China.  
761. In July 2008, law enforcement authorities in New 
South Wales, Australia, reported having seized 12.6 kg 
of pseudoephedrine and equipment that had 
purportedly been used in the illicit manufacture of 
methamphetamine in a private residence. 
 
  Substances not under international control 
 
762. Seizures of substances not under international 
control continued to be reported in Oceania. In 2007, 
Australian customs authorities seized 45 consignments 
of GBL, a precursor of GHB, totalling approximately 
68 litres. The primary method of transportation 
continued to be through the postal system. Sixty per 
cent of the seized consignments originated in the 
United Kingdom. In July 2008, Australian customs 
officers in Sydney intercepted a consignment of GBL 
that had been shipped without the required import 
permit. The Australian Federal Police searched the 
premises of the office of the importer and found 
3,000 litres of GBL. 
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 IV. Recommendations to Governments, the United Nations and other 
relevant international and regional organizations 
 
 
763. In accordance with its mandate, the Board 
monitors the application of the international drug 
control treaties. On an ongoing basis, the Board 
examines the functioning of the international drug 
control regime at the national and international level 
and identifies shortcomings. Based on its analysis, the 
Board makes recommendations to Governments and 
international and regional organizations.  
764. In the present chapter, the Board points at key 
recommendations contained in chapters II and III of its 
annual report. The Board wishes to remind 
Governments and relevant organizations that the 
recommendations contained in chapter I of its annual 
report are generally not included in chapter IV. The 
Board encourages those concerned to examine all 
recommendations and to implement them, as 
appropriate, and to keep the Board informed of their 
action in response to the recommendations 
 
 
 A. Recommendations to Governments 
 
 
765. The recommendations to Governments are 
grouped according to the following subject areas: 
treaty accession; treaty implementation and control 
measures; prevention of illicit drug production, 
manufacture, trafficking and abuse; prevention of 
diversion of precursors into the illicit traffic; 
availability and rational use of narcotic drugs and 
psychotropic substances for medical purposes; and the 
Internet and misuse of courier services. 
 
 1. Treaty accession 
 
766. The 1961 Convention, the 1961 Convention as 
amended by the 1972 Protocol, the 1971 Convention 
and the 1988 Convention are the foundations of the 
international drug control regime. The accession of all 
States and the universal implementation of the 
provisions of the conventions are imperative 
requirements to establish an effective and efficient 
drug control system in the world. 
Recommendation 1: While nearly all States have 
acceded to the international drug control treaties, there 
are still a few States which are not yet parties to one or 
more of the treaties.92 The Board reiterates its 
request to those States which are not yet parties to 
one or more of the international drug control 
treaties to take immediate action and accede to the 
treaties without further delay. 
 
 2. Treaty implementation and control measures 
 
767. Universal accession to the three main 
international drug control treaties will, however, not be 
sufficient without effective and universal 
implementation of all the provisions of the treaties and 
the application of the necessary control measures by all 
Governments. 
Recommendation 2: The timely submission to the 
Board of information required under the international 
drug control conventions is one of the key elements of 
the international drug control system. The Board 
reiterates its request to all Governments to furnish 
in a timely manner all statistical reports required 
under the conventions. Governments are 
encouraged to seek from the Board any information 
that will help them in meeting their reporting 
obligations under the conventions. 
Recommendation 3: Difficulties experienced by some 
Governments in submitting the required statistical data 
to the Board have different reasons, including the 
inadequate resources and inadequate training provided 
__________________ 
 92  The following States are not parties to the international 
drug control treaties and/or the 1972 Protocol amending 
the 1961 Convention: 
  (a) States not parties to the 1961 Convention as 
amended by the 1972 Protocol or to the 
1961 Convention in its unamended form: Cook Islands, 
Equatorial Guinea, Kiribati, Nauru, Samoa, Timor-Leste, 
Tuvalu and Vanuatu. 
  (b) States not parties to the 1972 Protocol 
amending the 1961 Convention: Afghanistan, Chad and 
Lao People’s Democratic Republic. 
  (c) States not parties to the Convention of 1971: 
Cook Islands, Equatorial Guinea, Haiti, Kiribati, Liberia, 
Nauru, Samoa, Solomon Islands, Timor-Leste, Tuvalu 
and Vanuatu. 
  (d) States not parties to the 1988 Convention: 
Equatorial Guinea, Holy See, Kiribati, Marshall Islands, 
Namibia, Nauru, Palau, Papua New Guinea, Solomon 
Islands, Somalia, Timor-Leste and Tuvalu. 
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to the authorities responsible for the control of licit 
activities related to narcotic drugs and psychotropic 
substances. The Board again calls upon the 
Governments concerned to allocate adequate 
resources to their national competent authorities to 
ensure the compliance of those authorities with all 
their control functions, including reporting 
obligations under the conventions.  
Recommendation 4: It is the practice of the Board to 
send to the Governments concerned the Board’s 
observations and recommendations, subsequent to its 
country missions to those countries, and to review on a 
regular basis their implementation of its 
recommendations. The Board notes that most 
Governments have made efforts to implement its 
recommendations and have made progress in various 
areas of drug control. However, a few Governments 
have not responded to the Board’s requests for 
information regarding the implementation of its 
recommendations. The Board reiterates that it can 
fulfil its mandate under the international drug 
control treaties only if Governments cooperate with 
it. The Board calls on all Governments to cooperate 
fully with the Board in organizing missions and in 
implementing the recommendations of the Board 
subsequent to its missions.  
 
  Narcotic drugs and psychotropic substances 
 
Recommendation 5: The Board notes that some 
Governments did not submit their estimates of 
requirements for narcotic drugs for 2009; therefore, the 
estimates for those countries were established by the 
Board. The Board urges the Governments concerned 
to examine their requirements for narcotic drugs for 
2009 and provide their own estimates to the Board 
for confirmation, in order to prevent any possible 
difficulties with the availability of narcotic drugs 
required for medical and scientific purposes in their 
countries.  
Recommendation 6: Some Governments have 
submitted the same estimates of requirements for 
narcotic drugs for several years. The Board requests 
the Governments concerned to regularly assess their 
requirements for narcotic drugs to ensure that the 
estimates furnished to the Board for confirmation 
reflect their actual needs for narcotic drugs during 
the year in question.  
Recommendation 7: A number of Governments have 
for several years not updated the assessments of their 
requirements for psychotropic substances and, as a 
result, those assessments might no longer reflect their 
actual medical and scientific requirements for those 
substances. Some of those Governments issued import 
authorizations for psychotropic substances in absence 
or in excess of the corresponding assessments. The 
Board encourages all Governments to review and 
update their assessments of requirements for 
psychotropic substances on a regular basis and 
communicate them to the Board. The Board calls 
upon all Governments not to authorize imports 
exceeding their assessments. 
Recommendation 8: The import and export 
authorization system for all psychotropic substances 
has proved particularly effective in the identification of 
diversion attempts. The Board reiterates its request 
to all Governments that have not yet done so to 
introduce the requirement of import and export 
authorizations for substances in Schedules III and 
IV of the 1971 Convention, in accordance with 
Economic and Social Council resolutions 1985/15, 
1987/30, 1991/44, 1993/38 and 1996/30.  
Recommendation 9: Traffickers use falsified import 
authorizations when attempting to divert narcotic drugs 
or psychotropic substances from international trade. 
The Board requests Governments of exporting 
countries to continue to verify the legitimacy of all 
orders for narcotic drugs and psychotropic 
substances. The Board advises the national 
competent authorities of those countries to use the 
estimates for narcotic drugs and the assessments for 
psychotropic substances, which are published by the 
Board, for this purpose. Import orders identified as 
suspicious because they exceed the estimates or 
assessments of the relevant importing countries 
should be verified with the Board, or brought to the 
attention of the importing countries, prior to 
authorizing such export. 
 
  Precursors 
 
Recommendation 10: Information obtained in 
investigations into seizures of substances identified as 
having been destined for use in the illicit manufacture 
of narcotic drugs, psychotropic substances and 
precursors is important for the identification of new 
trends in the illicit manufacture of drugs and their 
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precursors. The Board calls upon all competent 
authorities effecting such seizures to investigate 
those cases and to provide the Board with the 
results of those investigations. 
Recommendation 11: PEN Online, the automated 
online system for the exchange of pre-export 
notifications, has become an important tool in 
strengthening precursor control, giving Governments 
of importing countries the opportunity to instantly 
comment on the legitimacy of the shipments in 
question. The Board again encourages all 
Governments that have not yet done so to register 
for and use the PEN Online system. 
Recommendation 12: The Board continues to publish 
the annual legitimate requirements of countries for 
3,4-MDP-2-P, P-2-P, ephedrine and pseudoephedrine 
and for preparations containing the latter two 
substances. This information has assisted Governments 
in identifying shipments with the potential for 
diversion. The Board encourages all Governments to 
regularly revise their requirements for these 
substances and inform the Board accordingly. 
Recommendation 13: Traffickers attempted to divert 
precursors of amphetamine-type stimulants through the 
use of fictitious companies and falsified import 
authorizations and company documents. The Board 
urges the Governments concerned to strengthen the 
capacity of their competent authorities to 
investigate the legitimacy of precursor transactions. 
Recommendation 14: The Board notes with concern 
that a number of Governments of countries in Africa do 
not respond to enquiries about potentially suspicious 
transactions, partly because of the limited capacity of 
the competent authorities involved. The Board urges 
all Governments and relevant international 
organizations to provide assistance for training and 
building the capacity of the competent authorities of 
countries in Africa to enable them to confirm the 
legitimacy of relevant transactions and prevent 
diversions. 
 
 3. Prevention of illicit drug production, 
manufacture, trafficking and abuse 
 
768. One of the key objectives of the international 
drug control treaties is to limit the production, 
manufacture, export, import and distribution of, trade 
in and use of internationally controlled substances to 
legitimate purposes and to prevent their diversion and 
abuse. 
Recommendation 15: The Board notes with concern 
that, despite some decline in illicit opium poppy 
cultivation, Afghanistan remains by far the world’s 
biggest source of illicit opium poppy cultivation, with 
an estimated opium production of 7,700 tons in 2008, 
the second highest in history. The Board urges the 
Government of Afghanistan to take the necessary 
measures to ensure that sustained and measurable 
progress is made in the prevention, as well as the 
elimination, of illicit opium poppy cultivation. The 
Board calls upon the international community to 
continue to provide assistance to the Government of 
Afghanistan in addressing the drug problems in 
that country. Moreover, the Board urges the 
Government of Afghanistan to step up its efforts to 
eliminate the trade in opium, cannabis and other 
drugs in the country. 
Recommendation 16: The illicit cultivation of cannabis 
in Afghanistan has increased significantly over the past 
few years. There has been an increasing number of 
farmers switching from opium poppy cultivation to 
cannabis cultivation, yet insufficient action has been 
taken by the Government to prevent such cultivation. 
The Board urges the Government of Afghanistan to 
take immediate measures against the illicit 
cultivation of cannabis and to ensure that farming 
communities involved in any illicit cultivation have 
access to sustainable, legitimate livelihoods. The 
Board calls upon the international community to 
provide assistance to the Government of 
Afghanistan in that area as well. 
Recommendation 17: Drug-related corruption in 
Afghanistan is a widespread and deep-seated problem 
that has seriously impeded the Government’s efforts in 
drug control. The Board notes with concern that 
corrupt officials allow drug traffickers to continue to 
operate with impunity, while officials attempting to 
address the drug problem are often subject to 
harassment, death threats or violence. The Board 
reiterates that success in addressing drug-related 
corruption requires strong political will and firm 
action. The Board urges the Government of 
Afghanistan to take effective measures against 
corrupt officials at any level of government who are 
involved in illicit drug activities and to make public 
the outcome of any such measures.  
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Recommendation 18: The Board is concerned that the 
lack of coordination and information-sharing among 
the law enforcement authorities in Afghanistan and 
neighbouring and other countries is one of the main 
reasons that the Government of Afghanistan has been 
unable to achieve its goals regarding the eradication of 
illicit opium poppy. The Board calls on the 
Government of Afghanistan and the Governments 
of other countries in West Asia and beyond to 
accord high priority to cooperation and intelligence-
sharing among law enforcement authorities, in 
order to ensure effective joint efforts against the 
drug trade in Afghanistan and beyond (see also 
recommendation 32 below). 
Recommendation 19: The Board notes with concern 
that the smuggling of cocaine through West Africa is 
increasing drastically, posing a substantial threat to the 
stability of countries in the region. In many of those 
countries, there is limited law enforcement and 
criminal justice capacity and there are serious 
problems involving corruption, making those countries 
prime targets for drug trafficking organizations. As 
cocaine trafficking increases, the abuse of the drug 
emerges in the region, which is of particular concern as 
there is limited prevention and treatment capacity in 
many of those countries. The Board calls upon the 
members of the international community, 
particularly the United Nations, to provide the 
necessary assistance, including expertise and 
financial resources, to the countries in West Africa 
to enable them to address the growing problem of 
cocaine trafficking and drug abuse. The Board 
urges the Governments of countries in West Africa 
to take the measures necessary to counter cocaine 
trafficking and related corruption, in cooperation 
with other countries and international 
organizations. 
Recommendation 20: The Board notes that, since 2005, 
there have not been any further cannabis surveys 
conducted jointly by UNODC and the Government of 
Morocco. As accurate data on the extent of illicit 
cannabis cultivation are essential for effective and 
efficient measures to be taken against such cultivation, 
the Board encourages the Government of Morocco 
to update, in cooperation with UNODC, the existing 
data on the extent of illicit cannabis cultivation in 
its country.  
Recommendation 21: The Board notes with concern 
that, in some countries, cannabis is considered by some 
segments of society as a harmless, “soft” drug. In 
addition, partly in response to those developments, the 
Governments of some countries have introduced 
legislative measures involving decriminalization of the 
personal use of cannabis and preparatory acts to such 
use, such as the cultivation and possession of cannabis. 
The Board is concerned that such measures might send 
the wrong message to the general public regarding 
cannabis. The Board again wishes to draw the 
attention of Governments to the fact that cannabis 
is a narcotic drug included in Schedules I and IV of 
the 1961 Convention and that drugs in Schedule IV 
are those particularly liable to abuse. The Board 
calls on all Governments to develop and make 
available programmes for the prevention of 
cannabis abuse and for educating the general public 
about the dangers of such abuse. 
Recommendation 22: An increasing number of 
countries are confronted with the diversion and abuse 
of pharmaceutical preparations containing narcotic 
drugs or psychotropic substances. According to 
information furnished by Governments, the most 
abused pharmaceutical preparations are usually those 
which are most available on the licit market. The 
Board encourages all Governments concerned to 
increase their vigilance regarding trafficking in and 
abuse of such preparations and to consider 
enhancing existing control measures. The Board 
also reiterates its request to Governments to 
monitor the consumption levels of prescription 
medicaments containing narcotic drugs or 
psychotropic substances in order to identify possible 
cases involving diversion and to raise awareness in 
their countries about the consequences of the abuse 
of such preparations. 
Recommendation 23: The abuse of hydrocodone and 
oxycodone by youth continues to be on the rise in 
North America, particularly in the United States. The 
Board is concerned that the serious risks of non-
medical use of those narcotic drugs are not fully 
recognized by abusers. The Board encourages 
Governments of countries where the consumption of 
hydrocodone and oxycodone has increased 
considerably to prevent medically unjustifiable high 
levels of consumption of hydrocodone and 
oxycodone through additional measures to control 
domestic distribution channels and through efforts 
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to educate the public. In addition, Governments are 
requested to determine whether marketing practices 
of pharmaceutical companies have contributed to 
unduly high consumption levels of those narcotic 
drugs and, if so, to address that problem.  
Recommendation 24: The Board recognizes that cough 
syrups containing narcotic drugs are an effective 
medication for many patients and important in medical 
practice and health care. However, cough syrups are 
also known to be abused in a number of countries. The 
Board recommends that the Governments of 
countries experiencing abuse of cough syrups 
consider the introduction of stricter control and 
supervision of the channels of distribution of cough 
syrups containing narcotic drugs. The Board also 
recommends using programmes for drug abuse 
prevention to increase awareness of the risks 
associated with inappropriate use of cough syrups.  
Recommendation 25: The Board has received reports 
about the abuse of used fentanyl patches in several 
countries. The Board again calls upon the 
Governments of countries in which fentanyl patches 
are manufactured to investigate, in cooperation 
with the pharmaceutical industry, means to reduce 
the residual content of fentanyl in used patches. In 
addition, Governments are requested to ensure that 
the waste disposal of such patches is carried out 
with adequate safety and security measures in order 
to prevent any diversion to illicit markets. 
Recommendation 26: Global consumption of 
methadone has increased more than three times over 
the past decade. Methadone is used in several countries 
for the treatment of pain, but the sharp upward trend in 
its consumption is mainly attributable to its growing 
use in substitution treatment related to opioid 
dependency. The Board requests the Governments of 
all countries where methadone is used for medical 
purposes to be vigilant with regard to cases 
involving methadone diversion, trafficking or abuse 
and to take effective countermeasures, if necessary. 
Recommendation 27: The Board notes that a number of 
countries are already controlling ketamine (a substance 
currently not under international control) under their 
national legislations, in line with Commission on 
Narcotic Drugs resolution 49/6. The Board also notes 
that WHO will conduct a critical review of ketamine in 
2009. The Board requests all Governments to 
provide the Board and WHO with all information 
available on the abuse and diversion of ketamine in 
their countries. Furthermore, in order to facilitate 
the verification by Governments of the legitimacy of 
imports and exports of ketamine, the Board 
requests all Governments that have not yet done so 
to furnish it with updated information on their 
national regulatory control measures for ketamine 
for publication on the Board’s website. The Board 
encourages all Governments to consult this 
information on its website before authorizing 
exports of ketamine. 
Recommendation 28: The Commission on Narcotic 
Drugs in its resolution 51/13, entitled “Responding to 
the threat posed by the distribution of internationally 
controlled drugs, on the unregulated market”, 
encouraged all Governments, inter alia, to continue to 
offer to affected States their cooperation and support 
and requested Governments to give consideration to 
implementing the relevant and applicable 
recommendations of the Board as set out in the 
report of the Board for 2006.93 The Board calls 
on Governments to implement Commission 
resolution 51/13 without delay. In particular, 
Governments should adopt laws prohibiting the 
distribution of internationally controlled substances 
in the unregulated market, where necessary, and 
enforce those laws, in addition to complying with 
the international drug control regime.  
Recommendation 29: The Board remains concerned 
that, in a small number of countries, “drug 
consumption rooms” and “drug injection rooms”, 
where persons can abuse with impunity drugs acquired 
on the illicit market, remain in operation. The Board 
urges Governments to terminate the operation of 
these drug abuse rooms and similar outlets and to 
promote the access of drug abusers to health, social 
and drug abuse treatment services.  
 
 4. Prevention of diversion of precursors into the 
illicit traffic 
 
769. One of the objectives of the 1988 Convention is 
to prevent diversion of precursors into the illicit traffic 
for the purpose of illicit manufacture of narcotic drugs 
or psychotropic substances. 
__________________ 
 93  Report of the International Narcotics Control Board for 
2006 … . 
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Recommendation 30: Traffickers are increasingly 
exploiting other methods of diversion of precursors 
than diversion from international trade, in view of the 
intensified monitoring of international trade in 
precursors over the last few years. Presently, traffickers 
most often obtain precursors such as acetic anhydride 
through diversion from domestic trade and smuggling 
across borders. The Board encourages Governments 
to accord high priority to strengthening domestic 
control measures for precursors, with a view to 
preventing diversion from domestic distribution 
channels. 
Recommendation 31: Due to the strengthened controls 
over trade in ephedrine and pseudoephedrine raw 
materials by authorities worldwide, traffickers place 
orders for preparations containing ephedrine or 
pseudoephedrine with legitimate pharmaceutical 
companies, often under the false pretence that those 
preparations would be sent to developing countries for 
medical use. The Board urges all Governments to 
control pharmaceutical preparations containing 
ephedrine and pseudoephedrine in the same way as 
they control the scheduled substances themselves, 
ensuring, at the same time, that legitimate trade is 
not unduly impeded in the process. 
Recommendation 32: As a result of international 
interdiction activities and the exchange of information 
under Project Cohesion, the number of seizures and 
prevented diversions of acetic anhydride significantly 
increased during the period 2007-2008. Nevertheless, 
the diversion and smuggling of chemicals used in the 
illicit manufacture of heroin into Afghanistan continue 
to be problems and the Board is concerned that control 
mechanisms currently in place in Afghanistan may not 
be sufficient. The Board urges the Government of 
Afghanistan to continue to work with the 
international community to prevent such diversions 
and smuggling. Moreover, the Board wishes to 
remind Governments of Security Council 
resolution 1817 (2008), in which the Council invited 
all Member States, in particular those producing 
precursor chemicals, Afghanistan, neighbouring 
countries and all countries on the trafficking routes, 
to increase their cooperation with the Board, 
notably by fully complying with the provisions of 
article 12 of the 1988 Convention, in order to 
eliminate loopholes utilized by criminal 
organizations to divert precursor chemicals from 
licit international trade. 
Recommendation 33: Due to the prohibition by the 
Government of Mexico of imports of ephedrine and 
pseudoephedrine, trafficking networks have begun to 
obtain precursors in Central America and South 
America. Imports of those substances have increased 
significantly in those regions. While, in some 
countries, legislation is being adopted to address the 
problem, the provisions of that legislation need to be 
implemented at a faster pace. The Board encourages 
the Governments of countries in Central and South 
America to strengthen their mechanisms for 
monitoring trade in precursor chemicals and work 
together with the Board in identifying all the 
precursors and methods used in the illicit 
manufacture of amphetamine-type stimulants. 
Recommendation 34: The origins and methods of 
diversions of potassium permanganate in South 
America continue to be of concern to the Board. The 
number of identified or prevented diversions from 
international trade of chemicals used in the illicit 
manufacture of cocaine continues to decrease. 
However, it appears that traffickers have found ways to 
obtain the substances they need through diversion from 
domestic trade and smuggling within the region. The 
Board urges Governments in South America to 
strengthen controls over domestic distribution 
channels. The Board invites the Governments of 
countries in the Americas to take advantage of the 
experience acquired during Project Cohesion 
targeting acetic anhydride and to design similar 
strategies to combat the diversion of the chemicals 
used in the manufacture of cocaine. 
 
 5. Availability and rational use of narcotic drugs 
and psychotropic substances for medical 
purposes 
 
770. One of the fundamental objectives of the 
international drug control treaties is to ensure the 
availability of narcotic drugs and psychotropic 
substances for medical and scientific purposes and to 
promote the rational use of narcotic drugs and 
psychotropic substances. 
Recommendation 35: The discrepancies in 
consumption levels of narcotic drugs and psychotropic 
substances continue to be very significant in different 
regions. Some of those differences can be explained by 
cultural differences in medical treatment and by 
varieties in prescription patterns. However, excessively 
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high or low levels in drug consumption require special 
attention. The Board requests Governments to 
regularly examine trends in the consumption of 
internationally controlled substances in their 
countries and to take appropriate action, if 
necessary. The Board requests Governments to 
promote the rational use of those substances, in 
accordance with the pertinent recommendations of 
WHO. 
Recommendation 36: The consumption of opioid 
analgesics for the treatment of pain in many 
developing countries remains low. While several 
developing countries more than doubled their 
consumption of opioid analgesics during the past 
decade, the starting levels for those increases had been 
very low. The Access to Controlled Medications 
Programme, to be implemented by WHO, will provide 
effective assistance to Governments in promoting 
rational use of opioid analgesics. The Board again 
urges all Governments concerned to identify the 
impediments in their countries to adequate use of 
opioid analgesics for the treatment of pain and to 
take steps to improve the availability of those 
narcotic drugs for medical purposes, in accordance 
with the pertinent recommendations of WHO. The 
Board calls on all Governments to cooperate with 
WHO in the implementation of the Access to 
Controlled Medications Programme and to provide 
resources to WHO to enable the programme to be 
implemented without undue delay. 
Recommendation 37: In order to support adequate 
availability of narcotic drugs, the Board analyses the 
situation regarding the supply of opiate raw materials 
and the demand for those materials. For this purpose, 
the Board uses information from Governments of 
countries producing opiate raw materials, as well as 
from countries where those materials are utilized for 
the manufacture of opiates or substances not controlled 
under the 1961 Convention. The Board encourages 
Governments of countries producing and/or 
utilizing opiate raw materials to submit to the 
Board high-quality estimates and statistics and to 
keep the Board informed of any new developments 
that may have an impact on future changes in the 
supply of and the demand for opiate raw materials. 
 
 6. The Internet and misuse of courier services 
 
771. The global nature of the problems of the illegal 
sale of pharmaceutical preparations containing 
internationally controlled substances through the 
Internet and the misuse of postal and courier services 
for such smuggling requires close cooperation and joint 
efforts by the international community. Existing 
international and national coordination mechanisms 
need to be fully utilized to respond to this threat. 
Governments will need to apply additional measures at 
the national and the international levels to prevent any 
proliferation of the misuse of the Internet and postal 
and courier services for drug trafficking purposes. 
Recommendation 38: As most countries do not have 
sufficient legislation, administrative regulations and 
cooperative mechanisms to counter the illegal sale of 
pharmaceuticals containing internationally controlled 
substances through the Internet, the Board has 
developed and made available Guidelines for 
Governments on Preventing the Illegal Sale of 
Internationally Controlled Substances through the 
Internet. The Board invites all Governments to use 
the Guidelines and inform the Board of their 
experience in implementing the Guidelines. 
Recommendation 39: The Commission on Narcotic 
Drugs, in its resolution 50/11, encouraged Member 
States to notify the Board in a regular and standardized 
manner of seizures of substances under international 
control ordered via the Internet and delivered through 
the mail. The Board has developed and sent to 
Governments a questionnaire to be used for that 
purpose. The Board invites all Governments to 
regularly report to the Board, using the 
questionnaire it has sent to them, information on 
seizures of substances under international control 
ordered via the Internet and delivered through the 
mail. The Board also invites Governments to 
continue to inform the Board of national legislation 
related to the sale of internationally controlled 
substances through the Internet, national 
cooperative mechanisms and practical experience in 
the control of such sales, as well as details of 
national focal points for activities related to 
Internet pharmacies. 
Recommendation 40: In the past two years the Board 
has collected information on the misuse of courier 
services by drug traffickers and has noted that such 
misuse has occurred in all regions. Some Governments 
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have identified the use of courier services as a major 
modus operandi for drug smuggling. The Board 
encourages all Governments that have not yet done 
so, to establish legislative and administrative 
measures ensuring adequate safeguards against the 
misuse of postal and courier services for the 
purpose of drug trafficking, including the shipment 
of cannabis seeds and drug paraphernalia such as 
equipment specifically intended for the illicit 
production or abuse of cannabis. In addition, 
Governments should strengthen institutions 
responsible for the control of postal and courier 
services and establish channels for the exchange of 
information between regulatory authorities, law 
enforcement authorities, the judiciary, postal 
administrations and courier services to enable the 
rapid investigation of drug trafficking cases.  
Recommendation 41: The technique of controlled 
delivery has been identified by several Governments as 
being the most effective way to counter the smuggling 
of drugs through courier services. The Board 
encourages all Governments to use the technique of 
controlled delivery when appropriate and to 
cooperate with other Governments in this regard.  
Recommendation 42: The existing international 
agreements regarding mail shipments contain 
provisions useful also for action against the misuse of 
courier services for drug smuggling. The Board 
encourages Governments to apply the provisions of 
the Universal Postal Convention, which regulate the 
international shipments of mail by state postal 
services, to private courier services as well and to 
amend their legislation accordingly.  
 
 
 B. Recommendations to the United 
Nations Office on Drugs and Crime 
and to the World Health Organization 
 
 
772. UNODC is the primary entity of the United 
Nations responsible for providing technical assistance 
in drug control matters, as well as coordination of such 
assistance provided by Governments and other 
organizations. The treaty-based function of WHO is to 
provide recommendations, based on medical and 
scientific assessments, regarding changes in the scope 
of control of narcotic drugs under the 1961 Convention 
and psychotropic substances under the 
1971 Convention. In addition, WHO plays a key role in 
supporting the rational use of substances under 
international control.  
Recommendation 43: The control of licit activities 
related to narcotic drugs, psychotropic substances and 
precursors in several countries remains weak. The 
Board encourages UNODC to increase its technical 
support to Governments in programmes designed to 
strengthen their capacity to control licit activities 
related to narcotic drugs, psychotropic substances 
and precursors. 
Recommendation 44: The consumption of opioid 
analgesics for the treatment of pain in many 
developing countries remains low. WHO, in 
consultation with the Board, prepared an assistance 
programme called Access to Controlled Medications 
Programme. The programme is designed to address 
impediments to the rational use of opioid analgesics, 
focusing on regulatory, attitude and knowledge 
impediments. The Board encourages UNODC to 
cooperate with WHO in the implementation of the 
Access to Controlled Medications Programme, with 
a view to promoting rational use of opioid 
analgesics by health-care professionals.  
Recommendation 45: Several developing countries 
need to make additional efforts in order to establish 
estimates and/or assessments for the medical and 
scientific use of narcotic drugs, psychotropic 
substances and some precursors reflecting actual 
requirements for the adequate treatment of their 
populations. The Board requests WHO to increase 
support to Governments in their efforts to establish 
adequate estimates and/or assessments for the 
medical and scientific use of controlled substances. 
The Board encourages WHO to join the Board in an 
initiative to identify methods to be applied in 
developing countries in order to arrive at adequate 
estimates for narcotic drugs, assessments for 
psychotropic substances and estimates for some 
precursors. 
Recommendation 46: Several developing countries 
need to strengthen their capacity to provide treatment 
for drug addicts. The Board encourages WHO to 
increase its support to Governments in their efforts 
to strengthen their drug abuse treatment capacity 
and to ensure that the treatment is of high quality. 
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 C. Recommendations to other relevant 
international organizations 
 
 
773. International organizations such as INTERPOL, 
UPU and the World Customs Organization play an 
important role in international drug control. In cases 
where States require additional operational support in 
specific areas, such as drug law enforcement, the 
Board addresses relevant recommendations pertaining 
to the specific spheres of competence of the relevant 
international and regional organizations, including 
INTERPOL, UPU and the World Customs 
Organization. 
Recommendation 47: The Universal Postal Convention 
regulates the international shipments of mail by state 
postal services. The application of some provisions of 
the convention by Governments with regard to the 
operation of courier services would be useful in 
countering the misuse of courier services for drug 
smuggling. The Board encourages UPU to extend 
the provisions of the Universal Postal Convention 
applicable to state postal services to include private 
courier services and to specify those provisions as 
appropriate. The Board calls upon the UPU to 
inform the Board of any new developments in that 
regard. 
Recommendation 48: The Board emphasizes the need 
to address the problems of illegally operating Internet 
pharmacies and the smuggling of controlled substances 
by mail. The Board again encourages international 
organizations, in particular UPU, INTERPOL and 
the World Customs Organization, to share with the 
Board relevant experiences gained from any 
programmes they are implementing to address the 
problems of illegally operating Internet pharmacies 
and the smuggling of controlled substances by mail. 
 
 
 (Signed) (Signed) 
 Hamid Ghodse Maria Elena Medina Mora 
 President Rapporteur 
 
 
 (Signed) 
 Koli Kouame 
 Secretary 
 
 
Vienna, 14 November 2008 
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Annex I 
 
 
  Regional groupings used in the report of the International 
Narcotics Control Board for 2008 
 
 
 The regional groupings used in the report of the International Narcotics 
Control Board for 2008, together with the States in each of those groupings, are 
listed below. 
Africa 
 
Algeria 
Angola 
Benin 
Botswana 
Burkina Faso 
Burundi 
Cameroon 
Cape Verde 
Central African 
  Republic 
Chad 
Comoros 
Congo 
Côte d’Ivoire 
Democratic Republic 
  of the Congo 
Djibouti 
Egypt 
Equatorial Guinea 
Eritrea 
Ethiopia 
Gabon 
Gambia 
Ghana 
Guinea 
Guinea-Bissau 
Kenya 
Lesotho 
Liberia 
 
Libyan Arab 
  Jamahiriya 
Madagascar 
Malawi 
Mali 
Mauritania 
Mauritius 
Morocco 
Mozambique 
Namibia 
Niger 
Nigeria 
Rwanda 
Sao Tome and 
  Principe 
Senegal 
Seychelles 
Sierra Leone 
Somalia 
South Africa 
Sudan 
Swaziland 
Togo 
Tunisia 
Uganda 
United Republic of 
  Tanzania 
Zambia 
Zimbabwe 
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Central America and the Caribbean 
 
Antigua and Barbuda 
Bahamas 
Barbados 
Belize 
Costa Rica 
Cuba 
Dominica 
Dominican Republic 
El Salvador 
Grenada 
 
 
Guatemala 
Haiti 
Honduras 
Jamaica 
Nicaragua 
Panama 
Saint Kitts and Nevis 
Saint Lucia 
Saint Vincent and the 
  Grenadines 
Trinidad and Tobago 
 
North America 
 
Canada 
Mexico 
 
United States of 
  America 
 
South America 
 
Argentina 
Bolivia 
Brazil 
Chile 
Colombia 
Ecuador 
Guyana 
 
Paraguay 
Peru 
Suriname 
Uruguay 
Venezuela 
  (Bolivarian 
  Republic of) 
 
East and South-East Asia 
 
Brunei Darussalam 
Cambodia 
China 
Democratic People’s 
  Republic of Korea 
Indonesia 
Japan 
Lao People’s 
  Democratic Republic 
 
Malaysia 
Mongolia 
Myanmar 
Philippines 
Republic of Korea 
Singapore 
Thailand 
Timor-Leste 
Viet Nam 
 
South Asia 
 
Bangladesh 
Bhutan 
India 
Maldives 
Nepal 
Sri Lanka 
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West Asia 
 
Afghanistan 
Armenia 
Azerbaijan 
Bahrain 
Georgia 
Iran (Islamic 
  Republic of) 
Iraq 
Israel 
Jordan 
Kazakhstan 
Kuwait 
Kyrgyzstan 
 
Lebanon 
Oman 
Pakistan 
Qatar 
Saudi Arabia 
Syrian Arab Republic 
Tajikistan 
Turkey 
Turkmenistan 
United Arab Emirates 
Uzbekistan 
Yemen 
 
 
Europe 
 
Albania 
Andorra 
Austria 
Belarus 
Belgium 
Bosnia and 
  Herzegovina 
Bulgaria 
Croatia 
Cyprus 
Czech Republic 
Denmark 
Estonia 
Finland 
France 
Germany 
Greece 
Holy See 
Hungary 
Iceland 
Ireland 
Italy 
Latvia 
Liechtenstein 
Lithuania 
Luxembourg 
Malta 
 
Monaco 
Montenegro 
Netherlands 
Norway 
Poland 
Portugal 
Republic of 
  Moldova 
Romania 
Russian 
  Federation 
San Marino 
Serbia 
Slovakia 
Slovenia 
Spain 
Sweden 
Switzerland 
The former 
  Yugoslav 
  Republic of 
  Macedonia 
Ukraine 
United Kingdom 
  of Great Britain 
  and Northern 
  Ireland 
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Oceania 
 
Australia 
Cook Islands 
Fiji 
Kiribati 
Marshall Islands 
Micronesia 
  (Federated States of) 
Nauru 
New Zealand 
Niue 
Palau 
Papua New Guinea 
Samoa 
Solomon Islands 
Tonga 
Tuvalu 
Vanuatu 
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Annex II 
 
 
  Current membership of the International Narcotics 
Control Board 
 
 
  Joseph Bediako Asare 
 
 
 Born in 1942. National of Ghana. Private 
Consultant and Psychiatrist. 
 Medical Academy of Krakow, Poland (1965-
1971); postgraduate training at Graylands and 
Swanbourne Psychiatric Hospitals, Perth, Australia 
(1976-1977); Leicestershire Area Health Authority 
(1977-1980). Senior Registrar in Psychiatry, West 
Berkshire and South Oxford Area Health Authority 
(1981-1982); Chief Psychiatrist, Ghana Health Service; 
specialist in charge at Accra Psychiatric Hospital; 
Chairman, Ghana Chapter, West African College of 
Physicians; Vice-President, West African College of 
Physicians (2000-2004); Adviser to the Ministry of 
Health of Ghana (1984-2004); member of the Narcotics 
Control Board of Ghana (1990-2004); Chairman, 
Subcommittee on Demand Reduction, Narcotics 
Control Board of Ghana (1991-2004). Part-time 
lecturer in psychiatry, University of Ghana medical 
school (1991-2004). Faculty Fellow of the 
International Council on Alcohol and Addictions 
training programme on alcohol and drug abuse in 
Benin City, Nigeria (1986 and 1987); President, 
Psychiatric Association of Ghana (1999-2002). 
Member, Royal College of Psychiatrists (1980); 
Fellow, Royal College of Psychiatrists (2008); Fellow, 
West African College of Psychiatrists; Fellow, Ghana 
College of Physicians and Surgeons. Author of 
numerous works, including: Substance Abuse in 
Ghana; The Problem of Drug Abuse in Ghana: a Guide 
to Parents and Youth (1989); Alcohol Use, Sale and 
Production in Ghana: a Health Perspective (1999); 
Alcohol and Tobacco Abuse in Deheer (1997); 
“Psychiatric co-morbidity of drug abuse”, Assessing 
Standards of Drug Abuse (1993); “Baseline survey of 
the relationship between HIV and substance abuse in 
Ghana” (2004). Recipient of the Grand Medal (Civil 
Division) of the Republic of Ghana (1997). Participant 
in numerous meetings, including: consultative group 
that developed the manual on assessment standards of 
care in drug abuse treatment (1990-1992); NGO World 
Forum on Drug Demand Reduction, Bangkok (1994); 
drug programme expert meeting, Cleveland, United 
States of America (1995); Drug Expert Forum for 
Western and Central Africa, Cameroon (1995); local 
expert meeting for Western Africa, Dakar (2003). 
Member of the local expert network in West Africa 
(LENwest) (2002-2004).  
 Member of the International Narcotics Control 
Board (since 2005). Member of the Standing 
Committee on Estimates (2006 and 2008). Chairman of 
the Committee on Finance and Administration (since 
2007). 
 
 
  Sevil Atasoy 
 
 
 Born in 1949. National of Turkey. Professor of 
Biochemistry and Forensic Science, Istanbul 
University (since 1988). Expert witness in civil and 
criminal courts (since 1980). President of the Center of 
Crime Control and Prevention, Istanbul, Turkey (since 
2006). President of the International Forensic Science 
Services, Istanbul, Turkey (since 2003). 
 Recipient of the following degrees: Bachelor of 
Science in Chemistry (1972), Master of Science in 
Biochemistry (1976) and Doctor of Philosophy (Ph.D.) 
in Biochemistry (1979), Istanbul University. 
Hubert H. Humphrey Fellow, United States 
Information Agency (1995-1996); German Academic 
Exchange Service (DAAD) Fellow (1976, 1978 and 
1994); European Molecular Biology Organization 
Fellow (1985); North Atlantic Treaty Organization 
Fellow (1978). Director, Institute of Forensic Science, 
Istanbul University (1988-2005). Director, Department 
of Narcotics and Toxicology, Ministry of Justice of 
Turkey (1980-1993). Chairperson, Department of 
Forensic Basic Sciences, Istanbul University (1983-
1987); Professor of Biochemistry, Cerrahpasa School 
of Medicine, Istanbul University (1988-2005). Guest 
scientist, School of Public Health, University of 
California, Berkeley, and Drug Abuse Research Center, 
University of California, Los Angeles; Department of 
Genetics, Stanford University; Department of Genetics, 
Emory University; California Criminalistics Institute; 
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Federal Bureau of Investigation, Virginia; Crime 
Laboratories, Los Angeles Sheriff’s Department; 
Federal Criminal Police (BKA), Wiesbaden, Germany. 
Chairperson, Regional Symposium on Criminalistics 
(2000); and Chairperson, third European Academy of 
Forensic Sciences Meeting (2003). Member of the 
Experts Group on Technical Challenges to the Drug 
Community, United Nations Office on Drugs and 
Crime (UNODC) and Office of National Drug Control 
Policy of the United States (2003 and 2004); member 
of the expert group on risk reduction linked to 
substance use other than by injection, Pompidou Group 
of the Council of Europe (2002); member of the 
Mediterranean Network of the Pompidou Group 
(2001). Member of the Turkish delegation to the 
Commission of Narcotic Drugs (2001 and 2002). 
Founding editor, Turkish Journal of Legal Medicine 
(1982-1993). Member of the scientific board of the 
International Criminal Justice Review, the Turkish 
Journal on Addiction, the Turkish Journal of Forensic 
Sciences and the Croatian Journal of Legal Medicine. 
Founding President, Turkish Society of Forensic 
Sciences, Honorary Member of the Mediterranean 
Academy of Forensic Sciences. Member of the 
International Society of Forensic Toxicology; the Indo-
Pacific Association of Law, Medicine and Science; the 
International Association of Forensic Toxicologists; the 
American Academy of Forensic Sciences; the 
American Society of Crime Laboratory Directors; the 
Forensic Science Society, United Kingdom of Great 
Britain and Northern Ireland; the American Society of 
Criminology. Participant in projects on illicit drug 
issues, including: Crime Mapping of Drug Offences for 
the Ministry of Home Affairs (1998-2000); Global 
Study of Illicit Drug Markets: Istanbul, Turkey, for the 
United Nations Interregional Crime and Justice 
Research Institute (2000-2001); National Assessment 
of Nature and Extent of Drug Problems in Turkey, for 
UNODC (2002-2003); European School Survey on 
Alcohol and Other Drugs (2002-2003); Modelling the 
World Heroin Market, for the RAND Drug Policy 
Research Center and the Max Planck Institute (2003). 
Author of over 130 scientific papers, including papers 
on drug testing, drug chemistry, drug markets, drug-
related and drug-induced crime, drug abuse prevention, 
clinical and forensic toxicology, crime scene 
investigation and deoxyribonucleic acid (DNA) 
analysis.  
 Member of the International Narcotics Control 
Board (since 2005). Member of the Committee on 
Finance and Administration (2006). Chairman (2006) 
and Member (2007) of the Standing Committee on 
Estimates. Second Vice-President of the Board (2006). 
Rapporteur (2007). First Vice-President of the Board 
(2008). 
 
 
  Tatyana Borisovna Dmitrieva 
 
 
 Born in 1951. National of the Russian Federation. 
Director, V. P. Serbsky State Research Centre for 
Social and Forensic Psychiatry (since 1998). Chief 
Expert Psychiatrist, Ministry of Health and Social 
Development of the Russian Federation (since 2005). 
Administrative Board Member of the Foundation, 
Institute of Modern Development (since 2008). 
 Graduate of the Ivanovskii State Medical Institute 
(1975). Master of Science (1981) and Doctor of 
Medical Sciences (M.D.) (1990). Professor of 
Medicine (since 1993). Head of the Department of 
Psychiatry (1986-1989), Deputy Director of Research 
(1989-1990) and Director (1990-1996), V. P. Serbsky 
State Research Centre for Social and Forensic 
Psychiatry. Minister of Health of the Russian 
Federation (1996-1998). Chairman, Russian Security 
Council Commission on Health Protection (1996-
2000), Chairperson, Council of Trustees, Public 
Charitable Foundation Health (since 1997). Member of 
the Presidium of the Russian Academy of Medical 
Sciences (since 2001); Vice-Chairman, Russian Society 
of Psychiatrists (since 1995); Vice-President, World 
Association for Social Psychiatry Academician; 
Corresponding Member of the Russian Academy of 
Medical Sciences (since 1997); member of the Russian 
Academy of Medical Sciences (since 1999). Author of 
over 350 scientific works, recipient of five authors’ 
certificates for inventions and author of three books on 
drug abuse therapy, including Abuse of Psychoactive 
Substances (General and Forensic Psychiatric 
Practice) (2000) and Abuse of Psychoactive 
Substances: Clinical and Legal Aspects (2003). Editor-
in-Chief, Russian Psychiatric Journal. Editor-in-Chief, 
Clinical Research on Medication in Russia. Member of 
the editorial boards of several Russian and foreign 
medical journals, including the journal Narcology. 
Member of the editorial council, International Medical 
Journal; and member of the editorial council, Siberian 
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Journal of Psychiatry and Narcology. Recipient of the 
Order for Services to the Country, fourth class (2001) 
and third class (2006); and the Order of Honour 
(1995). Participant and speaker on psychiatry and drug 
abuse therapy at national and international congresses 
and conferences, including those organized by the 
World Health Organization (WHO), the European 
Union, the Council of Europe, the World Psychiatric 
Congress and the World Psychiatric Association. 
 Member of the International Narcotics Control 
Board (since 2005). Rapporteur of the Board (2006). 
Member (2006) and Chairman (2007) of the Standing 
Committee on Estimates. Second Vice-President of the 
Board (2007). 
 
 
  Philip Onagwele Emafo 
 
 
 Born in 1936. National of Nigeria. 
 Lecturer, Biochemistry, University of Ibadan 
(1969-1971). Lecturer and Senior Lecturer, 
Pharmaceutical Microbiology and Biochemistry, 
University of Benin, Nigeria (1971-1977). Chief 
Pharmacist and Director, Pharmaceutical Services, 
Federal Ministry of Health of Nigeria (1977-1988). 
Chairman, Pharmacists Board of Nigeria (1977-1988). 
Member of the WHO Expert Advisory Panel on the 
International Pharmacopoeia and Pharmaceutical 
Preparations (1979-2003). Rapporteur-General, 
International Conference on Drug Abuse and Illicit 
Trafficking, Vienna (1987). Chairman, Commission on 
Narcotic Drugs at its tenth special session (1988). 
Member of the Secretary-General’s Group of Experts 
on the United Nations Structure for Drug Abuse 
Control (1990). Member of the WHO Expert 
Committee on Drug Dependence (1992, 1994 and 
1998). Consultant to the United Nations International 
Drug Control Programme (1993-1995). Member of the 
ad hoc intergovernmental advisory group established 
by the Commission on Narcotic Drugs to assess 
strengths and weaknesses of global drug control efforts 
(1994). Member of the expert group convened by the 
Secretary-General pursuant to Economic and Social 
Council resolution 1997/37 to review the United 
Nations machinery for drug control (1997-1998). 
Member of the Advisory Group of the International 
Narcotics Control Board to review substances for 
control under article 12 of the United Nations 
Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 (1998-1999). 
Consultant to the Organization of African Unity, Addis 
Ababa (1998-1999). 
 Member of the International Narcotics Control 
Board (since 2000). Member of the Standing 
Committee on Estimates (2000-2004). Rapporteur of 
the Board (2001). First Vice-President of the Board 
(2005). President of the Board (2002, 2003, 2006 and 
2007). 
 
 
  Hamid Ghodse 
 
 
 Born in 1938. National of the Islamic Republic of 
Iran. Professor of Psychiatry and of International Drug 
Policy, University of London (since 1987). Director, 
International Centre for Drug Policy, St. George’s 
University of London (since 2003); Medical Director, 
Advisory Committee on Clinical Excellence Awards, 
England and Wales (2006); President, European 
Collaborating Centres for Addiction Studies (since 
1992); Non-Executive Director, National Patient Safety 
Agency, United Kingdom (since 2001); Chairman, 
Higher Degrees in Psychiatry, University of London 
(since 2003). 
 Recipient of the following degrees, qualifications 
and awards: Doctor of Medicine (M.D.), Islamic 
Republic of Iran (1965); Diploma Psychological 
Medicine (D.P.M.), United Kingdom (1974); Doctor of 
Philosophy (Ph.D.), University of London (1976); and 
Doctor of Science (D.Sc.), University of London 
(2002). Fellow of the Royal College of Psychiatrists 
(F.R.C.Psych.), United Kingdom (1985); Fellow of the 
Royal College of Physicians (F.R.C.P.), London 
(1992); Fellow of the Royal College of Physicians of 
Edinburgh (F.R.C.P.E.), Edinburgh (1997); Fellow of 
the Faculty of Public Health Medicine (F.F.P.H.), 
United Kingdom (1997); Fellow of the Higher 
Education Academy (F.H.E.A.), United Kingdom 
(2005); Honorary Fellow, Royal College of 
Psychiatrists (R.C.Psych.) (2006); Honorary Fellow, 
World Psychiatric Association (2008). Member of the 
WHO Expert Advisory Panel on Alcohol and Drug 
Dependence (since 1979); Adviser, Joint Formulary 
Committee, British National Formulary (since 1984); 
Honorary Consultant Psychiatrist, St. George’s and 
Springfield University Hospitals, London (since 1978); 
Honorary Consultant Public Health, Wandsworth 
Primary Care Trust, London (since 1997). Consultant 
E/INCB/2008/1  
 
128 
Psychiatrist, St. Thomas’s Teaching Hospital and 
Medical School, London (1978-1987); member, 
rapporteur, chairman and convener of various WHO 
and European Community expert committees, review 
groups and other working groups on drug and alcohol 
dependence; M. S. McLeod Visiting Professor, 
Southern Australia (1990); Honorary Professor, Peking 
University (since 1997). Author or editor of over 
300 scientific books and papers on drug-related issues 
and addictions, including the following books: The 
Misuse of Psychotropic Drugs, London (1981); 
Psychoactive Drugs and Health Problems, Helsinki 
(1987); Psychoactive Drugs: Improving Prescribing 
Practices, Geneva (1988); Substance Abuse and 
Dependence, Guildford (1990); Drug Misuse and 
Dependence: the British and Dutch Response, 
Lancashire, United Kingdom (1990); Misuse of Drugs 
(3rd ed.), London (1997); Drugs and Addictive 
Behaviour: a Guide to Treatment (3rd ed.), Cambridge 
(2002); Young People and Substance Misuse, London 
(2004); Addiction at Workplace, Aldershot (2005); 
International Drug Control into the 21st Century, 
Aldershot (2008). Editor-in-Chief, International 
Psychiatry; Honorary Editor-in-Chief Chinese Journal 
of Drug Dependence; member of the Editorial Board, 
International Journal of Social Psychiatry; member of 
the Editorial Board, Asian Journal of Psychiatry. 
Convener of WHO expert groups on medical education 
(1986), pharmacy education (1987), nurse education 
(1989) and rational prescribing of psychoactive drugs. 
Chairman, Association of Professors of Psychiatry of 
the British Isles (since 1991); Chairman, Association of 
European Professors of Psychiatry; Director, National 
Programme on Substance Abuse Deaths (since 1997); 
member of the International Association of 
Epidemiology (since 1998).  
 Member of the International Narcotics Control 
Board (since 1992). Member of the Standing 
Committee on Estimates (1992). President of the Board 
(1993, 1994, 1997, 1998, 2000, 2001, 2004, 2005 and 
2008). 
 
 
  Carola Lander 
 
 
 Born in 1941. National of Germany. 
 Pharmacist, doctoral degree in natural science; 
Certified Specialist in Public Health (Chamber of 
Pharmacists). Head of the Federal Opium Agency, the 
German authority with competence under article 17 of 
the Single Convention on Narcotic Drugs of 1961 and 
article 6 of the Convention on Psychotropic Substances 
of 1971, and Chairperson of the federal expert group 
for narcotic drugs (1992-2006). Research assistant and 
assistant professor, University of Berlin (1970-1979); 
person in charge of pharmaceutical quality control of 
herbal drugs, Federal Institute for Drugs and Medical 
Devices, Berlin (1979-1990); head of the division for 
the control of manufacturers of narcotic drugs, Federal 
Opium Agency of Germany (1990-1992). Member of 
the German delegation to the Commission on Narcotic 
Drugs (1990-2006). Lecturer on drug regulatory 
affairs, University of Bonn (2003-2005). Recipient of a 
certificate of appreciation for outstanding contributions 
in the field of drug law enforcement awarded by the 
Drug Enforcement Administration of the United States 
and recipient of a certificate of appreciation awarded 
by the former Yugoslav Republic of Macedonia. 
 Member of the International Narcotics Control 
Board (since 2007). Member of the Standing 
Committee on Estimates (2007). Vice-Chairperson of 
the Standing Committee on Estimates (2008). 
 
 
  Melvyn Levitsky 
 
 
 Born in 1938. National of the United States. 
Retired Ambassador in the United States Foreign 
Service. Professor of International Policy and Practice 
and Senior Fellow, International Policy Center, Gerald 
R. Ford School of Public Policy, University of 
Michigan (since 2006). Faculty Associate, Center for 
Russian and East European Studies, Faculty Advisor, 
Weiser Center for Emerging Democracies, University 
of Michigan. 
 United States diplomat for 35 years, serving as, 
inter alia, Ambassador of the United States to Brazil 
(1994-1998); Assistant Secretary of State for 
International Narcotics Matters (1989-1993); 
Executive Secretary and Special Assistant to the 
Secretary of the United States Department of State 
(1987-1989); Ambassador of the United States to 
Bulgaria (1984-1987); Deputy Director, Voice of 
America (1983-1984); Deputy Assistant Secretary of 
State for Human Rights and Humanitarian Affairs 
(1982-1983); Officer-in-Charge for Bilateral Relations, 
Office of Soviet Union Affairs (1975-1978); Political 
Officer, United States Embassy in Moscow (1973-
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1975); Consul, United States consulates in Frankfurt, 
Germany (1963-1965), and Belem, Brazil (1965-1967). 
Professor of International Relations and Public 
Administration, Maxwell School of Citizenship and 
Public Affairs, Syracuse University (1998-2006). 
Recipient of several United States Department of State 
Meritorious and Superior Honor Awards, Presidential 
Meritorious Service Awards and the United States 
Secretary of State’s Distinguished Service Award. 
Member of the Washington Institute of Foreign Affairs, 
the American Academy of Diplomacy and the 
American Foreign Service Association. Member of the 
Advisory Board, Drug Free America Foundation. 
Member of the Institute on Global Drug Policy. 
Member of the Board, Global Panel of the Prague 
Society. Member of the Public-Private Working Group 
on Sale of Controlled Substances via the Internet 
(Harvard University Law School). Distinguished 
Fellow, Daniel Patrick Moynihan Institute of Global 
Affairs, Maxwell School of Citizenship and Public 
Affairs, Syracuse University. Member of the University 
of Michigan Substance Abuse Research Center. Listed 
in Who’s Who in American Politics, Who’s Who in 
American Government and Who’s Who in American 
Education. 
 Member of the International Narcotics Control 
Board (since 2003). Chairman of the Committee on 
Finance and Administration (2004). Chairman of the 
Working Group on Strategy and Priorities (2005). 
 
 
  Maria Elena Medina-Mora 
 
 
 Born in 1953. National of Mexico. Director, 
National Institute of Psychiatry, Mexico City (since 
2008). Member of the National System of Researchers 
(since 1984). Member of the Colegio Nacional (since 
2006). 
 Recipient of a Bachelor of Arts degree (with 
honours) in Psychology (1976) and a Master of Arts 
degree (with honours) in Clinical Psychology (1979), 
Ibero-American University, Mexico; recipient of a 
doctoral degree in Social Psychology, Universidad 
Nacional Autónoma de México (1992). Member of the 
Board of Governors, Universidad Nacional Autónoma 
de México (since 2003). Member of the WHO Expert 
Committee on Addictions (since 1986). Research 
collaborator, WHO project on increasing comparability 
of drug use surveys (1976-1980). Researcher with 
WHO, the International Labour Organization, the 
United Nations Children’s Fund (UNICEF), the 
Addiction Research Foundation, Toronto, Canada, and 
the Alcohol Research Group, California, United States, 
as well as with the National Institute on Alcohol Abuse 
and Alcoholism and the National Institute on Drug 
Abuse of the National Institutes of Health, United 
States. Cooperated with the United Nations in the 
working group of the international board of drug 
surveillance in developing the Lisbon consensus 
document for drug reporting (2000) and with the 
working group that developed the draft Declaration on 
the Guiding Principles of Drug Demand Reduction 
(1997). Member of the Scientific Advisory Committee, 
Inter-American Drug Abuse Control Commission 
(CICAD) (2004). Member of the National Academy of 
Sciences (since 1992), National Association of 
Psychologists of Mexico (since 1991) and the National 
Academy of Medicine (since 1994). Member of the 
Board of Directors, National Institute of Public Health 
(1997-2005) and National Institute on Neurology and 
Neurosurgery (2006-2008). Professor at the 
undergraduate and graduate levels and adviser for 67 
Bachelor of Arts, Master of Arts and doctoral theses 
(since 1976). Member of the editorial board of Revista 
de Psicología Social y Personalidad, Salud Mental, 
Revista Mexicana de Psicología and Salud Pública de 
México, Public Psychiatry, Addictions, Hispanic 
Journal of Behavioral Sciences, Addiction Disorders 
and Their Treatment and Revista Brasileira de 
Psiquiatría. Recipient of the “Gerardo Varela” national 
award in public health, for meritorious research (1986); 
national prize in psychology, awarded by the National 
Association of Psychologists (1991); national prize in 
psychiatry, presented by the Camelo Foundation 
(1993). Recognized as distinguished health 
professional by the Mexican Society of Geography and 
Statistics (2002) and as honorary member by the 
Mexican Society of Psychology (2006) and Mexican 
Psychiatric Association (2007). Recipient of the 
Woman of the Year Award (2006). Author of more than 
160 research papers in journals, nearly 200 book 
chapters and of 4 books. 
 Member of the International Narcotics Control 
Board (2000-2004 and 2007). Member of the Standing 
Committee on Estimates (2000-2004 and 2007). 
Chairman of the Standing Committee on Estimates 
(2004). Second Vice-President (2003) of the Board. 
Rapporteur (2002 and 2008). 
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  Sri Suryawati 
 
 
 Born in 1955. National of Indonesia. Director, 
Centre for Clinical Pharmacology and Medicines 
Policy Studies, Gadjah Mada University. Coordinator, 
Master Degree Program for Medicine Policy and 
Management, Gadjah Mada University. Lecturer in 
Pharmacology/Clinical Pharmacology (since 1980); 
supervisor for more than 110 master’s and doctoral 
theses on drug policy, the rational use of medicines, 
clinical pharmacokinetics and drug management. 
 Pharmacist (1979). Specialist in pharmacology 
(1985); doctoral degree in clinical pharmacokinetics 
(1994). Head of Clinical Pharmacology, Faculty of 
Medicine, Gadjah Mada University, Indonesia (1999-
2006). Member of the WHO Expert Advisory Panel for 
Medicine Policy and Management. Member of the 
Executive Board of the International Network for the 
Rational Use of Drugs (INRUD). Member of the WHO 
Expert Committee on the Selection and Use of 
Essential Medicines (2002, 2003, 2005 and 2007). 
Member of the WHO Expert Committee on Drug 
Dependence (2002 and 2006). Member of the United 
Nations Millennium Project Task Force on HIV/AIDS, 
Malaria and Tuberculosis and Access to Essential 
Medicines (Task Force 5) (2001-2005). Consultant in 
essential medicine programmes and promoting rational 
use of medicines in Bangladesh (2006-2007), 
Cambodia (2001-2008), China (2006-2008), the Lao 
People’s Democratic Republic (2001-2003), Mongolia 
(2006-2008) and the Philippines (2006-2007). 
Consultant in medicine policy and drug evaluation in 
Cambodia (2003, 2005 and 2007), China (2003), 
Indonesia (2005-2006) and Viet Nam (2003). 
Facilitator in various international training courses in 
medicine policy and promoting the rational use of 
medicines, including WHO and INRUD courses on 
promoting the rational use of medicines (1994-2007), 
training courses on hospital drugs and therapeutics 
committees (2001-2007) and international courses on 
drug policy in developing countries (2002-2003). 
 Member of the International Narcotics Control 
Board (since 2007). Member of the Standing 
Committee on Estimates (2008).  
 
 
  Camilo Uribe Granja 
 
 
 Born in 1963. National of Colombia. Medical 
Director, Hospital of San Martín (Meta); toxicologist, 
Marly and Palermo clinics; General Director, New 
Clinic Fray Bartolomé de las Casas; consultant, 
National Drug Council. Numerous university teaching 
posts in forensics and clinical toxicology. Director-
General, the Integral Toxicology Unit (UNITOX), 
University Children’s Hospital of Saint Joseph (since 
2008). Member of the Commission of Public Health 
(since 2006), Member of the Commission of Mental 
Health (since 2007) and Chairman of the Commission 
of Drug Abuse (since 2008), National Academy of 
Medicine. 
 Member of the International Narcotics Control 
Board (since 2005). Member of the Committee on 
Finance and Administration (since 2007). Vice-
Chairman (2006 and 2007), Second Vice-Chairman 
(2008) and Chairman (2008) of the Standing 
Committee on Estimates (2008). 
 
 
  Brian Watters 
 
 
 Born in 1935. National of Australia. Chairman, 
Australian National Council on Drugs (2005). 
 Arts degree, majoring in medical sociology, 
University of Newcastle, Australia; trained in addiction 
counselling at University of Newcastle; qualified 
psychiatric chaplain. Major in the Salvation Army 
(1975-2008), including work as Commander of the 
Salvation Army’s addiction treatment programme in 
eastern Australia; consultant and media spokesman on 
addiction issues; adviser to the Salvation Army’s 
HIV/AIDS services in eastern Australia; President of 
the Network of Alcohol and Drug Agencies in New 
South Wales; member of New South Wales’ Health 
Minister’s Drug Advisory Council. Patron, “Drug Arm, 
Australia”; Board member, “Drug Free Australia”; 
member of the Leadership Council, International 
Substance Abuse and Addiction Coalition. Member of 
several Australian government committees, including: 
the expert advisory group on sustained release 
naltrexone; the state and national reference groups on 
the Council of Australian Governments “Diversion of 
Offenders” scheme; and the national “Tough on Drugs” 
reference group for non-governmental organization 
treatment grants. Frequent contributor to Australian 
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newspapers, magazines and journals, including the 
journal of the National Drug and Alcohol Research 
Centre; several publications, including Drug Dilemma: 
a Way Forward, and contributor to “Prevention, 
demand reduction and treatment: a way forward for 
Australia”, Heroin Crisis (1999). Officer of the Order 
of Australia (2003), for outstanding services in anti-
drug policy development and drug treatment. Keynote 
speaker at national and international conferences, 
including: International Council on Alcohol and 
Addictions, Vienna; European Cities against Drugs, 
Stockholm; Australian Conference on Drugs Strategy, 
Adelaide; International Substance Abuse and Addiction 
Coalition, Madrid. Participant, Commission on 
Narcotic Drugs (2003). Speaker of the National 
Chemical Diversion Conference, Darwin, Australia 
(2005). 
 Member of the International Narcotics Control 
Board (since 2005). First Vice-President of the Board 
(2007). Member of the Standing Committee on 
Estimates (2006 and 2008). 
 
 
  Raymond Yans 
 
 
 Born in 1948. National of Belgium.  
 Graduate in Germanic philology and in 
philosophy (1972). Belgian Foreign Service: Attaché, 
Jakarta (1978-1981); Deputy-Mayor of Liège (1982-
1989); Consul, Tokyo (1989-1994); Consul, Chargé 
d’affaires, Luxembourg (1999-2003); Head of the Drug 
Unit, Ministry of Foreign Affairs (1995-1999 and 
2003-2007); Chairman of the Dublin Group (2002-
2006); Chairman of the European Union Drug Policy 
Cooperation Working Group during the Belgian 
Presidency of the European Union; charged with the 
national coordination of the ratification and 
implementation process of the Convention on 
Psychotropic Substances of 1971 and the United 
Nations Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988 (1995-
1998); liaison between the Ministry of Foreign Affairs 
and the National Police for drug liaison officers in 
Belgian embassies (2003-2005); participation in the 
launching by the European Union Joint Action on New 
Synthetic Drugs of an early warning system to alert 
Governments to the appearance of new synthetic drugs 
(1999); active in the creation of the Cooperation 
Mechanism on Drugs between the European Union, 
Latin America and the Caribbean (1997-1999). Author 
of numerous articles, including: “The future of the 
Dublin Group” (2004) and “Is there anything such as a 
European Union Common Drug Policy” (2005). 
Member of the Belgian delegation to the Commission 
on Narcotic Drugs (1995-2007); all the preparatory 
sessions (on amphetamine-type stimulants, precursors, 
judicial cooperation, money-laundering, drug demand 
reduction and alternative development) for the 
twentieth special session of the General Assembly; 
representative of Belgium at the Meeting of Heads of 
National Drug Law Enforcement Agencies, Europe 
(1995-2005); Conference of the International Narcotics 
Control Board on the Control of Psychotropic 
Substances, Strasbourg (1995 and 1998); International 
Conference on Drugs, Dependence and 
Interdependence, Council of Europe, Lisbon (1996); 
European Union Seminar on Best Practices in Drug 
Enforcement by Law Enforcement Authorities, 
Helsinki (1999); Joint European Union/Southern 
African Development Community Conferences on 
Drug Control Cooperation, Mmabatho, South Africa 
(1995) and Gabarone (1998); European Perspectives on 
Policies on Drugs, Oslo (2005); United Nations Office 
on Drugs and Crime/Paris Pact round tables, Brussels 
(2003), Tehran and Istanbul (2005); meetings of the 
Paris Pact Policy Consultative Group, Rome (2003) 
and Vienna (2005); meetings of the High-level 
Dialogue on Drugs between the Andean Community 
and the European Union, the European 
Community/Andean Bilateral Drug Precursors 
Agreements and the European Union/Latin America 
and the Caribbean Coordination and Cooperation 
Mechanism, Lima (2005) and Vienna (2006). 
 Member of the International Narcotics Control 
Board (since 2007). Member of the Standing 
Committee on Estimates (since 2007). Member of the 
Committee on Finance and Administration (since 
2007). 
 
 
  Yu Xin 
 
 
 Born in 1965. National of China. Clinical 
Professor of Psychiatry, Institute of Mental Health, 
Peking University (since 2004). Licensed Psychiatrist, 
China Medical Association (since 1988). President, 
Chinese Psychiatrist Association (since 2005); 
Chairperson, Credential Committee for Psychiatrists, 
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Ministry of Health of China; Vice-President, Chinese 
Society of Psychiatry (since 2006); Vice-President, 
Management Association for Psychiatric Hospitals 
(since 2007); Vice-Chairman, Alzheimer’s Disease, 
China (since 2002). 
 Bachelor of Medicine, Beijing Medical 
University (1988); Fellow in Psychiatry, University of 
Melbourne, Australia (1996-1997); Fellow in 
Substance Abuse, Johns Hopkins University (1998-
1999); Doctor of Medicine (M.D.), Peking University 
(2000); Senior Fellow in Social Medicine, Harvard 
University (2003). Residency in psychiatry (1988-
1993) and Psychiatrist (1993-1998), Institute of Mental 
Health, Beijing Medical University; Head, Associate 
Professor of Psychiatry, Geriatric Psychiatrist, 
Department of Geriatric Psychiatry, Institute of Mental 
Health, Peking University (1999-2001); Assistant 
Director (2000-2001) and Executive Director (2001-
2004), Institute of Mental Health, Peking University. 
Author and co-author of numerous works on various 
topics in psychiatry, such as psychopharmacology, 
early intervention of schizophrenia, mental health and 
HIV/AIDS and drug use, mental health outcome of 
harmful alcohol use, neuropsychology of mental 
disorders, neuroimaging of late life depression, late 
onset psychosis, and assessment, treatment and care for 
dementia. Editor of several textbooks, including 
Geriatric Psychiatry, Textbook of Psychiatry for Asia 
and Psychiatry for Medical Students. Recipient of the 
Outstanding Clinician Award, Beijing Medical 
University, and the Innovation and Creation Award, 
Beijing Medical Professional Union (2004). Member of 
the expert group for the section on analgesics and 
sedatives of the State Food and Drug Administration 
(since 2000). Evaluator of the effectiveness of 
methadone clinics. Leader of a project to follow up the 
neurocognitive and mental functioning of patients 
infected with HIV/AIDS as a result of intravenous drug 
abuse. 
 Member of the International Narcotics Control 
Board (since 2007). Member of the Standing 
Committee on Estimates (since 2007). 
 
 
 
  
 
About the International Narcotics Control Board 
 
 
 The International Narcotics Control Board (INCB) is an independent and quasi-judicial control organ, established by 
treaty, for monitoring the implementation of the international drug control treaties. It had predecessors under the former drug 
control treaties as far back as the time of the League of Nations. 
 
Composition 
 
 INCB consists of 13 members who are elected by the Economic and Social Council and who serve in their personal 
capacity, not as Government representatives (see annex II of the present publication for the current membership). Three 
members with medical, pharmacological or pharmaceutical experience are elected from a list of persons nominated by the 
World Health Organization (WHO) and 10 members are elected from a list of persons nominated by Governments. Members 
of the Board are persons who, by their competence, impartiality and disinterestedness, command general confidence. The 
Council, in consultation with INCB, makes all arrangements necessary to ensure the full technical independence of the Board 
in carrying out its functions. INCB has a secretariat that assists it in the exercise of its treaty-related functions. The INCB 
secretariat is an administrative entity of the United Nations Office on Drugs and Crime, but it reports solely to the Board on 
matters of substance. INCB closely collaborates with the Office in the framework of arrangements approved by the Council 
in its resolution 1991/48. INCB also cooperates with other international bodies concerned with drug control, including not 
only the Council and its Commission on Narcotic Drugs, but also the relevant specialized agencies of the United Nations, 
particularly WHO. It also cooperates with bodies outside the United Nations system, especially the International Criminal 
Police Organization (INTERPOL) and the World Customs Organization. 
 
Functions 
 
 The functions of INCB are laid down in the following treaties: the Single Convention on Narcotic Drugs of 1961 as 
amended by the 1972 Protocol; the Convention on Psychotropic Substances of 1971; and the United Nations Convention 
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988. Broadly speaking, INCB deals with the 
following: 
 (a) As regards the licit manufacture of, trade in and use of drugs, INCB endeavours, in cooperation with 
Governments, to ensure that adequate supplies of drugs are available for medical and scientific uses and that the diversion of 
drugs from licit sources to illicit channels does not occur. INCB also monitors Governments’ control over chemicals used in 
the illicit manufacture of drugs and assists them in preventing the diversion of those chemicals into the illicit traffic; 
 (b) As regards the illicit manufacture of, trafficking in and use of drugs, INCB identifies weaknesses in national and 
international control systems and contributes to correcting such situations. INCB is also responsible for assessing chemicals 
used in the illicit manufacture of drugs, in order to determine whether they should be placed under international control. 
 In the discharge of its responsibilities, INCB: 
 (a) Administers a system of estimates for narcotic drugs and a voluntary assessment system for psychotropic 
substances and monitors licit activities involving drugs through a statistical returns system, with a view to assisting 
Governments in achieving, inter alia, a balance between supply and demand; 
 (b) Monitors and promotes measures taken by Governments to prevent the diversion of substances frequently used in 
the illicit manufacture of narcotic drugs and psychotropic substances and assesses such substances to determine whether there 
is a need for changes in the scope of control of Tables I and II of the 1988 Convention; 
 (c) Analyses information provided by Governments, United Nations bodies, specialized agencies or other competent 
international organizations, with a view to ensuring that the provisions of the international drug control treaties are 
adequately carried out by Governments, and recommends remedial measures; 
 (d) Maintains a permanent dialogue with Governments to assist them in complying with their obligations under the 
international drug control treaties and, to that end, recommends, where appropriate, technical or financial assistance to be 
provided. 
 INCB is called upon to ask for explanations in the event of apparent violations of the treaties, to propose appropriate 
remedial measures to Governments that are not fully applying the provisions of the treaties or are encountering difficulties in 
applying them and, where necessary, to assist Governments in overcoming such difficulties. If, however, INCB notes that the 
measures necessary to remedy a serious situation have not been taken, it may call the matter to the attention of the parties 
concerned, the Commission on Narcotic Drugs and the Economic and Social Council. As a last resort, the treaties empower 
  
 
 
INCB to recommend to parties that they stop importing drugs from a defaulting country, exporting drugs to it or both. In all 
cases, INCB acts in close cooperation with Governments. 
 INCB assists national administrations in meeting their obligations under the conventions. To that end, it proposes and 
participates in regional training seminars and programmes for drug control administrators. 
 
Reports 
 
 The international drug control treaties require INCB to prepare an annual report on its work. The annual report contains 
an analysis of the drug control situation worldwide so that Governments are kept aware of existing and potential situations 
that may endanger the objectives of the international drug control treaties. INCB draws the attention of Governments to gaps 
and weaknesses in national control and in treaty compliance; it also makes suggestions and recommendations for 
improvements at both the national and international levels. The annual report is based on information provided by 
Governments to INCB, United Nations entities and other organizations. It also uses information provided through other 
international organizations, such as INTERPOL and the World Customs Organization, as well as regional organizations. 
 The annual report of INCB is supplemented by detailed technical reports. They contain data on the licit movement of 
narcotic drugs and psychotropic substances required for medical and scientific purposes, together with an analysis of those 
data by INCB. Those data are required for the proper functioning of the system of control over the licit movement of narcotic 
drugs and psychotropic substances, including preventing their diversion to illicit channels. Moreover, under the provisions of 
article 12 of the 1988 Convention, INCB reports annually to the Commission on Narcotic Drugs on the implementation of 
that article. That report, which gives an account of the results of the monitoring of precursors and of the chemicals frequently 
used in the illicit manufacture of narcotic drugs and psychotropic substances, is also published as a supplement to the annual 
report. 
 Since 1992, the first chapter of the annual report has been devoted to a specific drug control issue on which INCB 
presents its conclusions and recommendations in order to contribute to policy-related discussions and decisions in national, 
regional and international drug control. The following topics were covered in past annual reports: 
 1992:  Legalization of the non-medical use of drugs 
 1993:  The importance of demand reduction 
 1994:  Evaluation of the effectiveness of the international drug control treaties 
 1995:  Giving more priority to combating money-laundering 
 1996:  Drug abuse and the criminal justice system 
 1997:  Preventing drug abuse in an environment of illicit drug promotion 
 1998:  International control of drugs: past, present and future 
 1999:  Freedom from pain and suffering 
 2000:  Overconsumption of internationally controlled drugs 
 2001:  Globalization and new technologies: challenges to drug law enforcement in the twenty-first 
  century 
 2002:  Illicit drugs and economic development 
 2003:  Drugs, crime and violence: the microlevel impact 
 2004:  Integration of supply and demand reduction strategies: moving beyond a balanced approach 
 2005:  Alternative development and legitimate livelihoods 
 2006:  Internationally controlled drugs and the unregulated market 
 2007:  The principle of proportionality and drug-related offences 
 Chapter I of the report of the International Narcotics Control Board for 2008 is entitled “The international drug control 
conventions: history, achievements and challenges”. 
 Chapter II presents an analysis of the operation of the international drug control system based primarily on information 
that Governments are required to submit directly to INCB in accordance with the international drug control treaties. Its focus 
is on the worldwide control of all licit activities related to narcotic drugs and psychotropic substances, as well as chemicals 
used in the illicit manufacture of such drugs. 
 Chapter III presents some of the major developments in drug abuse and trafficking and measures by Governments to 
implement the international drug control treaties by addressing those problems. Specific comments are made on the drug 
control situation in each of the countries in which an INCB mission or technical visit took place. 
 Chapter IV presents the main recommendations addressed by INCB to Governments, the United Nations Office on 
Drugs and Crime, WHO and other relevant international and regional organizations. 
Informes publicados en 2008 por la Junta Internacional de  
Fiscalización de Estupefacientes 
 
 El Informe de la Junta Internacional de Fiscalización de Estupefacientes 
correspondiente a 2008 (E/INCB/2008/1) se complementa con los siguientes 
informes: 
Informe de la Junta Internacional de Fiscalización de Estupefacientes sobre el 
seguimiento del vigésimo período extraordinario de sesiones de la Asamblea 
General (E/INCB/2008/1/Supp.1) 
Estupefacientes: Previsiones de las necesidades mundiales para 2009; 
Estadísticas de 2007 (E/INCB/2008/2) 
Sustancias Sicotrópicas: Estadísticas de 2007; Previsiones de las necesidades 
anuales para fines médicos y científicos de las sustancias de las Listas II, III 
y IV del Convenio sobre Sustancias Sicotrópicas de 1971 (E/INCB/2008/3) 
Precursores y productos químicos frecuentemente utilizados para la 
fabricación ilícita de estupefacientes y sustancias sicotrópicas: Informe de la 
Junta Internacional de Fiscalización de Estupefacientes correspondiente 
a 2008 sobre la aplicación del artículo 12 de la Convención de las Naciones 
Unidas contra el Tráfico Ilícito de Estupefacientes y Sustancias Sicotrópicas 
de 1988 (E/INCB/2008/4) 
 Las listas actualizadas de las sustancias sometidas a fiscalización 
internacional, que comprenden estupefacientes, sustancias sicotrópicas y sustancias 
frecuentemente utilizadas para la fabricación ilícita de estupefacientes y sustancias 
sicotrópicas, figuran en las ediciones más recientes de los anexos de los formularios 
estadísticos (“Lista Amarilla”, “Lista Verde” y “Lista Roja”), también publicados 
por la Junta. 
 
Cómo ponerse en contacto con la Junta Internacional 
de Fiscalización de Estupefacientes 
 
 La dirección de la secretaría de la Junta es la siguiente: 
 
Centro Internacional de Viena 
Despacho E-1339 
Apartado postal 500 
1400 Viena 
Austria 
 
 Además, para ponerse en contacto con la secretaría pueden utilizarse los 
medios siguientes: 
 
Teléfono:    + (43-1) 26060 
Télex:    135612 
Telefax:     + (43-1) 26060-5867 ó 26060-5868 
Dirección cablegráfica: unations vienna 
Correo electrónico:   secretariat@incb.org 
 
 El texto del presente informe también se puede consultar en el sitio web de la 
Junta (www.incb.org). 
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